|
█武汉大学科教管理与评价研究中心 陈立新 张琳 黄颖
第13个技术领域是有机化学。2021年,欧洲专利局在该领域共授权专利3547项(增长率为-17%),占总授权量的3.3%,是专利数量第17多的领域。
2021年,美国在该领域获得专利权1189项,占该领域专利授权总量的33.5%。中国在该领域做出专利发明155项,获得专利权143项。日本和韩国获得的专利权数量分别为324和213项。
表28.13-1 2021年各国有机化学领域的在欧专利发明和专利权数量
国家 和地区 | 发明 数量 | 专利权 数量 | 净流失 数量 | 专利 流失率 | 发明 份额 | 专利权 份额 | 份额 流失量 | |
1 | 美国 | 1271 | 1189 | 82 | 6.5% | 35.8% | 33.5% | 2.3% |
2 | 德国 | 469 | 446 | 23 | 4.9% | 13.2% | 12.6% | 0.6% |
3 | 日本 | 328 | 324 | 4 | 1.2% | 9.2% | 9.1% | 0.1% |
4 | 法国 | 181 | 168 | 13 | 7.2% | 5.1% | 4.7% | 0.4% |
5 | 中国 | 155 | 143 | 12 | 7.7% | 4.4% | 4.0% | 0.3% |
6 | 韩国 | 202 | 213 | -11 | -5.4% | 5.7% | 6.0% | -0.3% |
7 | 英国 | 171 | 145 | 26 | 15.2% | 4.8% | 4.1% | 0.7% |
8 | 意大利 | 73 | 58 | 15 | 20.5% | 2.1% | 1.6% | 0.4% |
9 | 荷兰 | 68 | 118 | -50 | -73.5% | 1.9% | 3.3% | -1.4% |
10 | 瑞士 | 152 | 244 | -92 | -60.5% | 4.3% | 6.9% | -2.6% |
11 | 瑞典 | 43 | 33 | 10 | 23.3% | 1.2% | 0.9% | 0.3% |
12 | 加拿大 | 33 | 27 | 6 | 18.2% | 0.9% | 0.8% | 0.2% |
13 | 以色列 | 19 | 17 | 2 | 10.5% | 0.5% | 0.5% | 0.1% |
14 | 印度 | 66 | 51 | 15 | 22.7% | 1.9% | 1.4% | 0.4% |
15 | 其他 | 316 | 371 | -55 | -17.4% | 8.9% | 10.5% | -1.6% |
小计 | 3547 | 3547 | 0 | 0% | 100% | 100% | 0% |
图28.13-1 2021年各国有机化学领域的在欧专利发明和专利权数量对比
2021年,在有机化学领域上获得欧洲专利授权最多的机构是巴斯夫公司、罗氏制药有限公司、LG化学公司。
表28.13-2 2021年有机化学领域在欧专利授权前10机构
机构名称 | 国家 | 机构英文名称 | 2021 | |
1 | 巴斯夫公司 | 德国 | BASF SE | 76 |
2 | 罗氏制药有限公司 | 瑞士 | HOFFMANN LA ROCHE | 69 |
3 | LG化学公司 | 韩国 | LG CHEMICAL LTD | 67 |
4 | 默克专利有限公司 | 德国 | MERCK PATENT GMBH | 50 |
5 | 默沙东公司 | 美国 | MERCK SHARP & DOHME | 40 |
6 | 先正达参股股份有限公司 | 瑞士 | SYNGENTA PARTICIPATIONS AG | 38 |
7 | 百时美施贵宝公司 | 美国 | SQUIBB BRISTOL MYERS CO | 33 |
8 | 诺华公司 | 瑞士 | NOVARTIS AG | 33 |
9 | 再生元制药公司 | 美国 | REGENERON PHARMA | 30 |
10 | 科思创聚合物有限公司 | 德国 | COVESTRO DEUTSCHLAND AG | 21 |
注:本表数据按照第一权利人进行统计。
图28.13-2 2021年有机化学领域在欧专利授权前10机构
感谢大连理工大学刘则渊教授、河南师范大学梁立明教授、科技部中国科学技术发展战略研究院武夷山研究员、大连理工大学丁堃教授、大连理工大学杨中楷教授对本报告的大力支持与帮助。同时,向以不同形式对本报告提出意见和建议的专家学者们表示诚挚的感谢。
如需要中美欧日韩五局及PCT专利数据、专利报告,以及咨询相关专利问题请添加微信号。
附表 2021年该领域欧洲授权专利
PATENT NO. | TITLE | ASSIGNEE |
EP1587540 | IDENTIFICATION AND ENGINEERING OF ANTIBODIES WITH VARIANT Fc REGIONS AND METHODS OF USING SAME | MACROGENICS INC |
EP1613613 | CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS | ANORMED INC |
EP1915394 | HIGH-LEVEL EXPRESSION OF RECOMBINANT ANTIBODY IN A MAMMALIAN HOST CELL | LONZA BIOLOGICS PLC |
EP1951885 | IN SITU FRUCTOOLIGOSACCHARIDE PRODUCTION AND SUCROSE REDUCTION | GENENCOR INT |
EP2019815 | INTEGRATED SYSTEM AND METHOD FOR PRODUCTION AND VAPORIZATION OF LIQUID HYDROCARBON FUELS FOR COMBUSTION | LPP COMB LLC |
EP2035526 | USE IN OLEDS OF TRANSITION METAL CARBENE COMPLEXES THAT CONTAIN NO CYCLOMETALLATION VIA NON-CARBENES | BASF SE |
EP2080749 | METHOD FOR SYNTHESIS OF CHEMICAL INDUSTRIAL RAW MATERIAL OR FUEL COMPOSITION | SANGI KK |
EP2141152 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL CHEMICAL CO |
EP2155351 | PRESSURE-ENHANCED EXTRACTION AND PARTITIONING OF MOLECULES | PRESSURE BIOSCIENCES INC |
EP2165377 | ORGANIC LIGHT-EMITTING DIODES CONTAINING CARBENE TRANSITION METAL COMPLEX EMITTERS AND AT LEAST ONE COMPOUND SELECTED FROM DISILYLCARBAZOLES, DISILYLDIBENZOFURANS, DISILYLDIBENZOTHIOPHENES, DISILYLDIBENZOPHOSPHOLES, DISILYLDIBENZOTHIOPHENE S-OXIDES AND DISILYLDIBENZOTHIOPHENE S,S-DIOXIDES | BASF SE |
EP2217625 | RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS | NEOGENIX ONCOLOGY INC |
EP2257612 | CATALYTIC PYROLYSIS OF SOLID BIOMASS AND RELATED BIOFUELS, AROMATIC, AND OLEFIN COMPOUNDS | UNIV MASSACHUSETTS |
EP2259360 | Organic light emitting devices having carrier transporting layers comprising metal complexes | UNIV PRINCETON |
EP2294043 | METHOD OF PREPARING GLYCEROL ALKYL ETHERS | GTBE COMPANY NV |
EP2307381 | NEW DRUGS FOR INHIBITING AGGREGATION OF PROTEINS INVOLVED IN DISEASES LINKED TO PROTEIN AGGREGATION AND/OR NEURODEGENERATIVE DISEASES | UNIV MUENCHEN L MAXIMILIANS |
EP2314692 | Methods and compositions for enhancing the efficacy and specificity of RNAi | UNIV MASSACHUSETTS |
EP2318336 | HIGH ENERGY REDUCTION IN A PROPANE DEHYDROGENATION UNIT BY UTILIZING A HIGH PRESSURE PRODUCT SPLITTER COLUMN | LUMMUS TECHNOLOGY INC |
EP2322930 | Sequences for detection and identification of methicillin-resistant Staphylococcus Aureus (MRSA) of MREJ type xiv | GENEOHM SCIENCES INC |
EP2325643 | Sequences for detection and identification of methicillin-resistant staphylococcus aureus (MRSA) of MREJ type XV | GENEOHM SCIENCES INC |
EP2325647 | SEQUENCES FOR DETECTION AND IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) OF MREJ TYPE XX | GENEOHM SCIENCES INC |
EP2331257 | CATALYST AND PROCESS USING THE CATALYST | MEXICHEM AMANCO HOLDING SA |
EP2334427 | FLUORINATION CATALYST AND PROCESS TO PRODUCE FLUORINATED HYDROCARBONS | MEXICHEM AMANCO HOLDING SA |
EP2344433 | AZEOTROPE-LIKE COMPOSITIONS OF 1,1,1,2,3-PENTACHLOROPROPANE AND HYDROGEN FLUORIDE | HONEYWELL INT INC |
EP2345668 | Sclerostin epitopes | UCB PHARMA SA |
EP2357250 | Production of polypeptides | WYETH RES IRELAND LTD |
EP2394732 | METHOD FOR REGENERATING FILTER | NIPPON CATALYTIC CHEM IND |
EP2403964 | METHODS AND PRODUCTS FOR IN VIVO ENZYME PROFILING | MASSACHUSETTS INST TECHNOLOGY |
EP2405940 | ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS | HEALTH PROT AGENCY |
EP2407784 | METHOD FOR DETECTING MUSCLE DEGENERATIVE DISEASES, AND METHOD FOR DETERMINING THERAPEUTIC EFFICACY ON THE DISEASES | OSAKA BIOSCIENCE INST |
EP2408807 | METHOD FOR THERAPEUTIC USE | AC IMMUNE SA |
EP2414328 | DIHYDROOROTATE DEHYDROGENASE INHIBITORS | MERCK SERONO SA |
EP2423188 | Agricultural/horticultural insecticide and method for using the same | MITSUI CHEMICALS AGRO INC |
EP2427775 | PEPTIDE LIGANDS OF SOMATOSTATIN RECEPTORS | BCN PEPTIDES SA |
EP2445343 | PRODRUGS OF NH-ACIDIC COMPOUNDS | ALKERMES INC |
EP2445924 | CAPTURE PURIFICATION PROCESSES FOR PROTEINS EXPRESSED IN A NON-MAMMALIAN SYSTEM | AMGEN INC |
EP2448968 | N-TERMINAL TRUNCATED AMYLOID BETA PROTOFIBRILS/ OLIGOMERS FOR USE IN THERAPEUTIC AND DIAGNOSTIC METHODS FOR ALZHEIMER'S DISEASE | BIOARCTIC NEUROSCIENCE AB |
EP2449057 | METHOD FOR CONVERTING LIGNOCELLULOSIC MATERIALS INTO USEFUL CHEMICALS | CIRCA GROUP PTY LTD |
EP2450341 | DEVICE FOR CRYSTALLIZING ACRYLIC ACID AND METHOD FOR CRYSTALLIZING ACRYLIC ACID USING SAME | NIPPON CATALYTIC CHEM IND |
EP2459555 | PROCESSES FOR CRYSTALLIZATION OF RIVAROXABAN | KRKA D D NOVO MESTO |
EP2491056 | VHH FOR APPLICATION IN TISSUE REPAIR, ORGAN REGENERATION, ORGAN REPLACEMENT AND TISSUE ENGINEERING | UNIV TWENTE |
EP2493849 | SWITCHABLE HYDROPHILICITY SOLVENTS AND METHODS OF USE THEREOF | UNIV KINGSTON |
EP2494008 | SYSTEMS AND PROCESSES FOR CATALYTIC PYROLYSIS OF BIOMASS AND HYDROCARBONACEOUS MATERIALS FOR PRODUCTION OF AROMATICS WITH OPTIONAL OLEFIN RECYCLE, AND CATALYSTS HAVING SELECTED PARTICLE SIZE FOR CATALYTIC PYROLYSIS | UNIV MASSACHUSETTS |
EP2496726 | METHOD FOR HANDLING AQUEOUS METHANESULFONIC ACID SOLUTIONS | BASF SE |
EP2504308 | METHOD FOR PRODUCING (METH)ACRYLATES FROM C17 ALCOHOL MIXTURES | BASF SE |
EP2506877 | THERAPIES FOR PREVENTING OR SUPPRESSING CLOSTRIDIUM DIFFICILE INFECTION | HEALTH PROT AGENCY |
EP2513022 | AZEOTROPE-LIKE COMPOSITIONS OF CIS-1,1,1,4,4,4-HEXAFLUORO-2-BUTENE | HONEYWELL INT INC |
EP2516557 | FIRE RESISTANT GLAZINGS | PILKINGTON GROUP LTD |
EP2531586 | LUBRICATING OIL ADDITIVE AND LUBRICATING OIL COMPOSITION CONTAINING SAME | CHEVRON ORONITE CO |
EP2538222 | Biochemical markers for CVD risk assessment | NORDIC BIOSCIENCE IMAGING AS |
EP2539707 | ARTIFICIAL MYCOLIC ACID MEMBRANES | UNIV WASHINGTON |
EP2539715 | METHODS FOR PREPARING PEG-HEMOGLOBIN CONJUGATES USING REDUCED REACTANT RATIOS | SANGART INC |
EP2542580 | ANTIBODIES AGAINST PHOSPHORYLCHOLINE IN COMBINATION THERAPY WITH BIOLOGIC AGENTS | MEDIRISTA BIOTECHNOLOGIES AB |
EP2552878 | SEPARATION OF CLOSE BOILING COMPOUNDS BY ADDITION OF A THIRD COMPOUND | HONEYWELL INT INC |
EP2556081 | A CYTOSINE ANALOGUE, A METHOD OF PREPARATION OF A CYTOSINE ANALOGUE, A DNA METHYLTRANSFERASE 1 INHIBITOR, A METHOD FOR DNA METHYLATION INHIBITION, THE USE OF THE ANALOGUE IN THE TREATMENT OF DISEASES ASSOCIATED WITH DEVIATIONS FROM NORMAL DNA METHYLATION | INST CHEMII BIOORG PAN |
EP2560986 | GENETICALLY MODIFIED SENDAI VIRUS FOR TREATMENT OF TUMOURS | UNIV EBERHARD KARLS |
EP2563817 | FLUORESCENT FUSION POLYPEPTIDES AND METHODS OF USE | STC UNM |
EP2563911 | INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ALANYL TRNA SYNTHETASES | ATYR PHARMA INC |
EP2564245 | INTRAOCULAR LENSES WITH COMBINATIONS OF UV ABSORBERS AND BLUE LIGHT CHROMOPHORES | NOVARTIS AG |
EP2565175 | Catalytic process for the production of 1,2-propanediol from crude glycerol stream | ARISTOTLE UNIVERSITY OF THESSALONIKI RES COMMITTEE |
EP2566965 | ANTAGONISTS OF SEMA3E/PLEXIND1 INTERACTION AS ANTI-CANCER AGENTS | NETRIS PHARMA |
EP2570471 | Preparation and use of aminoalkylphosphonic acid dialkyl ester compounds in a lubricant for antiwear and/or friction reduction | AFTON CHEMICAL CORP |
EP2571898 | HIGH-AFFINITY FULLY FUNCTIONAL SOLUBLE SINGLE-DOMAIN HUMAN CD4, ANTIBODIES, AND RELATED FUSION PROTEINS | US HEALTH |
EP2584409 | RESIST COMPOSITION, RESIST PATTERN FORMATION METHOD, POLYMERIC COMPOUND, AND COMPOUND | TOKYO OHKA KOGYO CO LTD |
EP2588502 | POLYMERIZATION PROCESS WITH IN-SITU INITIATOR FORMATION | AKZO NOBEL CHEMICALS INT BV |
EP2591001 | AGONISTIC ANTIBODY TO CD27 | BIONOVION HOLDING B V |
EP2591778 | Polyunsaturated fatty acid compositions obtainable by a simulated moving bed chromatographic separation process | BASF PHARMA CALLANISH LTD |
EP2592062 | Production of paraffin fuels using renewable materials by a continuous hydrogen-treatment method including a step of pre-treatment with hydrogen | IFP ENERGIES NOUVELLES |
EP2598470 | FORMULATIONS | SYNGENTA LTD |
EP2613375 | ORGANIC SEMICONDUCTOR PARTICULATE MATERIAL, ORGANIC SEMICONDUCTOR THIN-FILM, DISPERSION LIQUID FOR FORMING ORGANIC SEMICONDUCTOR FILM, METHOD FOR PRODUCING ORGANIC SEMICONDUCTOR THIN-FILM, AND ORGANIC THIN-FILM TRANSISTOR | UNIV SHINSHU |
EP2621957 | CHIMERIC SPIDER SILK AND USES THEREOF | UNIV NOTRE DAME DU LAC |
EP2626370 | Immunogenic compositions containing Escherichia coli H7 flagella and methods of use thereof | UNIV EDINBURGH |
EP2627168 | ALS INHIBITOR HERBICIDE TOLERANT BETA VULGARIS MUTANTS | BAYER IP GMBH |
EP2627629 | METHOD FOR PRODUCING ISOCYANATES | BASF SE |
EP2627639 | N-OPTIONALLY SUBSTITUTED ARYL-2-OLIGOMER-3-ALKOXYPROPIONAMIDES | NEKTAR THERAPEUTICS |
EP2633018 | SULFONATES FROM NATURAL OIL METATHESIS | STEPAN CO |
EP2636661 | Method for converting a heavy load using a catalytic cracking unit and a step for selective hydrogenation of gasoline from catalytic cracking | IFP ENERGIES NOUVELLES |
EP2637687 | VACCINES COMPRISING NON-SPECIFIC NUCLEOSIDE HYDROLASE AND STEROL 24-C-METHYLTRANSFERASE (SMT) POLYPEPTIDES FOR THE TREATMENT AND DIAGNOSIS OF LEISHMANIASIS | INFECTIOUS DISEASE RES INST |
EP2638064 | CELL CULTURE MEDIUM AND PROCESS FOR PROTEIN EXPRESSION, SAID MEDIUM AND PROCESS COMPRISING A PAM INHIBITOR | SANDOZ AG |
EP2640732 | AGENTS AND METHODS FOR VISUALISING ANALYTES | BIOPERCEPT AB |
EP2643345 | IMMUNOGENIC PEPTIDES FOR USE IN THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES, IMMUNE RESPONSES TO ALLOFACTORS, ALLERGIC DISEASES, TUMORS, GRAFT REJECTION AND IMMUNE RESPONSES AGAINST VIRAL VECTORS USED FOR GENE THERAPY OR GENE VACCINATION | IMNATE SARL |
EP2649095 | MIMETIC PEPTIDES DERIVED FROM COLLAGEN TYPE IV AND THEIR USE FOR TREATING ANGIOGENESIS- AND LYMPHANGIOGENESIS- DEPENDENT DISEASES | POPEL ALEKSANDER S |
EP2653506 | METHOD FOR STORING LEUCO CHROMOGEN-CONTAINING AQUEOUS SOLUTION | KYOWA MEDEX CO LTD |
EP2654803 | RADIOLABLED HER2 BINDING PEPTIDES | GEN ELECTRIC |
EP2658837 | GLYCERIDES AND FATTY ACID MIXTURES AND METHODS OF USING SAME | NALCO CO |
EP2670432 | IMMUNOGENIC BORDETELLA BRONCHISEPTICA COMPOSITIONS | ZOETIS LLC |
EP2670525 | DEVICE AND METHOD FOR THE GENERATION OF MOLECULAR MICROARRAYS | UNIV ALBERT LUDWIGS FREIBURG |
EP2670909 | METHOD FOR PRODUCTION OF DIMETHYL SULFONE BY OXIDATION OF A METHANOL BASED MEDIUM OBTAINED FROM A SULFATE CELLULOSE PROCESS | STORA ENSO OYJ |
EP2673262 | PROCESSES FOR PREPARING QUINOLINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS | EXELIXIS INC |
EP2674418 | BISCARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO |
EP2686000 | MULTIPLEXED DETECTION WITH ISOTOPE-CODED REPORTERS | MASSACHUSETTS INST TECHNOLOGY |
EP2694532 | AUREOBASIDIUM DERIVATIVES AND METHODS OF SYNTHESIS | AUREOGEN BIOSCIENCES INC |
EP2697385 | FERMENTATION PROCESS | GLAXOSMITHKLINE BIOLOG SA |
EP2698835 | Compound with branching alkyl-chains, method for preparing the same, and use thereof in photoelectric device | UNIV BEIJING |
EP2702122 | GREASE COMPOSITIONS COMPRISING ESTOLIDE BASE OILS | BIOSYNTHETIC TECHNOLOGIES LLC |
EP2707353 | CATALYTIC CARBONYLATION CATALYSTS AND METHODS | NOVOMER INC |
EP2710033 | HUMAN IMMUNODEFICIENCY VIRUS NEUTRALIZING ANTIBODIES AND METHODS OF USE THEREOF | UNIV ROCKEFELLER |
EP2710114 | HIGH-PURITY PRODUCTION OF MULTI-SUBUNIT PROTEINS SUCH AS ANTIBODIES IN TRANSFORMED MICROBES SUCH AS PICHIA PASTORIS | ALDERBIO HOLDINGS LLC |
EP2714625 | PRODUCTION OF CHEMICALS AND FUELS FROM BIOMASS | VIRENT INC |
EP2714735 | ANTIBODIES SPECIFIC FOR TGF-BETA | XOMA TECHNOLOGY LTD |
EP2719451 | FLUIDIZED BED REACTOR AND METHOD FOR CONVERTING OXYGENATES TO OLEFINS | FUDE BEIJING CHEMICAL & INDUSTRY CO LTD |
EP2725011 | NOVEL COMPOUND | TOKYO OHKA KOGYO CO LTD |
EP2727982 | High- and low- viscosity estolide base oils and lubricants | BIOSYNTHETIC TECHNOLOGIES LLC |
EP2729170 | ANTIBODY VARIANTS AND USES THEREOF | GENMAB BV |
EP2739591 | PROCESSES FOR MAKING CX-CY OLEFINS FROM C5 AND C6 PARAFFINS | UOP LLC |
EP2742019 | N1-CYCLIC AMINE-N5-SUBSTITUTED PHENYL BIGUANIDE DERIVATIVES, METHODS OF PREPARING THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | HANALL BIOPHARMA CO LTD |
EP2742047 | ANTIBACTERIAL PIPERIDINYL SUBSTITUTED 3,4-DIHYDRO-1H-[1,8]NAPHTHYRIDINONES | JANSSEN R & D IRELAND |
EP2748179 | PROTEIN PURIFICATION BY ANION EXCHANGE CHROMATOGRAPHY | BAXTER INT |
EP2751057 | PROCESS FOR PREPARING 2-CHLORO-3,3,3-TRIFLUOROPROPENE | HONEYWELL INT INC |
EP2751095 | NOVEL BENZODIAZEPINONES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR FUNCTIONS AND NEUROLOGICAL USES THEREOF | SANFORD BURNHAM MED RES INST |
EP2751128 | CELL-PENETRATING PEPTIDES HAVING A CENTRAL HYDROPHOBIC DOMAIN | MEDICAL RES COUNCIL |
EP2752240 | CATALYST FOR OXYGENATE SYNTHESIS AND METHOD FOR MANUFACTURING SAME, DEVICE FOR MANUFACTURING OXYGENATE, AND METHOD FOR MANUFACTURING OXYGENATE | SEKISUI CHEMICAL CO LTD |
EP2753356 | ANTI-SIGLEC-15 ANTIBODIES AND USES THEREOF | MEDIMMUNE LTD |
EP2756883 | METHOD FOR PREPARING 2,3,3,3-TETRAFLUOROPROPENE | SINOCHEM LANTIAN CO LTD |
EP2757883 | TRIAZOLOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS | MERCK SHARP & DOHME |
EP2763958 | PHOTOALIGNING MATERIALS | ROLIC AG |
EP2763963 | ENANTIONSELECTIVE PROCESSES TO INSECTICIDAL 3-ARYL-3-TRIFLUOROMETHYL-SUBSTITUTED PYRROLIDINES | SYNGENTA PARTICIPATIONS AG |
EP2764011 | ADENOVIRAL VECTOR-BASED RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE | GENVEC INC |
EP2766329 | PROCESS FOR PRODUCING 2,3,3,3-TETRAFLUOROPROPENE | HONEYWELL INT INC |
EP2766331 | PROCESS FOR PRODUCING 2,3,3,3-TETRAFLUOROPROPENE | BEKTESEVIC SELMA |
EP2771359 | TDP-43 SPECIFIC BINDING MOLECULES | BIOGEN IDEC INTERNAT NEUROSCIENCE GMBH |
EP2771737 | OPTICAL MEMBER, DISPLAY DEVICE HAVING THE SAME AND METHOD OF FABRICATING THE SAME | LG INNOTEK CO LTD |
EP2773672 | METHOD FOR PREPARING PHYSIOLOGICALLY ACTIVE POLYPEPTIDE COMPLEX | HANMI SCIENCE CO LTD |
EP2774969 | Process for converting bio-oil | UPM KYMMENE CORP |
EP2780312 | PROCESS SCHEME TO IMPROVE DIVALENT METAL SALTS REMOVAL FROM MONO ETHYLENE GLYCOL (MEG) | CAMERON INT CORP |
EP2780434 | DEVICE AND METHOD FOR UPGRADING PETROLEUM FEEDSTOCKS USING AN ALKALI METAL CONDUCTIVE MEMBRANE | CERAMATEC INC |
EP2791094 | A PROCESS FOR MANUFACTURING HALOARYL COMPOUNDS FROM MIXTURES OF ISOMERS OF DIHALODIARYLSULFONES | SOLVAY SPECIALTY POLYMERS USA |
EP2794858 | COMPOSITIONS AND METHODS INCLUDING B LYMPHOCYTE CELL LINE EXPRESSING MEMBRANE IMMUNOGLOBULIN DIFFERENT FROM SECRETED IMMUNOGLOBULIN | ELWHA LLC |
EP2797862 | OLEFIN OLIGOMERIZATION METHODS | CHEVRON PHILLIPS CHEMICAL CO |
EP2798059 | PROCESSES USING VLPS WITH CAPSIDS RESISTANT TO HYDROLASES | APSE LLC |
EP2799088 | Factor VIII polymer conjugates | BAXTER INT |
EP2808321 | METHOD FOR PRODUCING POLYTHIOL COMPOUND FOR OPTICAL MATERIALS AND COMPOSITION COMPRISING SAME FOR OPTICAL MATERIALS | KOC SOLUTION CO LTD |
EP2809146 | PLANT TRANSACTIVATION INTERACTION MOTIFS AND USES THEREOF | DOW AGROSCIENCES LLC |
EP2810662 | Factor VIII polymer conjugates | BAXTER INT |
EP2812309 | AN APPARATUS FOR CONTINUOUS SEPARATION OF VALINE AND A METHOD FOR CONTINUOUS SEPARATION OF VALINE USING THE SAME | CJ CHEILJEDANG CORP |
EP2812324 | HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF | SUNOVION PHARMACEUTICALS INC |
EP2812349 | METHODS FOR THE CHARACTERISATION OF INTERACTION SITES ON TARGET PROTEINS | PHYLOGICA LTD |
EP2813512 | PEPTIDE-COMPOUND CYCLIZATION METHOD | CHUGAI PHARMACEUTICAL CO LTD |
EP2814795 | PROCESS FOR THE PRODUCTION OF HCFC-1233zd | HONEYWELL INT INC |
EP2816053 | BASE-PROTECTED OLIGONUCLEOTIDE | AJINOMOTO KK |
EP2821415 | ANTI-LIPOARABINOMANNAN ANTIBODY AND IMMUNOASSAY FOR MYCOBACTERIOSIS USING SAID ANTIBODY | OTSUKA PHARMA CO LTD |
EP2821505 | Nucleotide-specific recognition sequences for designer tal effectors | BROAD INST INC |
EP2824105 | Indolopyridines as Eg5 kinesin modulators | 4SC AG |
EP2825041 | SOLID FORMS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR | CELGENE AVILOMICS RES INC |
EP2826079 | ELECTRONIC DEVICES | MERCK PATENT GMBH |
EP2829543 | Silated core polysulfides, their preparation and use in filled elastomer compositions | MOMENTIVE PERFORMANCE MAT INC |
EP2831104 | BIOMARKERS FOR USE IN INTEGRIN THERAPY APPLICATIONS | BIOGEN IDEC INC |
EP2834375 | SEQUENCES FOR DETECTION AND IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) OF MREJ TYPE XXI | GENEOHM SCIENCES CANADA INC |
EP2836475 | PURIFICATION OF BIO-BASED ACRYLIC ACID TO CRUDE AND GLACIAL ACRYLIC ACID | PROCTER & GAMBLE |
EP2839005 | MIRNA MODULATORS OF THERMOGENESIS | APTAMIR THERAPEUTICS INC |
EP2841484 | CONJUGATED POLYMERS | MERCK PATENT GMBH |
EP2841584 | A METHOD OF PRODUCTION OF 2,4-DIHYDROXYBUTYRIC ACID | ADISSEO FRANCE SAS |
EP2844288 | BINDING PROTEINS HAVING TETHERED LIGHT CHAINS | JANSSEN BIOTECH INC |
EP2844303 | LIPIDS THAT INCREASE INSULIN SENSITIVITY AND METHODS OF USING THE SAME | BETH ISRAEL HOSPITAL |
EP2844634 | NEW INTERMEDIATE COMPOUND FOR PREPARING VITAMIN B6 | DSM IP ASSETS BV |
EP2844654 | IMPROVED PROCESS FOR PREPARING RIVAROXABAN USING NOVEL INTERMEDIATES | SYMED LABS LTD |
EP2845905 | Production of oligosaccharides | JENNEWEIN BIOTECHNOLOGIE GMBH |
EP2847166 | PHENACENE COMPOUNDS FOR ORGANIC ELECTRONICS | BASF SE |
EP2852296 | HIGH-PURITY STEVIOL GLYCOSIDES | PURECIRCLE SDN BHD |
EP2852565 | PROCESS FOR PRODUCING CUMENE | BADGER LICENSING LLC |
EP2852589 | TRIAZOLES AS KV3 INHIBITORS | AUTIFONY THERAPEUTICS LTD |
EP2852603 | D-AMINO ACID COMPOUNDS FOR LIVER DISEASE | IDENIX PHARMACEUTICALS INC |
EP2855676 | COMPOSITIONS AND METHODS FOR PEPTIDE EXPRESSION AND PURIFICATION USING A TYPE lll SECRETION SYSTEM | UNIV UTAH RES FOUND |
EP2857419 | ANTIGEN-BINDING MOLECULE FOR ELIMINATING AGGREGATED ANTIGENS | CHUGAI PHARMACEUTICAL CO LTD |
EP2857830 | FLUORESCENT PROBE FOR HIGH-SENSITIVITY PANCREATIC FLUID DETECTION, AND METHOD FOR DETECTING PANCREATIC FLUID | UNIV TOKYO |
EP2858136 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT | IDEMITSU KOSAN CO |
EP2859018 | CANINIZED ANTI-NGF ANTIBODIES AND METHODS THEREOF | ZOETIS LLC |
EP2860173 | METHOD FOR PRODUCING AZIDE COMPOUND, AND METHOD FOR PRODUCING 1H-TETRAZOLE DERIVATIVE | NIPPON SODA CO |
EP2860178 | P2X3 receptor antagonists for treatment of pain | MERCK SHARP & DOHME |
EP2861241 | IMPROVED CD31 PEPTIDES | INST NAT SANTé ET DE LA RECH MéDICALE INSERM |
EP2861246 | COMPOSITIONS AND METHODS OF INHIBITING MASP-1 AND/OR MASP-2 AND/OR MASP-3 FOR THE TREATMENT OF VARIOUS DISEASES AND DISORDERS | OMEROS CORP |
EP2861742 | PLANTS HAVING INCREASED TOLERANCE TO HERBICIDES | BASF SE |
EP2864280 | SUPPORTED CATALYSTS FOR PRODUCING ALDOL CONDENSATION PRODUCTS | SYMRISE AG |
EP2864283 | PROCESS FOR THE PRODUCTION OF ACETIC ACID | LYONDELLBASELL ACETYLS LLC |
EP2864312 | NOVEL ANTI-CANCER THIOPHENE COMPOUNDS | UNIV LEUVEN KATH |
EP2864342 | 1,1 '-[[(SUBSTITUTED ALKYL)IMINO]BIS(ALKYLENE)]BIS-FERROCENES AND THEIR USE IN I ELECTROCHEMICAL ASSAYS BY LABELLING SUBSTRATES OF INTEREST | ATLAS GENETICS LTD |
EP2865446 | Process for producing optically active secondary alcohol | KANTO KAGAKU |
EP2865669 | NOVEL REBAMIPIDE PRODRUG, METHOD FOR PRODUCING SAME, AND USAGE THEREOF | SAMJIN PHARM CO LTD |
EP2867359 | METHODS FOR INACTIVATING VIRUSES DURING A PROTEIN PURIFICATION PROCESS | EMD MILLIPORE CORP |
EP2869841 | NOVEL PRIME-BOOSTING REGIMENS INVOLVING IMMUNOGENIC POLYPEPTIDES ENCODED BY POLYNUCLEOTIDES | GLAXOSMITHKLINE BIOLOG SA |
EP2870167 | STABLE LIGAND MIXTURES AND PROCESSES FOR MAKING SAME | INVISTA TECHNOLOGIES SRL |
EP2877189 | ENHANCED RECONSTITUTION AND AUTORECONSTITUTION OF THE HEMATOPOIETIC COMPARTMENT | TAIGA BIOTECHNOLOGIES INC |
EP2877488 | NEW MODULAR BASE-SPECIFIC NUCLEIC ACID BINDING DOMAINS FROM BURKHOLDERIA RHIZOXINICA PROTEINS | CELLECTIS SA |
EP2880012 | COMPOUNDS | PHOTOCURE ASA |
EP2882727 | IMMUNOMODULATORY COMPOUNDS | UNIV STRATHCLYDE |
EP2882765 | LIGHT EMITTING COMPOUNDS | UNIV NORTHUMBRIA NEWCASTLE |
EP2885288 | 1,4-DISUBSTITUTED PYRIDAZINE ANALOGS AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS | NOVARTIS AG |
EP2887804 | CYCLOALKANYL[B]INDOLES USEFUL AS GLP-1 MODULATORS | DARTMOUTH COLLEGE |
EP2889319 | Bio-polyol composition and bio-polyurethane foam material | |
EP2892916 | METHODS FOR PRODUCING HIGH TOUGHNESS SILK FIBRES | AMSILK GMBH |
EP2899799 | PHOTOELECTRIC CONVERSION ELEMENT AND METHOD FOR MANUFACTURING SAME | KONICA MINOLTA INC |
EP2900822 | OLIGOMERS WITH IMPROVED OFF-TARGET PROFILE | MIRRX THERAPEUTICS |
EP2901157 | METHOD OF DETECTION OF SCHMALLENBERG VIRUS (SBV) AND KIT | IDEXX LAB INC |
EP2903614 | NOVEL COMPOUNDS, THEIR SYNTHESIS AND THEIR USES | SPHAERA PHARMA PTE LTD |
EP2903953 | PROCESS FOR THE PRODUCTION OF HIGH-PURITY ISOBUTENE THROUGH THE CRACKING OF MTBE OR ETBE AND INTEGRATED PROCESS FOR THE PRODUCTION OF THE RELATIVE ETHER | SAIPEM SPA |
EP2906601 | THE DETECTION OF FREE AND PROTEIN-BOUND NON-HUMAN GAL-ALPHA-(1-3)-GAL EPITOPE | NAT UNIV IRELAND |
EP2907803 | FLUORANTHENE DERIVATIVE, LUMINESCENT ELEMENT MATERIAL CONTAINING SAME, AND LUMINESCENT ELEMENT | TORAY INDUSTRIES |
EP2909222 | 2',4'-BRIDGED NUCLEOSIDES FOR HCV INFECTION | IDENIX PHARMACEUTICALS INC |
EP2909307 | COMPOSITIONS AND METHODS RELATING TO A MUTANT CLOSTRIDIUM DIFFICILE TOXIN | PFIZER |
EP2910540 | NOVEL RUTHENIUM COMPLEX AND METHOD FOR PREPARING METHANOL AND DIOL | SHANGHAI INST ORGANIC CHEM |
EP2912018 | PROCESS AND CATALYST FOR THE PRODUCTION OF PYRIDINE AND ALKYL DERIVATIVES THEREOF | GRACE W R & CO |
EP2912019 | HETEROARYL INHIBITORS OF PDE4 | TETRA DISCOVERY PARTNERS LLC |
EP2912186 | PLATELET TARGETED TREATMENT | PLATELET TARGETED THERAPEUTICS LLC |
EP2913104 | Catalyst for oxidation or ammoxidation, and process for producing the same | ASAHI KASEI CHEMICALS CORP |
EP2913106 | CATALYST FOR DEHYDRATION OF GLYCERIN, METHOD FOR PREPARING SAME, AND METHOD FOR PREPARING ACROLEIN | LG CHEMICAL LTD |
EP2913321 | Novel cannabigerol derivatives | VIVACELL BIOTECHNOLOGY ESPANA S L |
EP2914570 | REMOVAL OF ALDEHYDES IN ACETIC ACID PRODUCTION | LYONDELLBASELL ACETYLS LLC |
EP2914616 | PEPTIDES THAT BIND TO AMINO-TERMINAL TRUNCATED AMYLOID-BETA-PEPTIDE AND USE OF SAID PEPTIDES | FORSCHUNGSZENTRUM JüLICH GMBH |
EP2914627 | ANTI-CD40 ANTIBODIES AND METHODS OF USE | APEXIGEN INC |
EP2914630 | NOVEL ANTIGEN BINDING PROTEINS AND THEIR USE AS ADDRESSING PRODUCT FOR THE TREATMENT OF CANCER | PIERRE FABRE MéDICAMENT |
EP2918422 | Reducing agent, ink-jet recording apparatus, discharge printing method, image forming method, reducing agent stabilizing method, and reducing agent enhancing method | BROTHER IND LTD |
EP2919779 | CANNABINOID RECEPTOR MEDIATING COMPOUNDS | US HEALTH |
EP2920188 | PROCESS FOR THE PREPARATION OF LIQUID TIN(II) ALKOXIDES | CHIANG MAI UNIVERSITY |
EP2920196 | TETHERING CYSTEINE RESIDUES USING CYCLIC DISULFIDES | UNIV BRANDEIS |
EP2920197 | PROLINE-LOCKED STAPLED PEPTIDES AND USES THEREOF | HARVARD COLLEGE |
EP2922812 | PROCESS FOR PREPARING A SALT OF A SULFURIZED ALKYL-SUBSTITUTED HYDROXYAROMATIC COMPOSITION | CHEVRON ORONITE CO |
EP2922816 | DTPA DI-ETHYL ESTERS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | UNIV NORTH CAROLINA |
EP2922859 | PHOSPHONUCLEOSIDES USEFUL IN THE TREATMENT OF VIRAL DISORDERS | UNIV CORK |
EP2925755 | NEUROPROTECTIVE AGENTS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | UNIV WAYNE STATE |
EP2925771 | A PROCESS FOR THE PREPARATION OF SOLOMONAMIDE ANALOGUES | COUNCIL SCIENT IND RES |
EP2925784 | BINDING PROTEINS COMPRISING AT LEAST TWO REPEAT DOMAINS AGAINST HER2 | MOLECULAR PARTNERS AG |
EP2927321 | CH3 DOMAIN VARIANT PAIR INDUCING FORMATION OF HETERODIMER OF HEAVY CHAIN CONSTANT REGION OF ANTIBODY AT HIGH EFFICIENCY, METHOD FOR PREPARING SAME, AND USE THEREOF | AJOU UNIV IND ACAD COOP FOUND |
EP2927981 | Organic photoelectronic device and image sensor | SAMSUNG ELECTRONICS CO LTD |
EP2928484 | COMPOUNDS USEFUL IN THE TREATMENT AND/OR CARE OF THE SKIN, HAIR AND/OR MUCOUS MEMBRANES AND THEIR COSMETIC OR PHARMACEUTICAL COMPOSITIONS | LUBRIZOL ADVANCED MAT INC |
EP2928898 | BETA-LACTAMASE INHIBITORS | VENATORX PHARMACEUTICALS INC |
EP2928921 | COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING EPO | NOVARTIS AG |
EP2928935 | BINDERS | KNAUF INSULATION SPRL |
EP2928940 | FUNCTIONNALIZED BENZODITHIOPHENE POLYMERS FOR ELECTRONIC APPLICATION | BASF SE |
EP2929335 | DEVICE AND METHODS FOR ANALYSIS OF BIOMOLECULE STRUCTURE, DYNAMICS AND ACTIVITY | NYMIRUM INC |
EP2931304 | WT1 VACCINE | UNIV PENNSYLVANIA |
EP2931398 | METHOD FOR ISOLATING DIAMONDOIDS | TOTAL SA |
EP2931400 | METHOD FOR CLEANING OF PACKED BED CHROMATOGRAPHY COLUMNS | GE HEALTHCARE BIO SCIENCES AB |
EP2931417 | ZEOLITIC ADSORBENTS, PROCESS FOR PREPARING SAME AND USES THEREOF | CECA SA |
EP2931744 | POLYPEPTIDES HAVING PHOSPHOLIPASE C ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME | NOVOZYMES AS |
EP2931750 | ANTIBODIES AGAINST IL-1 BETA | DELENEX THERAPEUTICS AG |
EP2932981 | Albumin-binding derivatives of GLP-1 | NOVO NORDISK AS |
EP2933254 | NOVEL COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT OR OPTICAL ISOMER THEREOF, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF VIRAL DISEASES CONTAINING SAME AS ACTIVE INGREDIENT | KOREA RES INST CHEM TECH |
EP2933874 | PHOTOELECTRIC CONVERSION ELEMENT | SHARP KK |
EP2934512 | USE OF CANNABINOIDS AND TERPENES FOR TREATMENT OF ORGANOPHOSPHATE AND CARBAMATE TOXICITY | KOTZKER CONSULTING LLC |
EP2934538 | FACTOR IXA INHIBITORS | MERCK SHARP & DOHME |
EP2934589 | GLYCAN-MODIFIED ANTI-CD4 ANTIBODIES FOR HIV PREVENTION AND THERAPY | UNIV ROCKEFELLER |
EP2935311 | APJ RECEPTOR AGONISTS AND USES THEREOF | AMGEN INC |
EP2935332 | ANTI-H7CR ANTIBODIES | AMPLIMMUNE INC |
EP2937325 | METHOD OF UPGRADING LOW-VALUE LINEAR ALPHA-OLEFINS OF C18 OR MORE | SK INNOVATION CO LTD |
EP2938608 | SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 | SANFORD BURNHAM MED RES INST |
EP2940103 | A METHOD FOR OBTAINING BIOFUELS USING ETHANOL, OR MIXTURES OF ALCOHOL AS BIOFUEL OR BIOCOMPONENT AND BIOFUEL OR BIOCOMPONENT FOR THE PREPARATION OF MOTOR FUELS | EKOBENZ SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA |
EP2941423 | DEOXYURIDINE TRIPHOSPHATASE INHIBITORS | UNIV SOUTHERN CALIFORNIA |
EP2941434 | MANGANESE-BASED MAGNETIC RESONANCE CONTRAST AGENTS | GEN HOSPITAL CORP |
EP2941435 | MANNOSE-RECEPTOR SELECTIVE LYSINYLATED CATIONIC AMPHIPHILES AND A PROCESS FOR PREPARATION THEREOF | COUNCIL SCIENT IND RES |
EP2943219 | VACCINE TO PREVENT MYCOPLASMAL INFECTION IN WATERFOWL | SZATHMARY DR SUSAN |
EP2943454 | TAPENTADOL MALEATE AND CRYSTALLINE FORMS THEREOF | FARMA GRS D O O |
EP2946001 | FORMULATION, PREPARATION AND USE OF A GLYCEROL-BASED BIOFUEL | INST UNIV DE CIèNCIA I TECNOLOGIA S A |
EP2946791 | Anti-CD277 antibodies and uses thereof | INSERM INST NAT DE LA SANTé ET DE LA RECH MéDICALE |
EP2948437 | NOVEL APPROACH FOR SYNTHESIS OF CATECHINS | SPHAERA PHARMA PRIVATE LTD |
EP2949789 | PROTEIN COMBINATION-BASED FV LIBRARY, AND PREPARATION METHOD THEREFOR | SCRIPPS KOREA ANTIBODY INST |
EP2951138 | METHOD FOR PRODUCING AN OLEFIN BY CATALYTIC CONVERSION OF AT LEAST ONE ALCOHOL | ADISSEO FRANCE SAS |
EP2951284 | RECOMBINANT YEAST TRANSFORMANT AND PROCESS FOR PREPARING IMMUNOGLOBULIN FC FRAGMENT EMPLOYING THE SAME | HANMI PHARM IND CO LTD |
EP2952511 | ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | CHEIL IND INC |
EP2953718 | METHOD FOR PURIFYING A CRUDE PNPNH COMPOUND | SAUDI BASIC IND CORP |
EP2953926 | POSITION-SPECIFIC ASYMMETRIC DEUTERIUM ENRICHED CATECHOLAMINE DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS | IMPHAR AG |
EP2953929 | PREPARATION OF FLUOROSULFONATE ESTERS AND ONIUM SALTS DERIVED THEREFROM | TRINAPCO INC |
EP2953976 | SPECIFIC SITES FOR MODIFYING ANTIBODIES TO MAKE IMMUNOCONJUGATES | IRM LLC |
EP2958158 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO |
EP2958904 | UNSATURATED FATTY ACID ESTER-BASED PLASTIC ADDITIVES | ARKEMA INC |
EP2961733 | DISULFIDE COMPOUNDS FOR DELIVERY OF PHARMACEUTICAL AGENTS | UNIV TUFTS |
EP2961760 | SELECTIVE REMOVAL OF A PROTEIN FROM A MIXTURE OF PROTEINS USING ACTIVATED CARBON BY ADJUSTING SOLUTION CONDITIONS | EMD MILLIPORE CORP |
EP2961774 | ALPHA-SYNUCLEIN ANTIBODIES AND USES THEREOF | UNIV UNITED ARAB EMIRATES |
EP2962992 | FULLERENE DERIVATIVE, ORGANIC SOLAR CELL USING SAME, AND MANUFACTURING METHOD THEREOF | LG CHEMICAL LTD |
EP2963035 | COMPOUND, LIGHT-EMITTING MATERIAL, AND ORGANIC LIGHT-EMITTING ELEMENT | UNIV KYUSHU NAT UNIV CORP |
EP2964603 | USE OF SULPHONIC ACID FOR RECOVERING GLYCEROL FROM A TRIGLYCERIDE TRANSESTERIFICATION REACTION | ARKEMA FRANCE |
EP2968299 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS INC |
EP2968337 | HETEROARYL COMPOUNDS AND USES THEREOF | CELGENE AVILOMICS RES INC |
EP2968597 | POLYALKYLENE OXIDE VALERATE HEMOGLOBIN CONJUGATES | SANGART INC |
EP2969140 | ONE-STEP PROCEDURE FOR THE PURIFICATION OF NUCLEIC ACIDS | ABBOTT MOLECULAR INC |
EP2970068 | PROCESS AND SYSTEMS FOR OBTAINING 1,4-BUTANEDIOL FROM FERMENTATION BROTHS | GENOMATICA INC |
EP2970083 | PROCESS TO PREPARE LEVULINIC ACID | SEGETIS INC |
EP2970095 | METHODS OF REFINING AND PRODUCING ISOMERIZED FATTY ACIDS ESTERS AND FATTY ACIDS FROM NATURAL OIL FEEDSTOCKS | ELEVANCE RENEWABLE SCIENCES |
EP2970154 | TETRAHYDROXAMATE CHELATORS OF ZIRCONIUM89 AND NIOBIUM90 FOR USE IN DIAGNOSTIC APPLICATIONS | US HEALTH |
EP2970277 | IMIDAZO(4,5-B) PYRIDIN-2-YL AMIDES AS KV7 CHANNEL ACTIVATORS | KNOPP BIOSCIENCES LLC |
EP2970308 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS INC |
EP2970315 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS INC |
EP2970378 | HYDROPHOBIC INTERACTION PROTEIN CHROMATOGRAPHY UNDER NO-SALT CONDITIONS | BIOGEN MA INC |
EP2970399 | PROTEIN PARTICLES COMPRISING DISULFIDE CROSSLINKERS AND USES RELATED THERETO | UNIV EMORY |
EP2970448 | HUMAN ANTIBODIES TO GREM 1 | REGENERON PHARMA |
EP2970456 | METHODS AND COMPOSITIONS FOR DELIVERING MRNA CODED ANTIBODIES | SHIRE HUMAN GENETIC THERAPIES |
EP2970468 | NOTCH2 BINDING MOLECULES FOR TREATING RESPIRATORY DISEASES | NOVARTIS AG |
EP2970916 | ADAPTED LEPIDOPTERAN INSECT CELLS FOR THE PRODUCTION OF RECOMBINANT PROTEINS | MERCK SHARP & DOHME |
EP2971123 | NUCLEIC ACID AMPLIFICATION | THERANOS INC |
EP2972258 | PURIFICATION OF RAPAMYCIN DERIVATIVES | BIOSENSORS INT GROUP LTD |
EP2975051 | READILY ISOLATED BISPECIFIC ANTIBODIES WITH NATIVE IMMUNOGLOBULIN FORMAT | REGENERON PHARMA |
EP2976317 | COMPOSITION COMPRISING HF AND 2,3,3,3-TETRAFLUOROPROPENE | ARKEMA FRANCE |
EP2976352 | PURIFICATION OF TRIPLE HELICAL PROTEINS | COMMW SCIENT IND RES ORG |
EP2978456 | RADIOLABELLING PROCESS | GE HEALTHCARE LTD |
EP2978855 | MICROFLUIDIC DEVICES AND METHODS FOR USE THEREOF IN MULTICELLULAR ASSAYS OF SECRETION | UNIV BRITISH COLUMBIA |
EP2980066 | METHOD FOR PRODUCING ISOCYANATE | ASAHI KASEI CHEMICALS CORP |
EP2981518 | AN IMPROVED PROCESS FOR THE PREPARATION OF FLUVOXAMINE MALEATE" | ZCL CHEMICALS LTD |
EP2981523 | INSECTICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG |
EP2981526 | NAPHTHYLUREA DERIVATIVES USEFUL AS KINASE INHIBITORS | RESPIVERT LTD |
EP2981529 | ORIDONIN ANALOGS, COMPOSITIONS, AND METHODS RELATED THERETO | UNIV TEXAS |
EP2982380 | ANTIBODIES REACTIVE WITH B7-H3, IMMUNOLOGICALLY ACTIVE FRAGMENTS THEREOF AND USES THEREOF | MACROGENICS INC |
EP2982690 | METHOD FOR THE PRODUCTION OF DOMAIN ANTIBODIES | ABLYNX NV |
EP2985347 | METHOD FOR DETECTING PROTEIN STABILITY AND USES THEREOF | SHANGHAI INST BIOL SCIENCES |
EP2986595 | EPOXIDATION PROCESS | SCIENT DESIGN CO |
EP2986618 | ORGANIC ANION LITHIUM IONIC COCRYSTAL COMPOUNDS AND COMPOSITIONS | UNIV SOUTH FLORIDA |
EP2986639 | COMPOSITION WITH REDUCED IMMUNOGENICITY | INST NAT SANTé ET DE LA RECH MéDICALE INSERM |
EP2989112 | MODIFIED G-QUADRUPLEX NANOPARTICLES | UNIV NANYANG TECH |
EP2990397 | PROCESS FOR THE PREPARATION OF 2,3,3,3 TETRAHYDROFLUOROPROPENE | MEXICHEM FLUOR SA DE CV |
EP2992010 | FC-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE | HOFFMANN LA ROCHE |
EP2994169 | LABELLED CARBOXYLIC ACIDS AND THEIR USES IN MOLECULAR IMAGING | IMP INNOVATIONS LTD |
EP2994457 | RADIOMITIGATING PHARMACEUTICAL FORMULATIONS | UNIV CALIFORNIA |
EP2997007 | METHODS OF DIRECT ADDITION OF (METH) ACRYLIC ACID TO BIO-BASED OILS | 3M INNOVATIVE PROPERTIES CO |
EP2997036 | PURIFICATION OF RECOMBINANTLY PRODUCED POLYPEPTIDES | MEDIMMUNE LTD |
EP2997043 | ANTAGONIST OF THE BTLA/HVEM INTERACTION FOR USE IN THERAPY | INSERM INST NAT DE LA SANTé ET DE LA RECH MéDICALE |
EP2998285 | EXTRACTION OF CARBOXYLIC ACIDS FROM A DILUTE AQUEOUS STREAM | PURAC BIOCHEM BV |
EP2999358 | SYNTHETIC MIXTURE OF OLIGOSACCHARIDES FOR T TREATING A MICROBIOTA OF A MAMMAL | GLYCOM AS |
EP3000482 | DOUBLE-ACYLATED GLP-1 DERIVATIVES | NOVO NORDISK AS |
EP3000819 | METHOD FOR PRODUCING GALACTOSE CONSTITUTING A RAW MATERIAL FOR PRODUCING TAGATOSE FROM WHEY PERMEATE LIQUID OR WHEY PERMEATE POWDER | CJ CHEILJEDANG CORP |
EP3002275 | PROCESS FOR PREPARING A CONCENTRATED, NON-GELLING, AQUEOUS SOLUTION OF BETAINE | HAYAT KIMYA SANAYI ANONIM SIRKETI |
EP3003299 | NOVEL N-3 IMMUNORESOLVENTS: STRUCTURES AND ACTIONS | BRIGHAM & WOMENS HOSPITAL |
EP3003390 | ANTI-C10ORF54 ANTIBODIES AND USES THEREOF | IGENICA BIOTHERAPEUTICS INC |
EP3004053 | A PROCESS FOR PREPARATION OF PYRROLES HAVING HYPOLIPIDEMIC HYPOCHOLESTEREMIC ACTIVITIES | CADILA HEALTHCARE LTD |
EP3004137 | IMPROVED METHOD FOR THE DETECTION, PREPARATION AND DEPLETION OF CD4+ T LYMPHOCYTES | IMCYSE SA |
EP3004155 | PEPTIDE COMPOUND | TAKEDA PHARMACEUTICAL |
EP3004171 | METHODS FOR INHIBITING ATHEROSCLEROSIS BY ADMINISTERING AN INHIBITOR OF PCSK9 | REGENERON PHARMA |
EP3006459 | METHOD AND COMPOSITIONS FOR ENHANCED ANTI-TUMOR EFFECTOR FUNCTIONING OF T CELLS | HOPE CITY |
EP3007709 | LIPID-BASED PLATINUM COMPOUNDS AND NANOPARTICLES | INVICTUS ONCOLOGY PVT LTD |
EP3008083 | METHOD FOR DETERMINING MUTATEABLE LIGAND-GPCR BINDING AT SINGLE AMINO ACID RESOLUTION AND PAIRS OF MUTATED LIGAND AND GPCR | SCHERRER INST PAUL |
EP3010055 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO |
EP3010509 | FREE BASE CRYSTALS | INTRA CELLULAR THERAPIES INC |
EP3010550 | CYCLIC PEPTIDES AS PROTEIN TARGETING AGENTS | CALIFORNIA INST OF TECHN |
EP3010936 | LECTIN-LIKE OXIDIZED LDL RECEPTOR1 ANTIBODIES AND METHODS OF USE | NOVARTIS AG |
EP3011971 | ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREOF | AMGEN FREMONT INC |
EP3013818 | (S)-ENANTIOMER OF MEPAZINE AS PARACASPASE (MALT1) INHIBITOR FOR TREATING CANCER | HELMHOLTZ ZENTRUM MüNCHEN DEUTSCHES FORSCHUNGSZENTRUM FüR GESUNDHEIT UND UMWELT GMBH |
EP3013839 | MACROCYCLIC COMPOUNDS AND THEIR USES AS ANION QUENCHERS | UNIVERSITé D AIX MARSEILLE |
EP3013840 | ELECTROCHROMIC COMPOUND, ELECTROCHROMIC COMPOSITION, DISPLAY ELEMENT, AND DIMMING ELEMENT | RICOH CO LTD |
EP3013854 | CD86 VARIANTS WITH IMPROVED AFFINITY FOR CTLA-4 | ALLIGATOR BIOSCIENCE AB |
EP3016671 | ACTIVELY TRANSPORTED AND PROTEASE-RESISTANT PEPTIDES AS BBB SHUTTLES AND SHUTTLE-CARGO CONSTRUCTS | UNIV BARCELONA |
EP3016931 | A NOVEL PROCESS FOR THE PREPARATION OF TETRALIN AND NAPHTHALENE DERIVATIVES | PHARMATHEN SA |
EP3016966 | CONCENTRATION AND PURIFICATION OF HYDROPHOBINS AND ANTIBODIES WITH A PHASE SEPARATION METHOD | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY |
EP3019190 | CATIONIC NEUROTOXINS | IPSEN BIOINNOVATION LTD |
EP3019272 | NOVEL CATALYSTS WITH A SILYLENE LIGAND | BLUESTAR SILICONES FRANCE |
EP3019273 | NOVEL CATALYSTS HAVING A SILENE LIGAND | BLUESTAR SILICONES FRANCE |
EP3019484 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | AGIOS PHARMACEUTICALS INC |
EP3019615 | CYSTOBACTAMIDES | HELMHOLTZ ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH |
EP3020708 | ORGANIC COMPOSITION, AND ORGANIC OPTOELECTRONIC ELEMENT AND DISPLAY DEVICE | SAMSUNG SDI CO LTD |
EP3020715 | TETRAZOLINONE COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL CO |
EP3021852 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | SAGE THERAPEUTICS INC |
EP3022217 | COMPOSITIONS FOR MODULATING TAU EXPRESSION | IONIS PHARMACEUTICALS INC |
EP3022221 | HUMANIZED ANTIBODIES WITH ULTRALONG COMPLEMENTARITY DETERMINING REGIONS | FABRUS INC |
EP3022225 | TRANSTHYRETIN AMYLOID-SELECTIVE AND POLYREACTIVE CATABODIES | UNIV TEXAS |
EP3022250 | METAL-ORGANIC MATERIALS AND METHOD FOR PREPARATION | YEDA RES & DEV |
EP3022321 | MIRROR BISULFITE ANALYSIS | ZYMO RES CORP |
EP3024049 | Fluorinated aromatic small molecules as functional additives for dispersion of conductive polymers | HERAEUS DEUTSCHLAND GMBH & CO KG |
EP3024862 | THE USE OF SUCCINONITRILE IN THE PRODUCTION OF POLYISOCYANATES WHICH CONTAIN IMINOOXADIAZINE DIONE GROUPS | COVESTRO DEUTSCHLAND AG |
EP3026049 | METHOD FOR PREPARING BENZAMIDE DERIVATIVE, NOVEL INTERMEDIATE USED IN PREPARATION OF BENZAMIDE, AND METHOD FOR PREPARING NOVEL INTERMEDIATE | DONG A ST CO LTD |
EP3026722 | COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD |
EP3027615 | ANTI-INFECTIVE COMPOUNDS | PASTEUR INSTITUT KOREA |
EP3027650 | ANTI-GARP PROTEIN AND USES THEREOF | UNIVERSITé CATHOLIQUE DE LOUVAIN |
EP3027666 | POLYMER CONTAINING SILANE GROUPS | SIKA TECHNOLOGY AG |
EP3029033 | COMPOUND, LIGHT-EMITTING MATERIAL, AND ORGANIC LIGHT-EMITTING DEVICE | UNIV KYUSHU NAT UNIV CORP |
EP3029034 | BENZOTRIAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO LTD |
EP3030581 | ANTIBODY BINDING SITES SPECIFIC FOR EGFRvIII | AFFIMED GMBH |
EP3031805 | ORGANIC METAL COMPLEX, LUMINESCENT MATERIAL, DELAYED PHOSPHOR AND ORGANIC LIGHT EMITTING ELEMENT | UNIV KYUSHU NAT UNIV CORP |
EP3031907 | MATERIALS AND METHODS TO ENHANCE HEMATOPOIETIC STEM CELLS ENGRAFTMENT PROCEDURES | UNIV INDIANA RES & TECH CORP |
EP3033081 | COMPOSITIONS AND METHODS FOR TREATING CHRONIC URTICARIA | KNOPP BIOSCIENCES LLC |
EP3033097 | FACTOR VIII-XTEN FUSIONS AND USES THEREOF | BIOGEN MA INC |
EP3033347 | COMPOSITIONS AND METHODS FOR MAKING NOSCAPINE AND SYNTHESIS INTERMEDIATES THEREOF | EPIMERON INC |
EP3033350 | PROGESTERONE PHOSPHATE ANALOGS AND USES RELATED THERETO | UNIV EMORY |
EP3036328 | RUST RESISTANCE GENE | COMMW SCIENT IND RES ORG |
EP3037105 | ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREOF | AMGEN FREMONT INC |
EP3037398 | METHOD FOR MANUFACTURING CHEMICAL COMPOUND | SUMITOMO CHEMICAL CO |
EP3037426 | PHOSPHORUS-CONTAINING COMPOUND, AND CURABLE EPOXY RESIN COMPOSITION CONTAINING SAME | ADEKA CORP |
EP3037534 | POLYPEPTIDE EXHIBITING FLUORESCENT PROPERTIES, AND UTILIZATION OF SAME | RIKEN |
EP3038644 | SITE-SPECIFIC ANTIBODY CONJUGATION METHODS AND COMPOSITIONS | STEMCENTRX INC |
EP3038650 | ANTIBODIES AND ASSAYS FOR DETECTION OF FOLATE RECEPTOR 1 | IMMUNOGEN INC |
EP3039039 | ANTIBODIES NEUTRALIZING GM-CSF FOR USE IN THE TREATMENT OF RHEUMATOID ARTHRITIS OR AS ANALGESICS | TAKEDA GMBH |
EP3039040 | ANTI CD30 CHIMERIC ANTIGEN RECEPTOR AND ITS USE | UNIVERSITÄT ZU KÖLN |
EP3039047 | REDUCTION OF ALDEHYDES IN AMINE CATALYSTS | HUNTSMAN PETROCHEMICAL LLC |
EP3039064 | EXTRACTION METHOD OF A POLYESTER POLYMER OR CUTIN FROM THE WASTED TOMATO PEELS AND POLYESTER POLIMER SO EXTRACTED | CHIESA VIRGINIO |
EP3040344 | Fab REGION-BINDING PEPTIDE | KANEKA CORP |
EP3041507 | NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A | MABVAX THERAPEUTICS INC |
EP3041603 | METHOD FOR PRODUCING ACRYLIC ACID | EVONIK DEGUSSA GMBH |
EP3041837 | CRYSTAL HAVING SPECIFIC CRYSTAL HABIT AND PHARMACEUTICAL COMPOSITION CONTAINING THE CRYSTAL AS ACTIVE INGREDIENT | POLA PHARMA INC |
EP3041853 | METALLACROWN COMPLEXES AND METHODS OF MAKING THE SAME | UNIV MICHIGAN |
EP3041864 | IL-18 BINDING PROTEIN (IL-18BP) IN INFLAMMATORY DISEASES | AB2 BIO SA |
EP3041946 | FERMENTATIVE PRODUCTION OF OLIGOSACCHARIDES | GLYCOM AS |
EP3043790 | NOVEL ANTHRANILIC AMIDES AND THE USE THEREOF | UNIV TULANE |
EP3044195 | COLLAGEN AND ELASTIN STIMULATING COMPOUND AND TOPICAL COMPOSITIONS COMPRISING SUCH COMPOUND | JOVENTIS S A |
EP3044199 | METHOD FOR THE DEHYDRATION OF 3-HYDROXYPROPANOIC ACID TO FORM ACRYLIC ACID | BASF SE |
EP3044208 | OXIME ESTER PHOTOINITIATORS | BASF SE |
EP3044228 | HIGHLY EFFICIENT SYNTHESIS OF LONG RNA USING REVERSE DIRECTION APPROACH | CHEMGENES CORP |
EP3044230 | CASPOFUNGIN DERIVATIVE | DSM SINOCHEM PHARM NL BV |
EP3045444 | METHOD OF PREPARING VANILLIN | JIAXING ZHONGHUA CHEMICAL CO LTD |
EP3045474 | THERAPEUTIC AGENTS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH UNDESIRED CELL PROLIFERATION | FUNDACIó PRIVADA INSTITUCIó CATALANA DE RECERCA I ESTUDIS AVANÇATS |
EP3046903 | PROCESS FOR OBTAINING METHIONINE | EVONIK DEGUSSA GMBH |
EP3046920 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES | BIOMARIN PHARM INC |
EP3046931 | CELL-PENETRATING BACTERIAL E3-UBIQITIN-LIGASES FOR USE IN IMMUNOTHERAPY | WESTFÄLISCHE WILHELMS UNIVERSITÄT MüNSTER |
EP3048107 | BENZOBIS (THIADIAZOLE) DERIVATIVE, INK CONTAINING SAME, AND ORGANIC ELECTRONIC DEVICE USING SAME | FUTURE INK CORP |
EP3048899 | ON-COLUMN VIRAL INACTIVATION METHODS | BIOGEN MA INC |
EP3049183 | METHANATION REACTOR FOR REACTING DIHYDROGEN WITH AT LEAST ONE CARBON-BASED COMPOUND AND PRODUCING METHANE | GDF SUEZ |
EP3049380 | APPARATUSES AND METHODS FOR FORMING C8 AROMATIC STREAMS WITH SELECTED AMOUNTS OF C9 AROMATICS | UOP LLC |
EP3049473 | DUALLY DERIVATIZED CHITOSAN NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME FOR GENE TRANSFER IN VIVO | ENGENE INC |
EP3050865 | PROCESS FOR THE REDUCTION OF CARBON DIOXIDE TO METHANE BY DBD PLASMA-ACTIVATED CATALYST | FUNDACIO INST RECERCA EN EN DE CATALUNYA |
EP3050896 | METHOD FOR PRODUCING POLYPEPTIDE HETEROMULTIMER | CHUGAI PHARMACEUTICAL CO LTD |
EP3052505 | BORON-CONTAINING COMPOUNDS | MERCK PATENT GMBH |
EP3052523 | METHODS OF TREATING AND DIAGNOSING ALPHA-V-BETA-6 OVEREXPRESSING CANCER | MEDIMMUNE LTD |
EP3052556 | LIGAND-FUNCTIONALIZED SUBSTRATES WITH ENHANCED BINDING CAPACITY | 3M INNOVATIVE PROPERTIES CO |
EP3053910 | ANILINE DERIVATIVES AND USES THEREOF | NISSAN CHEMICAL IND LTD |
EP3053944 | METHOD FOR PRODUCING POLYALKYLENE GLYCOL DERIVATIVE HAVING AMINO GROUP AT END, POLYMERIZATION INITIATOR FOR USE IN THE SAME, AND ALCOHOL COMPOUND AS RAW MATERIAL FOR THE POLYMERIZATION INITIATOR | SHINETSU CHEMICAL CO |
EP3055299 | PYRIMIDINE HYDROXY AMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS | ACETYLON PHARMACEUTICALS INC |
EP3055331 | CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER | OXFORD BIO THERAPEUTICS LTD |
EP3056217 | OSTEOARTHRITIS TREATMENT | UNIV MELBOURNE |
EP3056492 | MEGUMINE SALT AND CRYSTALLINE FORMS THEREOF OF A DRUG (DELAFLOXACIN) | ABBVIE INC |
EP3056568 | METHODS FOR CONTROLLING BLOOD PHARMACOKINETICS OF ANTIBODIES | CHUGAI PHARMACEUTICAL CO LTD |
EP3057610 | DRUG-CONJUGATES WITH A TARGETING MOLECULE AND TWO DIFFERENT DRUGS | SORRENTO THERAPEUTICS INC |
EP3057615 | ANTI-RSPO ANTIBODIES AND METHODS OF USE | HOFFMANN LA ROCHE |
EP3057933 | UNIT AND PROCESS FOR PURIFICATION OF CRUDE METHYL METHACRYLATE | ARKEMA FRANCE |
EP3057956 | POLYCYCLIC INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | DANA FARBER CANCER INST INC |
EP3059249 | ANTIBODIES BINDING TO PIVKA-II AMINO ACIDS 13-27 | ABBOTT LAB |
EP3060562 | SUBSTITUTED PYRIMIDINE COMPOUNDS AND THEIR USE AS SYK INHIBITORS | GENOSCO |
EP3060577 | PRODUCTION OF RECOMBINANT LUBRICIN | LUBRIS LLC |
EP3062151 | RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYPHENOLIC COMPOUND FOR USE IN THE COMPOSITION, AND ALCOHOLIC COMPOUND THAT CAN BE DERIVED THEREFROM | MITSUBISHI GAS CHEMICAL CO |
EP3063159 | PROCESS FOR PURIFICATION OF A NEUTRAL HUMAN MILK OLIGOSACCHARIDE USING SIMULATED MOVING BED CHROMATOGRAPHY | JENNEWEIN BIOTECHNOLOGIE GMBH |
EP3063195 | ADDITIVES MADE FROM FATTY DIAMIDES FOR NUCLEOPHILE-SENSITIVE CROSS-LINKABLE COMPOSITIONS | ARKEMA FRANCE |
EP3063592 | DIRECT PHOTOPATTERNING OF ROBUST AND DIVERSE MATERIALS | CALIFORNIA INST OF TECHN |
EP3064486 | PHENYL(META)ACRYLATE PRODUCTION METHOD AND PHENYL(META)ACRYLATE COMPOSITION | MITSUBISHI RAYON CO |
EP3064500 | SINGLE MOLECULE AND ORGANIC SOLAR CELL COMPRISING SAME | LG CHEMICAL LTD |
EP3066054 | BISMUTH-BASED ENERGETIC MATERIALS | SELLIER & BELLOT AS |
EP3066068 | HYDROXYTYROSOL DERIVATIVES THEIR METHOD OF PREPARATION AND USE IN PERSONAL CARE | EASTMAN CHEM CO |
EP3066110 | OPTIMAL MAIZE LOCI | DOW AGROSCIENCES LLC |
EP3066116 | TREATMENT OF DAMAGED NERVE WITH PTEN INHIBITOR | TISSUEGENE INC |
EP3066122 | PRE-HAPTOGLOBIN-2 MONOCLONAL ANTIBODIES AND USES THEREOF | BIO RAD LABORATORIES |
EP3066124 | ANTICORPS ALLOSTERIQUES DE LA NEUREGULINE, DIRIG脡S CONTRE HER3 | INSERM INST NAT DE LA SANTé ET DE LA RECH MéDICALE |
EP3068758 | EBNA1 INHIBITORS AND THEIR METHOD OF USE | WISTAR INST |
EP3068789 | METHOD FOR PREPARING A HALOSILANE | DOW CORNING |
EP3068793 | ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS | CODEXIS INC |
EP3068803 | DOSING REGIMENS FOR USE WITH PCSK9 INHIBITORS | SANOFI SA |
EP3070095 | ADENO-ASSOCIATED VIRUS WITH SITE-DIRECTED MUTAGENESIS AND SITE-DIRECTED MODIFICATION, AND PREPARATION METHOD AND APPLICATION THEREFOR | UNIV BEIJING |
EP3070163 | METHOD FOR PREPARING INDUCED PLURIPOTENT STEM CELL, COMPOSITION USED IN METHOD, AND USES THEREOF | GUANGZHOU INST BIOMED & HEALTH |
EP3071223 | CELL | UCL BUSINESS PLC |
EP3071538 | OLEFIN DOUBLE BOND ISOMERIZATION CATALYST WITH HIGH POISON RESISTANCE | LUMMUS TECHNOLOGY INC |
EP3071551 | FUSED RING INDENO COMPOUNDS FOR PREPARATION OF PHOTOCHROMIC COMPOUNDS | TRANSITIONS OPTICAL INC |
EP3071576 | PHOTOCHROMIC INDENO-FUSED RING PYRAN COMPOUNDS | TRANSITIONS OPTICAL INC |
EP3071592 | ARTIFICIAL DNA-BINDING PROTEINS AND USES THEREOF | FOND TELETHON |
EP3071598 | SINGLE CHAIN INTRABODIES THAT ALTER HUNTINGTIN MUTANT DEGRADATION | VYBION INC |
EP3072906 | ANTIBODY FORMULATION | NOVARTIS AG |
EP3074398 | A3 ADENOSINE RECEPTOR AGONISTS | US HEALTH |
EP3077396 | SYNTHESIS OF TRANS-8-CHLORO-5-METHYL-1 -[4-(PYRIDIN-2-YLOXY)-CYCLOHEXYL]-5,6-DIHYDRO-4H-2,3,5,10B-TETRAAZA-BENZO[E]AZULENE AND CRYTALLINE FORMS THEREOF | HOFFMANN LA ROCHE |
EP3078654 | MONOMER AND BLOCK COPOLYMER | LG CHEMICAL LTD |
EP3079697 | PROLYLHYDROXYLASE/ATF4 INHIBITORS FOR TREATING NEURAL CELL INJURY | UNIV CORNELL |
EP3079701 | SOLUBLE GUANYLATE CYCLASE ACTIVATORS | MERCK SHARP & DOHME |
EP3079722 | METHOD FOR THIOETHER CONJUGATION OF PROTEINS | NOVO NORDISK HEALTHCARE AG |
EP3080144 | STABILIZATION OF GLUTAMATE DEHYDROGENASE IN AN AQUEOUS SOLUTION | BIOMERIEUX |
EP3080161 | COMPOSITIONS AND METHODS FOR PHAGOCYTE DELIVERY OF ANTI-STAPHYLOCOCCAL AGENTS | UNIV NEW YORK |
EP3080277 | AXMI477, AXMI482, AXMI486 AND AXMI525 TOXIN GENES AND METHODS FOR THEIR USE | ATHENIX CORP |
EP3081549 | FLUOROPOLYETHER COMPOUND, AND LUBRICANT AND MAGNETIC DISC COMPRISING SAME | MORESCO CORP |
EP3081571 | IRIDIUM COMPLEX COMPOUND, METHOD FOR PRODUCING SAID COMPOUND, COMPOSITION CONTAINING SAID COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | MITSUBISHI CHEM CORP |
EP3082855 | COMPOSITION | UNIV EXETER |
EP3082858 | ADRENOMEDULLIN BINDER FOR USE IN THERAPY OF CANCER | ANGIOBIOMED GMBH |
EP3083038 | HETEROGENEOUS ALKANE DEHYDROGENATION CATALYST | DOW GLOBAL TECHNOLOGIES LLC |
EP3083048 | METAL-LIGAND COMPLEX, OLEFIN POLYMERIZATION CATALYST DERIVED THEREFROM, AND OLEFIN POLYMERIZATION METHOD UTILIZING THE CATALYST | DOW GLOBAL TECHNOLOGIES LLC |
EP3083527 | METHOD FOR MAKING POLYOLEFINS USING ALUMINUM HALIDE CATALYZED OLIGOMERIZATION OF OLEFINS | CHEVRON PHILLIPS CHEMICAL CO |
EP3083543 | IMPROVED PROCESS AND APPARATUS FOR MANUFACTURING AROMATIC CARBOXYLIC ACIDS | BP CORP NORTH AMERICA INC |
EP3083559 | THIAZOLE-SUBSTITUTED AMINOHETEROARYLS AS SPLEEN TYROSINE KINASE INHIBITORS | MERCK SHARP & DOHME |
EP3083560 | THIAZOLE-SUBSTITUTED AMINOHETEROARYLS AS SPLEEN TYROSINE KINASE INHIBITORS | MERCK SHARP & DOHME |
EP3083575 | C-6 SPIROCARBOCYCLIC IMINOTHIADIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE | MERCK SHARP & DOHME |
EP3083616 | BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY | ASTEX THERAPEUTICS LTD |
EP3083619 | P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS | ASANA BIOSCIENCES LLC |
EP3083629 | THE METHOD FOR MANUFACTURING OF VARDENAFIL AND ITS SALTS | ZAKLADY FARM POLPHARMA SA |
EP3083652 | COMPOSITION COMPRISING ESTERS OF LIGNIN AND OIL OR FATTY ACIDS | REN FUEL K2B AB |
EP3083659 | VIRAL PEPTIDES | EQUIGERMINAL SA |
EP3085385 | PHARMACEUTICAL COMPOSITION COMPRISING ADALIMUMAB | ZHEJIANG HISUN PHARM CO LTD |
EP3085388 | HYPERBRANCHED POLYMER CONJUGATES VIA NON-ENZYMATIC CLEAVABLE LINKER | ASCENDIS PHARMA GROWTH DISORDERS DIVISION AS |
EP3087064 | PRODRUGS OF UROLITIHNS AND USES THEREOF | AMAZENTIS SA |
EP3087087 | BETA-HAIRPIN PEPTIDOMIMETICS AS SELECTIVE ELASTASE INHIBITORS | POLYPHOR AG |
EP3087091 | VAR2CSA-DRUG CONJUGATES | ZYMEWORKS INC |
EP3087093 | PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES | STEALTH BIOTHERAPEUTICS CORP |
EP3088386 | METHOD FOR PRODUCING INTERNAL OLEFIN SULFONATE | KAO CORP |
EP3088412 | PROTEIN PURIFICATION METHOD | CHUGAI PHARMACEUTICAL CO LTD |
EP3088487 | SURFACE TREATING AGENT INCLUDING PERFLUORO(POLY)ETHER-GROUP-CONTAINING SILANE COMPOUND | DAIKIN IND LTD |
EP3089758 | COVALENTLY LINKED HELICAR-ANTI-HELICAR ANTIBODY CONJUGATES AND USES THEREOF | HOFFMANN LA ROCHE |
EP3089804 | SOLID-LIQUID SEPARATIONS WITH A NO-DRY ROTARY PRESSURE FILTER | BP CORP NORTH AMERICA INC |
EP3089958 | HIGH-PRESSURE CONDENSATE GENERATION IN THE MANUFACTURE OF PURIFIED AROMATIC CARBOXYLIC ACIDS | BP CORP NORTH AMERICA INC |
EP3089964 | HETEROATOM-CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS | UNIV SOUTHERN CALIFORNIA |
EP3089996 | BISPECIFIC ANTI-HAPTEN/ANTI-BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES, COMPLEXES THEREOF AND THEIR USE AS BLOOD BRAIN BARRIER SHUTTLES | HOFFMANN LA ROCHE |
EP3092220 | VITAMIN C PRODRUGS AND USES THEREOF | UNIV FLORIDA |
EP3092248 | FUSION POLYPEPTIDES AND METHODS OF USE | PROSIT SOLE BIOTECHNOLOGY BEIJING CO LTD |
EP3092251 | MONOVALENT BLOOD BRAIN BARRIER SHUTTLE MODULES | HOFFMANN LA ROCHE |
EP3092253 | ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33) | ANAPTYSBIO INC |
EP3092309 | CPMV ENHANCER ELEMENTS | MEDICAGO INC |
EP3093011 | METHOD FOR THE PREPARATION OF DIRECTLY TABLETTABLE MANNITOL | MERCK PATENT GMBH |
EP3093292 | METAL COMPLEX AND LIGHT EMITTING ELEMENT USING SAME | SUMITOMO CHEMICAL CO |
EP3093338 | RECOMBINANT ANAEROBIC GRAM-POSITIVE BACTERIA | TEIKYO HEISEI UNIVERSITY |
EP3094325 | HETEROARYLS AND USES THEREOF | MILLENNIUM PHARM INC |
EP3094351 | IMMUNOMODULATORY AGENTS | KADMON CORP LLC |
EP3094397 | METHANE-RICH NATURAL GAS SUPPLY FOR STATIONARY COMBUSTION SYSTEMS | DOW GLOBAL TECHNOLOGIES LLC |
EP3094612 | METHOD FOR PRODUCING E-1-CHLORO-3,3,3-TRIFLUOROPROPENE FROM 1,1,3,3-TETRACHLOROPROPENE | ARKEMA FRANCE |
EP3094630 | READ-THROUGH COMPOUND PRODRUGS SUPPRESSING PREMATURE NONSENSE MUTATIONS | UNIV CALIFORNIA |
EP3094652 | NOVEL VACCINES AGAINST HPV AND HPV-RELATED DISEASES | BAYLOR RES INST |
EP3096609 | HIGH-THROUGHPUT MOUSE MODEL FOR OPTIMIZING ANTIBODY AFFINITIES | CHILDRENS MEDICAL CENTER |
EP3096774 | CELLULAR PLATFORM FOR RAPID AND COMPREHENSIVE T-CELL IMMUNOMONITORING | EINSTEIN COLL MED |
EP3097071 | SYSTEM AND METHOD FOR UTILIZING HYDROGEN | HYDROGENIOUS TECHNOLOGIES GMBH |
EP3097079 | PROCESS FOR THE CYCLOADDITION OF A HETERO(ARYL) 1,3-DIPOLE COMPOUND WITH A (HETERO)CYCLOALKYNE | SYNAFFIX BV |
EP3097089 | ARYL AND ARYLALKYL SUBSTITUTED PYRAZOLYL AND PYRIMIDINYL TRICYCLIC ENONES AS ANTIOXIDANT INFLAMMATION MODULATORS | ABBVIE INC |
EP3097119 | HUMAN ANTIBODIES TO PD-1 | REGENERON PHARMA |
EP3098229 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP |
EP3098232 | MOLECULAR GELATORS FOR CONTAINING OIL SPILLAGE | HINDUSTAN PETROLEUM CORP LTD |
EP3099186 | NOVEL TRITERPENE-GLYCOSIDES AS SWEETENERS OR SWEETENER ENHANCERS | ANALYTICON DISCOVERY GMBH |
EP3099704 | MHC CLASS I EPITOPE DELIVERING POLYPEPTIDES | MOLECULAR TEMPLATES INC |
EP3099707 | OPIOID RECEPTOR BINDING AGENTS AND USES THEREOF | VIB VZW |
EP3099714 | HYBRIDOMA CELL LINES (MY-C-CC0C2-259-1 A4) AND USE THEREOF FOR PRODUCING A MONOCLONAL ANTIBODY AGAINST HUMAN CARDIAC MYOSIN BINDING PROTEIN C (C-PROTEIN, MYBPC3, CMYBP-C OR MY-C) | MARTIN-LUTHER-UNIVERSITÄT HALLE-WITTENBERG |
EP3099821 | CIRCULATING TUMOR CELL DIAGNOSTICS FOR DETECTION OF NEUROENDOCRINE PROSTATE CANCER (NEPC) | EPIC SCIENCES INC |
EP3101132 | ANTI-TRANSTHYRETIN HUMAN ANTIBODY | THE CHEMO-SERO-THERAPEUTIC RES INST |
EP3102215 | 4'-DIFLUOROMETHYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF INFLUENZA RNA REPLICATION | RIBOSCIENCE LLC |
EP3102230 | METHODS OF TREATING ALZHEIMER'S DISEASE | HOFFMANN LA ROCHE |
EP3102234 | AIPA, OMPA, AND ASP14 IN VACCINE COMPOSITIONS AND DIAGNOSTIC TARGETS FOR ANAPLASMA PHAGOCYTOPHILUM INFECTION | UNIV VIRGINIA COMMONWEALTH |
EP3102555 | COMPOSITIONS OF COMPOUNDS AND USES THEREOF | VM ONCOLOGY LLC |
EP3102575 | NOVEL SALTS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS | GALAPAGOS NV |
EP3102583 | 2,7-DISUBSTITUTED CEPHALOSPORIN DERIVATIVES AS BETA-LACTAMASE SUBSTRATES AND METHODS FOR THEIR USE FOR THE DIAGNOSIS OF TUBERCULOSIS | TEXAS A & M UNIV SYS |
EP3102585 | BORONIC ACID ESTERS AND PHARMACEUTICAL FORMULATIONS THEREOF | OHIO STATE INNOVATION FOUNDATION |
EP3103796 | NOVEL COMPOUND AND EPOXY RESIN COMPOSITION CONTAINING SAME | ADEKA CORP |
EP3103809 | IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS | BIOGEN HEMOPHILIA INC |
EP3103812 | ELISA FOR VEGF | GENENTECH INC |
EP3105230 | PYRIDOPYRAZINES MODULATORS OF GPR6 | TAKEDA PHARMACEUTICALS CO |
EP3105246 | TARGETED TGF BETA INHIBITION | MERCK PATENT GMBH |
EP3105249 | ANTIBODY MOLEULES TO DENGUE VIRUS AND USES THEREOF | VISTERRA INC |
EP3107395 | BIOACTIVE PROTEIN, USE THEREOF AND METHOD FOR ITS PRODUCTION | KOPPERT BV |
EP3107902 | COMPOUNDS AND METHODS FOR INHIBITING FASCIN | CORNELL UNIV CORNELL CENTER FOR TECH ENTPR & COMMERCIALIZATION ( CCTEC ) |
EP3107923 | WATER-SOLUBLE O-CARBONYL PHOSPHORAMIDATE PRODRUGS FOR THERAPEUTIC ADMINISTRATION | MICURX PHARMACEUTICALS INC |
EP3107931 | MEANS AND METHODS FOR REGULATING SECONDARY METABOLITE PRODUCTION IN PLANTS | VIB VZW |
EP3109246 | THIOPYRANOSE COMPOUND AND METHOD FOR PRODUCING SAME | FUJIFILM CORP |
EP3109257 | DIAGNOSIS AND THERAPY OF MULTIPLE SCLEROSIS | PATERNO' ROBERTO |
EP3110786 | PROCESS AND SYSTEM FOR PRODUCING ACRYLIC ACID | ARKEMA INC |
EP3110841 | PEPTIDES AND METHODS OF USE | BAXALTA INC |
EP3110945 | COMPOSITIONS AND METHODS FOR SITE DIRECTED GENOMIC MODIFICATION | MONSANTO TECHNOLOGY LLC |
EP3112000 | NOVEL FIRE RETARDANT COMPOUNDS | BOEING CO |
EP3112338 | CYCLOHEXENE DERIVATIVES AND THEIR USE AS ODORANTS | GIVAUDAN SA |
EP3112439 | LUMINESCENT MATERIAL, ORGANIC LUMINESCENT ELEMENT, AND COMPOUND | KYULUX INC |
EP3112873 | METHOXETAMINE ASSAY | RANDOX LABORATORIES LTD |
EP3113790 | PEPTIDES HORMONE ANALOGUES DERIVABLE FROM PREPROGLUCAGON | IMP INNOVATIONS LTD |
EP3114112 | CRYSTALLINE DERIVATIVES OF (S)-1-((2R,3R,4S,5S)-5-ALLYL-3-METHOXY-4-(TOSYLMETHYL)TETRAHYDROFURAN-2-YL)-3-AMINOPROPAN-2-OL | ALPHORA RES INC |
EP3114138 | IMPROVED MUTEINS OF CLOTTING FACTOR VIII | PFIZER |
EP3115064 | RNA-CODED ANTIBODY | CUREVAC AG |
EP3116491 | PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICALLY ACTIVE COMPOUNDS | AGIOS PHARMACEUTICALS INC |
EP3116507 | TREATMENT OF BRAIN AND CENTRAL NERVOUS SYSTEM TUMORS | KADMON CORP LLC |
EP3116525 | TCO CONJUGATES AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS | UNIV CALIFORNIA |
EP3116531 | PURIFYING INSULIN USING CATION EXCHANGE AND REVERSE PHASE CHROMATOGRAPHY IN THE PRESENCE OF AN ORGANIC MODIFIER AND ELEVATED TEMPERATURE | MERCK SHARP & DOHME |
EP3116887 | CARBOHYDRATE LIGANDS THAT BIND TO IGM ANTIBODIES AGAINST MYELIN-ASSOCIATED GLYCOPROTEIN | UNIVERSITÄT BASEL |
EP3116999 | METHODS AND COMPOSITIONS FOR SECRETION OF HETEROLOGOUS POLYPEPTIDES | HOFFMANN LA ROCHE |
EP3118183 | COMPOUND, RESIN, BASE LAYER FILM-FORMING MATERIAL FOR LITHOGRAPHY, BASE LAYER FILM FOR LITHOGRAPHY, PATTERN-FORMING METHOD, AND METHOD FOR REFINING COMPOUND OR RESIN | MITSUBISHI GAS CHEMICAL CO |
EP3119194 | NON-HUMAN ANIMALS THAT MAKE SINGLE DOMAIN BINDING PROTEINS | REGENERON PHARMA |
EP3119489 | METHOD AND DEVICE FOR SEPARATING A SUBSTANCE OUT OF A SOLUTION | BASF SE |
EP3119490 | IN VITRO PREDICTION OF IN VIVO HALF-LIFE OF ANTIBODIES | HOFFMANN LA ROCHE |
EP3119756 | 2-(2,4-DIFLUOROPHENYL)-1,1-DIFLUORO-1-(5-SUBSTITUTED-PYRIDIN-2-YL)-3-(1H-TETRAZOL-1-YL)PROPAN-2-OLS AND PROCESSES FOR THEIR PREPARATION | VIAMET PHARMACEUTICALS INC |
EP3119762 | BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER | CAPELLA THERAPEUTICS INC |
EP3119885 | ANTIBODY-FYNOMER CONJUGATES | MITSUBISHI TANABE PHARMA CORP |
EP3121162 | NITRATED HYDROCARBONS AND DERIVATIVES | ANGUS CHEMICAL |
EP3121188 | CRYSTALLINE 3',5'-CYCLIC DIGUANYLIC ACID | YAMASA CORP |
EP3121193 | PLANT CYTOCHROME P450 | SUN PHARMACEUTICAL IND (AUSTRALIA) PTY LTD |
EP3121211 | POLYMER AND ORGANIC SOLAR CELL COMPRISING SAME | LG CHEMICAL LTD |
EP3122363 | TREATMENT OF AUTISM | SYNAPTEC DEV LLC |
EP3122766 | IMPROVED ANTI-NUCLEAR ANTIBODY DETECTION AND DIAGNOSTICS FOR SYSTEMIC AND NON-SYSTEMIC AUTOIMMUNE DISORDERS | IMMCO DIAGNOSTICS INC |
EP3122776 | FGF21 RECEPTOR AGONISTS AND USES THEREOF | REGENERON PHARMA |
EP3124519 | COPOLYMER AND ORGANIC SOLAR CELL COMPRISING SAME | LG CHEMICAL LTD |
EP3126323 | MINIMIZING WATER CONTENT IN ETHANOLAMINE PRODUCT STREAMS | SABIC GLOBAL TECHNOLOGIES BV |
EP3126371 | METAL COMPLEXES, COMPRISING CARBENE LIGANDS HAVING AN O-SUBSTITUTED NON-CYCLOMETALATED ARYL GROUP AND THEIR USE IN ORGANIC LIGHT EMITTING DIODES | UDC IRELAND LTD |
EP3126380 | CHIMERIC ANTIGEN RECEPTOR (CAR) SIGNALLING SYSTEM | UCL BUSINESS PLC |
EP3127894 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO |
EP3127898 | OXIME ESTER COMPOUND AND PHOTOPOLYMERIZATION INITIATOR CONTAINING SAID COMPOUND | ADEKA CORP |
EP3127905 | HIGH-PURITY MAGNESIUM LITHOSPERMATE B AND PREPARATION METHOD THEREFOR | SHANGHAI INST MATERIA MEDICA CAS |
EP3127917 | METHOD FOR PREPARING ANTIBODY THROUGH REGULATION OF SUGAR CONTENT OF ANTIBODY | PRESTIGE BIOPHARMA PTE LTD |
EP3127923 | METHOD FOR IMPROVING SOLUBILITY OF PROTEIN AND PEPTIDE BY USING IMMUNOGLOBULIN FC FRAGMENT LINKAGE | HANMI PHARM IND CO LTD |
EP3129023 | POTENT SOLUBLE EPOXIDE HYDROLASE INHIBITORS | EICOSIS LLC |
EP3129347 | REACTIONS IN THE PRESENCE OF RUTHENIUM COMPLEXES | CALIFORNIA INST OF TECHN |
EP3129350 | MACROCYCLES | LUMIPHORE INC |
EP3129359 | DIAMINOTRIAZINE DERIVATIVES AS HERBICIDES | BASF SE |
EP3129368 | CYTOTOXIC COMPOUNDS WHICH ARE INHIBITORS OF THE POLYMERISATION OF TUBULIN | CENTRE NAT DE LA RECH SCIENT (C N R S ) |
EP3129373 | HISTONE DEACETYLASE INHIBITORS | |
EP3129393 | CRISPR ENZYME MUTATIONS REDUCING OFF-TARGET EFFECTS | BROAD INST INC |
EP3129399 | DRUG RELATED TRANSGENE EXPRESSION | SEATTLE CHILDREN'S HOSPITAL DBA SEATTLE CHILDREN'S RES INST |
EP3129405 | TRANSGENE GENETIC TAGS AND METHODS OF USE | SEATTLE CHILDREN'S HOSPITAL (DBA SEATTLE CHILDREN'S RES INSTITUTE) |
EP3129493 | IMPORT OF UNNATURAL OR MODIFIED NUCLEOSIDE TRIPHOSPHATES INTO CELLS VIA NUCLEIC ACID TRIPHOSPHATE TRANSPORTERS | SCRIPPS RESEARCH INST |
EP3129767 | REACTIVE LABELLING COMPOUNDS AND USES THEREOF | |
EP3130587 | HYDROPHILIC POLYMER DERIVATIVE HAVING CYCLIC BENZYLIDENE ACETAL LINKER | NOF CORP |
EP3130596 | NOVEL GLUCOSE DERIVATIVE, AND CELL IMAGING METHOD AND IMAGING AGENT USING SAID DERIVATIVE | UNIV HIROSAKI |
EP3131131 | LIGHT-EMISSION ELEMENT, AND COMPOSITION USED THEREIN | SUMITOMO CHEMICAL CO |
EP3131550 | METHODS FOR TREATING CANCER USING TOR KINASE INHIBITOR COMBINATION THERAPY | SIGNAL PHARM LLC |
EP3131908 | METHODS AND DEVICES FOR ISOLATING LEAD 203 | LANTHEUS MEDICAL IMAGING INC |
EP3131920 | MSP NANOPORES AND USES THEREOF | UAB RES FOUND |
EP3131994 | RAPID-CURING, MIGRATION-FREE COMPOSITION BASED ON ORGANIC POLYMERS CONTAINING SILANE GROUPS | SIKA TECH AG |
EP3132005 | METHOD FOR THERMAL CONVERSION OF KETOACIDS AND HYDROTREATMENT TO HYDROCARBONS | NESTE OIL OYJ |
EP3133932 | EGG WHITE PROCESSING | ALEXION PHARMA INC |
EP3134389 | QUINAZOLINE SCAFFOLD BASED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF | TECHNION RES & DEV FOUNDATION |
EP3134410 | INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL | HYDRA BIOSCIENCES INC |
EP3134431 | LDLR VARIANTS AND THEIR USE IN COMPOSITIONS FOR REDUCING CHOLESTEROL LEVELS | UNIV PENNSYLVANIA |
EP3134522 | RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS | UNIV MASSACHUSETTS |
EP3135666 | (S)-OXIRACETAM CRYSTAL FORM III, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | CHONGQING RUNZE PHARMACEUTICAL |
EP3135744 | MONOAMINE MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | SAMSUNG DISPLAY CO LTD |
EP3137169 | INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 | CELGENE QUANTICEL RES INC |
EP3137186 | METHODS FOR THE PURIFICATION OF PROTEINS USING CAPRYLIC ACID | NOVO NORDISK AS |
EP3137447 | INHIBITORS OF CREATINE TRANSPORT AND USES THEREOF | RGENIX INC |
EP3137451 | ELECTRON TRANSPORT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM & HAAS ELECT MATERIALS KOREA LTD |
EP3137456 | PYRIDAZINONE HERBICIDES | DU PONT |
EP3137461 | OPTICALLY ACTIVE PDE10 INHIBITOR | OMEROS CORP |
EP3137478 | PHOSPHOROUS PROTECTING GROUPS AND METHODS OF PREPARATION AND USE THEREOF | AGILENT TECHNOLOGIES INC |
EP3137487 | POLYPEPTIDES FOR GENERATING ANTI-INFLUENZA ANTIBODIES AND USES THEREOF | INDIAN INST SCIENT |
EP3137490 | MUTANT PORES | OXFORD NANOPORE TECH LTD |
EP3137494 | ISLET AMYLOID POLYPEPTIDES WITH IMPROVED SOLUBILITY | UNIV NEW YORK STATE RES FOUND |
EP3137497 | AAV VECTORS FOR RETINAL AND CNS GENE THERAPY | GENZYME CORP |
EP3137501 | ION CHANNEL MODULATORS AND USES THEREOF | MEDIMMUNE LTD |
EP3138580 | COVALENTLY LINKED ANTIGEN-ANTIBODY CONJUGATES | HOFFMANN LA ROCHE |
EP3138853 | FC VARIANTS WITH ALTERED BINDING TO FCRN | XENCOR INC |
EP3139947 | CONJUGATES OF AN IL-15 MOIETY AND A POLYMER | NEKTAR THERAPEUTICS |
EP3140292 | CATALYST RECYCLE METHODS | NOVOMER INC |
EP3140306 | PHOTO-STABLE AND THERMALLY-STABLE DYE COMPOUNDS FOR SELECTIVE BLUE LIGHT FILTERED OPTIC | FRONTIER SCIENT INC |
EP3140322 | MODIFIED FC GAMMA RECEPTOR TYPE III (FC III, HNA-1) POLYPEPTIDES AND THE USES THEREOF | ONE LAMBDA INC |
EP3141540 | CRYSTALLINE FORM OF CHLOROGENIC ACID AND PREPARATION METHOD THEREFOR | SICHUAN JIUZHANG BIOLOGICAL SCIENCE & TECH CO LTD |
EP3141565 | SPHERICAL PARTICLES | EVONIK DEGUSSA GMBH |
EP3142700 | MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES | MEDIMMUNE LLC |
EP3143022 | CARBOPYRONONE COMPOUNDS USEFUL AS DIAGNOSTIC ADJUVANTS | LIFE TECHNOLOGIES CORP |
EP3143037 | ALPHA4BETA7 INTEGRIN THIOETHER PEPTIDE ANTAGONISTS | PROTAGONIST THERAPEUTICS INC |
EP3143403 | METHODS FOR DETECTING AND/OR MEASURING ANTI-DRUG ANTIBODIES, IN PARTICULAR TREATMENT-EMERGENT ANTI-DRUG ANTIBODIES | ABLYNX NV |
EP3144015 | NOVEL LOW MOLECULAR WEIGHT CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY | SIRNA THERAPEUTICS INC |
EP3144302 | HETEROCYCLIC COMPOUND CONTAINING AROMATIC AMINE GROUP, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO LTD |
EP3144371 | HYDROXYALKYL SUBSTITUTED SUCCINIMIDES AND FUELS CONTAINING THEM | AFTON CHEMICAL CORP |
EP3145901 | PROCESS FOR GENERATING A MIXED MULTICOMPONENT VAPOR FOR PREPARATION OF MONOALKYL ETHERS OF DIPHENOLS | CAMLIN FINE SCIENCES LTD |
EP3145931 | TREATMENT OF AUTOIMMUNE DISEASE | MINGSIGHT PHARMACEUTICALS INC |
EP3145944 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX PHARMACEUTICALS INC |
EP3146080 | ALLELE-SPECIFIC AMPLIFICATION USING A COMPOSITION OF OVERLAPPING NON-ALLELE-SPECIFIC PRIMER AND ALLELE-SPECIFIC BLOCKER OLIGONUCLEOTIDES | UNIV RICE WILLIAM M |
EP3147282 | OPTICAL RESOLUTION METHOD OF LENALIDOMIDE | SHISEIDO CO LTD |
EP3148577 | NOVEL SEMI-SYNTHETIC MENINGOCOCCAL CONJUGATE VACCINE | BIOLOGICAL E LTD |
EP3148580 | TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENS AND METHODS OF USE THEREOF | MACROGENICS INC |
EP3148996 | C2-CARBOCYCLIC IMINOTHIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE | MERCK SHARP & DOHME |
EP3149000 | IMPROVED FORMS OF A PI3K DELTA SELECTIVE INHIBITOR FOR USE IN PHARMACEUTICAL FORMULATIONS | RHIZEN PHARMACEUTICALS S A |
EP3149015 | MINIMAL SAPONIN ANALOGUES, SYNTHESIS AND USE THEREOF | MEMORIAL SLOAN-KETTERING CANCER CENTER |
EP3149024 | DERIVATIVES OF DOLAPROINE-DOLAISOLEUINE PEPTIDES | AGENSYS INC |
EP3149028 | VARIANTS OF GH FAMILY 11 XYLANASE AND POLYNUCLEOTIDES ENCODING SAME | NOVOZYMES AS |
EP3149032 | NEW BISPECIFIC FORMAT SUITABLE FOR USE IN HIGH-THROUGH-PUT SCREENING | UCB BIOPHARMA SPRL |
EP3150218 | TARGETED INTERFERON DEMONSTRATES POTENT APOPTOTIC AND ANTI-TUMOR ACTIVITIES | UNIV CALIFORNIA |
EP3150579 | FLUORANTHENE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT-EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT | TORAY INDUSTRIES |
EP3150604 | BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE CARRYING BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLYL GROUPS, CARBAZOLYL GROUPS, BENZOFURANE GROUPS OR BENZOTHIOPHENE GROUPS FOR ORGANIC LIGHT EMITTING DIODES | IDEMITSU KOSAN CO |
EP3150625 | A FAMILY OF PESTICIDAL PROTEINS AND METHODS FOR THEIR USE | ATHENIX CORP |
EP3151940 | PROCESS FOR OPERATING A SIMULATED MOVING BED REACTOR | DOW GLOBAL TECHNOLOGIES LLC |
EP3152231 | PEPTIDES, AND METHODS AND APPARATUS UTILISING SAME | UNIV MANCHESTER |
EP3152235 | TRI-SPECIFIC BINDING MOLECULES AND METHODS OF USE THEREOF | MACROGENICS INC |
EP3153583 | EXPRESS HUMANIZATION OF ANTIBODIES | BIOATLA LLC |
EP3154583 | HUMAN MONOCLONAL ANTIBODIES TO GANGLIOSIDE GD2 | MABVAX THERAPEUTICS INC |
EP3154584 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS | XBIOTECH INC |
EP3154669 | COMPOSITIONS OF MONO-ALKYL ETHERS OF MONOANHYDRO-HEXITOLS, PRODUCTION METHODS THEREOF AND USE OF SAME | SYRAL BELGIUM NV |
EP3154941 | SMALL MOLECULE LFA-1 INHIBITORS | ALLOCYTE PHARMACEUTICALS AG |
EP3154945 | COMPLEXES | JOHNSON MATTHEY PLC |
EP3155004 | VACCINE FOR IMMUNOCOMPROMISED HOSTS | UNIV DO PORTO - REITORIA |
EP3155011 | GLYCOPROTEIN HORMONE RECEPTOR MUTATIONS | RSR LTD |
EP3156396 | N-SUBSTITUTED SULFONAMIDE COMPOUND AND METHOD FOR PRODUCING SAME | UBE INDUSTRIES |
EP3156402 | PYRIMIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO LTD |
EP3156413 | GANIRELIX PRECURSOR AND METHOD FOR PREPARING GANIRELIX ACETATE BY USING ANIRELIX PRECURSOR | HYBIO PHARMACEUTICAL CO LTD |
EP3157571 | FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | NOVARTIS AG |
EP3157674 | CATALYST COMPOSITIONS, METHODS OF PREPARATION THEREOF, AND PROCESSES FOR ALKOXYLATING ALCOHOLS USING SUCH CATALYSTS | SASOL (USA) CORP |
EP3157892 | SALT REMOVAL AND TRANSPORT SYSTEM FOR USE IN A MONOETHYLENEGLYCOL (MEG) RECLAMATION PROCESS | CAMERON SOLUTIONS INC |
EP3157895 | FULLERENE DERIVATIVES | MERCK PATENT GMBH |
EP3157937 | GREEN METHODS FOR PREPARING HIGHLY CO2 SELECTIVE AND H2S TOLERANT METAL ORGANIC FRAMEWORKS | UNIV KING ABDULLAH SCI & TECH |
EP3157952 | TREATMENT OF CONGESTIVE HEART FAILURE AND OTHER CARDIAC DYSFUNCTION USING A GDF15 MODULATOR | AVEO PHARMACEUTICALS INC |
EP3157953 | TREATMENT OF CHRONIC KIDNEY DISEASE AND OTHER RENAL DYSFUNCTION USING A GDF15 MODULATOR | AVEO PHARMACEUTICALS INC |
EP3159417 | METHODS OF NONSPECIFIC TARGET CAPTURE OF NUCLEIC ACIDS | GEN-PROBE INCORPORATED |
EP3160501 | INFLUENZA VIRUS HEMAGGLUTININ PROTEIN AS A VACCINE ANTIGEN | INST BIOTECHNOLOGII I ANTYBIOTYKOW |
EP3160935 | PROCESS FOR PREPARATION OF DI- AND POLYAMINES OF THE DIPHENYLMETHANE SERIES | COVESTRO DEUTSCHLAND AG |
EP3160936 | PROCESS FOR PREPARATION OF DI- AND POLYAMINES OF THE DIPHENYLMETHANE SERIES | COVESTRO DEUTSCHLAND AG |
EP3160958 | CRYSTALLINE SALTS OF (S)-6-((1-ACETYLPIPERIDIN-4-YL)AMINO)-N-(3-(3,4-DIHYDROISOQUINOLIN-2(1H)-YL)-2-HYDROXYPROPYL)PYRIMIDINE-4-CARBOXAMIDE | GLAXOSMITHKLINE IP DEV LTD |
EP3160984 | PROCESS FOR PREPARING D-ARGINYL-2,6-DIMETHYL-L-TYROSYL-L-LYSYL-L-PHENYLALANINAMIDE | FLAMMA SPA |
EP3160985 | PROCESS FOR THE PRODUCTION OF D-ARGINYL-2,6-DIMETHYL-L-TYROSYL-L-LYSYL-L-PHENYLALANINAMIDE | FLAMMA SPA |
EP3161051 | COMPOSITION FOR PREPARING AN AMORPHOUS POLYMERIC FOAM USING A BENZYLIDENE SORBITOL NUCLEATING AGENT | CLARIANT INT LTD |
EP3162796 | METHOD FOR PRODUCING 2-AMINO-6-METHYLNICOTINIC ACID | AGRO-KANESHO CO LTD |
EP3162797 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | HEESUNG MAT LTD |
EP3162799 | FLUOROALKYLATING AGENT | IHARA CHEMICAL IND CO |
EP3162809 | CARRIER FOR AFFINITY CHROMATOGRAPHY | JSR CORP |
EP3163644 | ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO LTD |
EP3164194 | Dickkopf2 (Dkk2) Inhibition Suppresses Tumor Formation | UNIV YALE |
EP3164204 | SELECTIVE NUCLEIC ACID SEPARATION | SIEMENS HEALTHCARE DIAGNOSTICS INC |
EP3164385 | NOVEL POLYMORPHIC FORM OF N-[2-(6-FLUORO-LH-INDOL-3-YL)ETHYL]-3-(2,2,3,3-TETRAFLUOROPROPOXY)BENZYLAMINE HYDROCHLORIDE FOR THE TREATMENT OF ALZHEIMER'S | H LUNDBECK AS |
EP3164409 | GROUP 8 TRANSITION METAL CATALYSTS AND METHOD FOR MAKING SAME AND PROCESS FOR USE OF SAME IN METATHESIS REACTION | GUANG MING INNOVATION COMPANY (WUHAN) |
EP3164410 | PROTEIN RECOVERY | HERIOT-WATT UNIV |
EP3165528 | IONIC COMPLEX, ELECTROLYTE FOR NONAQUEOUS ELECTROLYTE BATTERY, NONAQUEOUS ELECTROLYTE BATTERY AND IONIC COMPLEX SYNTHESIS METHOD | CENTRAL GLASS CO LTD |
EP3165539 | IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS | KIRIN-AMGEN INC |
EP3166634 | NOVEL VACCINE COMPOSITIONS FOR PORCINE EPIDEMIC DIARRHEA VIRUS AND PORCINE DELTACORONAVIRUS | ZOETIS SERVICES LLC |
EP3166636 | PSGL-1 MODULATORS AND USES THEREOF | SANFORD-BURNHAM MEDICAL RES INST |
EP3166916 | METHOD OF DEPOLYMERIZING LIGNIN | COMMISSARIAT à L'éNERGIE ATOMIQUE ET AUX éNERGIES ALTERNATIVES |
EP3166917 | METHOD OF PREPARING AROMATIC COMPOUNDS FROM LIGNIN | COMMISSARIAT à L'éNERGIE ATOMIQUE ET AUX éNERGIES ALTERNATIVES |
EP3166944 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM & HAAS ELECT MATERIALS KOREA LTD |
EP3166949 | THIENOTHIOPHENE-ISOINDIGO | BASF SE |
EP3166968 | COMPOSITIONS AND METHODS OF CHIMERIC AUTOANTIBODY RECEPTOR T CELLS | UNIV PENNSYLVANIA |
EP3166970 | IMPROVED A脽 PROTOFIBRIL BINDING ANTIBODIES | BIOARCTIC NEUROSCIENCE AB |
EP3167283 | DEVICE, USE OF SAID DEVICE, AND METHOD FOR SEPARATING SUBSTANCES WITH AN IMPROVED UTILIZATION OF THE CAPACITY OF CHROMATOGRAPHIC MEDIA | SARTORIUS STEDIM BIOTECH GMBH |
EP3167899 | ISOLATED POLYPEPTIDE OF THE TOXIN A AND TOXIN B PROTEINS OF C.DIFFICILE AND USES THEREOF | VALNEVA AUSTRIA GMBH |
EP3168232 | COMPOSITIONS, KITS, AND METHODS FOR THE DIAGNOSIS, PROGNOSIS, MONITORING, TREATMENT AND MODULATION OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AND HYPOXIA ASSOCIATED ANGIOGENESIS DISORDERS USING GALECTIN-1 | DANA FARBER CANCER INST INC |
EP3169670 | QUINOXALINE COMPOUNDS, METHOD FOR PREPARING THE SAME AND USE THEREOF | |
EP3169674 | ARYL-TRIAZOLYL-PYRIDINES AS PESTICIDES | BAYER ANIMAL HEALTH GMBH |
EP3169709 | CRYSTALLINE ANTIBODY FORMULATIONS | AMGEN INC |
EP3170901 | METHOD FOR IDENTIFYING EPITOPE OF PROTEIN | CHUGAI PHARMACEUTICAL CO LTD |
EP3171706 | NUTRITIONAL COMPOSITIONS CONTAINING PHOSPHATIDYLSERINE POWDER | ENZYMOTEC LTD |
EP3171870 | PROTEIN PHOSPHATASE 2A INHIBITORS FOR TREATING MYELODYSPLASTIC SYNDROMES | H LEE MOFFITT CANCER CT & RES |
EP3171892 | ANTI-PD-1 ANTIBODIES | CB THERAPEUTICS INC |
EP3172213 | MACROCYCLIC KINASE INHIBITORS AND USES THEREOF | DANA FARBER CANCER INST INC |
EP3172217 | PHOSPHORUS CONTAINING FLAME RETARDANTS | CHEMTURA CORP |
EP3172221 | PURIFICATION PLATFORM FOR BISPECIFIC ANTIBODIES | REGENERON PHARMA |
EP3172225 | COMPOSITIONS AND METHODS FOR INCREASING PLANT GROWTH AND YIELD USING RICE PROMOTERS | BENSON HILL BIOSYSTEMS INC |
EP3172230 | COMPOSITIONS AND METHODS FOR TARGETING OF THE SURFACTANT PROTEIN A RECEPTOR | PENN STATE RES FOUND |
EP3172231 | BCMA CHIMERIC ANTIGEN RECEPTORS | BLUEBIRD BIO INC |
EP3172296 | SELECTIVE ALKYLATION METHOD FOR PRODUCING P, P'-DI-ALKYLATED DIPHENYLAMINE ANTIOXIDANTS | CHEMTURA CORP |
EP3173485 | PLANT WITH TOLERANCE OF THE COLD | KWS SAAT SE & CO KGAA |
EP3174537 | MONOCYCLIC ISOXAZOLINES AS INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN | MERCK SHARP & DOHME |
EP3174868 | COMPOUNDS ACTIVE TOWARDS BROMODOMAINS | NUEVOLUTION AS |
EP3174894 | COMPOSITIONS AND METHODS OF USE FOR TREATING METABOLIC DISORDERS | NGM BIOPHARMACEUTICALS INC |
EP3174932 | CURE ACCELERATORS FOR ANAEROBIC CURABLE COMPOSITIONS | HENKEL IP & HOLDING GMBH |
EP3177282 | ANTIDIABETIC BICYCLIC COMPOUNDS | MERCK SHARP & DOHME |
EP3177616 | NOVEL ROUTES OF SYNTHESIS FOR THE PREPARATION OF SUVOREXANT | SANDOZ AG |
EP3177642 | ANGIOPOIETIN-LIKE 4 ANTIBODIES AND METHODS OF USE | NOVARTIS AG |
EP3177645 | SUBCUTANEOUSLY ADMINISTERED BISPECIFIC ANTIBODIES FOR USE IN THE TREATMENT OF CANCER | LINDHOFER HORST DR |
EP3177932 | BIOMARKERS OF POLYCYSTIC KIDNEY DISEASE AND USES THEREOF | GENZYME CORP |
EP3178472 | ORAL FORMULATIONS OF METHYLNALTREXONE | WYETH LLC |
EP3178850 | COMPOSITIONS COMPRISING CROSS-SPECIES-SPECIFIC ANTIBODIES AND USES THEREOF | AMGEN RES (MUNICH) GMBH |
EP3178929 | NEW ANTI-HUMAN IG(BETA) ANTIBODY | ASTELLAS PHARMA INC |
EP3179308 | UNDERLAYER FILM-FORMING COMPOSITION FOR LITHOGRAPHY, UNDERLAYER FILM FOR LITHOGRAPHY, AND PATTERN FORMING METHOD | MITSUBISHI GAS CHEMICAL CO |
EP3180004 | CANCER THERAPEUTICS | UNIV VIRGINIA PATENT FOUNDATION |
EP3180313 | 2-OXO-3,4-DIHYDROQUINOLIN-6-YL SULPHONAMIDES AND THEIR USE AS PLANT GROWTH REGULATORS. | UNIV CALIFORNIA |
EP3180320 | PROCESS FOR PREPARING FURFURAL FROM BIOMASS | SHELL INT RESEARCH |
EP3180330 | 2,2,2-TRIFLUOROETHYL-THIADIAZINES | HOFFMANN LA ROCHE |
EP3180332 | DIFLUOROPYRROLIDINES AS OREXIN RECEPTOR MODULATORS | EOLAS THERAPEUTICS INC |
EP3180352 | ADVANCED MACROMOLECULE TRANSDUCTION DOMAIN (AMTD) SEQUENCES FOR IMPROVEMENT OF CELL-PERMEABILITY, POLYNUCLEOTIDES ENCODING THE SAME, METHOD TO IDENTIFY THE UNIQUE FEATURES OF AMTDS COMPRISING THE SAME, METHOD TO DEVELOP THE AMTD SEQUENCES COMPRISING THE SAME | CELLIVERY THERAPEUTICS INC |
EP3180353 | MYCOBACTERIUM TUBERCULOSIS PROTEINS | OXFORD IMMUNOTEC LTD |
EP3180619 | SIGNAL AMPLIFICATION IN PLASMONIC SPECIFIC-BINDING PARTNER ASSAYS | ABAY SA |
EP3181575 | CELLULAR LIBRARIES OF PEPTIDE SEQUENCES (CLIPS) AND METHODS OF USING THE SAME | UNIV CALIFORNIA |
EP3183100 | PROCESS FOR THE RECOVERY OF CARBOXYLIC ACID AND WOOD TREATMENT PROCESS | SOLVAY ACETOW GMBH |
EP3183252 | OXALATE SALT OF RUXOLITINIB | RATIOPHARM GMBH |
EP3183260 | MODIFIED OLIGONUCLEOTIDES AND METHODS FOR THEIR SYNTHESIS | NOOGEN LLC |
EP3183270 | HIV ANTIBODY THERAPY AS TREATMENT SUBSTITUTE | CYTODYN INC |
EP3183272 | ASYMMETRIC MULTISPECIFIC ANTIBODIES | ARGEN-X N V |
EP3183362 | ELECTROCHEMICAL DETECTION OF MICROORGANISMS | UNIV NANYANG TECH |
EP3184513 | CRYSTALLINE AND AMORPHOUS FORMS OF OLAPARIB | OLON SPA |
EP3184533 | METAL COMPLEX, ITS METHOD OF PREPARATION AND USE | ARKEMA B V |
EP3184616 | METHOD FOR PRODUCING MONOGLYCERIDE-CONTAINING COMPOSITION | KAO CORP |
EP3185887 | METHOD FOR PREPARING CRYSTALLINE INSULIN OR INSULIN ANALOG COMPOSITIONS | MERCK SHARP & DOHME |
EP3186216 | THE OPTIMIZATION OF O-SULFONATED PHENOL PRODUCTION FOR CUMENE HYDROPEROXIDE CLEAVAGE | SABIC GLOBAL TECHNOLOGIES BV |
EP3186227 | NOVEL SULFONYLAMINOBENZAMIDE COMPOUNDS AS ANTHELMINTICS | NOVARTIS TIERGESUNDHEIT AG |
EP3186233 | PROBES FOR IMAGING HUNTINGTIN PROTEIN | CHDI FOUNDATION INC |
EP3186242 | INHIBITORS OF -AMINO- -CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE | TES PHARMA S R L |
EP3186247 | PROTEIN KINASE INHIBITORS | ASTAR BIOTECH LLC |
EP3186269 | COMPOSITIONS, METHODS AND KITS FOR TREATING COMPLEMENT RELATED DISORDERS | UNIV TUFTS |
EP3186274 | INTRACELLULAR OSTEOPONTIN REGULATES THE LINEAGE COMMITMENT OF LYMPHOID SUBSETS | DANA FARBER CANCER INST INC |
EP3188747 | ELEVATED INTRACRANIAL PRESSURE TREATMENT | UNIV BIRMINGHAM |
EP3189022 | SEPARATION PROCESS FOR C8 AROMATICS MIXTURE | SCG CHEMICALS CO LTD |
EP3189023 | PROCESS FOR THE ENHANCED SEPARATION OF ETHYLBENZENE | SCG CHEMICALS CO LTD |
EP3189025 | PROCESS FOR PRODUCING CHLOROTRIFLUOROETHYLENE | HONEYWELL INT INC |
EP3189053 | AN IMPROVED PROCESS FOR THE PREPARATION OF APIXABAN AND INTERMEDIATES THEREOF | UNICHEM LAB LTD |
EP3189065 | STEVIA EXTRACTS ENRICHED IN REBAUDIOSIDE D, E, N AND/OR O AND PROCESS FOR THE PREPARATION THEREOF | PURECIRCLE USA INC |
EP3189067 | RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE | US HEALTH |
EP3189071 | NOVEL AMYLIN AND CALCITONIN RECEPTOR AGONIST | NOVO NORDISK AS |
EP3189153 | COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF | BOEHRINGER INGELHEIM INT |
EP3189840 | METHYLPHENIDATE-PRODRUGS, PROCESSES OF MAKING AND USING THE SAME | KEMPHARM INC |
EP3190100 | POLYMERIZABLE COMPOUND, POLYMER, POLYMERIZABLE COMPOSITION, AND FILM | FUJIFILM CORP |
EP3190113 | PYRROLOPYRIMIDINE COMPOUNDS USED AS TLR7 AGONIST | CHAI TAI TIANQING PHARMACEUTICAL GROUP CO LTD |
EP3190120 | CATALYST FOR SYNTHESIZING POLYOLEFINS | UNIV TOKYO |
EP3191187 | COMBINATION THERAPIES WITH ANTI-CD38 ANTIBODIES | JANSSEN BIOTECH INC |
EP3191438 | SWEETNESS ENHANCER | PEPSICO INC |
EP3191446 | METHOD FOR PREPARING ALPHA-HYDROXYCARBOXYLIC ACID ESTERS IN WHICH AMMONIA IS RECYCLED | EVONIK ROEHM GMBH |
EP3191461 | CRYSTALLINE SOLID FORMS OF 6-CARBOXY-2-(3,5-DICHLOROPHENYL)-BENZOXAZOLE | PFIZER |
EP3191469 | 2-H-INDAZOLE DERIVATIVES AS CYCLIN-DEPENDENT KINASE (CDK) INHIBITORS AND THERAPEUTIC USES THEREOF | BETA PHARMA INC |
EP3191489 | PYRROLOPYRIMIDINES FOR USE IN INFLUENZA VIRUS INFECTION | JANSSEN SCIENCES IRELAND UC |
EP3191496 | NOVEL IMINES WITH TUNABLE NUCLEOPHILICITY AND STERIC PROPERTIES THROUGH METAL COORDINATION: APPLICATIONS AS LIGANDS AND METALLOORGANOCATALYSTS | UNIV KING ABDULLAH SCI & TECH |
EP3191502 | TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCES | SEATTLE GENETICS INC |
EP3193586 | NEW PHYTOPHTHORA RESISTANCE GENE | UNIV WAGENINGEN |
EP3193914 | ORGAN PROTECTION IN PSMA-TARGETED RADIONUCLIDE THERAPY OF PROSTATE CANCER | MOLECULAR INSIGHT PHARM INC |
EP3193934 | COMPOSITIONS FOR IMPROVING THE HEALTH RELATED QUALITY OF LIFE OF RHEUMATOID ARTHRITIS PATIENTS | SANOFI BIOTECHNOLOGY |
EP3194373 | DIAGNOSTIC SYSTEM AND PROCESS FOR RAPID BACTERIAL INFECTION DIAGNOSIS | UNIV NORTHEASTERN |
EP3194418 | SYNTHESIS OF ENT-PROGESTERONE AND INTERMEDIATES THEREOF | PREVACUS INC |
EP3194420 | IDENTIFYING STATUS OF MALE FERTILITY BY DETERMINING SPERM CAPACITATION | UNIV CORNELL |
EP3194437 | ANGIOPOETIN-LIKE 4 (ANGPTL4) ANTIBODIES AND METHODS OF USE | NOVARTIS AG |
EP3194443 | TARGETING CYTOTOXIC CELLS WITH CHIMERIC RECEPTORS FOR ADOPTIVE IMMUNOTHERAPY | NOVARTIS AG |
EP3194447 | ANTIBODIES CAPABLE OF BINDING TWO EPITOPES ON TISSUE FACTOR PATHWAY INHIBITOR (1-161) | NOVO NORDISK AS |
EP3194601 | ADENO-ASSOCIATED VIRAL VECTORS FOR TREATING MYOCILIN (MYOC) GLAUCOMA | GENZYME CORP |
EP3196181 | METHOD FOR PRODUCING BUTADIENE AND DEVICE FOR PRODUCING BUTADIENE | SEKISUI CHEMICAL CO LTD |
EP3196182 | IMPROVED METHOD FOR PRODUCING 2-CHLORO-3,3,3,-TRIFLUOROPROPENE (HCFC-1233XF) | HONEYWELL INT INC |
EP3196184 | IRIDIUM COMPLEX PRODUCTION METHOD | TANAKA PRECIOUS METAL IND |
EP3196211 | HUMAN ANTIBODY SPECIFIC TO C-MET AND PREPARATION METHOD THEREFOR | PHARMABCINE INC |
EP3196213 | ANTIBODIES DIRECTED TO HER-3 AND USES THEREOF | DAIICHI SANKYO EUROPE GMBH |
EP3197454 | CONTINUOUS FLOW CARBOXYLATION REACTION | SARCODE BIOSCIENCE INC |
EP3197473 | PROTEINS INCREASING PANCREATIC BETA CELL NUMBER AND METHODS OF USE | UNIV OREGON |
EP3197905 | METHOD FOR PRODUCING ETHYLENEDIALKYLPHOSPHINIC ACIDS, ESTERS AND SALTS, AND THE USE THEREOF AS FLAME RETARDANTS | CLARIANT PLASTICS & COATINGS LTD |
EP3197922 | PROTEIN ISOLATION | IDEA TREA LLC |
EP3198053 | USE OF AT LEAST ONE BINARY GROUP 15 ELEMENT COMPOUND, A 13/15 SEMICONDUCTOR LAYER AND BINARY GROUP 15 ELEMENT COMPOUNDS. | PHILIPPS UNIVERSITÄT MARBURG |
EP3199518 | PROCESS FOR PRODUCING HIGH-PURITY AQUEOUS UREA SOLUTION IN UREA PRODUCTION PROCESS | TOYO ENGINEERING CORP |
EP3199519 | METHOD FOR PRODUCING METHIONINE | SUMITOMO CHEMICAL CO |
EP3199544 | PREPARATION METHOD FOR GLATIRAMER ACETATE | HYBIO PHARMACEUTICAL CO LTD |
EP3200807 | ANALYSIS OF T-CELL MONOTYPIA | UNIV OXFORD INNOVATION LTD |
EP3200911 | METHOD FOR LIQUID AUTHENTICATION BY DETECTION OF FLAVONOID DERIVATIVES | SICPA HOLDING SA |
EP3201193 | BENZENECARBOTHIOCCYCLOPENTA[C]PYRROLE-1,3-DIONE COMPOUNDS AND PROCESS FOR SYNTHESIS THEREOF | COUNCIL SCIENT IND RES |
EP3201204 | C5-C6-FUSED TRICYCLIC IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE | MERCK SHARP & DOHME |
EP3201207 | BORONIC ACID DERIVATIVES | MERCK PATENT GMBH |
EP3201208 | BORONIC ACID DERIVATIVES | MERCK PATENT GMBH |
EP3201211 | NON-CALORIC SWEETENERS AND METHODS FOR SYNTHESIZING | CONAGEN INC |
EP3201213 | MIR-29 MIMICS AND USES THEREOF | MIRAGEN THERAPEUTICS INC |
EP3201215 | METHODS OF PREPARING INTERMEDIATE OF FLUTICASONE PROPIONATE | AMPHASTAR PHARMACEUTICALS INC |
EP3201218 | BETA-HAIRPIN PEPTIDOMIMETICS | POLYPHOR AG |
EP3201219 | BETA-HAIRPIN PEPTIDOMIMETICS | POLYPHOR AG |
EP3202757 | POLYETHER DIOL AND METHOD FOR PRODUCING SAME | MITSUBISHI GAS CHEMICAL CO |
EP3202872 | ORGANIC LIGHT EMITTING ELEMENT | LG CHEMICAL LTD |
EP3204040 | TREATMENT OF CANCER USING TLR9 AGONIST WITH CHECKPOINT INHIBITORS | IDERA PHARMACEUTICALS INC |
EP3204120 | METHODS AND COMPOSITIONS FOR INCREASING THE POTENCY OF ANTIFUNGAL AGENTS | PACIFIC NORTHWEST RES INST |
EP3204386 | SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | SIGNAL PHARM LLC |
EP3204410 | BIPHASIC SINGLE-CHAIN INSULIN ANALOGUES | UNIV CASE WESTERN RESERVE |
EP3204502 | METHOD TO REDUCE ONCOGENIC POTENTIAL OF INDUCED PLURIPOTENT STEM CELLS FROM AGED DONORS | MEMORIAL SLOAN-KETTERING CANCER CENTER |
EP3204511 | MUTANT PORES | OXFORD NANOPORE TECH LTD |
EP3205639 | PROTECTING-GROUP INTRODUCING AGENT FOR HYDROXY GROUP AND/OR MERCAPTO GROUP | UNIV KYUSHU NAT UNIV CORP |
EP3205649 | NOVEL FLUORINATED UNSATURATED CYCLIC CARBONATE AND PROCESS FOR PRODUCING SAME | DAIKIN IND LTD |
EP3205658 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP |
EP3206669 | FORMULATIONS HAVING ANTI-INFLAMMATORY ACTIVITY AND ANTIMICROBIAL ACTIVITY AGAINST GRAM-POSITIVE BACTERIA | NATUREZA INC |
EP3206689 | INHIBITORS OF LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE AND USES THEREOF | LA JOLLA INST OF ALLERGY & IMMUNOLOGY |
EP3207005 | ETHYLENE SEPARATION WITH PRESSURE SWING ADSORPTION | CHEVRON PHILLIPS CHEMICAL CO LP |
EP3207006 | A PROCESS FOR PRODUCING HIGHLY PURE CHLORINATED ALKANES | SPOLEK PRO CHEMICKOU A HUTNI VYROBU AS |
EP3207007 | PROCESS | SPOLEK PRO CHEMICKOU A HUTNI VYROBU AS |
EP3207010 | COMPOSITIONS COMPRISING 1,1,1,2,3 PENTACHLOROPROPANE | ARKEMA FRANCE |
EP3207011 | COMPOSITIONS CONTAINING 1,1,1,3,3-PENTACHLOROPROPANE | ARKEMA FRANCE |
EP3207012 | PROCESS | SPOLEK PRO CHEMICKOU A HUTNI VYROBU AS |
EP3207029 | TRYPTAMIDE COMPOSITIONS AND METHODS OF USE | SIGNUM BIOSCIENCES INC |
EP3207031 | ATAXIA TELENGIECTASIA AND RAD3-RELATED (ATR) PROTEIN KINASE INHIBITORS | ATRIN PHARMACEUTICALS LLC |
EP3207049 | NOVEL CHIMERIC INSECTICIDAL PROTEINS TOXIC OR INHIBITORY TO LEPIDOPTERAN PESTS | MONSANTO TECHNOLOGY LLC |
EP3207105 | PROCESS FOR THE PRODUCTION OF HIGH VALUE CHEMICALS FROM BIOLOGICALLY PRODUCED MATERIALS | TOTAL RES & TECHNOLOGY FELUY |
EP3208271 | NITROGEN-CONTAINING POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME | LG CHEMICAL LTD |
EP3208279 | MINI-HEPCIDIN PEPTIDES AND METHODS OF USING THEREOF | UNIV CALIFORNIA |
EP3209328 | INHIBITORS OF LACTATE TRANSPORTERS FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES | UNIV LONDON QUEEN MARY |
EP3209645 | AMPHOTERIC ESTER SULFONATES | EASTMAN CHEM CO |
EP3209653 | PROCESS FOR THE PREPARATION OF (R,S)-NICOTINE | NEXT GENERATION LABS LLC |
EP3209661 | PROCESS FOR PREPARING A POLYMORPH OF RIVAROXABAN | ZAKL FARM POLPHARMA SA |
EP3209690 | METHODS AND COMPOSITIONS FOR DOSING IN ADOPTIVE CELL THERAPY | JUNO THERAPEUTICS INC |
EP3209696 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF GLIOBLASTOMA | BIONTECH RNA PHARMACEUTICALS GMBH |
EP3210965 | PROCESS FOR THE PREPARATION OF (1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL | GRUENENTHAL GMBH |
EP3211005 | THERAPEUTIC USE OF SPECIFIC LIGAND IN MSRV ASSOCIATED DISEASES | GENEURO SA |
EP3211007 | PHARMACEUTICAL COMPOSITION FOR TREATING CROHN'S DISEASE | EISAI R&D MAN CO LTD |
EP3211085 | ADENO-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR | UNIV PENNSYLVANIA |
EP3211086 | METHODS AND COMPOSITION TO GENERATE UNIQUE SEQUENCE DNA PROBES, LABELING OF DNA PROBES AND THE USE OF THESE PROBES | JANSSEN DIAGNOSTICS LLC |
EP3211991 | LETTUCE PLANTS COMPRISING RESISTANCE AGAINST NASONOVIA RIBISNIGRI BIOTYPE 1 | NUNHEMS BV |
EP3212218 | GIP AGONIST COMPOUNDS AND METHODS | ZEALAND PHARMA AS |
EP3212230 | DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES | SEATTLE GENETICS INC |
EP3212600 | PRODUCTION OF SHORT CHAIN PERFLUOROALKYL IODIDES FROM HIGHER ORDER TELOMERS | CHEMOURS CO FC LLC |
EP3212634 | COMPOUNDS AND METHODS TO SUPPRESS AUTOIMMUNE RESPONSE | UNIV OREGON STATE |
EP3212650 | ADMINISTRATION OF UBIQUITIN-ACTIVATING ENZYME INHIBITOR AND CHEMOTHERAPEUTIC AGENTS | MILLENNIUM PHARM INC |
EP3212651 | ADMINISTRATION OF UBIQUITIN-ACTIVATING ENZYME INHIBITOR AND RADIATION | MILLENNIUM PHARM INC |
EP3212666 | HUMAN MONOCLONAL ANTIBODY SPECIFIC FOR THE F PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS (RSV) | ARIDIS PHARMACEUTICALS INC |
EP3212702 | PLASTICIZER COMPOSITIONS AND METHODS FOR MAKING PLASTICIZER COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC |
EP3212773 | EFFICIENT DELIVERY OF THERAPEUTIC MOLECULES TO CELLS OF THE INNER EAR | MASSACHUSETTS EYE & EAR INFIRMARY |
EP3212794 | POLYNUCLEOTIDE AGENTS TARGETING SERPINC1 (AT3) AND METHODS OF USE THEREOF | ALNYLAM PHARMACEUTICALS INC |
EP3213770 | IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE | IDERA PHARMACEUTICALS INC |
EP3214073 | NITROGEN-CONTAINING POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME | HEESUNG MAT LTD |
EP3214082 | PROCESS FOR MANUFACTURING PYRIMIDINE SULFAMIDE DERIVATIVES | ACTELION PHARMACEUTICALS LTD |
EP3215142 | IMMUNOREGULATORY AGENTS | FLEXUS BIOSCIENCES INC |
EP3215163 | BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT | BIOTHERA INC |
EP3215499 | IMINOSUGARS USEFUL FOR THE TREATMENT OF VIRAL DISEASES | EMERGENT VIROLOGY LLC |
EP3215517 | ETHER FUNCTIONALIZED LIGNIN FOR FUEL PRODUCTION | REN FUEL K2B AB |
EP3215518 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP | BICYCLE THERAPEUTICS LTD |
EP3215522 | T CELL RECEPTORS DIRECTED AGAINST BOB1 AND USES THEREOF | LEIDEN UNIV MEDICAL CENTER |
EP3215524 | FC-REGION VARIANTS WITH MODIFIED FCRN- AND PROTEIN A-BINDING PROPERTIES | HOFFMANN LA ROCHE |
EP3216783 | SULFONATE COMPOUND, PHOTOACID GENERATOR, AND PHOTOLITHOGRAPHIC RESIN COMPOSITION | SAN-APRO LTD |
EP3216797 | DINUCLEAR PLATINUM-CARBENE COMPLEXES AND THE USE THEREOF IN OLEDS | UDC IRELAND LTD |
EP3216871 | RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN MICE | REGENERON PHARMA |
EP3218009 | PROCESS FOR THE CONJUGATION OF A PEPTIDE OR PROTEIN WITH A REAGENT COMPRISING A LEAVING GROUP INCLUDING A PORTION OF PEG | POLYTHERICS LTD |
EP3218367 | PROCESS FOR THE PURIFICATION OF THE AXL TYROSINE RECEPTOR KINASE INHIBITOR "R428" | BERGENBIO AS |
EP3218380 | CRYSTALLINE FORM OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE HYDROGEN SULFATE | ARRAY BIOPHARMA INC |
EP3218386 | MODULATORY POLYNUCLEOTIDES | VOYAGER THERAPEUTICS INC |
EP3218397 | NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE | US HEALTH |
EP3218406 | BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF | MEDIMMUNE LTD |
EP3218493 | DISRUPTION OF ROCK1 GENE LEADS TO PLANTS WITH IMPROVED TRAITS | SCHMüLLING THOMAS |
EP3219702 | METHOD FOR RESOLUTION OF CITALOPRAM INTERMEDIATE 5-CYANOGEN DIOL | ZHEJIANG HUAHAI PHARM CO LTD |
EP3219712 | COUMARIN DYES AND CONJUGATES THEREOF | CYANAGEN SRL |
EP3220437 | ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO LTD |
EP3221291 | METHODS OF MANUFACTURING TREPROSTINIL AND TREPROSTINIL DERIVATIVE PRODRUGS | INSMED INC |
EP3221295 | MONOCARBOXYLATE TRANSPORT MODULATORS AND USES THEREOF | NIROGYONE THERAPEUTICS INC |
EP3221321 | FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE | AKARNA THERAPEUTICS LTD |
EP3221358 | CD47 ANTIBODIES, METHODS, AND USES | JANSSEN PHARMACEUTICA NV |
EP3221361 | ANTI-TRANSFERRIN RECEPTOR / ANTI-BACE1 MULTISPECIFIC ANTIBODIES AND METHODS OF USE | GENENTECH INC |
EP3222733 | POLYNUCLEOTIDE CAPTURE MATERIALS, AND METHODS OF USING SAME | HANDYLAB INC |
EP3223807 | METHOD OF PREVENTING OR TREATING A PULMONARY DISEASE OR CONDITION | UNIV ILLINOIS |
EP3223845 | HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS | XENCOR INC |
EP3223869 | GELATIN PURIFICATION | ROUSSELOT B V |
EP3224238 | NOVEL CYSTOBACTAMIDES | HELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH |
EP3224266 | METAL COMPLEXES OF SUBSTITUTED CATECHOLATES AND REDOX FLOW BATTERIES CONTAINING THE SAME | LOCKHEED MARTIN ADVANCED ENERGY STORAGE LLC |
EP3224267 | PHOSPHINIC VANADIUM COMPLEX, CATALYTIC SYSTEM COMPRISING SAID PHOSPHINIC VANADIUM COMPLEX AND PROCESS FOR THE (CO) POLYMERIZATION OF CONJUGATED DIENES | VERSALIS SPA |
EP3225610 | METHOD FOR MANUFACTURING COMPOUND | SUMITOMO CHEMICAL CO |
EP3225630 | OVARIAN CLEAR CELL CARCINOMA TEST METHOD AND TEST AGENT | PUBLIC UNIV CORP YOKOHAMA CITY UNIV |
EP3226888 | ADMINISTRATION OF A SELECTIVE IL-6-TRANS-SIGNALLING INHIBITOR | FERRING BV |
EP3226897 | ANTIBODIES TARGETING B-CELL MATURATION ANTIGEN AND METHODS OF USE | MEMORIAL SLOAN KETTERING CANCER CENTER |
EP3227254 | CATALYTIC OXIDATION OF BUT-3-ENE-1,2-DIOL | ADISSEO FRANCE SAS |
EP3227257 | PROCESS FOR THE MANUFACTURE OF CARBOXYLIC ANHYDRIDE | SOLVAY ACETOW GMBH |
EP3227260 | PROCESS FOR THE PREPARATION OF LEVULINIC ACID | PRAJ IND LTD |
EP3227268 | PROCESS FOR PRODUCTION OF 2,5-BIS-HYDROXYMETHYLFURAN, 2,5-BIS-HYDROXYMETHYLTETRAHYDROFURAN, 1,6-HEXANEDIOL AND 1,2,6-HEXANETRIOL FROM 5-HYDROXYMETHYLFURFURAL | RENNOVIA INC |
EP3227272 | BIFUNCTIONAL do2pa DERIVATIVES, CHELATES WITH METALLIC CATIONS AND USE THEREOF | CENTRE NAT DE LA RECH SCIENT (CNRS) |
EP3227276 | COMBINATIONS FOR THE TREATMENT OF NEUROBLASTOMA | IGNYTA INC |
EP3227284 | PESTICIDALLY ACTIVE AMIDE HETEROCYCLIC DERIVATIVES WITH SULPHUR CONTAINING SUBSTITUENTS | SYNGENTA PARTICIPATIONS AG |
EP3227299 | FORMULATION INHIBITING EFFECTS OF LOW ACID ENVIRONMENT | MERCK SHARP & DOHME |
EP3227339 | CHIMERIC ANTIGEN RECEPTORS TARGETING G-PROTEIN COUPLED RECEPTOR AND USES THEREOF | MEMORIAL SLOAN-KETTERING CANCER CENTER |
EP3228310 | METHYLGLYOXAL BIS(GUANYL-HYDRAZONE) FOR REGULATING OSTEOPONTIN IN A SUBJECT | PATHOLOGICA LLC |
EP3228628 | NOVEL DERMATOPHAGOIDES FARINAE PROTEIN | TAIHO PHARMACEUTICAL CO LTD |
EP3230241 | PROCESS FOR THE PREPARATION OF CIS-2,2,4,4-TETRAMETHYLCYCLOBUTANE-1,3-DIOL | EASTMAN CHEM CO |
EP3230294 | ORGANOMETALLIC SOLUTION BASED HIGH RESOLUTION PATTERNING COMPOSITIONS AND CORRESPONDING METHODS | INPRIA CORPORTION |
EP3230298 | 3-SUBSTITUTED 5-AMINO-6H-THIAZOLO[4,5-D]PYRIMIDINE-2,7-DIONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION | HOFFMANN LA ROCHE |
EP3230300 | INHIBITORS FOR INHIBITING TUMOR METASTASIS | FORSCHUNGSVERBUND BERLIN EV |
EP3230400 | NEW PHOTOCHROMIC COMPOUNDS AND INTERMEDIATE COMPOUNDS FOR PRODUCTION THEREOF | KAUNAS UNIV OF TECH |
EP3230461 | LENTIVIRAL VECTOR-BASED JAPANESE ENCEPHALITIS IMMUNOGENIC COMPOSITION | PASTEUR INSTITUT |
EP3230745 | PLASMA AUTOANTIBODY BIOMARKERS FOR BASAL LIKE BREAST CANCER | UNIV ARIZONA STATE |
EP3231791 | HYDROXYSULTAINE- AND SULFOBETAINE-BASED GEMINAL ZWITTERIONIC LIQUIDS, METHOD FOR OBTAINING SAME, AND USE THEREOF AS WETTABILITY MODIFIERS HAVING CORROSION INHIBITING PROPERTIES | INST MEXICANO DEL PETRóLEO |
EP3231795 | METHOD FOR PREPARING 2,5-DISUBSTITUTED FURAN COMPOUND | NINGBO INST MAT TECH & ENG CAS |
EP3231804 | COMPOUNDS AND COMPOSITIONS FOR THE DETECTION AND TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS | MASSACHUSETTS GEN HOSPITAL |
EP3232490 | ORGANIC LIGHT EMITTING DIODE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER | NOVALED GMBH |
EP3233068 | A PROCESS FOR PREPARATION OF BIOAVAILABLE WHITE CURCUMIN - A UNIQUE BLEND OF HYDROGENATED CURCUMINOIDS | AUREA BIOLABS PRIVATE LTD |
EP3233079 | (S)-N-(3-(6-ISOPROPOXYPYRIDIN-3-YL)-1H-INDAZOL-5-YL)-1-(2-(4-(4-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3,6-DIHYDROPYRIDIN-1(2H)-YL)-2-OXOETHYL)-3-(METHYLTHIO)PYRROLIDINE-3-CARBOXAMIDE COMPOSITIONS FOR PHARMACEUTICAL PREPARATIONS | MERCK SHARP & DOHME |
EP3233107 | NBP158 AND USES THEREOF | ZHANG WENTAO |
EP3233174 | INTRAOCULAR DELIVERY OF BIOACTIVE MOLECULES USING IONTOPHORESIS | KEMIN IND INC |
EP3233192 | COMPOSITIONS AND METHODS FOR TARGETED CYTOKINE DELIVERY | UNIV WASHINGTON |
EP3233772 | ISOPRENE EXTRACTION WITH PRESERVED C5 FEEDSTOCK | SABIC GLOBAL TECHNOLOGIES BV |
EP3233784 | FLUORINE COMPOUNDS | MERCK PATENT GMBH |
EP3233799 | DOPAMINE D2 RECEPTOR LIGANDS | BROAD INST INC |
EP3233808 | METHODS FOR MEASUREMENT OF INHIBITION OF C-JUN N-TERMINAL KINASE IN SKIN | SIGNAL PHARM LLC |
EP3233809 | FORMULATIONS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE | SIGNAL PHARM LLC |
EP3233824 | (S)-N-(3-(6-ISOPROPOXYPYRIDIN-3-YL)-1H-INDAZOL-5-YL)-1-(2-(4-(4-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3,6-DIHYDROPYRIDIN-1(2H)-YL)-2-OXOETHYL)-3- (METHYLTHIO)PYRROLIDINE-3-CARBOXAMIDE COMPOSITIONS FOR PHARMACEUTICAL PREPARATIONS | MERCK SHARP & DOHME |
EP3233845 | PARG INHIBITORY COMPOUNDS | CANCER RES TECH LTD |
EP3233866 | PYRAZOLOPYRIDINAMINES AS MKNK1 AND MKNK2 INHIBITORS | BAYER PHARMA AG |
EP3233884 | MICROBIAL TRANSGLUTAMINASES, SUBSTRATES THEREFOR AND METHODS FOR THE USE THEREOF | HOFFMANN LA ROCHE |
EP3233893 | ENHANCED PROTEIN EXPRESSION | DANISCO US INC |
EP3233895 | ANTI-ARRHYTHMICITY AGENTS | UNIV CALIFORNIA |
EP3233897 | ANTI IL-34 ANTIBODIES | UNIV NANTES |
EP3233907 | RODENT BISPECIFIC HETERODIMERIC PROTEINS | GENMAB AS |
EP3233912 | ANTIBODIES THAT BIND HUMAN C6 AND USES THEREOF | REGENESANCE B V |
EP3233921 | ANTI-C5 ANTIBODIES AND METHODS OF USE | CHUGAI PHARMACEUTICAL CO LTD |
EP3234602 | METHODS FOR IDENTIFYING MULTIPLE EPITOPES IN SELECTED SUB-POPULATIONS OF CELLS | APPRISE BIO INC |
EP3234607 | SANDWICH ASSAY DESIGN FOR SMALL MOLECULES | SIEMENS HEALTHCARE DIAGNOSTICS INC |
EP3235827 | AAV VIRONS WITH DECREASED IMMUNOREACTIVITY AND USES THEREFOR | GENZYME CORP |
EP3237372 | METHOD FOR PRODUCING OMEGA-HYDROXY FATTY ACID ESTER AND PRECURSOR COMPOUND THEREOF | KAO CORP |
EP3237419 | FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE | AKARNA THERAPEUTICS LTD |
EP3237446 | ANTI-PD-1 ANTIBODIES | ENUMERAL BIOMEDICAL HOLDINGS INC |
EP3237450 | ANTI-MERTK AGONISTIC ANTIBODIES AND USES THEREOF | UNIV ROCKEFELLER |
EP3237622 | METHODS FOR WOUND HEALING | ILYA PHARMA AB |
EP3239130 | CLEAN PROCESS FOR PREPARING CHLOROFORMYL SUBSTITUTED BENZENE | SHANGHAI FANGLUN NEW MAT TECH CO LTD |
EP3239157 | NOVEL GROUP 4 TRANSITION METAL COMPOUND AND USE THEREOF | HANWHA CHEMICAL CORP |
EP3239167 | CONOTOXIN PEPTIDE KAPPA-CPTX-BTL01, PREPARATION METHOD THEREFOR, AND USES THEREOF | BGI SHENZHEN |
EP3239168 | CONOTOXIN PEPTIDE -CPTX-BTL02, PREPARATION METHOD THEREFOR, AND USES THEREOF | BGI SHENZHEN |
EP3239176 | ANTI-ACTIVE GIP ANTIBODY | KAO CORP |
EP3239177 | NOVEL EGFRVIII ANTIBODY AND COMPOSITION COMPRISING SAME | PHARMABCINE INC |
EP3240781 | PROCESS FOR MANUFACTURING ETHYLENE OXIDE USING SCALED SELECTIVITY VALUES | DOW TECHNOLOGY INVESTMENTS LLC |
EP3240799 | S-ALKYLATED HEPCIDIN PEPTIDES AND METHODS OF MAKING AND USING THEREOF | UNIV CALIFORNIA |
EP3240801 | COMBINATION TUMOR IMMUNOTHERAPY | CHECKMATE PHARMACEUTICALS INC |
EP3240802 | GLUCAGON DERIVATIVES | HANMI PHARM IND CO LTD |
EP3240803 | METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS | NOVARTIS AG |
EP3240817 | REDUCTION OF ALDEHYDES IN AMINE CATALYSTS | HUNTSMAN PETROCHEMICAL LLC |
EP3241435 | ANIMAL MODELS AND THERAPEUTIC MOLECULES | KYMAB LTD |
EP3241824 | TRIFLUOROACETHYDRAZIDE COMPOUND AS WELL AS PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN PREPARING MEDICAMENT | GUANGZHOU MAGPIE PHARMACEUTICALS CO LTD |
EP3241843 | SOLUBILITY OPTIMIZATION OF IMMUNOBINDERS | ESBATECH ALCON BIOMED RES UNIT |
EP3241844 | ANTIBODY AGAINST NEUROPILIN 1 AND USE THEREOF | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION |
EP3241915 | COMPOSITIONS AND METHODS FOR DETECTING WEST NILE VIRUS | GEN-PROBE INCORPORATED |
EP3242865 | METHOD OF PREPARING ESTERS OF LACTIC AND LACTYLATIC ACID IN ALCOHOLYSIS REACTION OF ALIPHATIC POLYESTER | WROCLAWSKIE CENTRUM BADAN EIT+ SP Z O O |
EP3242891 | MONOMERIC FC DOMAINS | INNATE PHARMA |
EP3242964 | ELECTROCHEMICAL AND PHOTOELECTROCHEMICAL OXIDATION OF 5-HYDROXYMETHYLFURFURAL TO 2,5-FURANDICARBOXYLIC ACID AND 2,5-DIFORMYLFURAN | WISCONSIN ALUMNI RES FOUND |
EP3243818 | POLYMERS OF BENZODITHIOPHENE AND THEIR USE AS ORGANIC SEMICONDUCTORS | MERCK PATENT GMBH |
EP3243846 | MULTI-HEADED CHAIN SHUTTLING AGENTS AND THEIR USE FOR THE PREPARATION OF BLOCK COPOLYMERS | DOW GLOBAL TECHNOLOGIES LLC |
EP3244886 | INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS | JANSSEN PHARMACEUTICALS INC |
EP3245188 | SYNTHESIS OF CARBAMATE OR UREA COMPOUNDS | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST- NATUURWETENSCHAPPELIJK ONDERZOEK TNO |
EP3245195 | PREPARATION OF FURFURAL USING MIXED SOLVENTS | BASF SE |
EP3245200 | 2-(PYRAZIN-2-YLCARBONYLAMINOMETHYL)BENZIMIDAZOLIUM COMPOUNDS AS EPITHELIAL SODIUM CHANNEL INHIBITORS | BOEHRINGER INGELHEIM INT |
EP3245225 | COMPOSITIONS AND METHODS FOR TREATMENT AND DETECTION OF CANCERS | |
EP3245232 | HETERODIMERIC CAS9 AND METHODS OF USE THEREOF | UNIV CALIFORNIA |
EP3246301 | BUTADIENE PRODUCTION SYSTEM AND BUTADIENE PRODUCTION METHOD | SEKISUI CHEMICAL CO LTD |
EP3246315 | CAPROLACTAM PREPARATION METHOD | HUBEI JINXIANGNING CHEMICAL ENG TECHENOLOGY CO LTD |
EP3246337 | TRANSGENIC PLANT HAVING THE PROPERTY OF AN ENHANCED SEED YIELD AND INCREASED GROWTH | TECHNISCHE UNIVERSITÄT KAISERSLAUTERN |
EP3246395 | COMPOUND FOR IDENTIFYING PLURIPOTENT CELLS | UNIV KYOTO |
EP3247360 | HETEROCYCLIC INHIBITORS OF MONOCARBOXYLATE TRANSPORTERS | SCRIPPS RESEARCH INST |
EP3247701 | ANTHELMINTIC COMPOUNDS, COMPOSITIONS AND METHOD OF USING THEREOF | MERIAL INC |
EP3247718 | MODULATION OF CHARGE VARIANTS IN A MONOCLONAL ANTIBODY COMPOSITION | ONCOBIOLOGICS INC |
EP3248613 | BETA-GLUCURONIDE DRUG LINKER CONJUGATES | SEATTLE GENETICS INC |
EP3249029 | HIGHLY BORATED DISPERSANT CONCENTRATES FOR LUBRICATING OIL COMPOSITIONS AND METHODS FOR FORMING SAME | INFINEUM INT LTD |
EP3250211 | NOVEL PROCESS FOR PREPARATION OF GLUCOCORTICOID STEROIDS | CORAL DRUGS PVT LTD |
EP3250237 | HEMIASTERLIN DERIVATIVES FOR CONJUGATION AND THERAPY | SUTRO BIOPHARMA INC |
EP3250555 | PROCESS FOR THE PRODUCTION OF CONDENSED IMIDAZOLO DERIVATIVES | NOVARTIS AG |
EP3250564 | DESIGN SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXIMER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY | UNIV MARYLAND |
EP3250581 | ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS | GALECTO BIOTECH AB |
EP3250583 | EXPRESSION OF KLEBSIELLA OXYTOCA POLYPEPTIDES INVOLVED IN LYSINE DECARBOXYLATION, AND METHODS AND APPLICATIONS THEREOF | CATHAY R&D CENTER CO LTD |
EP3250584 | MULTI-EPITOPIC CONSTRUCT | THROMBOSIS RES INST |
EP3250586 | NOVEL PROTEINS SPECIFIC FOR ANGIOGENESIS | PIERIS PHARMACEUTICALS GMBH |
EP3250590 | COMPOSITIONS AND METHODS RELATING TO UNIVERSAL GLYCOFORMS FOR ENHANCED ANTIBODY EFFICACY | |
EP3250594 | ANTI-TRANSTHYRETIN ANTIBODIES | PROTHENA BIOSCIENCES LTD |
EP3250599 | BIOMARKER | UNIV OXFORD INNOVATION LTD |
EP3250604 | mAb-DRIVEN CHIMERIC ANTIGEN RECEPTOR SYSTEMS FOR SORTING/DEPLETING ENGINEERED IMMUNE CELLS | CELLECTIS |
EP3250611 | CAR T-CELLS RECOGNIZING CANCER-SPECIFIC IL 13R 2 | UNIV CHICAGO |
EP3250716 | MICROSCOPE-FREE IMAGING | HARVARD COLLEGE |
EP3251678 | BENZOXABOROLE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | ANACOR PHARMACEUTICALS INC |
EP3252051 | COMPOUND AND PHOTOELECTRIC DEVICE, IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD |
EP3252052 | PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT | TORAY INDUSTRIES |
EP3252053 | POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF HIV INFECTIONS | GILEAD SCIENCES INC |
EP3252064 | METALLOCENE COMPOUND | LG CHEMICAL LTD |
EP3253210 | 2-(HET)ARYL-SUBSTITUTED CONDENSED BICYCLIC HETEROCYCLE DERIVATIVES AS PEST CONTROL AGENTS | BAYER CROPSCIENCE AG |
EP3253382 | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | INTERCEPT PHARMACEUTICALS INC |
EP3253735 | LATENT ACIDS AND THEIR USE | BASF SE |
EP3253754 | 2-PHENYL-3H-IMIDAZO[4,5-B]PYRIDINE DERIVATES USEFUL AS INHIBITORS OF MAMMALIAN TYROSINE KINASE ROR1 ACTIVITY | KANCERA AB |
EP3253764 | MACROCYCLIC COMPOUNDS AS IRAK1/4 INHIBITORS AND USES THEREOF | MERCK PATENT GMBH |
EP3253781 | MODIFIED DKK2 PROTEIN, NUCLEIC ACID ENCODING THE SAME, PREPARATION METHOD THEREOF, AND USE THEREOF | MEDPACTO INC |
EP3253783 | SIGNALLING SYSTEM | UCL BUSINESS PLC |
EP3253800 | PROSTATE ANTIGEN STANDARDS AND USES THEREOF | OPKO DIAGNOSTICS LLC |
EP3254755 | HIGH DEGREE OF CONDENSATION TITANIUM-BASED INORGANIC-ORGANIC HYBRID SOLID MATERIAL, METHOD FOR PREPARING SAME AND USES THEREOF | CENTRE NAT RECH SCIENT |
EP3255058 | PROTEIN HAVING AFFINITY TO IMMUNOGLOBULIN, AND AFFINITY SEPARATION MEDIUM AND COLUMN FOR LIQUID CHROMATOGRAPHY USING SAME | MITSUBISHI CHEM CORP |
EP3255061 | SELECTIVE IMMUNODEPLETION OF ENDOGENOUS STEM CELL NICHE FOR ENGRAFTMENT | UNIV LELAND STANFORD JUNIOR |
EP3256144 | PEPTIDE INHIBITION OF CCR3-MEDIATED DISEASES OR CONDITIONS | UNIV ILLINOIS |
EP3256451 | IMIDAZOLYL TRICYCLIC ENONES AS ANTIOXIDANT IFLAMMATION MODULATORS | REATA PHARMACEUTICALS INC |
EP3256484 | NON-MEMBRANE DISRUPTIVE p53 ACTIVATING STAPLED PEPTIDES | AGENCY SCIENCE TECH & RES |
EP3258960 | LEPTOSPIRA IMMUNOPROTECTIVE PROTEINS AND METHODS OF IDENTIFICATION AND USE THEREOF | MERIAL INC |
EP3258970 | PROCESS FOR THE PURIFICATION OF GA-68 FROM ELUATE DERIVING FROM 68GE/ 68GA GENERATORS AND CHROMATOGRAPHIC COLUMNS FOR USE IN SAID PROCESS | ADVANCED ACCELERATOR APPLICATIONS INT S A |
EP3259271 | FLUORINATED TETRAHYDRONAPHTHYRIDINYL NONANOIC ACID DERIVATIVES AND USES THEREOF | SCIFLUOR LIFE SCIENCES INC |
EP3259278 | PROCESSES FOR PREPARING FUNCTIONALIZED F-POSS MONOMERS | NBD NANOTECHNOLOGIES INC |
EP3259283 | HYBRID PROTEIN FOR THE IDENTIFICATION OF NEDDYLATED SUBSTRATES | SANTONICO ELENA |
EP3260140 | METHODS AND PRODUCTS FOR TRANSFECTING CELLS | FACTOR BIOSCIENCE INC |
EP3260441 | METHOD FOR PREPARING FORMAMIDE COMPOUND | SHANGHAI GREENCARBON HI-TECH CO LTD |
EP3260460 | LIGAND COMPOUND, ORGANIC CHROME COMPOUND, CATALYST SYSTEM FOR OLEFIN OLIGOMERIZATION, AND METHOD FOR OLEFIN OLIGOMERIZATION USING SAME | LG CHEMICAL LTD |
EP3261741 | CPC DISTRIBUTION CHROMATOGRAPHY OF CANNABINOIDS | BIONORICA ETHICS GMBH |
EP3262021 | TREATMENT METHOD, COMPOUNDS, AND METHOD OF INCREASING TRPV2 ACTIVITY | FEINSTEIN INST MEDICAL RES |
EP3262047 | IMIDAZOPYRIMIDINE AND IMIDAZOTRIAZINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | SK BIOPHARMACEUTICALS CO LTD |
EP3262063 | IMMUNOTHERAPEUTIC TARGETING OF PLACENTAL-LIKE CHONDROITIN SULFATE USING CHIMERIC ANTIGEN RECEPTORS (CARS) AND IMMUNOTHERAPEUTIC TARGETING OF CANCER USING CARS WITH SPLIT-PROTEIN BINDING SYSTEMS | VAR2 PHARMACEUTICALS APS |
EP3263568 | BENZAMIDES | MERCK PATENT GMBH |
EP3263572 | METHOD FOR PRODUCING KAKEROMYCIN AND DERIVATIVES THEREOF | SEED RES INSTITUTE CO LTD |
EP3263578 | METHOD FOR PREPARING FRUCTOSE OR XYLULOSE FROM BIOMASS CONTAINING GLUCOSE OR XYLOSE USING BUTANOL, AND METHOD FOR SEPARATING THE SAME | KOREA RES INST CHEMICAL TECH |
EP3263601 | COMBINATION OF ANTI-KIR ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT CANCER | BRISTOL MYERS SQUIBB CO |
EP3265073 | DUAL FUNCTION MOLECULES FOR HISTONE DEACETYLASE INHIBITION AND ATAXIA TELANGIECTASIA MUTATED ACTIVATION AND METHODS OF USE THEREOF | SHUTTLE PHARMACEUTICALS LLC |
EP3265475 | Constitutive yeast LLP promoter-based expression system | SANDOZ AG |
EP3265480 | SYSTEM FOR PRESENTING PEPTIDES ON THE CELL SURFACE | PETER UND TRAUDL ENGELHORN-STIFTUNG ZUR FÖRDERUNG DER LEBENSWISSENSCHAFTEN |
EP3265560 | HOMOLOGOUS RECOMBINATION FACTORS | SINAI HEALTH SYS |
EP3265570 | RETROVIRAL AND LENTIVIRAL VECTORS | UCL BUSINESS PLC |
EP3265575 | CD20 BINDING MOLECULES AND USES THEREOF | IGM BIOSCIENCES INC |
EP3266767 | METHOD FOR PREPARING AN ANTIFIBROTIC AGENT | DIPHARMA FRANCIS SRL |
EP3266775 | METHOD FOR PRODUCING 1,2,4-OXADIAZOLE DERIVATIVE | ASAHI GLASS CO LTD |
EP3266791 | LABELLED NUCLEOTIDES | ILLUMINA CAMBRIDGE LTD |
EP3268038 | ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO FLT3 PROTEINS | AGENSYS INC |
EP3268050 | PORE-FORMING PROTEIN CONJUGATE COMPOSITIONS AND METHODS | UNIV COLUMBIA |
EP3268052 | PREPARATIONS OF META-IODOBENZYLGUANDINE AND PRECURSORS THEREOF | MOLECULAR INSIGHT PHARM INC |
EP3268338 | CATALYST AGGLOMERATION REMEDIATION | FINA TECHNOLOGY |
EP3268341 | BUBBLE COLUMN REACTOR BASED DIGESTER ANDMETHOD FOR ITS USE | GRUPO PETROTEMEX SA DE CV |
EP3268346 | PROCESSES FOR THE PREPARATION OF UNSATURATED MALONATES | INT FLAVORS & FRAGRANCES INC |
EP3268348 | PROCESS FOR MAKING MIXTURES OF ENANTIOMERS, AND MIXTURES OF ENANTIOMERS | BASF SE |
EP3268356 | HETEROCYCLIC COMPOUNDS AND METHODS FOR THEIR USE | NOVARTIS AG |
EP3268362 | SUBSTITUTED PYRIDINES AND USES THEREOF | PELOTON THERAPEUTICS INC |
EP3268371 | METHOD OF MANUFACTURING STEREOISOMERS OF BUPRENORPHINE AND ANALOGUES THEREOF | SIEGFRIED AG |
EP3268382 | MYELIN OLIGODENDROCYTE GLYCOPROTEIN, MYELIN BASIC PROTEIN, AND PROTEOLIPID PROTEIN COMPOSITIONS AND METHODS OF USE | US HEALTH |
EP3268383 | CYCLIC GALANIN-ANALOGS AND USES THEREOF | LANTHIOPEP BV |
EP3268384 | PROCESS FOR PREPARING RECOMBINANT INSULIN USING MICROFILTRATION | MERCK SHARP & DOHME |
EP3268386 | FUSION PROTEIN COMPRISING A LIGAND BINDING DOMAIN OF VEGF AND PDGF | |
EP3269697 | PROCESS FOR PRODUCING CONJUGATED DIENE | MITSUBISHI CHEM CORP |
EP3269698 | PROCESS FOR THE MANUFACTURE OF FLUORINATED OLEFINS | HONEYWELL INT INC |
EP3269703 | METHOD OF ISOMERIZING DIAMINODICYCLOHEXYLMETHANE | MITSUBISHI GAS CHEMICAL CO |
EP3269704 | METHOD OF ISOMERIZING 1,3,3-TRIMETHYL-1-(AMINOMETHYL)AMINOCYCLOHEXANE | MITSUBISHI GAS CHEMICAL CO |
EP3269781 | CURED-FILM-FORMING COMPOSITION, ALIGNMENT MATERIAL, AND PHASE DIFFERENCE MATERIAL | NISSAN CHEMICAL IND LTD |
EP3270926 | TRIAZOLYL PYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS | MERCK SHARP & DOHME |
EP3270950 | ISOLATED PEPTIDES AND FRAGMENTS THEREOF FROM FIBRINOGEN FOR USE AS DRUGS, PARTICULARLY IN SKIN INFLAMMATORY DISEASES | UNIV PARIS DESCARTES |
EP3271323 | PHOTOINITIATORS THAT ARE POLYMERIC OR POLYMERIZABLE FOR USE IN UV CURABLE PRESSURE SENSITIVE ADHESIVES | HENKEL IP & HOLDING GMBH |
EP3271329 | NOVEL HYDROPHILIC LINKERS AND LIGAND-DRUG CONJUGATES THEREOF | HANGZHOU DAC BIOTECH CO LTD |
EP3271339 | AMINO ACID ACYLATION REAGENTS AND METHODS OF USING THE SAME | REGENERON PHARMA |
EP3271342 | METHOD FOR MANUFACTURING FURAN-2,5-DICARBOXYLIC ACID (FDCA) FROM A SALT SOLUTION | PURAC BIOCHEM BV |
EP3271346 | ARYL COMPOUNDS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME | UNIV NEVADA RENO |
EP3271369 | METHOD FOR PRODUCING D-GALACTURONIC ACID DERIVATIVES AND COMPOSITIONS DIRECTLY FROM PECTINS | éCOLE NAT SUPéRIEURE DE CHIMIE |
EP3271375 | CLOSTRIDIUM DIFFICILE TOXINS A AND/OR B ANTIGEN AND EPITOPE ANTIBODY, AND PHARMACEUTICAL USES THEREOF | IMMUNE BIOSOLUTIONS INC |
EP3271380 | PURIFICATION OF BONE MORPHOGENETIC PROTEINS (BMPS) | ST BIOCHIMICO ITALIANO GIOVANNI LORENZINI S P A |
EP3271381 | AMYLIN ANALOGUES | ZEALAND PHARMA AS |
EP3271392 | AGENTS FOR USE IN THE THERAPEUTIC OR PROPHYLACTIC TREATMENT OF MYOPIA OR HYPEROPIA | JONAS SHEFALI BRINDA |
EP3271397 | NOVEL MONOCLONAL ANTIBODY INHIBITORS TARGETING POTASSIUM CHANNEL KCNK9 | UNIV JOHNS HOPKINS |
EP3271402 | ANTIBODIES TOWARDS AN EXTRACELLULAR REGION OF NBCN1 | UNIV AARHUS |
EP3273983 | NOVEL CYTOTOXIC AGENTS THAT PREFERENTIALLY TARGET LEUKEMIA INHIBITORY FACTOR (LIF) FOR THE TREATMENT OF MALIGNANCIES AND AS NEW CONTRACEPTIVE AGENTS | EVESTRA INC |
EP3273991 | ANTI-CD89 CYTOTOXIC COMPLEX | FRAUNHOFER GES FORSCHUNG |
EP3273994 | CAR T-CELL THERAPY DIRECTED TO LHR FOR THE TREATMENT OF SOLID TUMORS | UNIV SOUTHERN CALIFORNIA |
EP3274327 | POLYOL ESTERS OF METATHESIZED FATTY ACIDS AND USES THEREOF | ELEVANCE RENEWABLE SCIENCES |
EP3274353 | BISPHENOLATE TRANSITION METAL COMPLEXES, PRODUCTION AND USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC |
EP3274364 | ENGINEERED BOTULINUM NEUROTOXIN | HARVARD COLLEGE |
EP3275855 | METHODS FOR PRODUCING 2,6-DIMETHYL-1,5-HEPTADIEN-3-OL AND 2,6-DIMETHYL-1,5-HEPTADIEN-3-YL ACETATE | SHIN ETSU CHEMICAL CO LTD |
EP3275868 | METHOD FOR PRODUCING PYRAZOLE DERIVATIVE | ASAHI GLASS CO LTD |
EP3275872 | NEW TRIAZINE COMPOUNDS AS PHOTOSTABILISING AGENTS | 3V SIGMA SPA |
EP3275895 | NEUROPILIN-1 SPECIFIC BINDING PEPTIDE, FUSION PROTEIN FUSED WITH SAME, AND USE THEREOF | AJOU UNIV INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
EP3275896 | PROCESS FOR OBTAINING ANTIBODIES | UCB BIOPHARMA SPRL |
EP3275968 | ORTHO-SUBSTITUTED THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | INDUSTRY-ACADEMIC COOPERATION FOUNDATION DANKOOK UNIV |
EP3277270 | COMPOSITIONS AND METHODS FOR TREATING ANEMIA | AKEBIA THERAPEUTICS INC |
EP3277277 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS | MUTABILIS |
EP3277297 | METHODS AND COMPOSITIONS FOR STIMULATION OF CELL PROLIFERATION AND PROVISION OF BIOLOGICALLY ACTIVE MIXTURES OF FGF2 ISOFORMS | SANBIO INC |
EP3277305 | ANTIGEN BINDING MOLECULES COMPRISING A TRIMERIC TNF FAMILY LIGAND | HOFFMANN LA ROCHE |
EP3277625 | METHOD FOR RECOVERING HCl FROM A HCl CONTAINING GAS STREAM | AKZO NOBEL CHEMICALS INT BV |
EP3277677 | 1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS | MISSION THERAPEUTICS LTD |
EP3277685 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS | MUTABILIS |
EP3277698 | SI-CONTAINING FILM FORMING COMPOSITIONS AND METHODS OF USING THE SAME | L'AIR LIQUIDE SOCIéTé ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCéDéS GEORGES CLAUDE |
EP3277718 | DOSAGE REGIMEN FOR ANTI-MIF ANTIBODIES | BAXALTA GMBH |
EP3277722 | ANTIBODIES TO CANINE INTERLEUKIN-4 RECEPTOR ALPHA | INTERVET INT BV |
EP3277727 | TNFRSF14/ HVEM PROTEINS AND METHODS OF USE THEREOF | MEMORIAL SLOAN-KETTERING CANCER CENTER |
EP3277832 | MONOAZO DYES WITH CYCLIC AMINE AS FLUORESCENCE QUENCHERS | ENZO BIOCHEM INC |
EP3279181 | MIXTURE OF POLYMERIZABLE COMPOUND AND METHOD FOR PRODUCING SAME | ZEON CORP |
EP3279663 | USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES | THE BRIGHAM AND WOMEN'S HOSPITAL INC |
EP3279727 | COMPOUND, RESIST COMPOSITION, AND METHOD FOR FORMING RESIST PATTERN IN WHICH SAME IS USED | MITSUBISHI GAS CHEMICAL CO |
EP3280404 | METHODS FOR SELECTING PHOSPHATASE SELECTIVE AND NON-SELECTIVE PHOSPHATASE INHIBITORS | MEDICAL RES COUNCIL |
EP3280405 | INHIBITORS AND THEIR USES | MEDICAL RES COUNCIL |
EP3280694 | MODIFIED MICROORGANISM FOR THE OPTIMIZED PRODUCTION OF 2,4-DIHYDROXYBURYRATE | METABOLIC EXPLORER SA |
EP3280708 | SUBSTITUTED QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF | ARAXES PHARMA LLC |
EP3280723 | BACKBONE-CYCLIZED PEPTIDOMIMETICS | POLYPHOR AG |
EP3281521 | HUMANIZED IL-4 AND IL-4R ALPHA ANIMALS | REGENERON PHARMA |
EP3281975 | RESIN COMPOSITION COMPRISING PLASTICIZER COMPOSITION, AND PREPARATION METHOD THEREFOR | LG CHEMICAL LTD |
EP3281976 | PLASTICIZER COMPOSITION, RESIN COMPOSITION, AND PREPARATION METHODS THEREFOR | LG CHEMICAL LTD |
EP3283077 | BROMODOMAIN INHIBITORS | CELGENE QUANTICEL RES INC |
EP3283106 | THERAPEUTIC ANTIBODIES AND THEIR USES | PFIZER |
EP3283171 | DERIVATIVES OF AMPHOTERICIN B | REVOLUTION MEDICINES INC |
EP3283456 | A PROCESS FOR THE PRODUCTION OF ETHYLENICALLY UNSATURATED CARBOXYLIC ACIDS OR ESTERS | LUCITE INT UK LTD |
EP3283463 | DIMERIC QUINACRINE DERIVATIVES AS AUTOPHAGY INHIBITORS FOR CANCER THERAPY | UNIV PENNSYLVANIA |
EP3283465 | CRYSTALLINE FGFR4 INHIBITOR COMPOUND AND USES THEREOF | EISAI R&D MAN CO LTD |
EP3283471 | METHOD OF PRODUCING FURAN CARBOXYLATES FROM ALDARIC ACIDS BY USING SOLID HETEROGENEOUS CATALYSTS | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY |
EP3283472 | HEPATITIS B VIRAL ASSEMBLY EFFECTORS | UNIV INDIANA RES & TECH CORP |
EP3283484 | QUINOLINE DERIVATIVES AS INHIBITORS OF HEAT SHOCK FACTOR 1 PATHWAY ACTIVITY | CANCER RESEARCH TECH LTD |
EP3283508 | IMMUNOMODULATORY PROTEINS WITH TUNABLE AFFINITIES | ALPINE IMMUNE SCIENCES INC |
EP3283527 | COMBINATION THERAPY FOR CANCER | FIVE PRIME THERAPEUTICS INC |
EP3283528 | ANTI-VEGFR2 HUMAN ANTIBODY FOR ANTI-ANGIOGENIC AND TARGETED CANCER THERAPY | |
EP3284734 | METHOD FOR PRODUCING 2-HALOGENATED BENZOIC ACIDS | SUMITOMO SEIKA CHEMICALS |
EP3284736 | FLUORINATION OF AROMATIC RING SYSTEMS | NUTECH VENTURES |
EP3284756 | GENERATION AND PROFILING OF FULLY HUMAN HUCAL GOLD-DERIVED THERAPEUTIC ANTIBODIES SPECIFIC FOR HUMAN CD38 | MORPHOSYS AG |
EP3285071 | BIOMARKER COMPOSITION FOR DIAGNOSING STILL'S DISEASE, DIAGNOSTIC KIT, AND DIAGNOSTIC METHOD | AJOU UNIV INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
EP3285757 | SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF USE THEREOF | GTX INC |
EP3285805 | THERAPEUTIC ANTIBODIES AND USES THEREOF | MINOMIC INT LTD |
EP3286165 | METHOD AND SYSTEM FOR THE INTEGRATED PRODUCTION OF UREA AND MELAMINE | STAMICARBON |
EP3286171 | METHODS FOR HYDRAULIC ENHANCEMENT OF CROPS | ASILOMAR BIO INC |
EP3286198 | COMPOUNDS FOR TREATING PRURITIC CONDITIONS | TREVI THERAPEUTICS INC |
EP3286206 | NOVEL HYBRID ACTRIIB LIGAND TRAP PROTEINS FOR TREATING MUSCLE WASTING DISEASES | ALIVEGEN USA INC |
EP3286212 | POLYPEPTIDES TARGETING HIV FUSION | VIIV HEALTHCARE UK (NO 5) LTD |
EP3286213 | METHODS AND COMPOSITIONS FOR COMBINATION IMMUNOTHERAPY | ETUBICS CORP |
EP3286315 | METHODS OF IDENTIFYING BACTERIA COMPRISING BINDING POLYPEPTIDES | GENENTECH INC |
EP3287142 | METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION | UNIV LEICESTER |
EP3287436 | COMPOSITIONS FOR USE IN THE TREATMENT OF BCAT1-MEDIATED DISEASES | ERGON PHARMACEUTICALS LLC |
EP3287460 | HEMISULFATE SALT OF 5,10-METHYLENE-(6R)-TETRAHYDROFOLIC ACID | MERCK & CIE |
EP3287505 | COMPOUND FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | SAMSUNG SDI CO LTD |
EP3288577 | ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS | ALLYSTA PHARMACEUTICALS INC |
EP3288582 | NUCLEIC ACID CONSTRUCT | UCL BUSINESS PLC |
EP3288590 | MIXED DISULFIDE CONJUGATES OF THIENOPYRIDINE COMPOUNDS AND USES THEREOF | UNIV MICHIGAN REGENTS |
EP3288917 | PROCESS FOR ALDEHYDE MANUFACTURE | JOHNSON MATTHEY PLC |
EP3288922 | CATALYTIC HYDROGENATION OF SUBSTITUTED CYANOPYRIDINES AND PROCESS FOR PREPARING SUBSTITUTED PYRIDYLMETHYLBENZAMIDES | BAYER CROPSCIENCE AG |
EP3288925 | REAGENTS AND METHODS FOR BIOORTHOGONAL LABELING OF BIOMOLECULES IN LIVING CELLS | UNIV OREGON STATE |
EP3288926 | N-ARALKYLCARBONYL-PIPERAZINE AND -HOMOPIPERAZINE COMPOUNDS AND PERSONAL CARE COMPOSITIONS COMPRISING THE SAME | UNILEVER PLC |
EP3288928 | BUTYROLACTONES AS HERBICIDES | DU PONT |
EP3288930 | METHOD AND DEVICE FOR MANUFACTURING LACTIDE | PURAC BIOCHEM BV |
EP3288933 | OXINDOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | MUSC FOUND FOR RES DEV |
EP3288942 | RSV ANTIVIRAL PYRAZOLO- AND TRIAZOLO-PYRIMIDINE COMPOUNDS | JANSSEN SCIENCES IRELAND UC |
EP3288953 | BIS(AMINOPHENYLPHENOL) LIGANDS AND TRANSITION METAL COMPOUNDS PREPARED THEREFROM | UNIVATION TECH LLC |
EP3288960 | SHORT SYNTHETIC PEPTIDE FOR TREATMENT AND/OR PROPHYLAXIS OF AUTOIMMUNE AND INFLAMMATORY DISORDERS | |
EP3288973 | METHOD FOR MASS HUMANIZATION OF RABBIT ANTIBODIES | ABCHECK S R O |
EP3288977 | METHODS OF MEDIATING CYTOKINE EXPRESSION WITH ANTI CCR4 ANTIBODIES | DANA FARBER CANCER INST INC |
EP3288979 | IGF-1R ANTIBODY AND ITS USE FOR THE DIAGNOSIS OF CANCER | PIERRE FABRE MéDICAMENT |
EP3288980 | TREATMENT OF PD-L1-POSITIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY | BRISTOL MYERS SQUIBB CO |
EP3289087 | METHODS AND COMPOSITIONS FOR PRODUCING BRACHYTIC CORN PLANTS | MONSANTO TECHNOLOGY LLC |
EP3290423 | OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF | JIANGSU VCARE PHARMATECH CO LTD |
EP3290426 | 2-CYANOETHYL-CONTAINING ORGANOXYSILANE COMPOUND, SILSESQUIOXANE, AND MAKING METHODS | SHINETSU CHEMICAL CO |
EP3290430 | USE OF EXCESS CARBODIIMIDE FOR PEPTIDE SYNTHESIS AT ELEVATED TEMPERATURES | CEM CORP |
EP3291830 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS | IMMATICS BIOTECHNOLOGIES GMBH |
EP3291841 | ONCOLYTIC HSV1 VECTOR AND METHODS OF USE | BRIGHAM & WOMENS HOSPITAL INC |
EP3292098 | VERY LOW WATER HEAT TRANSFER FLUID WITH REDUCED LOW TEMPERATURE VISCOSITY | EVANS COOLING SYSTEMS INC |
EP3292102 | ISOINDOLINONES, PROCESSES FOR THE PRODUCTION OF CHIRAL DERIVATIVES THEREOF AND USE THEREOF | UNIVERSITá DEGLI STUDI DI SALERNO |
EP3292106 | PROCESS FOR THE PREPARATION OF AMPHIPHILIC IMIDAZOLINIUM COMPOUNDS | BAYER ANIMAL HEALTH GMBH |
EP3292136 | PENICILLIN-G ACYLASES | CODEXIS INC |
EP3292138 | PRODUCTION OF LARGE-SIZED MICRODYSTROPHINS IN AN AAV-BASED VECTOR CONFIGURATION | ROYAL HOLLOWAY & BEDFORD NEW COLLEGE |
EP3292149 | ANTI-CD71 ANTIBODIES, ACTIVATABLE ANTI-CD71 ANTIBODIES, AND METHODS OF USE THEREOF | CYTOMX THERAPEUTICS INC |
EP3292869 | KAL1 PROTEIN CONTROLLING CELL CYCLE OF HEMATOPOIETIC STEM CELL, AND USE THEREOF | SEOUL NAT UNIV R&DB FOUNDATION |
EP3293173 | METHOD FOR PRODUCING ISOCYANATE | ASAHI CHEMICAL IND |
EP3293175 | METHODS FOR PURIFICATION OF SERINE PROTEASES | PORTOLA PHARM INC |
EP3293199 | CHIMERIC ANTIGEN RECEPTORS | HEINRICH HEINE UNIV DUESSELDORF |
EP3293202 | ANTI HUMAN INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN (IL1RAP) ANTIBODIES AND USES THEREOF | CANTARGIA AB |
EP3294125 | DEVICE AND METHOD FOR DETECTING CREATININE AND ALBUMIN TO CREATININE RATIO | INDIAN INST SCIENT |
EP3294705 | EBNA1 INHIBITORS AND METHODS USING SAME | WISTAR INST |
EP3294713 | SUBSTITUTED TETRAHYDROQUINOLINONE COMPOUNDS AS ROR GAMMA MODULATORS | AURIGENE DISCOVERY TECH LTD |
EP3294725 | PROCESS FOR PREPARING 4-AMINO-PYRIDAZINES | BASF SE |
EP3294727 | ORGANIC LIGHT-EMITTING DIODE COMPRISING DIFFERENT MATRIX COMPOUNDS IN THE FIRST AND SECOND ELECTRON TRANSPORT LAYER | NOVALED GMBH |
EP3294735 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION | VERTEX PHARMA |
EP3294738 | MONO- OR DI-SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS | JANSSEN PHARMACEUTICALS INC |
EP3294746 | NOVEL SUBSTITUTED AMINOTHIAZOLOPYRIMIDINEDIONE FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION | HOFFMANN LA ROCHE |
EP3294747 | RUTHENIUM COMPLEXES, METHOD OF PRODUCING THEM, AND THEIR USE | UNIV WARSZAWSKI |
EP3294759 | METHODS FOR INCREASING PLANT GROWTH AND YIELD BY USING AN ICTB SEQUENCE | BENSON HILL BIOSYSTEMS INC |
EP3294760 | BACTERIA ENGINEERED TO REDUCE HYPERPHENYLALANINEMIA | SYNLOGIC INC |
EP3294769 | TREATMENT FOR MULTIPLE MYELOMA (MM) | MORPHOSYS AG |
EP3294775 | MULTIMERIC PROTEIN PURITY DETERMINATION | REGENERON PHARMA |
EP3294900 | ALBUMIN-BASED NON-COVALENT COMPLEXES AND METHODS OF USE THEREOF | SPECTRAL PLATFORMS INC |
EP3295962 | TETRAPYRROLES CONJUGATES AS MRI CONTRAST AGENT | NANO4IMAGING GMBH |
EP3296283 | ETHERS OF BIS(HYDROXYMETHYL)CYCLOHEXANES | BASF SE |
EP3296312 | SYNTHESIS OF PROTECTED 3'-AMINO 5'-PHOSPHORAMIDITE NUCLEOSIDE MONOMERS | GERON CORP |
EP3296319 | METHODS FOR TREATING COLORECTAL CANCER | CENTRE NAT RECH SCIENT |
EP3297661 | METHOD OF IMPROVING CHARACTERISTICS OF PROTEINS | FULL SPECTRUM GENETICS INC |
EP3297672 | TRISPECIFIC BINDING PROTEINS AND METHODS OF USE | HARPOON THERAPEUTICS INC |
EP3297678 | AN IMPROVED PROCESSES FOR THE PREPARATION OF CARFILZOMIB OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | LAURUS LABS PRIVATE LTD |
EP3298004 | COMPOUNDS TARGETING PROTEINS, COMPOSITIONS, METHODS, AND USES THEREOF | BIOTHERYX INC |
EP3298011 | QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS | PRINCIPIA BIOPHARMA INC |
EP3298027 | ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS | MERIAL INC |
EP3298044 | HUMAN MONOCLONAL ANTIBODIES FRAGMENTS INHIBITING BOTH THE CATH-D CATALYTIC ACTIVITY AND ITS BINDING TO THE LRP1 RECEPTOR | INST NAT SANTE RECH MED |
EP3299364 | NEBIVOLOL SYNTHESIS METHOD AND INTERMEDIATE COMPOUND THEREOF | ZHEJIANG AUSUN PHARMACEUTICAL CO LTD |
EP3299384 | TRUNCATED ROTAVIRUS VP4 PROTEIN AND APPLICATION THEREOF | UNIV XIAMEN |
EP3301099 | PHOSPHORESCENT HOMOLEPTIC TRIS-[DEUTERATED-2-(2-PYRIDINYL)PHENYL]-IRIDIUM COMPLEXES FOR USE IN LIGHT-EMITTING DEVICES | UNIVERSAL DISPLAY CORP |
EP3301109 | NOVEL DEPSIPEPTIDE AND USES THEREOF | NOVOBIOTIC PHARMACEUTICALS LLC |
EP3301115 | CONTINUOUS MULTISTEP PROCESS FOR PURIFYING ANTIBODIES | SANOFI SA |
EP3302471 | TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE | EISAI R&D MAN CO LTD |
EP3302572 | IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE | ARVINAS INC |
EP3302576 | MULTIVALENT TARGETING FLUORESCENT TRACER IN THE NEAR INFRARED RANGE FOR OPTICAL IMAGING | FLUOPTICS |
EP3303269 | PROCESS FOR THE SELECTIVE HYDROGENATION OF ACETYLENE TO ETHYLENE | UOP LLC |
EP3303288 | PROCESS FOR PREPARING CARBAZOLES | DOW GLOBAL TECHNOLOGIES LLC |
EP3303317 | METHODS AND COMPOSITIONS FOR INHIBITING THE INTERACTION OF MENIN WITH MLL PROTEINS | KURA ONCOLOGY INC |
EP3303324 | NOVEL CORROSION INHIBITORS | ECOLAB USA INC |
EP3303335 | HETEROCYCLIC COMPOUNDS FOR TREATING PSORIASIS | JS INNOPHARM SHANGHAI LTD |
EP3303340 | POLYKETIDES, METHODS OF USE AND PREPARATION | UNIV LEIDEN |
EP3303342 | IMIDAZO-PYRAZINYL DERIVATIVES USEFUL AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS | MERCK SHARP & DOHME |
EP3303374 | METHODS AND PRODUCTS FOR FUSION PROTEIN SYNTHESIS | UNIV OXFORD INNOVATION LTD |
EP3303379 | TIGIT-BINDING AGENTS AND USES THEREOF | ONCOMED PHARM INC |
EP3303384 | NEUTRALIZING ANTI-INFLUENZA BINDING MOLECULES AND USES THEREOF | MEDIMMUNE LLC |
EP3303636 | COMPANION METHODS AND KITS FOR IL-2-BASED THERAPIES AND MESENCHYMAL STEM CELL-BASED THERAPIES | AELAN CELL TECH INC |
EP3305754 | PROCESS FOR PRODUCING HIGHLY UNSATURATED FATTY ACID OF HIGH PURITY IN HIGH YIELD | BIZEN CHEMICAL CO LTD |
EP3305765 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEMICAL LTD |
EP3305771 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME | LG CHEMICAL LTD |
EP3305796 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP |
EP3305802 | NOVEL PEPTIDE AND COMPOSITION CONTAINING THE SAME | GEMVAX & KAEL CO LTD |
EP3307322 | HUMANIZED ANTI-CD40 ANTIBODIES AND USES THEREOF | PRIMATOPE THERAPEUTICS INC |
EP3307705 | PREPARATION OF HIGH CONDUCTIVITY COPPER FILMS | NAT RES COUNCIL CANADA |
EP3307708 | METHOD FOR PREPARING DIISOCYANATES IN THE GAS PHASE | COVESTRO DEUTSCHLAND AG |
EP3307722 | SOLID FORMS OF (Z)-4-(5-((3-BENZYL-4-OXO-2-THIOXOTHIAZOLIDIN-5-YLIDENE)METHYL)FURAN-2-YL)BENZOIC ACID | ADHAERE PHARMACEUTICALS INC |
EP3307736 | MANNITOL BASED GELATORS FOR OIL SPILLAGE APPLICATIONS | HINDUSTAN PETROLEUM CORP LTD |
EP3307752 | TERNARY MIXTURES OF 6'-SL, LNnT and LST c | GLYCOM AS |
EP3307762 | REPORTER CAS9 VARIANTS AND METHODS OF USE THEREOF | UNIV CALIFORNIA |
EP3307763 | MADS-BOX DOMAIN ALLELES FOR CONTROLLING SHELL PHENOTYPE IN PALM | MALAYSIAN PALM OIL BOARD MPOB |
EP3307783 | COMPOSITIONS AND CONJUGATES COMPRISING AN INTERLEUKIN AND POLYPEPTIDES THAT SPECIFICALLY BIND TGF-BETA | UNIV EMORY |
EP3307784 | CARBONIC ANHYDRASE IX-SPECIFIC ANTIBODIES AND USES THEREOF | NAT RES COUNCIL CANADA |
EP3309138 | METHOD FOR CO-PRODUCTION OF 2,3,3,3-TETRAFLUOROPROPYLENE AND 1,3,3,3-TETRAFLUOROPROPYLENE | ZHEJIANG QUZHOU JUXIN FLUORINE CHEMICAL CO LTD |
EP3309141 | ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO LTD |
EP3309149 | 6-BROMO-3-HYDROXY-2-PYRAZINECARBOXAMIDE CRYSTAL AND METHOD FOR PRODUCING SAME | TOYAMA CHEMICAL CO LTD |
EP3309171 | BLOOD-BRAIN BARRIER PERMEABLE PEPTIDE COMPOSITIONS | ICB INT INC |
EP3309172 | HUMANIZED ANTIBODY AGAINST AMYLOID BETA | AC IMMUNE SA |
EP3309549 | RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS | WATERS TECHNOLOGIES CORP |
EP3309614 | RADIATION SENSITIVE COMPOSITION | NISSAN CHEMICAL IND LTD |
EP3310347 | LONG-ACTING COAGULATION FACTORS AND METHODS OF PRODUCING SAME | OPKO BIOLOGICS LTD |
EP3310386 | COMBINATION THERAPIES FOR HEME MALIGNANCIES WITH ANTI-CD38 ANTIBODIES AND SURVIVIN INHIBITORS | JANSSEN BIOTECH INC |
EP3310755 | A NOVEL PROCESS FOR THE PREPARATION OF TERIFLUNOMIDE | BIOCON LTD |
EP3310782 | IMIDAZO-PYRAZINYL DERIVATIVES USEFUL AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS | MERCK SHARP & DOHME |
EP3310786 | DRUG DELIVERY AND IMAGING CHEMICAL CONJUGATE, FORMULATIONS AND METHODS OF USE THEREOF | NANOPHAGIX LLC |
EP3310790 | METHOD OF TARGETING MISMATCHED DNA USING D8 SQUARE PLANAR METAL COMPLEXES | UNIV HONG KONG |
EP3310792 | PROCESS FOR PREPARING AN ACRYLOYLOYLOXYSILANE | DOW CORNING |
EP3310793 | PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE | DOW CORNING |
EP3310795 | POLYMERIZATION OF SILYL- AND FLUORO-CONTAINING MONOMERS | SCRIPPS RESEARCH INST |
EP3310805 | PD-1-CD28 FUSION PROTEINS AND THEIR USE IN MEDICINE | KOBOLD SEBASTIAN |
EP3310811 | ANTI-CD3 ANTIBODIES AND METHODS OF USE | GENENTECH INC |
EP3310821 | COMPOSITIONS CONTAINING 1,1-DISUBSTITUTED ALKENE COMPOUNDS FOR PREPARING POLYMERS HAVING ENHANCED GLASS TRANSITION TEMPERATURES | SIRRUS INC |
EP3310854 | HYDRAZIDE COMPOUNDS SUITABLE FOR NUCLEATING POLYLACTIC ACID POLYMER | 3M INNOVATIVE PROPERTIES CO |
EP3310883 | PROCESS FOR PRODUCING TRANSPORT FUEL BLENDSTOCK | CADENHOUSE BEATY PATRICK JAMES |
EP3310909 | COMPOSITIONS AND METHODS FOR DIRECTING PROTEINS TO SPECIFIC LOCI IN THE GENOME | POSEIDA THERAPEUTICS INC |
EP3310919 | VECTORS FOR USE IN AN INDUCIBLE COEXPRESSION SYSTEM | ABSCI LLC |
EP3311169 | MODULATOR ASSAY | UCB BIOPHARMA SPRL |
EP3311170 | ANTIBODY | UCB BIOPHARMA SPRL |
EP3311171 | ANTIBODY EPITOPE | UCB BIOPHARMA SPRL |
EP3312153 | METHODS FOR MANUFACTURING AROMATIC HYDROCARBON, PARAXYLENE AND TEREPHTHALIC ACID | CHINA PETROLEUM & CHEM CORP |
EP3312169 | 5-HT3 RECEPTOR ANTAGONISTS | TAKEDA PHARMACEUTICALS CO |
EP3312177 | TRICYCLIC DERIVATIVE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | JEIL PHARMACEUTICAL CO LTD |
EP3312285 | METHOD OF PREPARING AROMATIC HYDROCARBON, P-XYLENE AND TEREPHTHALIC ACID, AND APPARATUS PRODUCING AROMATIC HYDROCARBON | CHINA PETROLEUM & CHEM CORP |
EP3312895 | ORGANIC SEMICONDUCTING MATERIAL COMPRISING AN ELECTRICAL N-DOPANT AND AN ELECTRON TRANSPORT MATRIX AND ELECTRONIC DEVICE COMPRISING THE SEMICONDUCTING MATERIAL | NOVALED GMBH |
EP3313805 | PROCESS FOR MANUFACTURING 1-CYCLOPROPYL-NAPHTHALENES | PATHEON AUSTRIA GMBH CO & KG |
EP3313852 | SUBSTITUTED PYRAZOLO/IMIDAZOLO BICYCLIC COMPOUNDS AS PDE2 INHIBITORS | MERCK SHARP & DOHME |
EP3313857 | POLYMER-CYCLODEXTRIN-LIPID CONJUGATES | WU NIAN |
EP3313864 | PRRSV MINOR PROTEIN-CONTAINING RECOMBINANT VIRAL VECTORS AND METHODS OF MAKING AND USE THEREOF | MERIAL INC |
EP3313865 | SYNTHETIC PEPTIDE COMPOUNDS AND METHODS OF USE | EASTERN VIRGINIA MEDICAL SCHOOL |
EP3313867 | A NUCLEIC ACID MOLECULE FOR CONFERRING INSECTICIDAL PROPERTIES IN PLANTS | SYNGENTA PARTICIPATIONS AG |
EP3313869 | CYCLIC RGD CELL-BINDING MOTIF AND USES THEREOF | SPIBER TECH AB |
EP3313874 | MASKING CHIMERIC ANTIGEN RECEPTOR T CELLS FOR TUMOR-SPECIFIC ACTIVATION | UNIV SOUTHERN CALIFORNIA |
EP3313878 | MATERIALS AND METHODS FOR PERFORMING HISTOCHEMICAL ASSAYS FOR HUMAN PRO-EPIREGULIN AND AMPHIREGULIN | VENTANA MED SYST INC |
EP3314038 | PURINE-BASED CORROSION INHIBITORS | ECOLAB USA INC |
EP3314257 | CELL TRACKING REAGENTS AND THEIR METHODS OF USE | LIFE TECHNOLOGIES CORP |
EP3315489 | METHOD FOR MANUFACTURING PENTAERYTHRITOL MERCAPTO CARBOXYLIC ACID ESTER, POLYMERIZABLE COMPOSITION, RESIN, OPTICAL MATERIAL, AND LENS | MITSUI CHEMICALS INC |
EP3315499 | CRYSTAL OF (6S,9aS)-N-BENZYL-6-[(4-HYDROXYPHENYL)METHYL]- 4,7-DIOXO-8-({6-[3-(PIPERAZIN-1-YL)AZETIDIN-1-YL]PYRIDIN- 2-YL}METHYL)-2-(PROP-2-EN-1-YL)-OCTAHYDRO-1H-PYRAZINO[2,1-c][1,2,4]TRIAZINE-1-CARBOXAMIDE COMPOUND | EISAI R&D MAN CO LTD |
EP3315504 | TETRACARBOXYLIC ACID DIESTER COMPOUND, POLYMER OF POLYIMIDE PRECURSOR AND METHOD FOR PRODUCING SAME, NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION, PATTERNING PROCESS, AND METHOD FOR FORMING CURED FILM | SHINETSU CHEMICAL CO |
EP3316880 | THIRD GENERATION TAXOIDS AND METHODS OF USING SAME | UNIV NEW YORK STATE RES FOUND |
EP3317244 | PROCESS FOR PRODUCING ACETIC ACID | CELANESE INT CORP |
EP3317245 | PROCESS FOR FLASHING A REACTION MEDIUM | CELANESE INT CORP |
EP3317255 | ARYL SULFONAMIDE COMPOUNDS AS CARBONIC ANHYDRASE INHIBITORS AND THEIR THERAPEUTIC USE | SIGNALCHEM LIFESCIENCES CORP |
EP3317277 | SOMATOSTATIN MODULATORS AND USES THEREOF | CRINETICS PHARMACEUTICALS INC |
EP3317278 | SOMATOSTATIN MODULATORS AND USES THEREOF | CRINETICS PHARMACEUTICALS INC |
EP3317279 | TRIAZA-SPIRODECANONES AS DDR1 INHIBITORS | HOFFMANN LA ROCHE |
EP3317285 | CHIRAL DIARYL MACROCYCLES AS MODULATORS OF PROTEIN KINASES | TP THERAPEUTICS INC |
EP3317301 | COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3 | NOVARTIS AG |
EP3318565 | PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL AND PYRROLO[2,3-D]PYRIDINYL ACRYLAMIDES | PFIZER |
EP3318571 | ION EXCHANGE CHROMATOGRAPHY WITH IMPROVED SELECTIVITY FOR THE SEPARATION OF POLYPEPTIDE MONOMERS, AGGREGATES AND FRAGMENTS BY MODULATION OF THE MOBILE PHASE | HOFFMANN LA ROCHE |
EP3318574 | POLYPEPTIDE HAVING BETA-GLUCOSIDASE ACTIVITY AND USES THEREOF | DSM IP ASSETS BV |
EP3319641 | NOVEL PSMA-SPECIFIC BINDING PROTEINS | UNIV MUENCHEN TECH |
EP3319723 | ZEOLITIC ADSORBENTS, METHOD FOR THE PRODUCTION THEREOF, AND USES OF SAME | IFP ENERGIES NOW |
EP3319941 | A TWO-STEP PROCESS FOR PREPARING 3-SUBSTITUTED PHENYLALKYLAMINES | SPECGX LLC |
EP3319948 | ACESULFAME POTASSIUM COMPOSITIONS AND PROCESSES FOR PRODUCING SAME | CELANESE INT CORP |
EP3319951 | METHOD FOR THE HYDROFORMYLATION OF 2-SUBSTITUTED BUTADIENES AND THE PRODUCTION OF SECONDARY PRODUCTS THEREOF, ESPECIALLY AMBROX | BASF SE |
EP3319976 | COMPOSITIONS AND METHODS FOR TREATING LUNG DISEASES AND LUNG INJURY | INSMED INC |
EP3319977 | PEPTIDE PURIFICATION USING MIXED-PHASE SOLID PHASE EXTRACTION MATERIAL | MAX PLANCK GESELLSCHAFT |
EP3319980 | FORMULATIONS FOR IMPROVING THE EFFICACY OF HYDROPHOBIC DRUGS | PEPTINOVO BIOPHARMA LLC |
EP3319987 | NOVEL P450-BM3 VARIANTS WITH IMPROVED ACTIVITY | CODEXIS INC |
EP3320033 | POLYETHYLENE TEREPHTHALATE DEPOLYMERIZATION | LOOP IND INC |
EP3320095 | SH3 DOMAIN DERIVATIVES | NEXT BIOMED THERAPIES OY |
EP3320342 | NEW HYDROGELS HAVING A SILYLATED STRUCTURE, AND METHOD FOR OBTAINING SAME | UNIV MONTPELLIER |
EP3320911 | ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS | ACCELERON PHARMA INC |
EP3321276 | FUSION PROTEINS FOR TREATING METABOLIC DISORDERS | NOVARTIS AG |
EP3321286 | BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES | ROCHE GLYCART AG |
EP3321377 | METHOD FOR DETERMINING SENSITIVITY TO SIMULTANEOUS INHIBITOR AGAINST PARP AND TANKYRASE | ASAN FOUND |
EP3322293 | ARYLOXYPYRIMIDINYL ETHERS AS HERBICIDES | DU PONT |
EP3322420 | BICYCLIC HETEROCYCLES AS INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN | MERCK SHARP & DOHME |
EP3322484 | COMPOSITIONS AND METHODS FOR TREATING CANCER | MEDIMMUNE LLC |
EP3322690 | DIARYL AMINE ANTIOXIDANTS PREPARED FROM BRANCHED OLEFINS | LANXESS SOLUTIONS US INC |
EP3322696 | PROCESS FOR MAKING HYDROXYETHYL PIPERAZINE COMPOUNDS | DOW GLOBAL TECHNOLOGIES LLC |
EP3322721 | NOVEL IMMUNOGLOBULIN-BINDING PROTEINS AND THEIR USE IN AFFINITY PURIFICATION | NAVIGO PROTEINS GMBH |
EP3322724 | IL-26 INHIBITORS | CENTRE HOSPITALIER UNIV VAUDOIS CHUV |
EP3322731 | METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR | SQUIBB BRISTOL MYERS CO |
EP3322733 | HIDE1 COMPOSITIONS AND METHODS | COMPUGEN LTD |
EP3322736 | FUSION POLYPEPTIDES AND METHODS OF USE | PROSIT SOLE BIOTECHNOLOGY BEIJING CO LTD |
EP3322804 | NUCLEASE-INDEPENDENT TARGETED GENE EDITING PLATFORM AND USES THEREOF | UNIV RUTGERS |
EP3322805 | PURIFICATION OF NUCLEIC ACIDS USING COPPER-TITANIUM OXIDES | ABBOTT MOLECULAR INC |
EP3323431 | DIAGNOSTIC FOR CANCER | UNIV TOKYO |
EP3324980 | MULTI-TARGETED SINGLE ENTITY CONJUGATES | ALNYLAM PHARMACEUTICALS INC |
EP3325097 | COMPOSITIONS AND AGENTS AGAINST HEPATITIS B VIRUS AND USES THEREOF | ARCTURUS THERAPEUTICS INC |
EP3325435 | PROCESS FOR THE PREPARATION OF 2,3,3,3-TETRAFLUOROPROPENE (1234YF) | MEXICHEM FLUOR SA DE CV |
EP3325436 | PROCESS FOR THE PREPARATION OF 3,3,3-TRIFLUOROPROPENE | MEXICHEM FLUOR SA DE CV |
EP3325437 | PROCESS FOR DRYING HYDRO(CHLORO)FLUOROOLEFINS | MEXICHEM FLUOR SA DE CV |
EP3325444 | METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM C | ACADIA PHARM INC |
EP3325445 | CONTROL OF AQUATIC WEEDS USING COMBINATIONS OF HALAUXIFEN, FLORPYRAUXIFEN AND OTHER AQUATIC HERBICIDES | DOW AGROSCIENCES LLC |
EP3325449 | HETEROCYCLIC COMPOUNDS, PARTICULARLY PYRIMIDINYLINDAZOLE COMPOUNDS FOR TREATING PARKINSON'S DISEASE | GLAXOSMITHKLINE IP DEV LTD |
EP3325470 | PESTICIDALLY ACTIVE 1,2,4-TRIAZOLE DERIVATIVES WITH SULPHUR CONTAINING SUBSTITUENTS | SYNGENTA PARTICIPATIONS AG |
EP3325487 | FORMULATION FOR SOFT ANTICHOLINERGIC ANALOGS | BODOR LABORATORIES INC |
EP3325515 | NOVEL BINDING PROTEINS BASED ON DI-UBIQUITIN MUTEINS AND METHODS FOR GENERATION | NAVIGO PROTEINS GMBH |
EP3325516 | A MONOCLONAL ANTIBODY INHIBITOR OF FACTOR XIIA | DYAX CORP |
EP3326218 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH |
EP3326622 | MODIFIED AXL PEPTIDES AND THEIR USE IN INHIBITION OF AXL SIGNALING IN ANTI-METASTATIC THERAPY | UNIV LELAND STANFORD JUNIOR |
EP3326715 | OXALIC ACID MONOAMIDE LIGAND, AND USES THEREOF IN COUPLING REACTION OF COPPER-CATALYZED ARYL HALOGEN SUBSTITUTE | SHANGHAI INST ORGANIC CHEMISTRY CAS |
EP3327008 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME | LG CHEMICAL LTD |
EP3327016 | PREPARATION OF MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | VERTEX PHARMA |
EP3327027 | CYTOTOXIC PEPTIDES AND ANTIBODY DRUG CONJUGATES THEREOF | PFIZER |
EP3327030 | VACCINES AND VACCINE COMPONENTS FOR INHIBITION OF MICROBIAL CELLS | PASTORAL GREENHOUSE GAS RES LTD |
EP3327040 | MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME | ALTOR BIOSCIENCE CORP |
EP3327065 | TOUCH SENSITIVE ELEMENT AND DISPLAY DEVISE COMPRISING THE SAME | LG DISPLAY CO LTD |
EP3328187 | NOVEL INSECT INHIBITORY PROTEINS | MONSANTO TECHNOLOGY LLC |
EP3328379 | BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION | UCB BIOPHARMA SPRL |
EP3328419 | PD-1-BINDING MOLECULES AND METHODS OF USE THEREOF | MACROGENICS INC |
EP3328425 | COMBINED USE OF ANTI PD-1 AND ANTI M-CSF ANTIBODIES IN THE TREATMENT OF CANCER | NOVARTIS AG |
EP3328426 | TREATMENT OF PATIENTS DIAGNOSED WITH PANCREATIC DUCTAL ADENOCARCINOMA USING MONOCLONAL ANTIBODIES AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) | INNOCIMAB PTE LTD |
EP3328542 | NOVEL CATALYTIC COMPOSITION COMPRISING NICKEL AND A PHOSPHINE-TYPE LIGAND, AND USE THEREOF IN AN OLEFIN OLIGOMERISATION METHOD | IFP ENERGIES NOW |
EP3328832 | FUCOSIDASE INHIBITORS | HORIZON ORPHAN LLC |
EP3328837 | INHIBITOR OF THE MUTATED ISOCITRATE DEHYDROGENASE IDH1 R132H | BAYER PHARMA AG |
EP3328852 | FACTOR XIA NEW MACROCYCLE BEARING A NON-AROMATIC P2' GROUP | SQUIBB BRISTOL MYERS CO |
EP3328880 | THERAPEUTIC AGENTS | KING S COLLEGE LONDON |
EP3328889 | BISPECIFIC ANTIBODY CONSTRUCTS BINDING DLL3 AND CD3 | AMGEN RES MUNICH GMBH |
EP3328892 | BISPECIFIC ANTIBODY CONSTRUCTS BINDING EGFRVIII AND CD3 | AMGEN RES MUNICH GMBH |
EP3329775 | PROCESSES FOR THE SYNTHESIS OF DIARYLTHIOHYDANTOIN AND DIARYLHYDANTOIN COMPOUNDS | MEDIVATION PROSTATE THERAPEUTICS LLC |
EP3330244 | PRODUCTION METHOD FOR 2,3,3,3-TETRAFLUOROPROPENE | ZHEJIANG QUZHOU JUXIN FLUORINE CHEMICAL CO LTD |
EP3330249 | AMINE-BASED COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | LG CHEMICAL LTD |
EP3330258 | 1, 3, 5-TRIAZINE DERIVATIVE AND METHOD OF USING SAME | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD |
EP3330262 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE CONTAINING SAME | LG CHEMICAL LTD |
EP3330342 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE USING SAME | HEESUNG MAT LTD |
EP3330370 | PROCESS FOR CULTIVATION OF CHO CELLS | NOVARTIS AG |
EP3330404 | COMPOSITIONS AND PROCESSES FOR DEPOSITING CARBON-DOPED SILICONCONTAINING FILMS | VERSUM MAT US LLC |
EP3331064 | USE OF 4,5-IMIDAZOLEDICARBOXYLIC ACID AS AN ELECTRODE ACTIVE MATERIAL | COMMISSARIAT ENERGIE ATOMIQUE |
EP3331533 | SYNTHESIS AND BIOLOGICAL ACTIVITY OF 2-METHYLENE ANALOGS OF CALCITRIOL AND RELATED COMPOUNDS | WISCONSIN ALUMNI RES FOUND |
EP3331552 | MODIFIED YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS | GLOBEIMMUNE INC |
EP3331843 | CYCLOPROPANATION OF SUBSTITUTED ALKENES | INT FLAVORS & FRAGRANCES INC |
EP3331857 | PROCESS FOR FLUORINATING COMPOUNDS | DOW AGROSCIENCES LLC |
EP3331865 | SYNTHESIS OF BENZODIAZEPINE DERIVATIVES | TRIO MEDICINES LTD |
EP3331877 | PYRAZOLE PYRIMIDINE DERIVATIVE AND USES THEREOF | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD |
EP3331880 | N-(PYRIDIN-2-YL)-4-(THIAZOL-5-YL)PYRIMIDIN-2-AMINE DERIVATIVES AS THERAPEUTIC COMPOUNDS | UNIV SOUTH AUSTRALIA |
EP3331890 | PROTECTED ORGANOBORONIC ACIDS WITH TUNABLE REACTIVITY, AND METHODS OF USE THEREOF | UNIV ILLINOIS |
EP3331891 | CHIRAL REAGENTS FOR PREPARATION OF HOMOGENEOUS OLIGOMERS | EISAI R&D MAN CO LTD |
EP3331900 | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS | IMMATICS BIOTECHNOLOGIES GMBH |
EP3331902 | CONSTRUCTS HAVING A SIRP-ALPHA DOMAIN OR VARIANT THEREOF | ALEXO THERAPEUTICS INC |
EP3331908 | ANTI-ANGPTL8 ANTIBODIES AND USES THEREOF | REGENERON PHARMA |
EP3331915 | IMMUNE-CHECKPOINT INHIBITORS FOR USE IN THE TREATMENT OF BLOOD-BORNE CANCERS | AMGEN RES MUNICH GMBH |
EP3332810 | FAST-ACTING INSULIN FORMULATION COMPRISING A SUBSTITUTED ANIONIC COMPOUND | ADOCIA |
EP3333151 | WATER ELIMINATION METHOD | DAIKIN IND LTD |
EP3333194 | ANTI-FAP ANTIBODIES AND METHODS OF USE | ROCHE GLYCART AG |
EP3333264 | CHIMERIC ANTIGEN RECEPTOR, AND T CELLS IN WHICH CHIMERIC ANTIGEN RECEPTOR IS EXPRESSED | YOO YOUNG PHARM CO LTD |
EP3334705 | CETYLATED FATTY ACIDS, SYSTEM FOR THE PREPARATION THEREOF AND USE THEREOF | PHARMANUTRA S P A |
EP3334721 | CGRP RECEPTOR ANTAGONISTS | LILLY CO ELI |
EP3334731 | PHENOXAZINE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH |
EP3334746 | CONNEXIN 45 INHIBITION FOR THERAPY | UNIV SYDNEY |
EP3334752 | STEVIOL GLYCOSIDE TRANSPORT | DSM IP ASSETS BV |
EP3334760 | CAPPED AND UNCAPPED ANTIBODY CYSTEINES, AND THEIR USE IN ANTIBODY-DRUG CONJUGATION | PFIZER |
EP3334804 | METHODS FOR PRODUCING ALKYLBENZENES, PARAFFINS, OLEFINS AND OXO ALCOHOLS FROM WASTE PLASTIC FEEDSTOCKS | PROCTER & GAMBLE |
EP3334824 | PD-1 ANTIBODIES | INNOVENT BIOLOGICS SUZHOU CO LTD |
EP3335043 | METHOD FOR DIFFERENTIALLY DIAGNOSING ACTH-DEPENDENT CUSHING'S SYNDROME | CORCEPT THERAPEUTICS INC |
EP3336098 | SKIN PERMEABLE PEPTIDE AND METHOD FOR USING SAME | IUCF HYU |
EP3336100 | PEPTIDE HAVING EFFECT OF PREVENTING OR TREATING CENTRAL NERVOUS SYSTEM DISEASES AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CENTRAL NERVOUS SYSTEM DISEASES, CONTAINING SAME AS ACTIVE INGREDIENT | IUCF HYU |
EP3336129 | PROCESS FOR THE PREPARATION OF HYDROXYL-FUNCTIONALIZED POLYSILOXANES | HENKEL AG & CO KGAA |
EP3336185 | ANTIBODY | UNIV OSAKA |
EP3337485 | CRYSTALLINE FORMS OF IBRUTINIB | SUN PHARMACEUTICAL IND LTD |
EP3337506 | COMBINATIONS AND USES THEREOF | MORPHOSYS AG |
EP3337519 | COMPOSITIONS COMPRISING MACROCYCLE DERIVATIVES INCORPORATING BRIDGED MACROCYCLES AND METHODS OF PRODUCING AND USING SAME | SOUTHWESTERN OKLAHOMA STATE UNIV |
EP3337778 | METHODS FOR REMOVING ACIDIC IMPURITIES FROM HALOGENATED PROPENES | HONEYWELL INT INC |
EP3337794 | HYDROPHILIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES | MERCK PATENT GMBH |
EP3337810 | COMPOUND LIBRARY PREPARATION PROCESS BASED ON EXCHANGE REACTION BETWEEN DIFERENTLY SUBSTITUTED DIOXABOROLANES OR DIOXABORINANES | ECOLE SUPERIEURE PHYSIQUE & CHIMIE IND VILLE DE PARIS |
EP3337812 | METHOD FOR THE REDUCTION OF HOST CELL PROTEINS IN AFFINITY CHROMATOGRAPHY | HOFFMANN LA ROCHE |
EP3337817 | METHOD FOR THE REDUCTION OF HOST CELL PROTEINS IN AFFINITY CHROMATOGRAPHY | HOFFMANN LA ROCHE |
EP3337901 | ATYPICAL CYS HIS RICH THIOREDOXIN 4 (ACHT4) BLOCKERS AND METHODS OF USE THEREOF | YEDA RES & DEV |
EP3339293 | COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG CHEMICAL LTD |
EP3339294 | PHARMACEUTICAL COMPOSITION AND APPLICATION REPLACING QUINOLONE DERIVATIVE, PHARMACEUTICAL ACCEPTABLE SALT, OR STEREOISOMER | UNIV JINAN |
EP3339298 | METHODS OF PREPARING OXA-BICYCLOALKENE | INT FLAVORS & FRAGRANCES INC |
EP3339299 | NOVEL CATECHOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | AUTOPHAGYSCIENCES INC |
EP3339311 | VOLATILE MONOAMINO-DIALKOXYSILANES AND THEIR USE FOR CREATING SILICON-CONTAINING FILMS | VERSUM MAT US LLC |
EP3339312 | ORGANOAMINOSILANE PRECURSORS AND METHODS FOR DEPOSITING FILMS COMPRISING SAME | VERSUM MAT US LLC |
EP3339314 | MODIFIED NUCLEOTIDES FOR NUCLEIC ACID SYNTHESIS, KIT COMPRISING SUCH NUCLEOTIDES AND USE THEREOF FOR THE PRODUCTION OF SYNTHETIC NUCLEIC ACID SEQUENCES OR GENES | DNA SCRIPT |
EP3339321 | MODULATORS OF MYC, METHODS OF USING THE SAME AND METHODS OF IDENTIFYING AGENTS THAT MODULATE MYC | TAIGA BIOTECHNOLOGIES INC |
EP3341368 | NOVEL 6-6 BICYCLIC AROMATIC RING SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS | JANSSEN PHARMACEUTICA NV |
EP3341370 | CGRP RECEPTOR ANTAGONISTS | LILLY CO ELI |
EP3341377 | POLYFLUORENO[4,5-CDE]OXEPINE CONJUGATES AND THEIR USE IN METHODS OF ANALYTE DETECTION | AAT BIOQUEST INC |
EP3341389 | PEPTIDE INHIBITORS OF TELOMERASE TRANSLOCATION AND THERAPEUTIC USES THEREOF | MEDICAL COLLEGE WISCONSIN INC |
EP3341393 | MODIFIED ANTHRAX TOXIN PROTECTIVE ANTIGEN | US HEALTH |
EP3341394 | IMPROVED CELL-PERMEABLE (ICP)-SOCS3 RECOMBINANT PROTEIN AND USES THEREOF | CELLIVERY THERAPEUTICS INC |
EP3341396 | IMPROVED CELL-PERMEABLE (ICP)-SOCS3 RECOMBINANT PROTEIN AND USES THEREOF | CELLIVERY THERAPEUTICS INC |
EP3341410 | CHIMERIC ANTIGEN RECEPTORS WITH INTEGRATED CONTROLLABLE FUNCTIONS | CELLECTIS |
EP3341415 | ANTI-HYPUSINE ANTIBODIES AND USES THEREOF | HOFFMANN LA ROCHE |
EP3341725 | METHODS FOR DETECTING PHOSPHORYLATED ALPHA-SYNUCLEIN | PROTHENA BIOSCIENCES LTD |
EP3341793 | LIQUID, HYBRID UV/VIS RADIATION CURABLE RESIN COMPOSITIONS FOR ADDITIVE FABRICATION | DSM IP ASSETS BV |
EP3342599 | HEAT-SENSITIVE RECORDING MATERIAL | SANKO CO LTD |
EP3342765 | CATHEPSIN K INHIBITOR AND APPLICATION THEREOF | SUNSHINE LAKE PHARMA CO LTD |
EP3342769 | ORGANIC COMPOUND, METHOD FOR MANUFACTURING SAME, ORGANIC SEMICONDUCTOR MATERIAL CONTAINING SAME, AND ORGANIC TRANSISTOR CONTAINING SAME | DAINIPPON INK & CHEMICALS |
EP3342774 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEMICAL LTD |
EP3342786 | ANTI-DLL3 ANTIBODY | CHUGAI PHARMACEUTICAL CO LTD |
EP3342861 | SPECIFICALLY PURIFIED ANTI-PRESEPSIN ANTIBODY | MOCHIDA PHARM CO LTD |
EP3343658 | COMPOSITION AND LIGHT-EMITTING ELEMENT IN WHICH SAME IS USED | SUMITOMO CHEMICAL CO |
EP3344303 | MENISCAL REPAIR ADHESIVE | COHERA MEDICAL INC |
EP3344598 | INHIBITING CPI FORMATION FROM ADIPONITRILE | INVISTA NORTH AMERICA SARL |
EP3344622 | GUANIDINE SUBSTITUTED IMIDAZO[4,5-c]RING COMPOUNDS | 3M INNOVATIVE PROPERTIES CO |
EP3344623 | IMIDAZO[4,5-c]RING COMPOUNDS CONTAINING SUBSTITUTED GUANIDINE GROUPS | 3M INNOVATIVE PROPERTIES CO |
EP3344763 | YEAST STRAINS CO-EXPRESSING EXOGENOUS GLUCOAMYLASES, THE METHOD FOR OBTAINING SAID YEAST STRAINS AND THE USE THEREOF TO PRODUCE BIOETHANOL | LESAFFRE & CIE |
EP3344803 | MODULAR POLYPEPTIDE LIBRARIES AND METHODS OF MAKING AND USING SAME | UNIV CALIFORNIA |
EP3344805 | METHOD FOR THE SELECTION OF APTAMERS FOR UNBOUND TARGETS | NEOVENTURES BIOTECHNOLOGY INC |
EP3345596 | INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER | RHODE ISLAND HOSPITAL |
EP3345866 | METHOD FOR PRODUCING A CYCLIC SILANE COMPOUND | EVONIK DEGUSSA GMBH |
EP3345894 | COMPOUND HAVING PROTEIN TYROSINE PHOSPHATASE SHP-1 AGONIST ACTIVITY | |
EP3345905 | DEUTERATED BENZOQUINOLIZINE DERIVATIVES AS INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | AUSPEX PHARMACEUTICALS INC |
EP3345915 | 5-POSITION MODIFIED PYRAMIDINES AND THEIR USE | SOMALOGIC INC |
EP3345917 | ANTIPROTOZOAL COMPOUNDS | BACOBA AG |
EP3345929 | FUSION POLYPEPTIDE IN WHICH ANTI-INFLAMMATORY POLYPEPTIDE AND FERRITIN MONOMER FRAGMENT ARE BOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING INFLAMMATORY DISEASES, CONTAINING SAME AS ACTIVE INGREDIENT | KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND |
EP3346852 | APPARATUSES AND METHODS FOR GENERATING A HIGH-CONCENTRATION PROTEIN PRODUCT FROM A BLANCHED BIOMASS | PARABEL LTD |
EP3347018 | INHIBITORS OF CYCLIN-DEPENDENT KINASES | DANA FARBER CANCER INST INC |
EP3347348 | PREPARATION OF 3-HYDROXY-3,6-DIMETHYLHEXAHYDROBENZOFURAN-2-ONE AND DERIVATIVES THEREOF | P2 SCIENCE INC |
EP3347356 | TRICYCLIC FUSED PYRIDIN-2-ONE DERIVATIVES AND THEIR USE AS BRD4 INHIBITORS | JUBILANT BIOSYS LTD |
EP3347359 | PROCESS FOR MAKING ISOIDIDE | ARCHER DANIELS MIDLAND CO |
EP3347376 | NOVEL IGFR-LIKE RECEPTOR AND USES THEREOF | HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM GESUNDHEIT & UMWELT GMBH |
EP3347468 | COMBINATION COMPRISING IMMUNOSTIMULATORY OLIGONUCLEOTIDES | MOLOGEN AG |
EP3347929 | METHODS OF PREPARING MULTILAYERED ELECTROCHROMIC SYSTEMS | YEDA RES & DEV |
EP3348625 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEMICAL LTD |
EP3348636 | METHOD FOR MODIFYING GENOME SEQUENCE THAT SPECIFICALLY CONVERTS NUCLEOBASE OF TARGETED DNA SEQUENCE, AND MOLECULAR COMPLEX USED IN SAID METHOD | UNIV KOBE NAT UNIV CORP |
EP3349582 | NOVEL INSECT INHIBITORY PROTEINS | MONSANTO TECHNOLOGY LLC |
EP3349775 | SOLID PHASE PEPTIDE SYNTHESIS METHODS AND ASSOCIATED SYSTEMS | MASSACHUSETTS INST TECHNOLOGY |
EP3349793 | ANTI-S100A8 FOR TREATING LEUKEMIA | UNIV LAVAL |
EP3350144 | PROCESS FOR THE CYCLOPROPANATION OF OLEFINS USING N-METHYL-N-NITROSO COMPOUNDS | GIVAUDAN SA |
EP3350154 | AN IMPROVED PROCESS FOR PREPARATION OF TRIENTINE DIHYDROCHLORIDE | EMCURE PHARMACEUTICALS LTD |
EP3350160 | AMPHOTERIC BETAINE COMPOUNDS | EASTMAN CHEM CO |
EP3350162 | MONO- OR DI-SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS | JANSSEN PHARMACEUTICALS INC |
EP3350178 | NOVEL IMIDAZO [4,5-C]QUINOLINE AND IMIDAZO [4,5-C][1,5]NAPHTHYRIDINE DERIVATIVES AS LRRK2 INHIBITORS | PFIZER |
EP3350179 | CRYSTALLINE FORMS | IDORSIA PHARMACEUTICALS LTD |
EP3350186 | NANO- AND MICRO-SIZED PARTICLES OF 20-CAMPTOTHECIN OR DERIVATIVE THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND TREATMENT OF CANCERS THEREWITH | CAO PHARMACEUTICALS INC |
EP3350189 | METAL COMPLEXES | UEA ENTERPRISES LTD |
EP3350191 | NUCLEOTIDE ANALOGS | UNIV CALIFORNIA |
EP3350195 | THE METHOD OF SYNTHESIS AND PURIFICATION OF A NUCLEOSIDE AND/OR A NUCLEOTIDE, A MODIFIED NUCLEOSIDE AND/OR NUCLEOTIDE, A DNA MOLECULE AND AN OLIGONUCLEOTIDE LIBRARY COMPRISING SAID MODIFIED NUCLEOSIDE AND/OR NUCLEOTIDE AND THE USE OF SAID OLIGONUCLEOTIDE LIBRARY | PURE BIOLOGICS SPOLKA AKCYJNA |
EP3350213 | T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS | US HEALTH |
EP3350220 | ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF | SCHOLAR ROCK INC |
EP3350222 | LIGANDS FOR INTEGRIN AVBETA6, SYNTHESIS AND USES THEREOF | UNIV MUENCHEN TECH |
EP3350322 | A NOVEL ENDOLYSIN POLYPEPTIDE | MICREOS HUMAN HEALTH BV |
EP3350333 | POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION | MODERNATX INC |
EP3351536 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEMICAL LTD |
EP3351552 | 2'- SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | GILEAD SCIENCES INC |
EP3351580 | POLYMER CONJUGATE OF HEXA-COORDINATED PLATINUM COMPLEX | NIPPON KAYAKU KK |
EP3352185 | PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, DYE COMPOSITION, AND OXIDE SEMICONDUCTOR ELECTRODE | FUJIFILM CORP |
EP3352283 | ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM-ION SECONDARY CELL, AND MODULE | DAIKIN IND LTD |
EP3352752 | DETECTING AND TREATING GROWTH HORMONE DEFICIENCY | AMMONETT PHARM LLC |
EP3352856 | METHODS OF TREATING INTRAOCULAR PRESSURE WITH ACTIVATORS OF TIE-2 | AERPIO THERAPEUTICS INC |
EP3353137 | PROCESSES AND APPARATUSES FOR PRODUCTION OF BUTADIENE | UOP LLC |
EP3353147 | SYNTHESIS OF TERPHENYL COMPOUNDS | VECTUS BIOSYSTEMS LTD |
EP3353152 | METHOD | NORSK MEDISINSK SYKLOTRONSENTER AS |
EP3353156 | TEAD TRANSCRIPTION FACTOR AUTOPALMITOYLATION INHIBITORS | MASSACHUSETTS GEN HOSPITAL |
EP3353157 | FAR SUPERIOR OXIDATION CATALYSTS BASED ON MACROCYCLIC COMPOUNDS | UNIV CARNEGIE MELLON |
EP3353161 | TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS | US HEALTH |
EP3353164 | BI-HETEROARYL SUBSTITUTED 1,4-BENZODIAZEPINES AND USES THEREOF FOR THE TREATMENT OF CANCER | JANSSEN PHARMACEUTICA NV |
EP3353171 | ISOXAZOLINE-SUBSTITUTED BENZAMIDES AND ANALOGUES AS INSECTICIDES | SYNGENTA PARTICIPATIONS AG |
EP3353172 | ISOXAZOLINE-SUBSTITUTED BENZAMIDES AND ANALOGUES AS INSECTICIDES | SYNGENTA PARTICIPATIONS AG |
EP3353173 | PESTICIDALLY ACTIVE POLYCYCLIC DERIVATIVES WITH 5-MEMBERED SULFUR CONTAINING HETEROCYCLIC RING SYSTEMS | SYNGENTA PARTICIPATIONS AG |
EP3353181 | NEW BICYCLIC COMPOUNDS AS DUAL ATX/CA INHIBITORS | HOFFMANN LA ROCHE |
EP3353184 | NOVEL BRANCHED AMPHIPHILIC LIPIDS | UNIV BRETAGNE OCCIDENTALE |
EP3353187 | METAL CARBENE OLEFIN METATHESIS CATALYSTS | UMICORE AG & CO KG |
EP3353195 | POLYPEPTIDES HAVING CELLOBIOHYDROLASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME | NOVOZYMES AS |
EP3353201 | RECOMBINANT IMMUNOGLOBULIN HEAVY CHAINS COMPRISING A SORTASE CONJUGATION LOOP AND CONJUGATES THEREOF | HOFFMANN LA ROCHE |
EP3353212 | OPTIMIZED ANTI-CD3 BISPECIFIC ANTIBODIES AND USES THEREOF | REGENERON PHARMA |
EP3353214 | AGENTS INHIBITING KALLIKREIN-8 FOR USE IN THE PREVENTION OR TREATMENT OF ALZHEIMER'S DISEASE | UNIV DUISBURG ESSEN |
EP3353302 | ACTIVATION OF TASTE RECEPTOR GENES IN MAMMALIAN CELLS USING CRISPR-CAS-9 | B R A I N AG |
EP3354636 | METHOD FOR THE HYDROAMINOMETHYLATION OF CYCLIC DIENES TO DI-SECONDARY AMINES | OXEA GMBH |
EP3354637 | NEW POLYMORPHIC FORMS OF MINOCYCLINE BASE AND PROCESSES FOR THEIR PREPARATION | HOVIONE SCIENTIA LTD |
EP3354651 | TRIFLUOROMETHYL ALCOHOLS AS MODULATORS OF ROR-GAMMA-T | JANSSEN PHARMACEUTICA NV |
EP3355890 | HUMAN PLASMA KALLIKREIN INHIBITORS | BIOCRYST PHARM INC |
EP3355907 | BI-SPECIFIC THERAPEUTIC PROTEINS FOR TISSUE REPAIR | SILVER CREEK PHARMACEUTICALS INC |
EP3356326 | METHOD FOR PRODUCING MERCAPTANS BY HYDROGEN-ASSISTED DISULFIDE ENZYME HYDROGENOLYSIS | ARKEMA FRANCE |
EP3356335 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG |
EP3356359 | INHIBITORS OF KRAS G12C MUTANT PROTEINS | ARAXES PHARMA LLC |
EP3356362 | 2-(HET)ARYL-SUBSTITUTED CONDENSED BICYCLIC HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS | BAYER CROPSCIENCE AG |
EP3356368 | BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLE CARRYING BENZIMIDAZOLO[1,2-A]BENZIMIDAZOLYL GROUPS, CARBAZOLYL GROUPS, BENZOFURANE GROUPS OR BENZOTHIOPHENE GROUPS FOR ORGANIC LIGHT EMITTING DIODES | IDEMITSU KOSAN CO |
EP3356370 | 11,13-MODIFIED SAXITOXINS FOR THE TREATMENT OF PAIN | SITEONE THERAPEUTICS INC |
EP3356379 | PROCESS FOR PRODUCING RUTHENIUM COMPLEXES AND INTERMEDIATES THEREOF AND THEIR USE IN OLEFIN METATHESIS | APEIRON SYNTHESIS SA |
EP3356390 | METHODS AND COMPOSITIONS FOR ANTIBODY-EVADING VIRUS VECTORS | UNIV NORTH CAROLINA CHAPEL HILL |
EP3356404 | ANTI-PD1 ANTIBODIES AND METHODS OF USE | HOFFMANN LA ROCHE |
EP3356407 | BISPECIFIC ANTI-CD19XCD3 T CELL ACTIVATING ANTIGEN BINDING MOLECULES | HOFFMANN LA ROCHE |
EP3356410 | BISPECIFIC ANTI-CEAXCD3 T CELL ACTIVATING ANTIGEN BINDING MOLECULES | HOFFMANN LA ROCHE |
EP3356411 | BISPECIFIC ANTIBODIES SPECIFIC FOR PD1 AND TIM3 | HOFFMANN LA ROCHE |
EP3356412 | TARGETING METASTASIS STEM CELLS THROUGH A FATTY ACID RECEPTOR (CD36) | FUNDACIO INST DE RECERCA BIOMEDICA IRB BARCELONA |
EP3356419 | TETRAVALENT MULTISPECIFIC ANTIBODIES | HOFFMANN LA ROCHE |
EP3356524 | ENHANCED GENE DELIVERY TO NATURAL KILLER CELLS, HEMATOPOIETIC STEM CELLS AND MACROPHAGES | VYCELLIX INC |
EP3356561 | THERAPEUTIC AND DIAGNOSTIC METHODS FOR AUTOIMMUNE DISEASES AND/OR INFLAMMATION | MOMENTA PHARMACEUTICALS INC |
EP3357574 | CATALYST COMPOSITION FOR HYDROFORMYLATION REACTION, AND HYDROFORMYLATION METHOD USING SAME | LG CHEMICAL LTD |
EP3357899 | METHOD FOR CHLORINATION AND DEHYDROGENATION OF ETHANE | ZHONGKE YIGONG XIAMEN CHEMICAL TECH CO LTD |
EP3357912 | SPIRO COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEMICAL LTD |
EP3357925 | SALT TYPE AND CRYSTAL TYPE OF 4H-PYRAZOLO [1, 5-ALPHA]BENZIMIDAZOLE COMPOUND AND PREPARATION METHOD AND INTERMEDIATE THEREOF | HUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC |
EP3357927 | AEROGEL PRECURSOR, PREPARATION METHOD THEREFOR, AEROGEL PREPARED THEREFROM, AND AEROGEL PREPARATION METHOD USING SAME | LG CHEMICAL LTD |
EP3357928 | NOVEL DYES WITH PHOSPHINIC ACID, PHOSPHINATE, PHOSPHONATE AND PHOSPHONAMIDATE SUBSTITUENTS AS AUXOCHROMIC GROUPS AND METHODS FOR PREPARING THE SAME | MAX PLANCK GESELLSCHAFT |
EP3358010 | NOVEL ARTIFICIAL BIOLUMINESCENT ENZYMES | AIST |
EP3358017 | ANTIBODY FOR IMMUNOASSAY AND METHOD FOR PREPARING SAME | SEKISUI MEDICAL CO LTD |
EP3359241 | FORMULATIONS OF PTHRP ANALOGUES, TRANSDERMAL PATCHES THEREOF, AND USES THEREOF | RADIUS HEALTH INC |
EP3359511 | METHOD AND SYSTEM FOR EXTRACTING STRANDED GAS FROM UNDERWATER ENVIRONMENTS, CONVERTING IT TO CLATHRATES, AND SAFELY TRANSPORTING IT FOR CONSUMPTION | PHOENIX STUART L |
EP3359525 | NEW ALKYNYL-SUBSTITUTED 3-PHENYLPYRROLIDINE-2,4-DIONES AND USE THEREOF AS HERBICIDES | BAYER CROPSCIENCE AG |
EP3359536 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CFTR | PROTEOSTASIS THERAPEUTICS INC |
EP3359542 | SPIRO[3H-INDOLE-3,2 虂-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS | BOEHRINGER INGELHEIM INT |
EP3359556 | MODULATING GAMMA - C -CYTOKINE ACTIVITY | BIONIZ LLC |
EP3359559 | GLYCOSYLATED YGHJ POLYPEPTIDES FROM ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC) | UNIV SYDDANSK |
EP3359673 | PODOSPHAERA LEUCOTRICHA RESISTENCE PROVIDING GENES IN MALUS DOMESTICA | EDMUND MACH FOND |
EP3360867 | PREPARATION METHOD OF 2-MERCAPTOBENZOTHIAZOLE | SENNICS CO LTD |
EP3360877 | 1,6- DIAZABICYCLO [3,2,1]OCTAN- 7- ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS | WOCKHARDT LTD |
EP3360893 | HIGH-AFFINITY AND SOLUBLE PDL-1 MOLECULE | GUANGZHOU INST BIOMED & HEALTH |
EP3360895 | PREPARATION COMPRISING FACTOR VIII AND VON WILLEBRAND FACTOR PEPTIDES | OCTAPHARMA AG |
EP3361294 | COLOR CONVERSION COMPOSITION, COLOR CONVERSION SHEET, AND LIGHT SOURCE UNIT, DISPLAY, LIGHTING SYSTEM, BACKLIGHT UNIT, LED CHIP AND LED PACKAGE CONTAINING SAME | TORAY INDUSTRIES |
EP3361521 | LIGHT-EMITTING ELEMENT | SUMITOMO CHEMICAL CO |
EP3362066 | COMBINATION THERAPY FOR TREATING MALIGNANCIES | AGIOS PHARMACEUTICALS INC |
EP3362427 | PRODUCTION OF PROPYLENE GLYCOL MONOALKYL ETHER | LYONDELL CHEMICAL TECH LP |
EP3362436 | PROCESS FOR THE CATALYTIC DIRECTED CLEAVAGE OF AMIDE-CONTAINING COMPOUNDS | UNIV ANTWERPEN |
EP3362440 | PROCESS FOR THE PRODUCTION OF 1,4-BUTANEDIOL AND TETRAHYDROFURAN FROM FURAN | SHELL INT RESEARCH |
EP3362448 | NEW COMPOUNDS INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA | INVENTIVA |
EP3362449 | SIBIRILINE DERIVATIVES FOR USE FOR PREVENTING AND/OR TREATING DISORDERS ASSOCIATED WITH CELLULAR NECROPTOSIS | INST NAT SANTE RECH MED |
EP3362454 | EP4 ANTAGONISTS | EISAI R&D MAN CO LTD |
EP3362459 | ACETATE COMPLEXES AND METHODS FOR ACETATE QUANTIFICATION | GEN ELECTRIC |
EP3362462 | IN SITU DETECTION OF NUCLEOTIDE VARIANTS IN HIGH NOISE SAMPLES, AND COMPOSITIONS AND METHODS RELATED THERETO | ADVANCED CELL DIAGNOSTICS INC |
EP3362464 | METHODS FOR EXTRACTING PROTEINS FROM BLOOD PLASMA | PLASMA TECH LLC |
EP3362469 | GENERATING MAIZE PLANTS WITH ENHANCED RESISTANCE TO NORTHERN LEAF BLIGHT | PIONEER HI BRED INT |
EP3362470 | CHIMERIC ANTIGEN RECEPTORS CONTAINING A CHLOROTOXIN DOMAIN | HOPE CITY |
EP3362471 | PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING | TOLERO PHARMACEUTICALS INC |
EP3362473 | USE OF A FIBRINOGEN CAPTURE AGENT TO DETECT A CIZ1 B-VARIANT | CIZZLE BIOTECHNOLOGY LTD |
EP3362480 | ANTIBODY SPECIFICALLY BINDING TO ERBB3 AND USE THEREOF | ISU ABXIS CO LTD |
EP3362569 | CXCR6-TRANSDUCED T CELLS FOR TARGETED TUMOR THERAPY | UNIV MUENCHEN LUDWIG MAXIMILIANS |
EP3363777 | METHOD FOR PRODUCING DIOL | DAIKIN IND LTD |
EP3363779 | PRODUCTION METHOD OF ASYMMETRIC CHAIN CARBONATE | DAIKIN IND LTD |
EP3363796 | METHOD FOR PRODUCING HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICALS CO |
EP3364995 | SINGLE-CHAIN CD27-RECEPTOR AGONIST PROTEINS | APOGENIX AG |
EP3365318 | BENZIL MONOKETALAND USE THEREOF | MERCK PATENT GMBH |
EP3365322 | PROCESS FOR PREPARING (Z)-ENDOXIFEN OF HIGH PURITY | US HEALTH |
EP3365347 | BORON COMPOUNDS AS INHIBITORS OF LIPOXYGENASE AND THE LIPOXYGENASE PATHWAY, AND PREPARATION AND USE THEREOF | UNIV LEIPZIG |
EP3365366 | TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR PREVENTION OR TREATMENT OF HIV INFECTION | SANOFI SA |
EP3365373 | BINDING MOLECULES THAT INHIBIT CANCER GROWTH | MERUS NV |
EP3366307 | COMPOSITIONS AND METHODS OF INHIBTING MASP-1 AND/OR MASP-3 FOR THE TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA | OMEROS CORP |
EP3366667 | METHOD OF ANALYSING A CELL OR OTHER BIOLOGICAL MATERIAL CONTAINING NUCLEIC ACID | BIOSTATUS LTD |
EP3366673 | CARBAZOLE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING SAME | LG CHEMICAL LTD |
EP3366676 | CRYSTALLINE FORMS OF BEDAQUILINE FUMARATE AND PREPARATION METHODS THEREFOR | ZHEJIANG HISUN PHARM CO LTD |
EP3366700 | GELATIN, CHEMICALLY MODIFIED PRODUCT THEREOF, AQUEOUS COMPOSITION AND MEDICAL LAMINATE CONTAINING SAME, PRODUCTION METHOD FOR MEDICAL LAMINATE, AND CELL SHEET ISOLATION METHOD | TOKYO METRO IND TECH RES INST |
EP3366749 | COMPOSITION FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE | SAMSUNG SDI CO LTD |
EP3366750 | STABILIZER AND STABILIZATION METHOD | FUJIFILM WAKO PURE CHEMICAL CORP |
EP3368209 | SYNTHESIS OF ORGANIC PEROXYDES USING AN OSCILLATORY FLOW MIXING REACTOR | ARKEMA FRANCE |
EP3368501 | IMPROVED CATALYST FOR ETHYLBENZENE CONVERSION IN A XYLENE ISOMERIZATION PROCESS | BP CORP NORTH AMERICA INC |
EP3368513 | PROCESS FOR THE SYNTHESIS OF PIRFENIDONE | PROCOS SPA |
EP3368514 | TRISUBSTITUTEDSILYLPHENOXYHETEROCYCLES AND ANALOGUES | BAYER CROPSCIENCE AG |
EP3368521 | CONDENSED BICYCLIC HETEROCYCLE DERIVATIVES AS PEST CONTROL AGENTS | BAYER CROPSCIENCE AG |
EP3368522 | PYRIDINE OR PYRIMIDINE DERIVATIVES | HOFFMANN LA ROCHE |
EP3368523 | NOVEL PYRDAZINONE HERBICIDES | DU PONT |
EP3368524 | HETEROARYLCARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS | BOEHRINGER INGELHEIM INT |
EP3368527 | PALBOCICLIB SALTS | EGYT GYOGYSZERVEGYESZETI GYAR |
EP3368534 | VALBENAZINE SALTS AND POLYMORPHS THEREOF | NEUROCRINE BIOSCIENCES INC |
EP3368538 | WEE 1 KINASE INHIBITORS AND METHODS OF MAKING AND USING THE SAME | UNIV COLORADO REGENTS |
EP3368569 | POLYPEPTIDES AGAINST IL-23 | ABLYNX NV |
EP3368578 | ANTI-HTRA1 ANTIBODIES AND METHODS OF USE THEREOF | HOFFMANN LA ROCHE |
EP3368579 | HINGE MODIFIED ANTIBODY FRAGMENTS AND METHODS OF MAKING | HOFFMANN LA ROCHE |
EP3368676 | METHODS AND COMPOSITIONS FOR RAPID PLANT TRANSFORMATION | PIONEER HI BRED INT |
EP3368678 | GENETIC CONSTRUCT | QUETHERA LTD |
EP3369724 | PROCESS FOR THE PREPARATION OF IOPAMIDOL | BRACCO IMAGING SPA |
EP3369727 | AMINE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEMICAL LTD |
EP3369732 | ANDROGEN RECEPTOR MODULATING COMPOUNDS | ORION CORP |
EP3371140 | PROCESS FOR CONVERSION OF ACYCLIC C5 COMPOUNDS TO CYCLIC C5 COMPOUNDS AND CATALYST COMPOSITION FOR USE THEREIN | EXXONMOBIL CHEMICAL PATENTS INC |
EP3371141 | PRODUCTION OF CYCLIC C5 COMPOUNDS | EXXONMOBIL CHEMICAL PATENTS INC |
EP3371147 | INNOVATIVE PREPARATION AND CRYSTALLIZATION OF IOSIMENOL | OTSUKA PHARMA CO LTD |
EP3371148 | REGULATORS FOR CONTROLLING LINEAR AND PSEUDO-RING EXPANSION POLYMERIZATION OF VINYL MONOMERS | DISPOLTEC B V |
EP3371150 | PROCESS FOR PREPARING BRIVARACETAM | UCB BIOPHARMA SPRL |
EP3371157 | METHOD FOR PRODUCING 5-HYDROXYMETHYLFURFURAL IN THE PRESENCE OF CATALYSTS OF THE FAMILY OF HOMOGENEOUS SULFONIC ACIDS IN THE PRESENCE OF AT LEAST ONE APROTIC POLAR SOLVENT | IFP ENERGIES NOW |
EP3371159 | METHODS OF FORMING AROMATIC CONTAINING COMPOUNDS | UNIV MINNESOTA |
EP3371195 | SELECTIVE HDAC8 INHIBITORS AND THEIR USES | HOCHSCHULE DARMSTADT |
EP3371206 | METHODS OF MAKING FUCOSYLATED AND AFUCOSYLATED FORMS OF A PROTEIN | HOFFMANN LA ROCHE |
EP3371223 | BI-SPECIFIC ANTIBODIES FOR ENHANCED TUMOR SELECTIVITY AND INHIBITION AND USES THEREOF | MERCK PATENT GMBH |
EP3371311 | BI-FUNCTIONAL CHIMERIC PROTEINS AND USES THEREOF | ORIONIS BIOSCIENCES NV |
EP3372281 | POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY | VIIV HEALTHCARE CO |
EP3372581 | FULLERENE DERIVATIVE AND n-TYPE SEMICONDUCTOR MATERIAL | DAIKIN IND LTD |
EP3372602 | PYRROLOQUINOLINE QUINONE B CRYSTAL FORM AND PREPARATION METHOD THEREFOR | ZHUCHENG HAOTIAN PHARM CO LTD |
EP3372605 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS | ARRAY BIOPHARMA INC |
EP3372607 | CRYSTALLINE FORM OF BTK KINASE INHIBITOR AND PREPARATION METHOD THEREOF | JIANGSU HENGRUI MEDICINE CO |
EP3372608 | PROCESS FOR THE PREPARATION OF TRIS[3-(ALKOXYSILYL)PROPYL]ISOCYANURATS | EVONIK DEGUSSA GMBH |
EP3372609 | PROCESS FOR THE PREPARATION OF TRIS[3-(ALKOXYSILYL)PROPYL]ISOCYANURATES | EVONIK DEGUSSA GMBH |
EP3373928 | NOVEL FORMULATIONS | GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS US LLC |
EP3373935 | CYANOPYRIDINE DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS, COMPOSITIONS, AND THEIR USE | MERCK SHARP & DOHME |
EP3374027 | RATIONAL DRUG DESIGN TARGETING RESISTANT GRAM-NEGATIVE BACTERIAL INFECTIONS TO POLYMYXIN-CLASS ANTIBIOTICS | UNIV COLUMBIA |
EP3374081 | VANADIUM PYRIDINE-IMINE COMPLEX, CATALYTIC SYSTEM COMPRISING SAID VANADIUM PYRIDINE-IMMINE COMPLEX AND A (CO) POLYMERIZATION PROCESS OF CONJUGATED DIENES | VERSALIS SPA |
EP3374336 | METHODS FOR USING NITRIC OXIDE TO INHIBIT POPCORN POLYMERIZATION DURING BUTADIENE PROCESSING | SABIC GLOBAL TECHNOLOGIES BV |
EP3374337 | METHODS AND SYSTEMS FOR PURIFYING 1,3-BUTADIENE FROM A C4 HYDROCARBON STREAM | SABIC GLOBAL TECHNOLOGIES BV |
EP3374340 | PROCESS FOR PRODUCING ALDEHYDES | DOW TECHNOLOGY INVESTMENTS LLC |
EP3374348 | TRI-FUNCTIONAL CROSSLINKING REAGENTS | ETH ZUERICH |
EP3374358 | AZETIDINE DERIVATIVES FOR TAU IMAGING | LILLY CO ELI |
EP3374378 | CHARGE-REVERSED N-TERMINAL SPIDER SILK PROTEIN DOMAIN AND USES THEREOF | SPIBER TECH AB |
EP3374392 | IMPROVED SERUM ALBUMIN-BINDING IMMUNOGLOBULIN VARIABLE DOMAINS | ABLYNX NV |
EP3374394 | TRISPECIFIC MOLECULE COMBINING SPECIFIC TUMOR TARGETING AND LOCAL IMMUNE CHECKPOINT INHIBITION | UNIV MUENCHEN LUDWIG MAXIMILIANS |
EP3374410 | REACTIVE FLAME RETARDANTS FOR POLYURETHANE AND POLYISOCYANURATE FOAMS | ICL IP AMERICA INC |
EP3374411 | REACTIVE FLAME REARDANTS FOR POLYURETHANE AND POLYISOCYANURATE FOAMS | ICL IP AMERICA INC |
EP3374478 | LUBRICATING COMPOSITION COMPRISING THIOETHER-SUBSTITUTED PHENOLIC COMPOUND | LUBRIZOL CORP |
EP3374479 | BOROXINE BASED SEAL COMPATIBILITY AGENTS | AFTON CHEMICAL CORP |
EP3375789 | ANTI-PNEUMOCOCCAL HYPERIMMUNE GLOBULIN FOR THE TREATMENT AND PREVENTION OF PNEUMOCOCCAL INFECTION | ADMA BIOLOGICS INC |
EP3376857 | NON-HUMAN ANIMALS HAVING A HUMANIZED LYMPHOCYTE-ACTIVATION GENE 3 | REGENERON PHARMA |
EP3377049 | CRYSTALLINE FORMS OF TAPENTADOL SALTS AND PROCESS FOR PREPARATION THEREOF | MSN LABORATORIES PRIVATE LTD |
EP3377090 | METHODS FOR TREATMENT OF BILE ACID-RELATED DISORDERS | NGM BIOPHARMACEUTICALS INC |
EP3377468 | ALLYL ALCOHOL BY CATALYTIC ISOMERIZATION OF A PROPYLENE OXIDE STREAM | LYONDELL CHEMICAL TECH LP |
EP3377472 | HOMOGENEOUS PROCESS FOR HYDRODEHALOGENATING HALOGENATED HETEROARYL COMPOUNDS | JOHNSON MATTHEY PLC |
EP3377482 | MODULATORS OF ROR-GAMMA | VITAE PHARMACEUTICALS INC |
EP3377507 | NEW 5-AZIDO-5-DEOXY-2 :3-ISOPROPYLIDENE-D-ARABINOSE COMPOUNDS; THEIR METHOD OF MANUFACTURE AND THEIR USE FOR THE SYNTHESIS OF ARA-N3, KDO-N3 AND 4EKDO-N3 | CENTRE NAT RECH SCIENT |
EP3377519 | LABYRINTHOPEPTINS AS ANTI-VIRAL AGENTS | HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH |
EP3377529 | SIGLEC-10 ANTIBODIES | INNATE PHARMA |
EP3377530 | METHODS OF IDENTIFYING IMMUNE CELLS IN PD-L1 POSITIVE TUMOR TISSUE | VENTANA MED SYST INC |
EP3377623 | PROCESS FOR OBTAINING AN AQUEOUS EXTRACT ENRICHED WITH SMALL RNAS FROM A PLANT MATERIAL AND EXTRACTS RESULTING FROM THE PROCESS | ISP INVESTMENTS LLC |
EP3377624 | TOPICAL COMPOSITION COMPRISING A SMALL RNA TIGER LILY EXTRACT AND METHOD OF COSMETIC CARE TO REDUCE SKIN SIGNS OF AGING | ISP INVESTMENTS LLC |
EP3378848 | HYDROGENATION METHOD FOR SYNTHESIS OF METHANE AND METHANOL | KARLSRUHER INST TECHNOLOGIE |
EP3378857 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH |
EP3378870 | NOVEL ANTIMICROBIAL PEPTIDE AND USE THEREOF | NOVACELL TECH INC |
EP3380117 | GENETICALLY MODIFIED CELLS AND USES THEREOF | CARTHERICS PTY LTD |
EP3380119 | FMDV AND E2 FUSION PROTEINS AND USES THEREOF | MERIAL INC |
EP3380122 | ANTI-5T4 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES | SYNTHON BIOPHARMACEUTICALS BV |
EP3380452 | SITE-SPECIFIC ISOTOPIC LABELING OF 1, 4-DIENE SYSTEMS | RETROTOPE INC |
EP3380457 | MONOSULFONIC PHENYLTETRAZOLE COMPOUNDS WITH APPLICATIONS | HANGZHOU JENNIFER BIOTECH CO LTD |
EP3380460 | PROCESS AND REACTOR FOR THE EPOXIDATION OF PROPENE | EVONIK DEGUSSA GMBH |
EP3380462 | METHODS FOR ANALYSIS AND RESOLUTION OF PREPARATIONS OF DIANHYDROGALACTITOL AND DERIVATIVES OR ANALOGS THEREOF | DEL MAR PHARMACEUTICALS BC LTD |
EP3380471 | COMT INHIBITING METHODS AND COMPOSITIONS | LIEBER INST FOR BRAIN DEVELOPMENT |
EP3380477 | METHOD FOR THE PREPARATION OF COMPOUNDS HAVING A 16-OXABICYCLO[10.3.1]PENTADECENE SCAFFOLD AND THE SUBSEQUENT PRODUCTS THEREOF | BASF SE |
EP3380502 | PEPTIDES | IMMUNOCORE LTD |
EP3380517 | POLYPEPTIDES INHIBITING CD40L | ABLYNX NV |
EP3381068 | ORGANIC SEMICONDUCTIVE LAYER COMPRISING PHOSPHINE OXIDE COMPOUNDS | NOVALED GMBH |
EP3381461 | PEPTIDES AND METHODS OF USING SAME | SERPIN PHARMA LLC |
EP3381892 | METHOD FOR PRODUCING POLYTHIOL COMPOUND, METHOD FOR PRODUCING CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED ARTICLE | HOYA LENS THAILAND LTD |
EP3381893 | POLYTHIOL COMPOUND MANUFACTURING METHOD, CURABLE COMPOSITION MANUFACTURING METHOD, AND CURED PRODUCT MANUFACTURING METHOD | HOYA LENS THAILAND LTD |
EP3381894 | POLYTHIOL COMPOSITION WITH IMPROVED LONG-TERM STORAGE STABILITY AND OPTICAL LENSES USING SAME | SKC CO LTD |
EP3381895 | METHOD FOR PRODUCING CARBOXYLIC ACID THIOESTER | MITSUBISHI CHEM CORP |
EP3381899 | INTERMEDIATE COMPOUND FOR PROCESS OF PRODUCING CYCLOALKYLCARBOXAMIDO-INDOLE COMPOUNDS | VERTEX PHARMA |
EP3381923 | NOVEL METHOD FOR PREPARING LITHIUM BIS(FLUOROSULFONYL)IMIDE | CLS INC |
EP3381936 | GHRELIN O-ACYLTRANSFERASE (GOAT) AND USES THEREOF | UNIV CORDOBA |
EP3381938 | METHOD FOR INCREASING COLLAGEN YIELD, AND COLLAGEN PREPARED USING SAME | SEWON CELLONTEC CO LTD |
EP3382023 | GENE CAPABLE OF INCREASING PROTEIN CONTENT IN SEED, AND METHOD FOR UTILIZATION THEREOF | TOYOTA MOTOR CO LTD |
EP3382024 | GENE CAPABLE OF INCREASING PROTEIN CONTENT IN SEED, AND METHOD FOR UTILIZATION THEREOF | TOYOTA MOTOR CO LTD |
EP3382025 | GENE CAPABLE OF INCREASING PROTEIN CONTENT IN SEED, AND METHOD FOR UTILIZATION THEREOF | TOYOTA MOTOR CO LTD |
EP3382395 | VARICELLA ZOSTER | TANAKA PRECIOUS METAL IND |
EP3383180 | SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE |
EP3383421 | STAPLED HELICAL PEPTIDES AND METHODS OF SYNTHESIS | UNIV HONG KONG |
EP3383422 | CIRCULAR TANDEM REPEAT PROTEINS | HUTCHINSON FRED CANCER RES |
EP3383440 | SYNP162, A PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN ROD PHOTORECEPTORS | FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RES |
EP3383493 | C5-C6-CARBOCYCLIC FUSED IMINOTHIADIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE | MERCK SHARP & DOHME |
EP3383840 | METHOD FOR PRODUCING ISOCYANATES | COVESTRO DEUTSCHLAND AG |
EP3383842 | PROCESS FOR PRODUCING HYDROGEN BIS(FLUOROSULFONYL)IMIDE | COORSTEK FLUOROCHEMICALS INC |
EP3383854 | WATER-SOLUBLE UV-ABSORBING COMPOUNDS AND USES THEREOF | NOVARTIS AG |
EP3383861 | ARYLATION METHOD | UMICORE AG & CO KG |
EP3383867 | COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY | CHIESI FARM SPA |
EP3383870 | SCREENING METHODS FOR ASPHALTENE STABILIZERS | BP CORP NORTH AMERICA INC |
EP3383877 | HETEROCYCLE COMPOUNDS AND USES THEREOF | SHANGHAI AEON BIOTECH CO LTD |
EP3383885 | CRYSTALLIZATION OF 25-HYDROXY-7-DEHYDROCHOLSTEROL | DSM IP ASSETS BV |
EP3383911 | ANTIBODIES AND MOLECULES THAT IMMUNOSPECIFICALLY BIND TO BTN1A1 AND THE THERAPEUTIC USES THEREOF | STCUBE & CO INC |
EP3383924 | REDOX POLYMERIZABLE COMPOSITION WITH PHOTOLABILE REDUCING AGENTS | 3M INNOVATIVE PROPERTIES CO |
EP3384065 | PROCESS FOR THE GENERATION OF METALLIC FILMS | BASF SE |
EP3384292 | SEROLOGIC TEST FOR THERAPY CONTROL OF HPV16 POSITIVE CARCINOMA | ABVIRIS DEUTSCHLAND GMBH |
EP3385250 | CRYSTALS OF MONOVALENT CATION SALT OF 3-HYDROXYISOVALERIC ACID, AND METHOD FOR PRODUCING SAID CRYSTALS | KYOWA HAKKO BIO CO LTD |
EP3385255 | FUNGICIDAL COMPOUND, FUNGICIDE COMPOSITION AND PREPARATION AND USE THEREOF | ZHEJIANG BOSST CROPSCIENCE CO LTD |
EP3385256 | PREPARATION METHOD FOR EUTECTIC HYDRATE CRYSTAL FORM II OF AHU-377 AND DIOVAN TRISODIUM SALT | CRYSTAL PHARMATECH CO LTD |
EP3385267 | SYNTHESIS OF BORONIC ESTER AND ACID COMPOUNDS | MILLENNIUM PHARM INC |
EP3385274 | MUTANT OF HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN | UNIV XIAMEN |
EP3385387 | SIMIAN ADENOVIRUS NUCLEIC ACID- AND AMINO ACID-SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREOF | GLAXOSMITHKLINE BIOLOGICALS SA |
EP3386519 | SIRNA STRUCTURES FOR HIGH ACTIVITY AND REDUCED OFF TARGET | NITTO DENKO CORP |
EP3386919 | A TIN-CONTAINING ZEOLITIC MATERIAL HAVING A BEA FRAMEWORK STRUCTURE | BASF SE |
EP3386935 | PRODUCTION OF XYLENE DERIVATIVES | RHODIA OPERATIONS |
EP3386937 | TWO-BED PARAFFIN TO OLEFIN ENHANCEMENT PROCESS | UOP LLC |
EP3386946 | PROCESS FOR PREPARING AN ALKANESULPHONIC ACID | EVONIK DEGUSSA GMBH |
EP3386947 | METHOD FOR PRODUCING N-RETINOYLCYSTEIC ACID ALKYL ESTER | ARDENIA INVESTMENTS LTD |
EP3386978 | BRIDGED PIPERIDINE DERIVATIVES | HOFFMANN LA ROCHE |
EP3386980 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | PLEXXIKON INC |
EP3386984 | HEXAHYDROPYRAZINOTRIAZINONE DERIVATIVES AS KINASE INHIBITORS | UCB BIOPHARMA SPRL |
EP3386986 | GOLD PORPHYRIN-PEG CONJUGATES AND METHODS OF USE | UNIV HONG KONG |
EP3386997 | MONOMALEIMIDE-FUNCTIONALIZED PLATINUM COMPOUNDS FOR CANCER THERAPY | UNIV WIEN MED |
EP3386998 | DIASTEREOSELECTIVE SYNTHESIS OF PHOSPHATE DERIVATIVES AND OF THE GEMCITABINE PRODRUG NUC-1031 | NUCANA PLC |
EP3386999 | PROCESS FOR PREPARING COMPOSITIONS COMPRISING ALKYL(ALKYL-GLUCOSIDE)URONATES, SAID COMPOSITIONS AND USE THEREOF AS A SURFACTANT | ECOLE NAT SUPERIEURE DE CHIMIE |
EP3387015 | TYPE II ANTI-CD20 ANTIBODY FOR REDUCING FORMATION OF ANTI-DRUG ANTIBODIES | HOFFMANN LA ROCHE |
EP3387019 | RELAXIN IMMUNOGLOBULIN FUSION PROTEINS AND METHODS OF USE | THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RES |
EP3387079 | AMINIMIDE COMPOSITIONS | PPG IND OHIO INC |
EP3387137 | TARGETING PEPTIDES FOR DIRECTING ADENO-ASSOCIATED VIRUSES (AAVs) | CALIFORNIA INST OF TECHN |
EP3388412 | METHOD FOR PURIFYING PHENOL | LG CHEMICAL LTD |
EP3388438 | SPIRO-STRUCTURED COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG CHEMICAL LTD |
EP3388446 | IMPROVED ANGIOGENESIS-INHIBITING PEPTIDE AND COMPOSITION FOR PREVENTING AND TREATING ANGIOGENESIS-RELATED DISEASE COMPRISING SAME AS ACTIVE INGREDIENT | AVIXGEN INC |
EP3388450 | HIV VACCINE BASED ON TARGETING MAXIMIZED GAG AND NEF TO DENDRITIC CELLS | BAYLOR RES INSTITUTE |
EP3388496 | ORGANIC LIGHT-EMITTING ELEMENT | LG CHEMICAL LTD |
EP3389105 | COMPOSITION AND LIGHT-EMITTING ELEMENT IN WHICH SAME IS USED | SUMITOMO CHEMICAL CO |
EP3389106 | ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO LTD |
EP3389109 | HETEROCYCLE SUBSTITUTED PHOSPHOROUS DERIVATIVES AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD |
EP3389379 | MICROBIOCIDAL PHENYLAMIDINE DERIVATIVES | SYNGENTA PARTICIPATIONS AG |
EP3389662 | PROCESS FOR THE PREPARATION OF TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS FOR USING THE SAME FOR THE TREATMENT OF CANCER | GENENTECH INC |
EP3390327 | METHODS AND SYSTEMS FOR RECOVERING DICYCLOPENTADIENE FROM PYGAS | SABIC GLOBAL TECHNOLOGIES BV |
EP3390345 | PROCESS FOR THE SEPARATION OF ORGANIC COMPOUNDS | VITO NV |
EP3390357 | BIARYL MONOBACTAM COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF BACTERIAL INFECTIONS | MERCK SHARP & DOHME |
EP3390359 | (R)-N-(ADAMANTYL-2-YL)PYRROLIDINE-2-CARBOXAMIDE DERIVATIVES FOR COSMETIC USE | DSM IP ASSETS BV |
EP3390365 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH |
EP3390370 | BIS-TRIAZOLE COMPOUNDS WITH ANTI-BIOFILM AND ANTI-CORROSION PROPERTIES | UNIV DE TOULON |
EP3390376 | PROCESSES AND SYSTEMS FOR REMOVING AN ALKYL IODIDE IMPURITY FROM A RECYCLE GAS STREAM IN THE PRODUCTION OF ETHYLENE OXIDE | SHELL INT RESEARCH |
EP3390384 | QUINOLINE-3-CARBOXAMIDES AS H-PGDS INHIBITORS | ASTEX THERAPEUTICS LTD |
EP3390387 | HETEROARYLBENZIMIDAZOLE COMPOUNDS | BAYER PHARMA AG |
EP3390388 | LANTHANIDE COMPLEXES FOR CRYSTALLISING BIOLOGICAL MACROMOLECULES AND DETERMINING THE CRYSTALLOGRAPHIC STRUCTURE THEREOF | ECOLE NORMALE SUPERIEURE LYON |
EP3390389 | POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS | MERCK PATENT GMBH |
EP3390392 | ALKYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS | AMGEN INC |
EP3390400 | HETEROARYLHYDROXYPYRIMIDINONES AS AGONISTS OF THE APJ RECEPTOR | SQUIBB BRISTOL MYERS CO |
EP3390404 | TRICYCLIC COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS | NOVARTIS AG |
EP3390412 | WATER-SOLUBLE DERIVATIVES OF 3,5-DIPHENYL-DIAZOLE COMPOUNDS | MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WSS |
EP3390424 | FKBP DOMAIN WITH TRANSGLUTAMINASE RECOGNITION SITE | ROCHE DIAGNOSTICS GMBH |
EP3390427 | PROCESS FOR THE MANUFACTURE OF DEGARELIX AND ITS INTERMEDIATES | FRESENIUS KABI IPSUM S R L |
EP3390441 | HUMAN IMMUNODEFICIENCY VIRUS NEUTRALIZING ANTIBODIES | GILEAD SCIENCES INC |
EP3390450 | ANTI-CD28 HUMANIZED ANTIBODIES FORMULATED FOR ADMINISTRATION TO HUMANS | OSE IMMUNOTHERAPEUTICS |
EP3390452 | NEW USE OF AN ANTI-CD303 TRANSMEMBRANE PROTEIN ANTIBODY | LAB FRANCAIS DU FRACTIONNEMENT |
EP3390693 | METHOD FOR GENERATING CARBON-BASED SECONDARY ENERGY CARRIERS OR BASIC CHEMICAL PRODUCTS | ZENTRUM FUER SONNENENERGIE UND WASSERSTOFF FORSCHUNG BADEN WUERTTEMBERG |
EP3392232 | FLUORENE MULTIFUNCTIONAL PHOTOINITIATOR AND PREPARATION AND USE THEREOF, AND PHOTOSENSITIVE RESIN COMPOSITION CONTAINING FLUORENE PHOTOINITIATOR AND USE THEREOF | CHANGZHOU TRONLY ADVANCED ELECTRONIC MAT CO LTD |
EP3392234 | METHOD FOR PRODUCING FERULIC ACID FROM CORNHUSK AT HIGH PURITY AND HIGH YIELD | CJ CHEILJEDANG CORP |
EP3392236 | METHOD FOR PRODUCING AROMATIC AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO INC |
EP3392239 | DIALKYL SULFIDE, METHOD FOR PRODUCING DIALKYL SULFIDE, EXTREME-PRESSURE ADDITIVE, AND LUBRICATING FLUID COMPOSITION | DAINIPPON INK & CHEMICALS |
EP3392242 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | LG CHEMICAL LTD |
EP3392249 | MACROCYCLES WITH HETROCYCLIC P2' GROUPS AS FACTOR XIA INHIBITORS | SQUIBB BRISTOL MYERS CO |
EP3392261 | STEROIDAL COMPOUND, COMPOSITION CONTAINING THE SAME AND USE THEREOF | SHENZHEN TARGETRX INC |
EP3392262 | CYCLOPEPTIDE, PHARMACEUTICAL OR COSMETIC COMPOSITION COMPRISING THE SAME AND METHOD FOR PREPARING THE SAME | |
EP3392269 | ANTI TENASCIN C ANTIBODIES TO TREAT INFLAMMATORY DISEASES | IMPERIAL INNOVATIONS LTD |
EP3393470 | METABOLISM RESISTANT FENFLURAMINE ANALOGS AND METHODS OF USING THE SAME | ZOGENIX INTERNATIONAL LTD |
EP3393489 | SYNTHETIC LUNG SURFACTANT WITH ENHANCED STABILITY AND EFFECTIVENESS | LOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT |
EP3393505 | RECOMBINANT ZIKA VACCINES | THEMIS BIOSCIENCE GMBH |
EP3393522 | IMPROVED HYBRID DUAL RECOMBINANT AAV VECTOR SYSTEMS FOR GENE THERAPY | INST NAT SANTE RECH MED |
EP3393613 | A DYNAMIC MELT CRYSTALLIZATION PROCESS FOR PURIFYING DICYCLOPENTADIENE FROM A MIXED LIQUID HYDROCARBON STREAM | SABIC GLOBAL TECHNOLOGIES BV |
EP3394020 | INTERMOLECULAR REACTION OF PROPARGYL ETHERS WITH DIMETHYLFURAN IN THE PRESENCE OF GOLD(I) COMPLEXES | DSM IP ASSETS BV |
EP3394021 | CONVERSION OF A PERFLUORINATED VINYL ETHER INTO A PARTIALLY FLUORINATED SATURATED ETHER DERIVATIVE | 3M INNOVATIVE PROPERTIES CO |
EP3394023 | METHODS FOR CONVERTING FLUORINATED COMPOUNDS | 3M INNOVATIVE PROPERTIES CO |
EP3394025 | PREPARATION OF PHENYL COMPOUNDS | TNO |
EP3394040 | CFTR REGULATORS AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIV OF CALIFORNIA A CALIFORNIA CORPORATION |
EP3394045 | COCRYSTAL, PRODUCTION METHOD THEREOF, AND MEDICAMENT CONTAINING COCRYSTAL | TAKEDA PHARMACEUTICALS CO |
EP3394049 | CYANOPYRROLIDINE DERIVATIVES AS INHIBITORS FOR DUBS | MISSION THERAPEUTICS LTD |
EP3394071 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS | MUTABILIS |
EP3394083 | CFTR REGULATORS AND METHODS OF USE THEREOF | UNIV CALIFORNIA |
EP3394084 | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS | IMMATICS BIOTECHNOLOGIES GMBH |
EP3394086 | COMPOSITIONS WITH THERMOLABILE DYES | ROCHE DIAGNOSTICS GMBH |
EP3394089 | POLYPEPTIDES FOR INHIBITING COMPLEMENT ACTIVATION | GREENOVATION BIOTECH GMBH |
EP3394266 | NUCLEIC ACIDS ENCODING REPETITIVE AMINO ACID SEQUENCES RICH IN PROLINE AND ALANINE RESIDUES THAT HAVE LOW REPETITIVE NUCLEOTIDE SEQUENCES | XL PROTEIN GMBH |
EP3394292 | METHODS OF LIBRARY CONSTRUCTION FOR POLYNUCLEOTIDE SEQUENCING | SOMAGENICS INC |
EP3395438 | REACTOR | IHI CORP |
EP3395786 | BUTADIENE PREPARATION METHOD | LG CHEMICAL LTD |
EP3395793 | PROCESS FOR THE PREPARATION OF ALPHA-FUNCTIONALIZED KETONES | IGM GROUP B V |
EP3395796 | A CRYSTALLINE TRIHYDRATE FORM OF (3S,3S ) 4,4 -DISULFANEDIYLBIS (3-AMINOBUTANE 1-SULFONIC ACID) | QUANTUM GENOMICS |
EP3395799 | COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG CHEMICAL LTD |
EP3395800 | HETEROCYCLIC QUATERNARY NITROGEN COMPOUNDS COMPRISING A POLYMERIC SUBSTITUENT AND THEIR USE AS A PHOTOLATENT CATALYST IN CURABLE COMPOSITIONS | HENKEL AG & CO KGAA |
EP3395818 | 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES | BAYER PHARMA AG |
EP3395825 | REAL TIME MONITORING AND CONTROL OF PROTEIN PRODUCTION PROCESSES USING IMPEDANCE SPECTROSCOPY | BAXALTA GMBH |
EP3395832 | ANTI P2X7 RECEPTOR ANTIBODIES AND FRAGMENTS THEREOF | BIOSCEPTRE INTERNATIONAL LTD |
EP3395835 | ANTIBODY HAVING ENHANCED ACTIVITY, AND METHOD FOR MODIFYING SAME | CHUGAI PHARMACEUTICAL CO LTD |
EP3395952 | COMPOSITION FOR PRODUCING D-PSICOSE COMPRISING D-PSICOSE 3-EPIMERASE AND SALT AND METHOD FOR PRODUCING D-PSICOSE USING SAME | CJ CHEILJEDANG CORP |
EP3397615 | MIXED DECYL MERCAPTANS COMPOSITIONS AND METHODS OF MAKING SAME | CHEVRON PHILLIPS CHEMICAL CO LP |
EP3397630 | PROCESS FOR THE PREPARATION OF PANTOPRAZOLE SODIUM SESQUIHYDRATE | KRKA TOVARNA ZDRAVIL D D NOVO MESTO |
EP3397635 | METHODS FOR THE MANUFACTURE OF AN AROMATIC BISIMIDE AND A POLYETHERIMIDE | SABIC GLOBAL TECHNOLOGIES BV |
EP3397636 | PROCESS FOR THE PREPARATION OF QUINOLINE-2(1H)-ONE DERIVATIVES | HONOUR R&D |
EP3397637 | COMPOUND FOR PHOTOACTIVE ORGANIC ELECTRONIC COMPONENTS AND PHOTOACTIVE ORGANIC ELECTRONIC COMPONENT CONTAINING THE COMPOUND | HELIATEK GMBH |
EP3397640 | XANTHINE DERIVATIVE INHIBITORS OF BET PROTEINS | INST NAT SANTE RECH MED |
EP3397964 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING OVARIAN CANCER | PROGASTRINE ET CANCERS S A R L |
EP3397966 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING GASTRIC CANCER | PROGASTRINE ET CANCERS S A R L |
EP3398200 | TIN-CONTAINING DOPANT COMPOSITIONS, SYSTEMS AND METHODS FOR USE IN ION IMPLANTATION SYSTEMS | PRAXAIR TECHNOLOGY INC |
EP3398928 | METHOD FOR PRODUCING CYCLOPENTYL ALKYL ETHER COMPOUND | ZEON CORP |
EP3398932 | METHOD FOR SELECTIVELY SYNTHESIZING CATIONIC LIPIDS | SAMYANG BIOPHARMACEUTICALS |
EP3398950 | NOVEL KINASE INHIBITOR AGAINST WILD-TYPE EGFR AND MUTATED EGFR | PRECEDO PHARMACEUTICALS CO LTD |
EP3398951 | SALT OF QUINOLONE COMPOUND, POLYMORPHS THEREOF, PREPARATION METHOD THEREFOR, COMPOSITION, AND APPLICATIONS | SHANGHAI PHARMACEUTICALS HOLDING CO LTD |
EP3398952 | SYNTHESIS PROCESS OF RUXOLITINIB | CHAI TAI TIANQING PHARMACEUTICAL GROUP CO LTD |
EP3398956 | NOVEL RIG-I LIGANDS AND METHODS FOR PRODUCING THEM | UNIV BONN RHEINISCHE FRIEDRICH WILHELMS |
EP3398963 | CHEMICALLY MODIFIED MRNA FOR USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH THE CFTR GENE | UNIV TUEBINGEN MEDIZINISCHE FAKULTAET |
EP3399040 | METHOD OF PREPARING PORCINE CIRCOVIRUS TYPE 2 CAPSID PROTEIN AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | |
EP3399873 | HIGHLY SOLUBLE STEVIOL GLYCOSIDES | PURECIRCLE USA INC |
EP3399993 | METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | WILSON D TRAVIS |
EP3400066 | TREATMENTS AND PREVENTION OF OPIOID NEONATAL ABSTINENCE SYNDROME | OHIO STATE INNOVATION FOUNDATION |
EP3400206 | IMPROVED PROCESSES FOR PREPARING HALOGENATED ALKANES | BLUE CUBE IP LLC |
EP3400208 | PROCESS FOR THE PREPARATION OF ETHYLENE GLYCOL FROM SUGARS | TOPSOE HALDOR AS |
EP3400227 | QUINOLINE ANALOGS AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | HOU XIAOLIN |
EP3400238 | MUTATED VON WILLEBRAND FACTOR | CSL BEHRING RECOMBINANT FACILITY AG |
EP3400239 | TETRAVALENT ANTI-PSGL-1 ANTIBODIES AND USES THEREOF | BIOALLIANCE CV |
EP3400244 | ANTI-CD37 CHIMERIC ANTIGEN RECEPTORS AND IMMUNE CELLS EXPRESSING THEM | UNIV OSLO HF |
EP3401298 | NOVEL FLUORINE-CONTAINING COMPOUND HAVING UNSATURATED BOND, AND SURFACE MODIFIER USING SAME | TOSOH FINECHEM CORP |
EP3401299 | REACTOR FOR CARRYING OUT EXOTHERMIC EQUILIBRIUM REACTIONS | AIR LIQUIDE |
EP3401300 | METHOD FOR CARRYING OUT EXOTHERMIC EQUILIBRIUM REACTIONS | AIR LIQUIDE |
EP3401301 | HYDROXYPIVALALDEHYDE PRODUCTION METHOD | MITSUBISHI GAS CHEMICAL CO |
EP3401313 | AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD |
EP3401316 | CHEMICAL PROCESS | GLAXO GROUP LTD |
EP3401327 | DIFFERENTIAL IN TUMOUR GENE PRODUCTS AND USE OF SAME | ASTELLAS PHARMA INC |
EP3401335 | COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF | GENENTECH INC |
EP3402494 | CHIMERIC PROTEINS AND METHODS OF IMMUNOTHERAPY | UNIV LELAND STANFORD JUNIOR |
EP3402515 | IMPROVED METHODS FOR MONITORING IMMUNE STATUS OF A SUBJECT | BERENSON JAMES R |
EP3402771 | PROCESS FOR THE PREPARATION OF OLEFIN CONTAINING FLUORINE | SRF LTD |
EP3402775 | METHOD FOR THE PREPARATION OF SUBSTITUTED 2-ARYL-ETHANOLS | BAYER CROPSCIENCE AG |
EP3402790 | SPIROHEPTANE SALICYLAMIDES AND RELATED COMPOUNDS AS INHIBITORS OF ROCK | SQUIBB BRISTOL MYERS CO |
EP3402814 | METHODS OF PRODUCING PATIENT-SPECIFIC ANTI-CANCER THERAPEUTICS AND METHODS OF TREATMENT THEREFOR | BERKELEY LIGHTS INC |
EP3402851 | BRANCHED POLYOL ADDITIVES FOR ELECTROPHORETIC MEDIA | E INK CALIFORNIA LLC |
EP3402876 | VASCULAR EXTRACELLULAR MATRIX HYDROGEL | UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION |
EP3402911 | PROCESS FOR PRODUCING OXALIC ACID | AVANTIUM KNOWLEDGE CENTRE BV |
EP3403070 | FLUORESCENCE ASSAY FOR QUANTIFICATION OF PICOLINATE AND OTHER COMPOUNDS IN OXIDIZERS AND OXIDIZING COMPOSITIONS | ECOLAB USA INC |
EP3404013 | PURIFICATION OF 1,4-BIS (4-PHENOXYBENZOYL)BENZENE BY CENTRIFUGAL FILTRATION | ARKEMA FRANCE |
EP3404014 | PRODUCTION METHOD FOR GRANULES OF CALCIUM SALT, AND SAID GRANULES | UNICAL |
EP3404019 | PROCESS FOR THE PREPARATION OF HIGH PURITY MIGLUSTAT | NAVINTA LLC |
EP3404035 | OXYSTEROL-STATIN COMPOUNDS FOR BONE GROWTH | WARSAW ORTHOPEDIC INC |
EP3404073 | HYDROPHILIC ISOCYANURATES CONTAINING ALOXYSILANE | EVONIK DEGUSSA GMBH |
EP3404081 | PROCESS AND INSTALLATION FOR THE CONVERSION OF CRUDE OIL TO PETROCHEMICALS HAVING AN IMPROVED PROPYLENE YIELD | SAUDI BASIC IND CORP |
EP3404106 | SELECTIVE GENE THERAPY EXPRESSION SYSTEM | GENETHON |
EP3405034 | PROCESS FOR THE PREPARATION OF 4-ALKOXY-3-HYDROXYPICOLINIC ACIDS | DOW AGROSCIENCES LLC |
EP3405198 | DEVICE FOR DETECTION OF VITAMIN D METABOLITES | AFFIMEDIX INC |
EP3405454 | INDOLINE DERIVATIVES, COMPOSITIONS COMPRISING THEM AND USES THEREOF | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD |
EP3405462 | PROCESS FOR THE PREPARATION OF GLYCEROL CARBONATE | UNIV BELFAST |
EP3405467 | PROCESS FOR THE SYNTHESIS OF INTERMEDIATES OF NEBIVOLOL | MENARINI INT OPERATIONS LUXEMBOURG SA |
EP3405469 | N-((1-PHENYL-9H-PYRIDO[3,4-B]INDOL-3-YL)METHYL)CINNAMAMIDES AS ANTICANCER AGENTS AND PREPARATION THEREOF | COUNCIL SCIENT IND RES |
EP3405485 | ENDOTHELIN-1 RECEPTOR BASED ENDOTHELIN-1 SPONGE | JAIN ARJUN |
EP3405487 | IgY ANTIBODIES FOR THE PREVENTION OF SEA LICE INFESTATION AND INFECTION | NORIFISH AS |
EP3405490 | MONO AND BISPECIFIC ANTIBODIES FOR EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III AND CD3 AND THEIR USES | PFIZER |
EP3405495 | NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES | INNATE PHARMA |
EP3406262 | MONOCLONAL ANTIBODIES SPECIFIC FOR THE PIII ANTIGEN OF HUMAN ADENOVIRUS (ADV), PRODUCED AND SECRETED BY CELL HYBRIDOMAS, USEFUL FOR DETECTION AND DIAGNOSIS OF ADV INFECTION | UNIV PONTIFICIA CATOLICA CHILE |
EP3406600 | TRPM8 RECEPTOR AGONIST COMPOUNDS AND USES THEREOF | UNIV MIGUEL HERNANDEZ DE ELCHE |
EP3406604 | METHOD FOR PREPARING 3-((2S,5S)-4-METHYLENE-5-(3-OXOPROPYL)TETRAHYDROFURANE-2-YL) PROPANOL DERIVATIVE, AND INTERMEDIATE THEREFOR | YONSUNG FINE CHEMICAL CO LTD |
EP3406608 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | AGIOS PHARMACEUTICALS INC |
EP3406612 | CARBOLINE DERIVATIVE SERVING AS BROMODOMAIN INHIBITOR | NINGBO WENDA PHARMA TECH LTD |
EP3406617 | USE OF PHOSPHINE OXIDE COMPOUNDS IN A SEMICONDUCTING LAYER COMPRISED IN AN ELECTRONIC DEVICE | NOVALED GMBH |
EP3406627 | IGG4 FC FRAGMENT COMPRISING MODIFIED HINGE REGION | HANMI PHARM IND CO LTD |
EP3407414 | NON-AQUEOUS ELECTROLYTE AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG CHEMICAL LTD |
EP3407717 | MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO | DOW AGROSCIENCES LLC |
EP3407718 | MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO | DOW AGROSCIENCES LLC |
EP3407720 | MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO | DOW AGROSCIENCES LLC |
EP3407889 | ORGANIC COMPOUNDS | INTRA CELLULAR THERAPIES INC |
EP3408257 | LINKER MOLECULE AND USE THEREOF IN METHODS FOR PURIFYING PEPTIDES | BELYNTIC GMBH |
EP3408260 | CRYSTALLINE(2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-(ETHOXYMETHYL)-4-(3-HYDROXYISOXAZOLE-5-CARBOXAMIDO)-2-METHYLPENTANOIC ACID AND USES THEREOF | THERAVANCE BIOPHARMA R&D IP LLC |
EP3408263 | MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO | DOW AGROSCIENCES LLC |
EP3408270 | COMPOUNDS FOR INHIBITING BACTERIAL GROWTH VIA PHOSPHATIDYLGLYCEROL BINDING | UNIV WICHITA STATE |
EP3408277 | EXTRACTION OF PHYTOSTEROLS FROM TALL OIL SOAP USING A SOLVENT SELECTED FROM DIBROMOMETHANE, BROMOFORM, TETRABROMOMETHANE OR A COMBINATION THEREOF | STORA ENSO OYJ |
EP3408282 | INCREASED TRIACYLGLYCEROL PRODUCTION IN MICROALGAE | TOTAL RAFFINAGE CHIMIE |
EP3408289 | COLLAGEN TYPE VII ALPHA 1 ASSAY | NORDIC BIOSCIENCE AS |
EP3408349 | CHEMILUMINESCENT PROBES FOR DIAGNOSTICS AND IN VIVO IMAGING | UNIV RAMOT |
EP3408381 | ATTENUATED INFECTIOUS BRONCHITIS VIRUS | THE PIRBRIGHT INST |
EP3409343 | LIQUID HAVING OXYGEN ABSORBING ABILITY, METHOD FOR PRODUCING SAME, AND COMPLEX SOLUTION CONTAINING SAME | SHARP KK |
EP3409356 | FLUID BED AMMOXIDATION REACTION CATALYST, AND ACRYLONITRILE PRODUCTION METHOD | ASAHI CHEMICAL IND |
EP3409656 | PRODUCTION OF ADIPIC ACID AND DERIVATIVES FROM CARBOHYDRATE-CONTAINING MATERIALS | ARCHER DANIELS MIDLAND CO |
EP3409667 | AMIDE COMPOUNDS FOR THE TREATMENT OF HIV INFECTIONS | GILEAD SCIENCES INC |
EP3409671 | ISOTHIAZOLE DERIVATIVES AS GPR120 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES | JANSSEN PHARMACEUTICA NV |
EP3409678 | NEW HALOGEN GERMANIDES AND METHOD FOR THEIR PREPARATION | EVONIK DEGUSSA GMBH |
EP3409680 | SYNTHESIS OF BIS(ACYL)PHOSPHINES BY ACTIVATION OF UNREACTIVE METAL PHOSPHIDES | IGM GROUP B V |
EP3409682 | COMPOUND AND USE THEREOF AND PLATINUM COMPLEX AND LIPIDOSOME THEREOF | UNIV SHENYANG PHARMACEUTICAL |
EP3411036 | 3,5-DISUBSTITUTED PYRAZOLES USEFUL AS CHECKPOINT KINASE 1 (CHK1) INHIBITORS, AND THEIR PREPARATIONS AND APPLICATIONS | |
EP3411346 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIV DEGLI STUDI UDINE |
EP3411347 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIV DEGLI STUDI UDINE |
EP3411349 | METHOD OF INDUSTRIALLY PRODUCING MONOCHLOROACETIC ACID | PCC MCAA SP Z O O |
EP3411350 | METHOD OF PRODUCING HIGH-PURITY MONOCHLOROACETIC ACID | PCC MCAA SP Z O O |
EP3411358 | SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICALS CO |
EP3411359 | METHODS OF PREPARING HYDROXYLAMINE DERIVATIVES USEFUL IN THE PREPARATION OF ANTI-INFECTIVE AGENTS | MERCK SHARP & DOHME |
EP3411388 | TRUNCATED GLYCOPROTEIN G OF HERPES SIMPLEX VIRUS 2 | SIMPLEXIA AB |
EP3411389 | NEW STREPTOCOCCAL PROTEASES | GENOVIS AB |
EP3411391 | UBIQUITIN VARIANTS AND USES THEREOF AS 53BP1 INHIBITORS | GOVERNING COUNCIL UNIV TORONTO |
EP3411393 | ADMINISTRATION OF ENGINEERED T CELLS FOR TREATMENT OF CANCERS IN THE CENTRAL NERVOUS SYSTEM | HOPE CITY |
EP3411400 | TREATMENT OF INFLAMMATORY DISEASES WITH INHIBITORS OF C5A ACTIVITY | INFLARX GMBH |
EP3411402 | BCMA AND CD3 BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS | AMGEN RES MUNICH GMBH |
EP3411408 | ANTI-ROR1 ANTIBODIES AND USES THEREOF | HUTCHINSON FRED CANCER RES |
EP3411410 | PD-1 ANTIBODIES | INNOVENT BIOLOGICS SUZHOU CO LTD |
EP3412302 | MODIFIED FGF-21 POLYPEPTIDES AND USES THEREOF | SQUIBB BRISTOL MYERS CO |
EP3412644 | INTEGRATED SYSTEM COMPRISING ELECTROCATALYSIS DEVICE OF GLYCEROL AND CHEMICAL CATALYSIS DEVICE OF BIOMASS | KOREA RES INST CHEMICAL TECH |
EP3412645 | METHOD FOR PRODUCING TETRAFLUOROPROPENE | DAIKIN IND LTD |
EP3412650 | METHOD FOR EXTRACTING 1,5-PENTANEDIAMINE FROM SOLUTION SYSTEM CONTAINING 1,5-PENTANEDIAMINE SALT | CATHAY R&D CENTER CO LTD |
EP3412665 | SUVOREXANT INTERMEDIATE AND PREPARATION METHOD THEREOF | ZHEJIANG HUAHAI PHARM CO LTD |
EP3413887 | INTERMEDIATES IN THE SYNTHESIS OF ERIBULIN AND RELATED METHODS OF SYNTHESIS | EISAI R&D MAN CO LTD |
EP3413895 | C5-C6-OXACYLIC FUSED IMINOTHIADIAZINE DIOXIDE COMPOUNDS BEARING AN ETHER LINKER AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE | MERCK SHARP & DOHME |
EP3414215 | MANGANESE BASED COMPLEXES AND USES THEREOF FOR HOMOGENEOUS CATALYSIS | YEDA RES & DEV |
EP3414220 | PROCESSES FOR CONVERTING OLEFINS TO ALCOHOLS, ETHERS, OR COMBINATIONS THEREOF | DOW TECHNOLOGY INVESTMENTS LLC |
EP3414221 | PROCESS TO PREPARE HIGHER ETHYLENE AMINES AND ETHYLENE AMINE DERIVATIVES | AKZO NOBEL CHEMICALS INT BV |
EP3414222 | PROCESS TO PREPARE HIGHER ETHYLENE AMINES AND ETHYLENE AMINE DERIVATIVES | AKZO NOBEL CHEMICALS INT BV |
EP3414223 | PROCESS TO CONVERT CYCLIC ALKYLENE UREAS INTO THEIR CORRESPONDING ALKYLENE AMINES | AKZO NOBEL CHEMICALS INT BV |
EP3414227 | PIPERIDINONE FORMYL PEPTIDE 2 RECEPTOR AND FORMYL PEPTIDE 1 RECEPTOR AGONISTS | SQUIBB BRISTOL MYERS CO |
EP3414229 | QUINOLINONE LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF | PHARMAKEA INC |
EP3414232 | PROCESS TO PREPARE HIGHER ETHYLENE AMINES AND ETHYLENE AMINE DERIVATIVES | AKZO NOBEL CHEMICALS INT BV |
EP3414238 | SUBSTITUTED -OXYIMIDAZOLYL-CARBOXAMIDES AS PEST CONTROL AGENTS | BAYER CROPSCIENCE AG |
EP3414247 | SPIROINDOLINONES AS DDR1 INHIBITORS | HOFFMANN LA ROCHE |
EP3414253 | C5-C6-OXACYLIC FUSED IMINOTHIAZINE DIOXIDE COMPOUNDS BEARING AN ETHER LINKER AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE | MERCK SHARP & DOHME |
EP3414255 | PREPARATIVE ELECTROPHORETIC METHOD FOR TARGETED PURIFICATION OF GENOMIC DNA FRAGMENTS | UNIV WASHINGTON |
EP3414324 | MULTIPLE LIGASE COMPOSITIONS, SYSTEMS, AND METHODS | RGENE INC |
EP3415160 | POLYPEPTIDES DERIVED FROM ENTEROCOCCUS AND THEIR USE FOR VACCINATION AND THE GENERATION OF THERAPEUTIC ANTIBODIES | UNIV FREIBURG ALBERT LUDWIGS |
EP3415496 | METHOD FOR PRODUCING 1, 2-BENZENE DIMETHANOL COMPOUND | SDS BIOTECH CORP |
EP3415505 | METHODS OF CHEMICAL SYNTHESIS OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INCLUDING METHYLTHIONINIUM CHLORIDE (MTC) | WISTA LAB LTD |
EP3415508 | ELECTRON BUFFERING MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | ROHM & HAAS ELECT MATERIALS KOREA LTD |
EP3415512 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME | LG CHEMICAL LTD |
EP3415516 | HAPTENS OF RISPERIDONE AND PALIPERIDONE | JANSSEN PHARMACEUTICA NV |
EP3415528 | FC FUSION PROTEINS COMPRISING NOVEL LINKERS OR ARRANGEMENTS | SQUIBB BRISTOL MYERS CO |
EP3415585 | ORGANIC LIGHT-EMITTING ELEMENT | LG CHEMICAL LTD |
EP3416205 | LIGHT-EMITTING ELEMENT AND METHOD FOR MANUFACTURING SAME | SUMITOMO CHEMICAL CO |
EP3416676 | DOSING AND USE OF LONG-ACTING CLR/RAMP AGONISTS | ADEPTHERA LLC |
EP3416740 | PROCESSES TO CREATE MULTIPLE VALUE STREAMS FROM BIOMASS SOURCES | INTERCONTINENTAL GREAT BRANDS LLC |
EP3416935 | COMPOSITION AND METHOD FOR DISPERSING SCALES AND SOLID DEPOSITS | HINDUSTAN PETROLEUM CORP LTD |
EP3416936 | METHANOL PRODUCTION PROCESS | FUNDACIO INSTITUT CATALA DINVESTIGACIO QUIM ICIQ |
EP3416946 | TETRACYCLIC PYRIDONE COMPOUNDS AS ANTIVIRALS | NOVARTIS AG |
EP3416959 | PESTICIDALLY ACTIVE PYRAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG |
EP3416966 | PROCESS FOR THE PREPARATION OF 4-PHENYL-5-ALKOXYCARBONYL-2-THIAZOL-2-YL-1,4-DIHYDROPYRIMIDIN-6-YL]METHYL]-3-OXO-5,6,8,8A-TETRAHYDRO-1H-IMIDAZO[1,5-A]PYRAZIN-2-YL]-CARBOXYLIC ACID | HOFFMANN LA ROCHE |
EP3416983 | ANTIBODIES FOR IL-17C | MORPHOSYS AG |
EP3416984 | CHIMERIC CANINE ANTI-CD20 ANTIBODY | ELANCO US INC |
EP3417055 | NOVEL RECOMBINANT ADENO-ASSOCIATED VIRUS CAPSIDS RESISTANT TO PRE-EXISTING HUMAN NEUTRALIZING ANTIBODIES | UNIV LELAND STANFORD JUNIOR |
EP3417454 | METHOD FOR COATING METAL SURFACES WITH SPIN TRANSITION COMPOUNDS | UNIV WIEN TECH |
EP3417701 | GENETICALLY MODIFIED MICE AND ENGRAFTMENT | REGENERON PHARMA |
EP3418275 | NOVEL 2,3,5-SUBSTITUTED THIOPHENE COMPOUND AS PROTEIN KINASE INHIBITOR | KOREA INST SCI & TECH |
EP3418386 | COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF HEPATITIS B VIRUS | ARROWHEAD PHARMACEUTICALS INC |
EP3419744 | COMPOSITION COMPRISING A FLUORINE-CONTAINING SURFACTANT | UNIV INNSBRUCK |
EP3419957 | AROMATIC COMPOUNDS FROM FURANICS | TNO |
EP3419974 | PROCESS FOR THE SEPARATION OF ENANTIOMERS OF PIPERAZINE DERIVATIVES | ASCENEURON SA |
EP3419975 | IMINOTHIADIAZINANE DIOXIDE DERIVATIVES AS PLASMEPSIN V INHIBITORS | UCB BIOPHARMA SPRL |
EP3419984 | METHOD FOR PREPARING A MONOSACCHARIDE AND/OR OLIGOSACCHARIDE AND/OR POLYSACCHARIDE MIXTURE BY PURIFYING A LIGNOCELLULOSIC MATERIAL HYDROLYSATE | INST POLYTECHNIQUE GRENOBLE |
EP3419995 | NOVEL IMMUNOSTIMULATING VECTOR SYSTEM | PROVECS MEDICAL GMBH |
EP3419999 | ANTIBODIES HAVING SPECIFICITY FOR BTLA AND USES THEREOF | INST NAT SANTE RECH MED |
EP3420001 | BINDING MEMBERS TO PD-L1 | CELL MEDICA SWITZERLAND AG |
EP3421446 | METHODS AND APPARATUS FOR PRODUCING A LOW-MOISTURE CARBOXYLIC ACID WET CAKE | GRUPO PETROTEMEX SA DE CV |
EP3421449 | PRODUCTION METHOD FOR 1,1'-BINAPHTHYL DERIVATIVE, AND 1,1'-BINAPHTHYL DERIVATIVE | UNIV KYOTO |
EP3421457 | PYRIMIDINE FGFR4 INHIBITORS | EISAI R&D MAN CO LTD |
EP3421464 | RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AS WELL AS PREPARATION METHOD AND USE THEREOF | BEIJING TIDE PHARMACEUTICAL CO LTD |
EP3421470 | SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES IN CRYSTALLINE FORM | ADVERIO PHARMA GMBH |
EP3421489 | ANTI-MESOTHELIN CHIMERIC ANTIGEN RECEPTORS | US HEALTH |
EP3421603 | GENE THERAPY FOR NEURODEGENERATIVE DISORDERS | GENZYME CORP |
EP3423426 | PROCESS FOR PRODUCING EXO-TETRAHYDRODICYCLOPENTADIENE | MONUMENT CHEMICAL HOUSTON LLC |
EP3423432 | INTEGRATED SYNTHESIS OF AMMONIA AND UREA | THYSSENKRUPP IND SOLUTIONS AG |
EP3423440 | 5-METHYL-6-PHENYL-4,5-DIHYDRO-2H-PYRIDAZIN-3-ONE DERIVATIVE | OTSUKA PHARMA CO LTD |
EP3423442 | METHOD FOR THE MANUFACTURE OF CYCLODODECASULFUR | EASTMAN CHEM CO |
EP3423455 | SEMICONDUCTING POLYMER | BASF SE |
EP3423457 | PROCESS FOR THE PREPARATION OF AN ANTIBODY-RIFAMYCIN CONJUGATE | HOFFMANN LA ROCHE |
EP3423459 | METHOD OF PURIFYING ANTIFUNGAL COMPOUNDS AND EXOPOLYSACCHARIDES FROM A MICROBIAL CELL CULTURE | BAYER CROPSCIENCE LP |
EP3423460 | METHOD OF PRODUCING HIGH PURITY D-PSICOSE | CJ CHEILJEDANG CORP |
EP3423464 | PROCESS AND NEW INTERMEDIATES FOR THE PREPARATION OF 11-METHYLENE STEROIDS | BIONICE S L U |
EP3423467 | NEW DIFLUOROKETAMIDE DERIVATIVES AS HTRA1 INHIBITORS | HOFFMANN LA ROCHE |
EP3423470 | IMMUNOMODULATORS | SQUIBB BRISTOL MYERS CO |
EP3423477 | NEW ANTIMICROBIAL PEPTIDES, THEIR VARIANTS AND USES | CHAIN ANTIMICROBIALS OY |
EP3423484 | HUMAN NEUTRALIZING ANTIBODIES BINDING TO INFLUENZA B NEURAMINIDASE | JANSSEN VACCINES & PREVENTION BV |
EP3423485 | MUTANT PORE | OXFORD NANOPORE TECH LTD |
EP3423486 | MUTANT PORE | OXFORD NANOPORE TECH LTD |
EP3423487 | MUTANT PORES | OXFORD NANOPORE TECH LTD |
EP3423495 | ANTIBODIES SPECIFIC TO HUMAN POLIOVIRUS RECEPTOR (PVR) | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD |
EP3423497 | MONOCLONAL ANTIBODIES THAT SPECIFICALLY RECOGNIZE CANINE DLA-DR ANTIGEN AND THEIR USES | INST IMMUNOLOGII I TERAPII DOSWIADCZALNEJ POLSKIEJ AKADEMII NAUK |
EP3424532 | INFLUENZA VIRUS ANTIBODY COMPOSITIONS | THE SEC DEP FOR HEALTH |
EP3424537 | SMALL MOLECULE DRUG CONJUGATES | EIDGENOESSICHE TECHNISCHE HOCHSCHULE ZUERICH |
EP3424903 | METHOD FOR PRODUCING SULFOXIDE DERIVATIVE | KUMIAI CHEMICAL INDUSTRY CO |
EP3424911 | POSACONAZOLE, COMPOSITION, INTERMEDIATE, PREPARATION METHOD THEREFOR, AND USES THEREOF | ZHEJIANG AUSUN PHARMACEUTICAL CO LTD |
EP3424932 | BORONOPHTHALIDES FOR THERAPEUTIC USE | ANACOR PHARMACEUTICALS INC |
EP3424934 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP |
EP3424935 | PYRIDYL CARBENE PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORP |
EP3424936 | METAL COMPLEXES | MERCK PATENT GMBH |
EP3424946 | A FUSION PROTEIN HAVING TRANSCRIPTION MODULATING DOMAIN AND A PROTEIN TRANSDUCTION DOMAIN, AND AN INHIBITOR FOR TRANSCRIPTION FACTOR FUNCTION COMPRISING THE SAME | UNIV YONSEI IACF |
EP3424948 | VASCULAR ENDOTHELIAL GROWTH FACTOR TARGETING PEPTIDE-ELASTIN FUSION POLYPEPTIDE AND SELF-ASSEMBLING NANOSTRUCTURE, WHICH ARE FOR INHIBITING ANGIOGENESIS | IUCF HYU ERICA CAMPUS |
EP3425687 | ORGANIC SEMICONDUCTOR COMPOSITION, ORGANIC THIN FILM COMPRISING SAME, AND USE THEREOF | AIST |
EP3426348 | 3-DESOXY DERIVATIVE AND PHARMACEUTICAL COMPOSITIONS THEREOF | INTERCEPT PHARMACEUTICALS INC |
EP3426639 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | MILLIKEN & CO |
EP3426641 | IMMUNOPROTEASOME INHIBITOR ANALOGS | UNIV CALIFORNIA |
EP3426654 | DIRECT PALLADIUM-CATALYZED AROMATIC FLUORINATION | HARVARD COLLEGE |
EP3426656 | TRICYCLIC COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS | NOVARTIS AG |
EP3426668 | PRECIOUS METAL COMPOUNDS | UMICORE AG & CO KG |
EP3426672 | PEPTOID AFFINITY LIGANDS | MIKE ANN LLC |
EP3426673 | PEPTOID AFFINITY LIGANDS | MIKE ANN LLC |
EP3426750 | PHOSPHORESCENT FERRO-MAGNETIC PARTICLE FORMULATION AND METHOD OF NON-DESTRUCTIVE TESTING THEREWITH | ILLINOIS TOOL WORKS |
EP3426788 | PLANT REGULATORY ELEMENTS AND USES THEREOF | MONSANTO TECHNOLOGY LLC |
EP3427580 | HUMAN ARCAP TRANSGENIC MOUSE | |
EP3427728 | PHARMACEUTICAL COMPOSITIONS COMPRISING NITROXYL DONORS | CARDIOXYL PHARMACEUTICALS INC |
EP3428145 | METHOD FOR PRODUCING FLUORINATED COMPOUND | DAIKIN IND LTD |
EP3428149 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD |
EP3428152 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEMICAL LTD |
EP3428162 | ANTHELMINTIC COMPOUNDS AND COMPOSITIONS AND METHOD OF USING THEREOF | MERIAL INC |
EP3428169 | 6,6A-DIHYDRO FURO[3,2-B]FURAN-2-(5H)ONE DERIVATIVES, THEIR PREPARATION AND USE FOR TREATING TUMORS | UNIV DELLA CALABRIA |
EP3428170 | ANTI-INFLUENZA POLYCYCLIC PYRIDONE DERIVATIVE AND PRODRUG THEREOF | SHIONOGI & CO |
EP3428177 | PEPTIDE EXHIBITING HAIR GROWTH PROMOTING ACTIVITY AND/OR MELANIN PRODUCTION PROMOTING ACTIVITY AND USE THEREOF | CAREGEN CO LTD |
EP3428182 | ANTI-INFLAMMATORY PEPTIDES AND COMPOSITION COMPRISING THE SAME | KAEL GEMVAX CO LTD |
EP3428192 | ANTI-CD28 HUMANIZED ANTIBODIES | OSE IMMUNOTHERAPEUTICS |
EP3428194 | IMPROVED DUAL SPECIFICITY POLYPEPTIDE MOLECULE | IMMATICS BIOTECHNOLOGIES GMBH |
EP3428256 | PROCESS FOR PREPARING AN IODINATED FATTY ACID ETHYL ESTER | |
EP3428287 | CONFORMATIONALLY-PREORGANIZED, MINIPEG-CONTAINING GAMMA-PEPTIDE NUCLEIC ACIDS | UNIV CARNEGIE MELLON |
EP3428986 | STABLE AND EFFICIENT ELECTROLUMINESCENT MATERIALS | UNIVERSAL DISPLAY CORP |
EP3428989 | LIGHT-EMITTING ELEMENT | SUMITOMO CHEMICAL CO |
EP3429352 | PROCESS FOR CONVERTING S-ENANTIOMER TO ITS RACEMIC FORM | FMC CORP |
EP3429585 | BRIDGED BICYCLIC INHIBITORS OF MENIN-MLL AND METHODS OF USE | KURA ONCOLOGY INC |
EP3429633 | A METHOD OF ENGINEERING DRUG-SPECIFIC HYPERSENSITIVE T-CELLS FOR IMMUNOTHERAPY BY GENE INACTIVATION | CELLECTIS |
EP3429994 | 2-CYANOISOINDOLINE DERIVATIVES FOR TREATING CANCER | MISSION THERAPEUTICS LTD |
EP3429998 | PROCESS FOR PREPARING QUINOLIN-2-YL-PHENYLAMINE DERIVATIVES AND THEIR SALTS | RATIOPHARM GMBH |
EP3430002 | FUROIC ACID PREPARATION METHOD | UNIV LILLE |
EP3430012 | 4,6 DIHYDROPYRROLO [3,4-C]PYRAZOLE-5 (1H)-CARBONITRILE DERIVATES FOR TREATING CANCER | MISSION THERAPEUTICS LTD |
EP3430020 | A PREPARATION METHOD OF DIASTEREOMERICALLY PURE TENOFOVIR ALAFENAMIDE OR ITS SALTS | ZENTIVA KS |
EP3430031 | PEPTIDES WITH ANTI-CANCER ACTIVITY | IDP DISCOVERY PHARMA S L |
EP3430032 | NOVEL ALPHA-1-MICROGLOBULIN DERIVED PROTEINS AND THEIR USE | A1M PHARMA AB |
EP3430038 | COMPOSITIONS AND METHODS FOR CD20 IMMUNOTHERAPY | HUTCHINSON FRED CANCER RES |
EP3430051 | ANTI-PY1235-MET IMMUNOLOGICAL BINDING REAGENT | THE US SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
EP3430054 | METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND ANTI-GPC3 ANTIBODIES | CHUGAI PHARMACEUTICAL CO LTD |
EP3430093 | ENERGY CURABLE COMPOSITIONS COMPRISING POLYMERIC AMINOACRYLATES | SUN CHEMICAL CORP |
EP3430407 | COMPOSITIONS, DEVICES, AND METHODS FOR CELL SEPARATION | QT HOLDINGS CORP |
EP3431103 | TARGETING ABCB5 FOR CANCER THERAPY | BRIGHAM & WOMENS HOSPITAL INC |
EP3431460 | NOVEL FORMULATION AND METHOD OF SYNTHESIS | GE HEALTHCARE LTD |
EP3431470 | EPOXY COMPOUND, CURABLE COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING EPOXY COMPOUND, AND REACTIVE DILUENT | JXTG NIPPON OIL & ENERGY CORP |
EP3431475 | SOLID FORMS OF A SELECTIVE CDK4/6 INHIBITOR | PFIZER |
EP3431483 | METALLOCENE COMPOUND, OLEFIN POLYMERIZATION CATALYST COMPONENT AND OLEFIN POLYMERIZATION CATALYST EACH COMPRISING SAME, AND METHOD FOR PRODUCING OLEFIN POLYMER USING SAID OLEFIN POLYMERIZATION CATALYST | JAPAN POLYETHYLENE CORP |
EP3431504 | ANTI-PHOSPHOLIPASE D4 ANTIBODY | SBI BIOTECH CO LTD |
EP3431614 | CATALYST-FREE SURFACE FUNCTIONALIZATION AND POLYMER GRAFTING | ILLUMINA INC |
EP3433224 | CURCUMIN PURIFICATION | BIOPTEQ SPRL |
EP3433225 | NOVEL DERIVATIVES OF CURCUMINOIDS AND USE THEREOF AS AN ANTICANCER AGENT | |
EP3433234 | ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | MERCK SHARP & DOHME |
EP3433236 | CYANOPYRIMIDINE DERIVATIVES SUITABLE AS COMPONENTS IN LIQUID CRYSTAL MEDIA | MERCK PATENT GMBH |
EP3433238 | PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETED HIGH-AFFINITY AGENTS FOR ENDORADIOTHERAPY OF PROSTATE CANCER | UNIV JOHNS HOPKINS |
EP3433243 | NOVEL DERIVATIVES AND THEIR USE AS SELECTIVE INHIBITORS OF CASPASE-2 | INST NAT SANTE RECH MED |
EP3433244 | HERBICIDES | SYNGENTA PARTICIPATIONS AG |
EP3433250 | HERBICIDES | SYNGENTA PARTICIPATIONS AG |
EP3433252 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG |
EP3433268 | PURIFICATION OF GLUCAGON-LIKE PEPTIDE 1 ANALOGS | BACHEM HOLDING AG |
EP3433273 | BINDING MOLECULES TO CD38 AND PD-L1 | BIOMUNEX PHARMACEUTICALS |
EP3433276 | EARLY INTERVENTION METHODS TO PREVENT OR AMELIORATE TOXICITY | SEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST |
EP3434664 | AZEOTROPE COMPOSITIONS COMPRISING 3,3,3-TRIFLUOROPROPENE AND HYDROGEN FLUORIDE AND PROCESSES FOR SEPARATION THEREOF | CHEMOURS CO FC LLC |
EP3434665 | METHOD FOR PRODUCING -FLUORO ACRYLIC ACID ESTER, AND COMPOSITION CONTAINING HIGHLY-PURE FLUOROCYCLOPROPANE DERIVATIVE, AND COMPOSITION CONTAINING HIGHLY-PURE -FLUORO ACRYLIC ACID ESTER | AGC INC |
EP3434670 | NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE USING SAME | LG CHEMICAL LTD |
EP3434673 | EGFR INHIBITOR FREE BASE OR ACID SALT POLYCRYSTALLINE FORM, PREPARATION METHOD THEREFOR, AND APPLICATION | JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD |
EP3434682 | ELECTRON-ACCEPTING COMPOUND, COMPOSITION FOR CHARGE TRANSPORT FILM, AND LIGHT-EMITTING ELEMENT USING SAME | MITSUBISHI CHEM CORP |
EP3434687 | NOVEL OXYNTOMODULIN DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR TREATING OBESITY COMPRISING THE SAME | HANMI SCIENCE CO LTD |
EP3435472 | LIQUID ELECTROLYTE COMPRISING AN ALKALI METAL SALT OF A PHOSPHATE COMPOUND | DAIKIN IND LTD |
EP3436019 | SOLID FORMS OF (1S,4S)-4-(2-(((3S4R)-3-FLUOROTETRAHYDRO-2H-PYRAN-4-YL) AMINO)-8-((2,4,6-TRICHLOROPHENYL) AMINO)-9H-PURIN-9-YL)-1-METHYLCYCLOHEXANE-1-CARBOXAMIDE AND METHODS OF THEIR USE | SIGNAL PHARM LLC |
EP3436025 | METHODS FOR THE SEPARATION AND DETECTION OF AN OXYSTEROL | WARSAW ORTHOPEDIC INC |
EP3436079 | CHIMERIC ANTIGEN AND T CELL RECEPTORS AND METHODS OF USE | KITE PHARMA INC |
EP3436172 | SYSTEM AND METHOD TO REMOVE ACIDIC SPECIES FROM A RICH MEG STREAM BY STRIPPING | CAMERON SOLUTIONS INC |
EP3436419 | METHODS AND APPARATUSES FOR PHENOL FRACTIONATION IN A SINGLE DIVIDING WALL COLUMN | HONEYWELL INT INC |
EP3436422 | PRODUCTION OF 1,5-PENTANEDIOL VIA UPGRADING OF TETRAHYDROFURFURYL ALCOHOL | WISCONSIN ALUMNI RES FOUND |
EP3436425 | AN IMPROVED PROCESS FOR THE PREPARATION OF BUTORPHANOL TARTRATE | HIKAL LTD |
EP3436427 | METHOD AND COMPOSITION FOR TREATING NEURONAL HYPER-EXCITABILITY | UNIV CALIFORNIA |
EP3436429 | BISCARBODIIMIDES AND POLYCARBODIIMIDES AND METHOD FOR THEIR PREPARATION | DOW GLOBAL TECHNOLOGIES LLC |
EP3436432 | SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF | GENENTECH INC |
EP3436435 | SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS | JANSSEN PHARMACEUTICALS INC |
EP3436437 | SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS | JANSSEN PHARMACEUTICALS INC |
EP3436456 | FUSED HEXACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB BIOPHARMA SPRL |
EP3436458 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB BIOPHARMA SPRL |
EP3436459 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB BIOPHARMA SPRL |
EP3436460 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB BIOPHARMA SPRL |
EP3436463 | CRYSTALLINE FORMS OF 2-[(2S)-1-AZABICYCLO[2.2.2]OCT-2-YL]-6-(3-METHYL-1H- PYRAZOL-4-YL)THIENO[3,2-D]PYRIMIDIN-4(3H)-ONE HEMIHYDRATE | TAKEDA PHARMACEUTICALS CO |
EP3436471 | RECOMBINASE MUTANTS | ILLUMINA INC |
EP3436478 | MULTISPECIFIC ANTIBODIES FOR USE IN THE TREATMENT OF A NEOPLASM OF THE URINARY TRACT | LINDHOFER HORST DR |
EP3436481 | DUAL FUNCTION ANTIBODIES SPECIFIC TO GLYCOSYLATED PD-L1 AND METHODS OF USE THEREOF | STCUBE INC |
EP3436483 | ERBB2-TARGETING ANTIBODY | ST BIOCHIMICO ITALIANO GIOVANNI LORENZINI S P A |
EP3436558 | SURFACTANTS FOR SPOT PREVENTION IN AUTOMATIC DISHWASHING COMPOSITIONS | ROHM & HAAS |
EP3437657 | ANTIBODY MODIFIED BY SUBSTITUTING CYSTEINE AT AMINO ACID POSITIONS 80 AND 171 OF KABAT NUMBERING | SYSMEX CORP |
EP3438081 | METHOD FOR PRODUCING BUTADIENE | LG CHEMICAL LTD |
EP3438082 | RESTARTING METHOD | NIPPON KAYAKU KK |
EP3438102 | GLYCIDYL ESTER COMPOUND PREPARATION METHOD | KOLON INC |
EP3438104 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD |
EP3438113 | TETRADENTATE LIGAND, AND PRODUCTION METHOD THEREFOR, SYNTHETIC INTERMEDIATE THEREOF, AND TRANSITION METAL COMPLEX THEREOF | TAKASAGO PERFUMERY CO LTD |
EP3438116 | LABELLED NUCLEOTIDES | ILLUMINA CAMBRIDGE LTD |
EP3438271 | DECANEDIOIC ACID PRODUCED BY MICROBIAL FERMENTATION AND PREPARATION METHOD THEREOF | CATHAY R&D CENTER CO LTD |
EP3439622 | A PROCESS FOR SYNTHESIZING AN AMIDO ALKYL BETAINE STARTING FROM AN ALCOHOL, AN AMIDO ALKYL BETAINE PREPARED BY THE PROCESS WITH INCREASED VISCOSITY, AND USE THEREOF AS A VISCOELASTIC SURFACTANT | RHODIA OPERATIONS |
EP3439641 | COMPOSITIONS, KITS AND METHODS FOR MAINTAINING EYELID HYGIENE | OCUSOFT INC |
EP3439653 | REDUCING TUMOR BURDEN BY ADMINISTERING CCR1 ANTAGONISTS IN COMBINATION WITH PD-1 INHIBITORS OR PD-L1 INHIBITORS | CHEMOCENTRYX INC |
EP3439658 | SOLUBLE C5aR ANTAGONISTS | CHEMOCENTRYX INC |
EP3439689 | METHODS FOR TREATING HYPERLIPIDEMIA WITH AN ANGPTL8 INHIBITOR AND AN ANGPTL3 INHIBITOR | REGENERON PHARMA |
EP3440057 | SILICONE ATOMS CONTAINING IVACAFTOR ANALOGUES | PROTEOSTASIS THERAPEUTICS INC |
EP3440062 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY ENRICHED ISOXAZOLINE COMPOUNDS - CRYSTALLINE TOLUENE SOLVATE OF (S)-AFOXOLANER | MERIAL INC |
EP3440094 | TDP-43 MITOCHONDRIAL LOCALIZATION INHIBITOR FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE | UNIV CASE WESTERN RESERVE |
EP3440101 | CD8-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING | INDI MOLECULAR INC |
EP3440106 | T CELL RECEPTORS | ADAPTIMMUNE LTD |
EP3440155 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM & HAAS ELECT MATERIALS KOREA LTD |
EP3441086 | ANTI-PD-1 MONOCLONAL ANTIBODY | AKESO BIOPHARMA INC |
EP3441379 | PROCESS FOR THE PRODUCTION OF E-1,3,3,3-TETRAFLUOROPROPENE BY DEHYDROFLUORINATION | CHEMOURS CO FC LLC |
EP3441767 | APPARATUS FOR DETECTING DEGREE OF MALIGNANCY OF CIRCULATING TUMOR CELL UNIT, AND KIT FOR SAME | ON CHIP BIOTECHNOLOGIES CO LTD |
EP3442584 | COMBINATIONS OF PBD-BASED ANTIBODY DRUG CONJUGATES WITH BCL-2 INHIBITORS | SEATTLE GENETICS INC |
EP3442931 | CONTINUOUS METHOD FOR PRODUCING GRIGNARD ADDUCTS AND A DEVICE FOR CARRYING OUT SAME | FRAUNHOFER GES FORSCHUNG |
EP3442941 | PROCESS FOR PREPARATION OF CARMUSTINE | INTAS PHARMACEUTICALS LTD |
EP3442993 | METHODS AND KITS FOR THE RAPID DETECTION OF THE ESCHERICHIA COLI O25B-ST131 CLONE | INST NAT SANTE RECH MED |
EP3443009 | ANTI-TIM-3 ANTIBODIES AND COMPOSITIONS | SYMPHOGEN AS |
EP3443123 | METHODS AND COMPOSITIONS FOR DETECTING SINGLE T CELL RECEPTOR AFFINITY AND SEQUENCE | UNIV TEXAS |
EP3444235 | PRODUCTION OF ACETIC ACID WITH AN INCREASED PRODUCTION RATE | CELANESE INT CORP |
EP3444244 | PREPARATION PROCESS FOR HIGH-PURITY DABIGATRAN ETEXILATE | ZHEJIANG HUAHAI PHARM CO LTD |
EP3444257 | ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE | BOE TECHNOLOGY GROUP CO LTD |
EP3444261 | 2,2-DIFLUOROPROPIONAMIDE DERIVATIVE OF BARDOXOLONE METHYL, PHARMACEUTICAL COMPOSITIONS AND POLYMORPHS THEREOF FOR USE IN TREATING CERTAIN CONDITIONS | REATA PHARMACEUTICALS INC |
EP3444271 | IL-15 AND IL-15RAPLHA SUSHI DOMAIN BASED MODULOKINES | CYTUNE PHARMA |
EP3445357 | BIFUNCTIONAL MOLECULES FOR DEGRADATION OF EGFR AND METHODS OF USE | DANA FARBER CANCER INST INC |
EP3445370 | METHODS FOR THE PREPARATION OF OBETICHOLIC ACID AND DERIVATIVES THEREOF | INTERCEPT PHARMACEUTICALS INC |
EP3445451 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF LYSOSOMAL STORAGE DISORDERS AND DISORDERS CHARACTERIZED BY LYSOSOMAL DYSFUNCTION | BAYLOR COLLEGE MEDICINE |
EP3445743 | PRODRUG OF AMINO ACID DERIVATIVE | TAISHO PHARMA CO LTD |
EP3445754 | LIGNIN RECOVERY AND FURFURAL PRODUCTION FROM BIOMASS PREHYDROLYSATE STREAMS | FPINNOVATIONS |
EP3445763 | NOVEL CRYSTALLINE SALT FORMS OF 3-(1,2,4-TRIAZOLO[4,3-A]PYRIDINE-3-YLETHYNYL)-4-METHYL-N-(4-((4-METHYLPIPERAZIN-1-YL)METHYL)-3-TRIFLUOROMETHYLPHENYL)BENZAMIDE FOR MEDICAL APPLICATION | LLC 芦FUSION PHARMA禄 |
EP3445766 | NEW ANTIMICROBIAL COMPOUND | SINTEF TTO AS |
EP3445776 | RLMA-INACTIVATED FILAMENTOUS FUNGAL HOST CELL | NOVOZYMES AS |
EP3447042 | MANUFACTURING METHOD OF 1,2-DICHLOROHEXAFLUOROCYCLOPENTENE | BEIJING YUJI SCIENCE AND TECH CO LTD |
EP3447051 | METHOD FOR PREPARING TYROSINE KINASE INHIBITOR AND DERIVATIVE THEREOF | JIANGSU HENGRUI MEDICINE CO |
EP3447052 | METHODS OF PREPARING NEW IDH1 INHIBITORS | AGIOS PHARMACEUTICALS INC |
EP3447057 | ORGANIC SEMICONDUCTORS | CAMBRIDGE DISPLAY TECH LTD |
EP3447059 | SILICON-CONTAINING SULFURIC ACID ESTER SALT | NISSHINBO HOLDINGS INC |
EP3447060 | NOVEL ORGANOSILICON COMPOUND AND METHOD FOR PRODUCING SAME | SHINETSU CHEMICAL CO |
EP3447070 | COMPOUNDS FOR TREATING THE REMYELINATION BLOCKADE IN DISEASES ASSOCIATED WITH THE EXPRESSION OF HERV-W ENVELOPE PROTEIN | GENEURO SA |
EP3448380 | 1,5-DISUBSTITUTED 1,2,3-TRIAZOLES ARE INHIBITORS OF RAC/CDC42 GTPASES | UNIV PUERTO RICO |
EP3448386 | ISOQUINOLIN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF | SAMUMED LLC |
EP3448389 | QUINAZOLINE AND INDOLE COMPOUNDS TO TREAT MEDICAL DISORDERS | ACHILLION PHARMACEUTICALS INC |
EP3448429 | HUMANIZED AFFINITY MATURED ANTI-FCRN ANTIBODIES | SYNTIMMUNE INC |
EP3448522 | NOVEL SUBSTITUTED IMIDAZOPYRIDINE COMPOUNDS AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN-2,3-DIOXYGENASE | IOMET PHARMA LTD |
EP3448836 | METHODS AND SYSTEMS FOR THE MANUFACTURE OF AN AROMATIC PHTHALIC BISIMIDE AND A POLYETHERIMIDE | SABIC GLOBAL TECHNOLOGIES BV |
EP3448838 | ISOQUINOLIN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF | SAMUMED LLC |
EP3448853 | COMPOUNDS FOR MODULATING AQUAPORINS | APOGLYX AB |
EP3448861 | A PROCESS FOR THE PREPARATION OF 2-PYRAZOLO[1,5-A]PYRAZIN-2-YLPYRIDO[1,2-A]PYRIMIDIN-4-ONE | HOFFMANN LA ROCHE |
EP3448864 | SILSESQUINOXANES AS TRANSPORT COMPOUNDS | UNIV DARMSTADT TECH |
EP3448868 | miRNA TRANSCRIPTOME METHODS AND COMPOSITIONS | BIO RAD LABORATORIES |
EP3448882 | ANTI-KK-LC-1 T CELL RECEPTORS | US HEALTH |
EP3448992 | ANTIMICROBIAL AGENTS AGAINST SALMONELLA BACTERIA | LYSANDO AG |
EP3449017 | TARGETED MEASURE OF TRANSCRIPTIONAL ACTIVITY RELATED TO HORMONE RECEPTORS | UNIV TEXAS |
EP3450420 | METHOD FOR INCREASING UV TRANSMITTANCE OF ETHYLENE GLYCOL | CHANGCHUN MEIHE SCIENCE AND TECH DEVELOPMENT CO LTD |
EP3450426 | METHOD FOR SYNTHESIZING SILODOSIN AND INTERMEDIATE THEREOF | ZHEJIANG TIANYU PHARMACEUTICAL CO LTD |
EP3450434 | DEUTERATED DERIVATIVES OF RUXOLITINIB | CONCERT PHARMACEUTICALS INC |
EP3450439 | METHOD FOR PRODUCING MONOMER FOR SINGLE-STRANDED NUCLEIC ACID MOLECULE | SUMITOMO CHEMICAL CO |
EP3450448 | THERAPEUTIC PEPTIDE FOR EXCITATORY NEUROTOXICITY-RELATED INJURIES | BIOCELLS BEIJING BIOTECH CO LTD |
EP3450452 | MODIFIED FIBROIN | SPIBER INC |
EP3450458 | HUMAN ANTIBODIES TO GFR 3 AND METHODS OF USE THEREOF | REGENERON PHARMA |
EP3450560 | MODIFIED TRANSFERRIN DNA BINDING DOMAIN, RECOMBINANT DNA POLYMERASE AND PREPARATION METHOD THEREFOR | FOREGENE COMPANY LTD |
EP3451064 | ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE AND IMAGE-FORMING DEVICE | KYOCERA DOCUMENT SOLUTIONS INC |
EP3452071 | CHIMERIC NEUROTOXINS | IPSEN BIOPHARM LTD |
EP3452436 | IN-KIT PREPARATION OF GALLIUM-68 LABELLED RADIOPHARMACEUTICALS | AZIENDA USL DI REGGIO NELL EMILIA |
EP3452438 | INTEGRATED TECHNIQUES FOR PRODUCING BIO-METHANOL | ULTRA CLEAN ECOLENE INC |
EP3452442 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM & HAAS ELECT MATERIALS KOREA LTD |
EP3452463 | AMIDE-SUBSTITUTED PYRIDINYLTRIAZOLE DERIVATIVES AND USES THEREOF | BAYER PHARMA AG |
EP3452471 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH |
EP3452476 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | INCYTE HOLDINGS CORP |
EP3452487 | CATALYTIC SUPPORT AND USES THEREOF | SCG CHEMICALS CO LTD |
EP3452491 | QUANTITATIVE PROFILING OF PROGESTERONE METABOLITES FOR THE PREDICTION OF SPONTANEOUS PRETERM DELIVERY | UNIV INDIANA RES & TECH CORP |
EP3452495 | ADENO-ASSOCIATED VIRUS POLYNUCLEOTIDES, POLYPEPTIDES AND VIRIONS | CHILDRENS MEDICAL RES INSTITUTE |
EP3452497 | ALPHA-AMYLASE VARIANTS AND POLYNUCLEOTIDES ENCODING THE SAME | NOVOZYMES AS |
EP3452502 | THE CONTORSBODY - A SINGLE CHAIN TARGET BINDER | HOFFMANN LA ROCHE |
EP3452583 | ENGINEERED NUCLEASES USEFUL FOR TREATMENT OF HEMOPHILIA A | PREC BIOSCIENCES INC |
EP3452590 | PLATE MAGNET | STEMCELL TECH INC |
EP3453695 | A PROCESS FOR THE PRODUCTION OF OLEFINS AND USE THEREOF | DO CARMO ROBERTO WERNECK |
EP3453696 | METHOD FOR PRODUCING CONJUGATED DIENE | KURARAY CO |
EP3453708 | PROCESS FOR THE PREPARATION OF 5-CHLORO-N-(2-ISOPROPOXY-5-METHYL-4-PIPERIDIN-4-YL-PHENYL)-N-2-(ISOPROPYLSULFONYL)PHENYL)-2,4-DIAMINE DI-HYDROCHLORIDE | NOVARTIS AG |
EP3453713 | BUFADIENOLIDE COMPOUNDS SUBSTITUTED IN POSITION 3 BY AN AMINE GROUP FOR USE IN THE TREATMENT OF CANCER | NEUPHARMA INC |
EP3453723 | ANTI-ASIC1 ANTIBODIES AND USES THEREOF | REGENERON PHARMA |
EP3454854 | PROCESS FOR SYNTHESIZING 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)-PYRIDIN-3-YL)METHOXY)BENZALDEHYDE | GLOBAL BLOOD THERAPEUTICS INC |
EP3454887 | TARGETED MUTANT INTERFERON-BETA AND USES THEREOF | ORIONIS BIOSCIENCES NV |
EP3455202 | METHOD FOR PURIFYING AN AQUEOUS LACTIC ACID SOLUTION | FUTERRO SA |
EP3455203 | VINYLOGOUS PHENETHYLAMINES AS NEUROTRANSMITTER RELEASERS | RES TRIANGLE INST |
EP3455213 | METHOD FOR PURIFYING CANNABINOID COMPOUNDS | SYMRISE AG |
EP3455239 | PARTICLE FOR THE ENCAPSIDATION OF A GENOME ENGINEERING SYSTEM | FLASH THERAPEUTICS |
EP3455242 | SEPARATION METHOD | GE HEALTHCARE BIOPROCESS R&D AB |
EP3455243 | SEPARATION MATRIX | GE HEALTHCARE BIOPROCESS R&D AB |
EP3455246 | METHOD FOR THE AFFINITY PURIFICATION OF RECOMBINANT PROTEINS BASED ON THE LECTIN ACTIVITY OF THE CRD OF A GALECTIN | UNIV DE LORRAINE |
EP3455248 | ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER AND PD1 BINDING MOIETY | HOFFMANN LA ROCHE |
EP3455253 | C-TERMINALLY FUSED TNF FAMILY LIGAND TRIMER-CONTAINING ANTIGEN BINDING MOLECULES | HOFFMANN LA ROCHE |
EP3455254 | ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER AND A TENASCIN BINDING MOIETY | HOFFMANN LA ROCHE |
EP3455255 | ANTI-CTLA-4 ANTIBODIES | AGENCY SCIENCE TECH & RES |
EP3455257 | ANTI-PD-L1 ANTIBODIES | IGM BIOSCIENCES INC |
EP3455258 | METHODS OF TREATING SKIN CANCER BY ADMINISTERING A PD-1 INHIBITOR | REGENERON PHARMA |
EP3455307 | LIQUID INK CONTAINING A HYDANTOIN CO-SOLVENT | HEWLETT PACKARD DEVELOPMENT CO |
EP3455322 | HYDROFLUOROOLEFINS AND METHODS OF USING SAME | 3M INNOVATIVE PROPERTIES CO |
EP3456190 | ANTIBODY PRODUCING NON-HUMAN MAMMALS | MERUS NV |
EP3456330 | CORTEXOLONE 17ALPHA-VALERATE FOR USE IN THE TREATMENT OF TUMOURS | COSMO TECHNOLOGIES LTD |
EP3456339 | NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER INCLUDING NSCLC | IMMATICS BIOTECHNOLOGIES GMBH |
EP3456346 | PD-1 AND LAG-3 BINDING MOLECULES AND METHODS OF USE THEREOF | MACROGENICS INC |
EP3456720 | NOVEL CRYSTALLINE SALT FORM OF 2,2-DIMETHYL-6-((4-((3,4,5-TRIMETHOXYPHENYL)AMINO)-1,3,5-TRIAZIN-2-YL)AMINO)-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE FOR MEDICAL APPLICATION | LIMITED MOLECULAR TECH |
EP3456736 | ANTIBODY VARIANTS | TILLOTTS PHARMA AG |
EP3456743 | ONCOSTATIN M RECEPTOR ANTIGEN BINDING PROTEINS | KINIKSA PHARMACEUTICALS LTD |
EP3458053 | USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS | BIOHAVEN PHARM HOLDING CO LTD |
EP3458439 | 2-ETHYLIDENE-1,5-DIMETHYL-3,3-DIPHENYLPYRROLIDINE ANALOGS AND METHODS FOR THEIR SYNTHESIS AND USE | ALERE SAN DIEGO INC |
EP3458441 | PROCESS FOR THE MANUFACTURE OF 6-ALKYNYL-PYRIDINE DERIVATIVES | BOEHRINGER INGELHEIM INT |
EP3458445 | KRAS G12C INHIBITORS | MIRATI THERAPEUTICS INC |
EP3458448 | METHODS OF USING FASN INHIBITORS | FORMA THERAPEUTICS INC |
EP3458454 | NOVEL MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER | UNIV RUTGERS |
EP3458455 | NOVEL PYRAZINE COMPOUNDS WITH OXYGEN, SULFUR AND NITROGEN LINKER FOR THE TREATMENT OF INFECTIOUS DISEASES | HOFFMANN LA ROCHE |
EP3458469 | INTERMEDIATES FOR THE SYNTHESIS OF BILE ACID DERIVATIVES, IN PARTICULAR OF OBETICHOLIC ACID | NZP UK LTD |
EP3458472 | METHOD FOR PURIFICATION AND ACTIVATION OF BOTULINUM NEUROTOXIN | HARVARD COLLEGE |
EP3458478 | ANTI PD-1 AND ANTI-LAG3 ANTIBODIES FOR CANCER TREATMENT | BOEHRINGER INGELHEIM INT |
EP3458480 | ANTIBODY DIRECTED AGAINST THE ENDOTHELIN RECEPTOR BETA SUB-TYPE | COMMISSARIAT ENERGIE ATOMIQUE |
EP3458485 | TETHERED INTERLEUKIN-2 TO ITS RECEPTOR IL-2RBETA, A PLATFORM TO ENHANCE NATURAL KILLER AND REGULATORY T CELL ACTIVITY | MASSACHUSETTS GEN HOSPITAL |
EP3459560 | ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III CHIMERIC ANTIGEN RECEPTORS AND USE OF SAME FOR THE TREATMENT OF CANCER | US HEALTH |
EP3459564 | PLASMA KALLIKREIN BINDING PROTEINS | DYAX CORP |
EP3459925 | METHOD FOR PREPARING 2-HYDROXYL-4-(2, 3-DISUBSTITUTED BENZYLOXY)-5-SUBSTITUTED BENZALDEHYDE DERIVATIVE | INST MATERIA MEDICA CAMS |
EP3459944 | AZEPANYL-DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME WITH ANTIPARASITIC ACTIVITY | MERCK PATENT GMBH |
EP3459946 | HETEROCYCLIC COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD |
EP3459947 | NOVEL CHIRAL PHASE-TRANSFER CATALYST, AND METHOD FOR PREPARING -AMINO ACID BY USING SAME | UNIV YEUNGNAM RES COOPERATION FOUNDATION |
EP3459954 | NOVEL POLYMORPH OF TRIAZOLO PYRAZINE DERIVATIVE AND METHOD FOR PREPARING SAME | ABION INC |
EP3459956 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEMICAL LTD |
EP3460050 | CELL CULTURING METHOD, CULTURE MEDIUM, AND CULTURE MEDIUM KIT | FUJIFILM CORP |
EP3460062 | ISOLATED POLYNUCLEOTIDES AND POLYPEPTIDES, AND METHODS OF USING SAME FOR INCREASING PLANT YIELD AND/OR AGRICULTURAL CHARACTERISTICS | EVOGENE LTD |
EP3461815 | NOVEL POLY SULFONATED FLUORESCENCE DYES | ATTO TEC GMBH |
EP3461830 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | SAMSUNG ELECTRONICS CO LTD |
EP3461831 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | SAMSUNG ELECTRONICS CO LTD |
EP3461834 | NEUROACTIVE STEROIDS | SAGE THERAPEUTICS INC |
EP3462173 | ANTIBODIES TO RISPERIDONE AND USE THEREOF | JANSSEN PHARMACEUTICA NV |
EP3463435 | ANTIBODIES TO ALPHA-SYNUCLEIN AND USES THEREOF | MEDIMMUNE LTD |
EP3463647 | MIXED OXIDES FOR THE OXIDATIVE CLEAVAGE OF LIPIDS USING OXYGEN TO AFFORD MONO- AND DI-CARBOXYLIC ACIDS | CATALISI INNOVATIVA PER IL RICICLO DEL CARBONIO E |
EP3463654 | CATALYST SYSTEMS AND ETHYLENE OLIGOMERIZATION METHOD | CHEVRON PHILLIPS CHEMICAL CO LP |
EP3464231 | PROCESS FOR THE PREPARATION OF PURIFIED DICARBOXYLIC ACIDS | NOVAMONT SPA |
EP3464235 | PROCESS FOR THE PREPARATION OF POLYSANTOL-TYPE COMPOUNDS | FIRMENICH & CIE |
EP3464239 | PROCESS FOR PRODUCING METHYL MERCAPTAN FROM DIMETHYL SULFIDE | NOVUS INT INC |
EP3464244 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH |
EP3464248 | 3-OXO-2,6-DIPHENYL-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES | BAYER PHARMA AG |
EP3464251 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG |
EP3464255 | BIOMASS CONVERSION | TNO |
EP3464260 | UREA MOTIF CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS ANTIBACTERIAL DRUGS | UNIV MUENCHEN TECH |
EP3464261 | HERBICIDAL URACILPYRID | BASF SE |
EP3464276 | NEW CRYSTALLINE FORM OF N-[5-(3,5-DIFLUORO-BENZYL)-1H-INDAZOL-3-YL]-4-(4-METHYL-PIPERAZIN-1-YL)-2-(TETRAHYDRO-PYRAN-4-YLAMINO)-BENZAMIDE | NERVIANO MEDICAL SCIENCES SRL |
EP3464278 | XANTHONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE | HOFFMANN LA ROCHE |
EP3464286 | PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER | GENENTECH INC |
EP3464289 | ULTRA-POTENT VINCA ALKALOIDS: ADDED MOLECULAR COMPLEXITY FURTHER DISRUPTS THE TUBULIN DIMER-DIMER INTERFACE | SCRIPPS RESEARCH INST |
EP3464293 | MOLECULAR PROBES FOR DETECTION AND IMAGING OF PANCREATIC CANCER | UNIV PORTLAND STATE |
EP3464299 | LANTHANIDE TOOLBOX FOR ORGANELLE SPECIFIC MOLECULAR IMAGING | NEW LIFE MEDICINE TECH COMPANY LIMITED |
EP3464300 | NOVEL COMPOUNDS, FUNCTIONALISED DIOXABOROLANE OR DIOXABORINANE DERIVATIVES, METHOD FOR PREPARING SAME AND USES THEREOF | ECOLE SUPERIEURE DE PHYSIQUE ET CHIMIE IND DE LA VILLE DE PARIS |
EP3464310 | TAGGED MULTI-NUCLEOTIDES USEFUL FOR NUCLEIC ACID SEQUENCING | HOFFMANN LA ROCHE |
EP3464315 | METHODS FOR THE PREPARATION OF DEOXYCHOLIC ACID, AND INTERMEDIATES USEFUL IN THE PREPARATION OF DEOXYCHOLIC ACID | BIONICE S L U |
EP3464323 | PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF GENOME-EDITING MOLECULES | AADIGEN LLC |
EP3464324 | ANGIOTENSIN-1-RECEPTOR ANTAGONISTS | FERRING BV |
EP3464352 | CONSTRUCTION AND CHARACTERIZATION OF MULTIMERIC IL-15-BASED MOLECULES WITH CD3 BINDING DOMAINS | ALTOR BIOSCIENCE CORP |
EP3464354 | ANTIBODIES THAT BIND TO HUMAN ANTI-M脺LLERIAN HORMONE (AMH) AND THEIR USES | KOHLMANN ANGELICA |
EP3464361 | ANTI-CD40 ANTIBODIES AND THEIR USES | ABBVIE BIOTHERAPEUTICS INC |
EP3464373 | USE OF ANTI-PD-1 ANTIBODY IN THE TREATMENT OF PATIENTS WITH COLORECTAL CANCER | SQUIBB BRISTOL MYERS CO |
EP3465811 | NONAQUEOUS ELECTROLYTE COMPOSITIONS COMPRISING FLUORINATED SULFONES | DU PONT |
EP3466255 | NON-HUMAN ANIMALS HAVING A HUMANIZED CLUSTER OF DIFFERENTIATION 47 GENE | REGENERON PHARMA |
EP3466916 | ORGANIC AMINE SALT COMPOUND HAVING ANIONS SERVING AS CO2 DONORS AND APPLICATION OF SAME AS FOAMING AGENT | UNIV SHANDONG TECHNOLOGY |
EP3466919 | PROCESS FOR PRODUCTION OF 1,6-HEXANEDIOL FROM 1,2-6-HEXANETRIOL | ARCHER DANIELS MIDLAND CO |
EP3466937 | PHOTOELECTRIC CONVERSION ELEMENT, TWO-DIMENSIONAL SENSOR, IMAGE SENSOR AND IMAGING DEVICE | CANON KK |
EP3466939 | NEW DAPAGLIFLOZIN CRYSTAL FORM AND PREPARATION METHOD AND USE THEREOF | JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD |
EP3466950 | NOVEL BETA-LACTAMASE INHIBITORS | MEDSHINE DISCOVERY INC |
EP3466978 | FUSION PROTEIN FOR IMPROVING PROTEIN EXPRESSION FROM TARGET mRNA | UNIV KYUSHU NAT UNIV CORP |
EP3467083 | LIQUID DETERGENT COMPOSITION FOR TEXTILE PRODUCTS | KAO CORP |
EP3467102 | COMPOSITION COMPRISING FUSION PROTEIN OF RV2299C AND ESAT-6 FOR PROMOTING MATURATION OF DENDRITIC CELL | QURATIS INC |
EP3467928 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | CENTRAL GLASS CO LTD |
EP3468526 | FRAGRANCE MATERIAL | TAKASAGO PERFUMERY CO LTD |
EP3468949 | CRYSTALLINE PHARMACEUTICAL CO-CRYSTALS OF GLYCOPYRRONIUM BROMIDE WITH LACTOSE | HOVIONE SCIENTIA LTD |
EP3468963 | DIHYDROPYRIMIDINYL BENZAZEPINE CARBOXAMIDE COMPOUNDS | HOFFMANN LA ROCHE |
EP3468977 | FXR (NR1H4) MODULATING COMPOUNDS | GILEAD SCIENCES INC |
EP3468979 | MOLECULAR WHITE-LIGHT EMITTER | PHILIPPS UNIV MARBURG |
EP3468982 | RECOVERY OF LACTOSE FROM AN AQUEOUS SOLUTION | COOL SEPARATIONS B V |
EP3468998 | ANTI-TNFRSF25 ANTIBODIES | PELICAN THERAPEUTICS INC |
EP3469070 | HERPESVIRUS WITH MODIFIED GLYCOPROTEIN B | UNIV BOLOGNA ALMA MATER STUDIORUM |
EP3469072 | HERPESVIRUS WITH MODIFIED GLYCOPROTEIN H FOR PROPAGATION IN A CELL | UNIV BOLOGNA ALMA MATER STUDIORUM |
EP3470392 | METHOD FOR PRODUCING UNSATURATED NITRILE | ASAHI CHEMICAL IND |
EP3470393 | XYLYLENE DIISOCYANATE COMPOSITION, XYLYLENE DIISOCYANATE MODIFICATION COMPOSITION, TWO-COMPONENT RESIN STARTING MATERIAL, AND RESIN | MITSUI CHEMICALS INC |
EP3470397 | CRYSTALLINE FORMS OF A PROLYL HYDROXYLASE INHIBITOR | FIBROGEN INC |
EP3470402 | CRYSTALLINE FORMS OF NEUROTROPHIN MIMETIC COMPOUNDS AND THEIR SALTS | PHARMATROPHIX INC |
EP3470414 | BENZODIAZEPINE DERIVATIVE WITH ACTIVITY ON THE CENTRAL NERVOUS AND VASCULAR SYSTEMS | UNIV LA HABANA |
EP3470423 | IMMUNOSUPPRESSIVE TGF-BETA SIGNAL CONVERTER | BAYLOR COLLEGE MEDICINE |
EP3470432 | METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST | SANOFI BIOTECHNOLOGY |
EP3471730 | PHARMACEUTICAL SALTS OF N-(2-(2-(DIMETHYLAMINO)ETHOXY)-4-METHOXY-5-((4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YL)AMINO)PHENYL)ACRYLAMIDE AND CRYSTALLINE FORMS THEREOF | BETA PHARMA INC |
EP3472128 | COMPOUND COMPRISING CERTAIN LEVEL OF BIO-BASED CARBON | CLARIANT INT LTD |
EP3472134 | PROCESS FOR PREPARING COMPOUNDS USEFUL AS INTERMEDIATES FOR THE PREPARATION OF RALTEGRAVIR | PHARMATHEN SA |
EP3472139 | PROCESS FOR THE EPOXIDATION OF A TETRASUBSTITUTED ALKENE | BASF AGRO BV |
EP3472160 | BICYCLIC PYRIDINE, PYRAZINE, AND PYRIMIDINE DERIVATIVES AS PI3K BETA INHIBITORS | JANSSEN PHARMACEUTICA NV |
EP3472162 | HETEROARYL ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | HOFFMANN LA ROCHE |
EP3472173 | COATINGS FOR COMPONENTS OF ELECTROCHEMICAL CELLS | SION POWER CORP |
EP3472191 | METABOLICALLY STABLE PEPTIDE ANALOGS | UNIV STRASBOURG |
EP3472195 | METABOLICALLY STABLE SPEXIN PEPTIDE ANALOGS | UNIV STRASBOURG |
EP3472207 | BINDING MOLECULES BINDING PD-L1 AND LAG-3 | F STAR DELTA LTD |
EP3472314 | PREPARATION OF FACTOR XA DERIVATIVES | PORTOLA PHARM INC |
EP3473611 | TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF | ARBUTUS BIOPHARMA CORP |
EP3473621 | METHOD FOR PRODUCING DIPHENYLMETHANE DERIVATIVE | DAE WOONG PHARMA |
EP3473625 | PREPARATION METHOD FOR CHIRAL PYRROLOPYRIMIDINE COMPOUND | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD |
EP3473630 | BORON-BASED PRODRUG STRATEGY FOR INCREASED BIOAVAILABILITY AND LOWER-DOSAGE REQUIREMENTS FOR DRUG MOLECULES CONTAINING AT LEAST ONE PHENOL (OR AROMATIC HYDROXYL) GROUP | XAVIER UNIV OF LOUISIANA |
EP3473632 | NOVEL DIPHENYLMETHANE PROTECTIVE AGENT | SEKISUI MEDICAL CO LTD |
EP3473648 | HUMAN ANTIBODIES TO PD-L1 | REGENERON PHARMA |
EP3473725 | FERMENTATION TECHNIQUE WITH PICHIA YEAST EXPRESSING RECOMBINANT PROTEIN | JIANGSU JLAND BIOTECH CO LTD |
EP3475252 | CATALYSTS AND PROCESSES FOR PRODUCING ALDEHYDES | EASTMAN CHEM CO |
EP3475265 | COMPOUNDS FOR THE DETECTION OF SENESCENT CELLS | UNIV MANCHESTER |
EP3475273 | 3-AMINO-1,2,4-TRIAZINE DERIVATIVES AND THEIR USE FOR CONTROLLING UNDESIRED PLANT GROWTH | BAYER CROPSCIENCE AG |
EP3475278 | (DIS)SYMMETRIC AZOMETHINE-TYPE DIRECT DYE COMPRISING AT LEAST ONE PYRAZOLOPYRIDINE UNIT, PROCESS FOR DYEING KERATIN FIBERS USING THIS DYE | OREAL |
EP3475279 | TRIAZOLOPYRIDINES AS GAMMA-SECRETASE MODULATORS | HOFFMANN LA ROCHE |
EP3475288 | PROCESS FOR THE PREPARATION OF HIGH-PURITY PRASUGREL | RICHTER GEDEON NYRT |
EP3475303 | ANTI-CD19 ANTIBODY FORMULATIONS | MORPHOSYS AG |
EP3475340 | P(CN)3 REACTIONS WITH LITHIUM DICYNAMIDE PRODUCING LITHIATED CARBON PHOSPHONITRIDE EXTENDED SOLIDS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS THE SECRETARY OF THE NAVY |
EP3475706 | MHC-E RESTRICTED EPITOPES, BINDING MOLECULES AND RELATED METHODS AND USES | JUNO THERAPEUTICS INC |
EP3476824 | METHOD FOR PRODUCING 2,6-NAPHTHALENE DICARBOXYLIC ACID | UENO FINE CHEMICALS IND LTD |
EP3476828 | METHOD FOR PRODUCING IRON COMPLEX AND METHOD FOR PRODUCING ESTER COMPOUND USING IRON COMPLEX | KURARAY CO |
EP3476830 | POLYMETHINE COMPOUNDS AND THEIR USE AS FLUORESCENT LABELS | ILLUMINA CAMBRIDGE LTD |
EP3476845 | ORGANIC THIN-FILM TRANSISTOR, ORGANIC SEMICONDUCTOR FILM, COMPOUND, ORGANIC-THIN-FILM-TRANSISTOR COMPOSITION, AND ORGANIC-THIN-FILM-TRANSISTOR MANUFACTURING METHOD | FUJIFILM CORP |
EP3476849 | EPOXY COMPOUND, CURABLE COMPOSITION CONTAINING THIS, AND CURED PRODUCT OF CURABLE COMPOSITION | JXTG NIPPON OIL & ENERGY CORP |
EP3478650 | HIGH RESOLUTION SYSTEMS, KITS, APPARATUS, AND METHODS USING LATERAL FLOW FOR HIGH THROUGHPUT MICROBIOLOGY APPLICATIONS | GEN AUTOMATION LAB TECH INC |
EP3478651 | PROCESS FOR THE PREPARATION OF ALPHA, BETA UNSATURATED ALDEHYDES BY OXIDATION OF ALCOHOLS IN THE PRESENCE OF A LIQUID PHASE | BASF SE |
EP3478656 | DICARBAZOLBIPHENYL DERIVATES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH |
EP3478657 | DICARBAZOLBIPHENY DERIVATES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH |
EP3478658 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR POTENTIATING GENE SILENCING | OLIX PHARMACEUTICALS INC |
EP3478660 | METHOD FOR THE PURIFICATION OF ETHOXYQUIN | BASF SE |
EP3478668 | NOVEL TRIAZINE PRECONDENSATE AND METHOD FOR OBTAINING THE SAME | BOREALIS AGROLINZ MELAMINE |
EP3478682 | [1,2,4]TRIAZOLO[1,5-A]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS | SQUIBB BRISTOL MYERS CO |
EP3478683 | DIAZEPINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF HEPATITIS B INFECTIONS | NOVIRA THERAPEUTICS INC |
EP3478698 | METHOD FOR THE SEPARATION OF ENANTIOMERIC MIXTURES FROM METAL COMPLEXES | MERCK PATENT GMBH |
EP3478710 | FUSION PROTEIN FOR USE IN THE TREATMENT OF HVG DISEASE | MEDIZINISCHE HOCHSCHULE HANNOVER |
EP3478745 | PROCESSES AND SYSTEMS FOR REMOVING WATER AND SALT FROM A NEUTRALIZED POLYETHER POLYOL | COVESTRO LLC |
EP3478748 | DUAL CURABLE THIOL-ENE COMPOSITION, COMPRISING A POLYTHIOL, AN UNSATURATED COMPOUND, A PHOTOINITIATOR AND AN ORGANIC HYDROPEROXIDE, AS WELL AS A CROSS-LINKED POLYMER SEALANT PREPARED THEREFROM FOR USE IN AEROSPACE | 3M INNOVATIVE PROPERTIES CO |
EP3480183 | PRODUCTION METHOD FOR (METH)ACRYLIC ACID OR ESTER THEREOF | MITSUBISHI CHEM CORP |
EP3480185 | METHOD FOR PREPARING POLYTHIOL COMPOUND, METHOD FOR PREPARING CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | HOYA LENS THAILAND LTD |
EP3480188 | METHOD FOR PREPARING URATE-ANION EXCHANGER 1 INHIBITOR | TIANJIN INSTITUTE OF PHARMACEUTICAL RES CO LTD |
EP3480189 | METHOD FOR PRODUCING PROPYLENE OXIDE | SUMITOMO CHEMICAL CO |
EP3480191 | METHOD FOR PRODUCING BICYCLIC COMPOUND | ONO PHARMACEUTICAL CO |
EP3480194 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | LG CHEMICAL LTD |
EP3480246 | MIXTURES OF SALTS FOR DISSOLVING CELLULOSE | UNIV SANTIAGO COMPOSTELA |
EP3481794 | RENEWABLE ISOPARAFFINS AS DILUENT IN HYDROMETALLURGICAL LIQUID-LIQUID EXTRACTION PROCESS | OUTOTEC FINLAND OY |
EP3481796 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH |
EP3481797 | PHOTOCHLORINATION OF CHLOROFORM TO CARBON TETRACHLORIDE | OCCIDENTAL CHEM CO |
EP3481815 | 1,3-DIHYDROXY-PHENYL DERIVATIVES USEFUL AS IMMUNOMODULATORS | SQUIBB BRISTOL MYERS CO |
EP3481826 | TYROSINE KINASE INHIBITORS | RIGEL PHARMACEUTICALS INC |
EP3481827 | IMIDAZO[1,2-A]PYRIDINE DERIVATIVES, METHODS FOR PREPARING THE SAME AND USE THEREOF | JEIL PHARMACEUTICAL CO LTD |
EP3481829 | FUSED PYRIMIDINE DERIVATIVES | HOFFMANN LA ROCHE |
EP3481848 | GENOMIC SEQUENCES ENCODING FOR AN ATTENUATED MUTANT ZIKA VIRUS | INST NAT SANTE RECH MED |
EP3481851 | METHOD FOR THE FERMENTATIVE PRODUCTION OF MOLECULES OF INTEREST BY MICROORGANISMS COMPRISING GENES CODING SUGAR PHOSPHOTRANSFERASE SYSTEM (PTS) | METABOLIC EXPLORER SA |
EP3483146 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | HEESUNG MAT LTD |
EP3483152 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEMICAL LTD |
EP3483161 | INTERMEDIATES USED TO MAKE ENTECAVIR | ZHEJIANG AUSUN PHARMACEUTICAL CO LTD |
EP3483163 | TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES AS CB2 RECEPTOR ANTAGONISTS | HOFFMANN LA ROCHE |
EP3483170 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING ORGANOMETALLIC COMPOUND | SAMSUNG ELECTRONICS CO LTD |
EP3483177 | CHIMERIC ANTIGEN RECEPTORS | CELGENE CORP |
EP3483183 | IMMUNOCONJUGATE COMPRISING HUMANISED RS7 ANTIBODIES | IMMUNOMEDICS INC |
EP3483234 | USE OF SPECIALISED DERIVATIVES OF QUATERNISED NITROGEN COMPOUNDS AS ADDITIVES IN FUELS AND LUBRICANTS | BASF SE |
EP3484293 | LACTONASE ENZYMES AND METHODS OF USING SAME | FORNIA BIOSOLUTIONS INC |
EP3484471 | METHOD FOR PRODUCING A POLYMORPHIC FORM OF 3-[5-AMINO-4-(3- CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE | MEREO BIOPHARMA 1 LTD |
EP3484495 | NOVEL FATTY ACID MODIFIED UROCORTIN-2 ANALOGS FOR THE TREATMENT OF DIABETES AND CHRONIC KIDNEY DISEASE | LILLY CO ELI |
EP3484614 | ORGANOGELS ALLOWING REDUCTION AND CONTROL OF THE EVAPORATION OF VOLATILE ORGANIC LIQUIDS | CENTRE NAT RECH SCIENT |
EP3484841 | DECENE OLIGOMERS | CHEVRON PHILLIPS CHEMICAL CO LP |
EP3484848 | HEAT-SENSITIVE RECORDING MATERIAL | KOEHLER SE AUGUST PAPIERFABRIK |
EP3484853 | METHOD FOR PRODUCING A POLYMORPHIC FORM OF 3-[5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE | MEREO BIOPHARMA 1 LTD |
EP3484857 | CATALYST FOR CURABLE COMPOSITIONS CONTAINING HEXAHYDROTRIAZINE STRUCTURAL UNITS | SIKA TECH AG |
EP3484860 | EPOXIDATION PROCESS | SCIENT DESIGN CO |
EP3484862 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING A SYMPTON ASSOCIATED WITH GOUT OR HYPERURICEMIA | ARTHROSI THERAPEUTICS INC |
EP3484867 | INHIBITORS OF TRYPTOPHAN 2,3-DIOXYGENASE | NETHERLANDS TRANSLATIONAL RES CENTER B V |
EP3484875 | PYRAZOLYLAMINOBENZIMIDAZOLE DERIVATIVES AS JAK INHIBITORS | LILLY CO ELI |
EP3484884 | FUSED PYRIMIDINE DERIVATIVES | HOFFMANN LA ROCHE |
EP3484891 | REAGENTS FOR REVERSIBLY PROTECTING BIOLOGICAL MOLECULES | BIOMERIEUX SA |
EP3484909 | ANTISECRETORY FACTOR 17 | LANTMAENNEN AS FAKTOR AB |
EP3484912 | METHODS AND COMPOSITIONS RELATING TO COVALENTLY CIRCULARIZED NANODISCS | HARVARD COLLEGE |
EP3484921 | ANTI-IL-22R ANTIBODIES | ARGENX BVBA |
EP3486232 | METHOD FOR PRODUCING 5-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID | API CORP |
EP3486236 | SYNTHESIS METHOD AND INTERMEDIATE FOR PROTHIOCONAZOLE AND ENANTIOMER THEREOF | ORIENTAL LUZHOU AGROCHEMICALS CO LTD |
EP3486238 | POLYFUNCTIONAL OXETANE COMPOUND AND PREPARATION METHOD THEREFOR | CHANGZHOU TRONLY ADVANCED ELECTRONIC MAT CO LTD |
EP3486245 | 2-AMINO-N-(PIPERIDIN-1-YL-PYRIDIN-3-YL) PYRAZOLO[1,5ALPHA]PYRIMIDINE-3-CARBOXAMID AS INHIBITOR OF ATR KINASE | VERTEX PHARMA |
EP3486248 | IMPROVED METHODS FOR THE ACYLATION OF MAYTANSINOL | IMMUNOGEN INC |
EP3486249 | 99MTC-EDDA/HYNIC-IPSMA AS A RADIOPHARMACEUTICAL FOR DETECTING THE OVEREXPRESSION OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN | INSTITUTO NAC DE INVESTIGACIONES NUCLEARES |
EP3486272 | AROMATIC POLYTHIOL COMPOUND FOR OPTICAL MATERIAL | SKC CO LTD |
EP3487851 | AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS | NOVARTIS AG |
EP3487859 | ANTIMETASTATIC 2H-SELENOPHENO[3,2-H]CHROMENES, SYNTHESIS THEREOF, AND METHODS OF USING SAME AGENTS | LATVIAN INST ORGANIC SYNTHESIS |
EP3487860 | CONDENSED BICYCLIC HETEROCYCLE DERIVATIVES AS PEST CONTROL AGENTS | BAYER CROPSCIENCE AG |
EP3487861 | DIORGANYLPHOSPHINIC ACID SALTS, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF | CLARIANT PLASTICS & COATINGS LTD |
EP3487866 | PREFORMED CATALYTIC SYSTEM COMPRISING A RARE-EARTH METALLOCENE | MICHELIN & CIE |
EP3487870 | MONOMERIC STREPTAVIDIN MUTANTS, METHODS OF USING THE SAME AND PROCESSES OF MANUFACTURING PROTEINS | UNIV NEW YORK STATE RES FOUND |
EP3487873 | IMPROVED FILAMENTOUS FUNGAL HOST | NOVOZYMES AS |
EP3487967 | ALIPHATIC TETRAHEDRAL BORATE COMPOUNDS FOR LUBRICATING COMPOSITIONS | LUBRIZOL CORP |
EP3489213 | COMPOSITION FOR USE IN A METHOD FOR THE PREPARATION OF OPTICALLY ACTIVE CARBONYL COMPOUNDS | BASF SE |
EP3489218 | METHOD FOR THE PRODUCTION OF PHENYLAMINOHYDROXYANTHRACHINONES | LANXESS DEUTSCHLAND GMBH |
EP3489226 | INHIBITORS OF SODIUM GLUCOSE COTRANSPORTER 1 | LEXICON PHARMACEUTICALS INC |
EP3489239 | PROCESSES AND INTERMEDIATES FOR MAKING A JAK INHIBITOR | INCYTE HOLDINGS CORP |
EP3489243 | CARBENE COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICES | UNIV SOUTHERN CALIFORNIA |
EP3489249 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD |
EP3489251 | IMPROVED VACCINES AND METHODS FOR USING THE SAME | UNIV PENNSYLVANIA |
EP3489256 | ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER | HOFFMANN LA ROCHE |
EP3489264 | CHAIN SHUTTLING AGENTS AND THEIR USE FOR THE PREPARATION OF BLOCK COPOLYMERS | DOW GLOBAL TECHNOLOGIES LLC |
EP3489396 | MOLECULE LIBRARY CONSTRUCTED ON THE BASIS OF BACKBONE STRUCTURE OF MICROPROTEIN | AIST |
EP3490961 | OXIDATIVE DEHYDROGENATION (ODH) OF ETHANE | SHELL INT RESEARCH |
EP3490962 | OXIDATIVE DEHYDROGENATION (ODH) OF ETHANE | SHELL INT RESEARCH |
EP3490964 | PROCESS FOR PRODUCING HALOGENATED OLEFINS | CHEMOURS CO FC LLC |
EP3490967 | PARAFFIN REMOVAL FROM C4 CONTAINING STREAMS | LYONDELL CHEMICAL TECH LP |
EP3490973 | POLYMORPHIC FORMS OF BELINOSTAT AND PROCESSES FOR PREPARATION THEREOF | FRESENIUS KABI ONCOLOGY LTD |
EP3490975 | O-SUBSTITUTED HYDROXAMIC ACIDS | UNIV JOHNS HOPKINS |
EP3490991 | COELENTERAZINE ANALOGUES | PROMEGA CORP |
EP3490998 | PHENOLATE TRANSITION METAL COMPLEXES, PRODUCTION AND USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC |
EP3490999 | SYNTHESIS OF M-TERPHENYL PENDANT BIS-ETHER LIGANDS AND METAL COMPLEX AND THEIR USE IN OLEFIN POLYMERIZATION | DOW GLOBAL TECHNOLOGIES LLC |
EP3491004 | DIAGNOSTIC METHODS, THERAPEUTIC AGENTS AND USES THEREOF | METABOLON INC |
EP3491172 | METHOD AND SYSTEM FOR THE PRODUCTION OF HYDROCARBONS | THYSSENKRUPP IND SOLUTIONS AG |
EP3491384 | COMPOSITIONS AND METHODS FOR RAPID CLONING OF T-CELL RECEPTORS | HEALTH RESEARCH INC |
EP3492448 | 4-ALKOXY-3-(TRIFLUOROMETHYL)BENZYL ALCOHOL PRODUCTION METHOD | MITSUBISHI TANABE PHARMA CORP |
EP3492450 | QUATERNARY AMMONIUM COMPOUND AND SUPPRESSION OF GENERATION OF VOLATILE ORGANIC COMPOUND FROM POLYACETAL UTILIZING SAME | ASAHI CHEMICAL IND |
EP3492451 | PROCESS FOR THE PREPARATION OF HISTAMINE H3 RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV |
EP3492465 | S1P1 AGONIST AND APPLICATION THEREOF | SHIJIAZHUANG SAGACITY NEW DRUG DEV CO LTD |
EP3492474 | INTERMEDIATES USED IN THE PRODUCTION OF DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS | GLAXOSMITHKLINE LLC |
EP3492480 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP |
EP3492560 | IMPROVED LIQUID PHASE ALKYLATION PROCESS | EXXONMOBIL CHEMICAL PATENTS INC |
EP3494103 | 1-HYDROXYMETHYL-1,2,2,6-TETRAMETHYL-CYCLOHEXANE AND DERIVATIVES THEREOF AND THEIR USE AS AROMA CHEMICALS | BASF SE |
EP3494113 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH |
EP3494120 | OXADIAZOLOPYRIDINE DERIVATES FOR USE AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS | BOEHRINGER INGELHEIM INT |
EP3494121 | BORON-CONTAINING COMPOUNDS | VENATORX PHARMACEUTICALS INC |
EP3495339 | REACTION PRODUCT PREPARATION METHOD | NGK INSULATORS LTD |
EP3495344 | FLUORENE DERIVATIVE, ORGANIC LIGHT EMITTING DEVICE USING SAME, AND MANUFACTURING METHOD THEREFOR | LG CHEMICAL LTD |
EP3495350 | COMPOUND INHIBITING FORMATION OF C-MYC/MAX/DNA COMPLEX | NAT CANCER CT |
EP3495352 | CRYSTAL FORM OF ANDROGEN RECEPTOR ANTAGONIST MEDICATION, PREPARATION METHOD THEREFOR, AND USE | CRYSTAL PHARMACEUTICAL SUZHOU CO LTD |
EP3495353 | AMIDATE COMPOUND, CATALYST FOR POLYURETHANE PRODUCTION, AND METHOD FOR PRODUCING POLYURETHANE RESIN | KOEI CHEMICAL CO |
EP3495357 | 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE | UNIV COLUMBIA |
EP3495362 | IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | UNIV SHANDONG |
EP3495373 | HYDROCARBYLOXYDISILANES | DOW SILICONES CORP |
EP3495387 | BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES AND THEIR USE IN THE TREATMENT OF OCULAR VASCULAR DISEASES | ROCHE GLYCART AG |
EP3495392 | ANTI-CGRP COMPOSITIONS AND USE THEREOF | ALDERBIO HOLDINGS LLC |
EP3495415 | RUBBER COMPOSITION, TIRE, ADDITIVE, AND HYDRAZIDE COMPOUND | BRIDGESTONE CORP |
EP3496715 | COMPOUNDS USEFUL FOR ALTERING THE LEVELS OF BILE ACIDS FOR THE TREATMENT OF DIABETES AND CARDIOMETABOLIC DISEASE | MERCK SHARP & DOHME |
EP3496716 | COMPOUNDS USEFUL FOR ALTERING THE LEVELS OF BILE ACIDS FOR THE TREATMENT OF DIABETES AND CARDIOMETABOLIC DISEASE | MERCK SHARP & DOHME |
EP3496724 | PROTEIN KINASE REGULATORS | NANJING GATOR MEDITECH COMPANY LTD |
EP3496737 | APOM-FC FUSION PROTEINS, COMPLEXES THEREOF WITH SPHINGOSINE L-PHOSPHATE (SIP), AND METHODS FOR TREATING VASCULAR AND NON-VASCULAR DISEASES | CHILDRENS MEDICAL CT CORP |
EP3496951 | SILVER ION CARBOXYLATE N-HETEROAROMATIC COMPLEXES AND USES | EASTMAN KODAK CO |
EP3497084 | PROCESS FOR THE PREPARATION OF 3-AMINO-1-(2,6-DISUBSTITUTED-PHENYL)PYRAZOLES | BAYER CROPSCIENCE AG |
EP3497086 | AMINO PYRIMIDINE SSAO INHIBITORS | LILLY CO ELI |
EP3497087 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | NEUPHARMA INC |
EP3497088 | EPOXIDATION PROCESS | SCIENT DESIGN CO |
EP3497093 | SULFONYL PYRIDYL TRP INHIBITORS | HOFFMANN LA ROCHE |
EP3497096 | AN ANTIMICROBIAL COMPOUND | THE UNIV OF DURHAM |
EP3497103 | PYRIDOPYRIMDINONE CDK2/4/6 INHIBITORS | PFIZER |
EP3497104 | SOLID STATE FORMS OF LUMATEPERONE DITOSYLATE SALT | ASSIA CHEM IND LTD |
EP3497446 | METHOD AND COMPOSITION FOR DETECTION OF PEPTIDE CYCLIZATION USING PROTEIN TAGS | HOFFMANN LA ROCHE |
EP3497492 | OPTICAL COMPENSATION FILM HAVING REVERSED WAVELENGTH DISPERSION | AKRON POLYMER SYSTEMS INC |
EP3498292 | USPA2 PROTEIN CONSTRUCTS AND USES THEREOF | GLAXOSMITHKLINE BIOLOGICALS SA |
EP3498369 | METHOD FOR PRODUCING OXIDE CATALYST, METHOD FOR PRODUCING UNSATURATED NITRILE AND METHOD FOR PRODUCING UNSATURATED ACID | ASAHI CHEMICAL IND |
EP3498688 | METHOD FOR PRODUCING N-( -ALKOXYETHYL)FORMAMIDE | MITSUBISHI CHEM CORP |
EP3498691 | NOVEL CATIONIC PHOTOINITIATOR, AND PREPARATION METHOD THEREFOR AND APPLICATIONS THEREOF | CHANGZHOU TRONLY NEW ELECTRONIC MAT CO LTD |
EP3498705 | 2-ACETYL-6-(2-(2-(4-BROMOBENZYLIDENE)HYDRAZINYL)THIAZOLE-4-YL)-3,7,9-TRIHYDROXY-8,9B-DIMETHYLDIBENZO[B,D]FURAN-1(9BH)-ONE EXHIBITING AN INHIBITORY EFFECT ON HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME | OBSHESTVO S OGRANICHENNOI OTVETSTVENNOSTJU INNOVATIE PHARMACOLOGY RES IPHAR |
EP3498715 | ANTI-HCMV VIRUS COMPOUND | MEDSHINE DISCOVERY INC |
EP3498719 | TERTIARY HYDROXYL FUNCTIONAL ALKOXYSILANES AND METHODS FOR PREPARING THEREOF | HENKEL AG & CO KGAA |
EP3498722 | METHOD FOR PREPARING OLIGOMERIC MANNURONIC DIACID | SHANGHAI GREEN VALLEY PHARMACEUTICAL CO LTD |
EP3498729 | THERAPEUTIC TARGETS FOR ALZHEIMER'S DISEASE | UNIV BIRMINGHAM |
EP3498732 | ANTI-NERVE GROWTH FACTOR ANTIBODIES AND METHODS OF PREPARING AND USING THE SAME | NEXVET AUSTRALIA PTY LTD |
EP3498809 | FATTY GLYCERIDE PREPARATION METHOD | ZHEJIANG MED XINCHANG PHARM |
EP3498828 | METHOD FOR TREATING SOLUTION CONTAMINATED WITH PORCINE CIRCOVIRUSES | ASAHI KASEI MEDICAL CO LTD |
EP3498849 | AXMI115 VARIANT INSECTICIDAL GENE AND METHODS FOR ITS USE | ATHENIX CORP |
EP3500546 | PROPENYLAMINES AND METHODS OF MAKING AND USING SAME | 3M INNOVATIVE PROPERTIES CO |
EP3500550 | CROSS-LINKED POLYGLYCEROL ESTERS | EVONIK DEGUSSA GMBH |
EP3500551 | PROCESS FOR PREPARING SUBSTITUTED BIPHENYLS | BASF SE |
EP3500553 | PROCESS FOR PRODUCING AN ISOCYANATE AND AT LEAST ONE FURTHER CHEMICAL PRODUCT IN AN INTEGRATED PRODUCTION | COVESTRO DEUTSCHLAND AG |
EP3500554 | PROCESS FOR CONVERSION OF DIMETHYL SULFIDE TO METHYL MERCAPTAN | CHEVRON PHILLIPS CHEMICAL CO LP |
EP3500573 | GABA(A) RECEPTOR MODULATORS AND METHODS TO CONTROL AIRWAY HYPERRESPONSIVENESS AND INFLAMMATION IN ASTHMA | UWM RES FOUNDATION INC |
EP3500577 | ORGANIC SEMICONDUCTING COMPOUNDS | MERCK PATENT GMBH |
EP3500586 | CONTINUOUS PROCESS FOR REDUCING HETEROGENEITY OF THERAPEUTIC PROTEIN | ENZENE BIOSCIENCES LTD |
EP3500593 | T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME | IMMATICS BIOTECHNOLOGIES GMBH |
EP3500673 | CARBOXYLATED 2'-AMINO-LNA NUCLEOTIDES AND OLIGONUCLEOTIDES COMPRISING THE SAME | PANZNER STEFFEN |
EP3500859 | MARKER FOR NEURAL STEM CELLS | XINTELA AB |
EP3502142 | BISPECIFIC ANTIBODY AND ANTIBODY CONJUGATE FOR TUMOUR THERAPY AND USE THEREOF | BENHEALTH BIOPHARMACEUTIC SHENZHEN CO LTD |
EP3502240 | TARGETING BCL11A DISTAL REGULATORY ELEMENTS FOR FETAL HEMOGLOBIN REINDUCTION | CHILDRENS MEDICAL CT CORP |
EP3503895 | ANTIVIRAL PRODRUGS OF TENOFOVIR | MERCK SHARP & DOHME |
EP3504177 | PROCESS FOR THE PREPARATION OF CYCLIC KETONES | SRF LTD |
EP3504185 | NOVEL SUBSTITUTED N'-HYDROXYCARBAMIMIDOYL-1,2,5-OXADIAZOLE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS | MERCK SHARP & DOHME |
EP3504194 | N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE | NOVARTIS AG |
EP3504200 | HETEROCYCLICALLY SUBSTITUTED BIPHENYLS, ESPECIALLY FOR USE IN OPTOELECTRONIC APPARATUSES | CYNORA GMBH |
EP3504210 | 7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION | HOFFMANN LA ROCHE |
EP3504218 | COMPOSITION COMPRISING SILICON AND METHOD FOR PREPARING SAME | SILINNOV SCRL |
EP3504229 | REGULATION OF GENE EXPRESSION USING ENGINEERED NUCLEASES | SANGAMO THERAPEUTICS INC |
EP3504249 | DIALKYL PEROXIDE COMPOSITION FOR MODIFYING THE RHEOLOGY OF POLYPROPYLENE IN MOLTEN STATE | ARKEMA FRANCE |
EP3504340 | TAGGED NUCLEOTIDES USEFUL FOR NANOPORE DETECTION | HOFFMANN LA ROCHE |
EP3504546 | MARKER COMPOSITIONS, AND METHODS FOR MAKING AND USING SAME | UNITED COLOR MFG INC |
EP3505498 | METHOD FOR RECYCLING MOTHER LIQUOR IN PTA REFINED UNIT | TIANHUA INST OF CHEMICAL MACHINERY AND AUTOMATION CO LTD |
EP3505506 | METHOD FOR PRODUCING 3,7-DIMETHYL-7-OCTENOL AND METHOD FOR PRODUCING 3,7-DIMETHYL-7-OCTENYL CARBOXYLATE COMPOUND | SHINETSU CHEMICAL CO |
EP3505511 | DIAZADIENYL COMPOUND, RAW MATERIAL FOR FORMING THIN FILM, AND METHOD FOR PRODUCING THIN FILM | ADEKA CORP |
EP3505516 | CRYSTAL OF SALT OF QUINAZOLINE DERIVATIVE | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD |
EP3505524 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP |
EP3506983 | SUBSTITUTED UREAS AND METHODS OF MAKING AND USING SAME | MEBIAS DISCOVERY LLC |
EP3507267 | MAGNETIC SEPARATION AND RECYCLE OF CATALYST COMPONENTS IN A BIO-MASS TO GLYCOLS PROCESS | SHELL INT RESEARCH |
EP3507271 | PROCESS FOR PREPARING SALICYLOYL-L-CARNITINE HYDROCHLORIDE | DRUGON PHARMA SWITZERLAND AG |
EP3507273 | PRODUCTION OF TERT- BUTYL HYDROPEROXIDE SOLUTION AND PROCESS TO FORM PRODUCTS THEREFROM | LYONDELL CHEMICAL TECH LP |
EP3507278 | SUBSTITUTED TRICYCLIC HETEROCYCLIC COMPOUNDS | SQUIBB BRISTOL MYERS CO |
EP3507291 | FUSED BICYCLIC SGC STIMULATORS | CYCLERION THERAPEUTICS INC |
EP3507293 | PROCESS FOR THE GENERATION OF THIN INORGANIC FILMS | BASF SE |
EP3507294 | BINUCLEAR AND TRINUCLEAR METAL COMPLEXES COMPOSED OF TWO INTER-LINKED TRIPODAL HEXADENTATE LIGANDS FOR USE IN ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH |
EP3508472 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO LTD |
EP3508473 | METHOD FOR PRODUCING CARBAMIC ACID ESTER | AIST |
EP3508483 | DIHYDROPYRIMIDINE COMPOUND AND PREPARATION METHOD AND USE THEREOF | SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD |
EP3508489 | A PROCESS FOR THE PREPARATION OF ACYLPHOSPHANES | ETH ZUERICH |
EP3508554 | PHOTOCHROMIC OPTICAL MATERIAL AND PREPARATION METHOD THEREFOR | JIANGSU SHIKEXINCAI COMPANY LTD |
EP3508620 | UREYLENE ADDITIVE, ITS USE AND A PREPARATION METHOD THEREFOR | ATOTECH DEUTSCHLAND GMBH |
EP3509155 | NON-AQUEOUS ELECTROLYTE SOLUTION ADDITIVE, NON-AQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY, COMPRISING NON-AQUEOUS ELECTROLYTE SOLUTION ADDITIVE | LG CHEMICAL LTD |
EP3510007 | 18F]-LABELLED LACTATE DERIVATIVE AS PET RADIOTRACER | UNIV LOUVAIN |
EP3510016 | PROCESS FOR THE PRODUCTION OF N-BOC-2-AMINO-3,3-DIMETHYLBUTYRIC ACID | SIEGFRIED NANTONG PHARMACEUTICALS CO LTD |
EP3510017 | PARTIALLY FLUORINATED AROMATIC ESTERS | 3M INNOVATIVE PROPERTIES CO |
EP3510024 | PYRIDYL SUBSTITUTED INDOLE COMPOUNDS | SQUIBB BRISTOL MYERS CO |
EP3510033 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS | NOVARTIS AG |
EP3510035 | DUAL PROTECTED PRO-COELENTERAZINE SUBSTRATES | PROMEGA CORP |
EP3510036 | IMIDAZOQUINOLINE DERIVATIVES AND THEIR USE IN THERAPY | GLAXOSMITHKLINE BIOLOGICALS SA |
EP3510038 | METAL COMPLEXES CONTAINING ALLYL LIGANDS | MERCK PATENT GMBH |
EP3510043 | USE OFMCM7 TO OBTAIN ACETIC ACID-RESISTANT YEAST STRAINS | LESAFFRE & CIE |
EP3510044 | AMYLIN ANALOGUES | ZEALAND PHARMA AS |
EP3510045 | MONOCLONAL ANTIBODIES AGAINST HEMAGGLUTININ OF H5-SEROTYPE INFLUENZA VIRUSES AND THEIR USES, HYBRIDOMAS PRODUCING SAID ANTIBODIES, COMPOSITIONS AND DIAGNOSTIC KITS | INST BIOTECHNOLOGII I ANTYBIOTYKOW |
EP3511309 | METHOD FOR PREPARING ETHYLENE IN PROPYLENE PREPARATION PROCESS USING PROPANE DEHYDROGENATION REACTION | HYOSUNG CHEMICAL CORP |
EP3511314 | SYSTEM FOR PRODUCING ESTER COMPOSITION, AND METHOD FOR PRODUCING ESTER COMPOSITION, USING SAME | LG CHEMICAL LTD |
EP3511315 | METHOD FOR PRODUCING N-METHYL-PARA-ANISIDINE | OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU IFOTOP |
EP3511321 | ORGANIC LIGHT-EMITTING ELEMENT, AND LIGHT-EMITTING MATERIAL AND COMPOUND FOR USE THEREIN | TOYO BOSEKI |
EP3511324 | IMIDE COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL CO |
EP3512026 | ELECTROLYTE ADDITIVE AND LITHIUM SECONDARY BATTERY ELECTROLYTE COMPRISING SAME | LG CHEMICAL LTD |
EP3512027 | ELECTROLYTE ADDITIVE AND ELECTROLYTE, COMPRISING SAME, FOR LITHIUM SECONDARY BATTERY | LG CHEMICAL LTD |
EP3512835 | A PROCESS FOR PURIFICATION OF CARFILZOMIB INTERMEDIATE | FRESENIUS KABI ONCOLOGY LTD |
EP3512843 | PLANT GROWTH REGULATOR COMPOUNDS | SYNGENTA PARTICIPATIONS AG |
EP3512856 | NOVEL CYTOTOXIC AGENTS AND CONJUGATES THEREOF | POLYTHERICS LTD |
EP3512857 | SPIRO BICYCLIC INHIBITORS OF MENIN-MLL INTERACTION | JANSSEN PHARMACEUTICA NV |
EP3512861 | CYCLIC DINUCLEOTIDES AS STING (STIMULATOR OF INTERFERON GENES) AGONISTS | TAKEDA PHARMACEUTICALS CO |
EP3512863 | 2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR RNA VIRUS TREATMENT | ATEA PHARMACEUTICALS INC |
EP3512882 | ANTI-C-MET ANTIBODIES AND ANTIBODY DRUG CONJUGATES THEREOF FOR EFFICIENT TUMOR INHIBITION | MERCK PATENT GMBH |
EP3513191 | HUMAN OTIC PROGENITOR IDENTIFICATION AND ISOLATION | UNIV SHEFFIELD |
EP3514134 | PROCESS FOR THE SEPARATION OF OXYMETHYLENE ETHERS | RWTH AACHEN |
EP3514135 | FLUORENE PHOTOINITIATOR, PREPARATION METHOD THEREFOR, PHOTOCURABLE COMPOSITION HAVING SAME, AND USE OF SAME IN PHOTOCURING FIELD | CHANGZHOU TRONLY ADVANCED ELECTRONIC MAT CO LTD |
EP3514159 | ALUMINIUM METAL ORGANIC FRAMEWORK MATERIAL | TEXAS A & M UNIV SYS |
EP3514165 | NUCLEOSIDE DERIVATIVE OR SALT THEREOF, REAGENT FOR SYNTHESIZING POLYNUCLEOTIDE, METHOD FOR PRODUCING POLYNUCLEOTIDE, POLYNUCLEOTIDE, AND METHOD FOR PRODUCING BINDING NUCLEIC ACID MOLECULE | NEC SOLUTION INNOVATORS LTD |
EP3514168 | PROTEASE-CLEAVAGE RESISTANT, SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES AND CELL-TARGETED MOLECULES COMPRISING THE SAME | MOLECULAR TEMPLATES INC |
EP3514173 | DKK-1 ANTIBODIES | LILLY CO ELI |
EP3514174 | MATERIALS AND METHODS FOR PERFORMING HISTOCHEMICAL ASSAYS FOR HUMAN PRO-EPIREGULIN AND AMPHIREGULIN | VENTANA MED SYST INC |
EP3514883 | ELECTROLYTE ADDITIVE AND LITHIUM SECONDARY BATTERY ELECTROLYTE COMPRISING SAME | LG CHEMICAL LTD |
EP3515864 | SiH-FREE VINYLDISILANES | DOW SILICONES CORP |
EP3515894 | INDAZOLE COMPOUNDS FOR USE IN TENDON AND/OR LIGAMENT INJURIES | NOVARTIS AG |
EP3515897 | PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME | ABIDE THERAPEUTICS INC |
EP3515899 | SOLKETAL-ETHERS, PRODUCTION METHOD AND USES THEREOF | CEPSA S A U |
EP3515900 | COMPOUNDS COMPRISING TWO OR MORE EXOVINYLENE CYCLIC-CARBONATE UNITS | BASF SE |
EP3515915 | PROCESS FOR PREPARING BETA-LACTAMASE INHIBITOR HYDROXYLUREA INTERMEDIATES | MERCK SHARP & DOHME |
EP3515918 | PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE | BASF AGRO BV |
EP3515920 | NEW ANTIMICROBIAL COMPOUNDS, THEIR USE FOR THE TREATMENT OF MAMMALIAN INFECTIONS AND A NEW METABOLIC MECHANISM | LEIBNIZ INST FUER NATURSTOFF FORSCHUNG UND INFEKTIONSBIOLOGIE E V HANS KNOELL INST HKI |
EP3515924 | CRYSTALLINE FORMS | IDORSIA PHARMACEUTICALS LTD |
EP3515929 | HEPATITIS B THERAPEUTIC VACCINES | THEVAX GENETICS VACCINE CO LTD |
EP3516728 | SILYL ESTER PHOSPHINATES AS ELECTROLYTE ADDITIVES | BASF SE |
EP3517531 | METHOD FOR PRODUCING (R)-5-(3,4-DIFLUOROPHENYL)-5-[(3-METHYL-2-OXOPYRIDIN-1(2H)-YL)METHYL]IMIDAZOLIDINE-2,4-DIONE AND INTERMEDIATE FOR PRODUCING SAME | KAKEN PHARMA CO LTD |
EP3517536 | AMINOTRIAZINE DERIVATIVES USEFUL AS TANK-BINDING KINASE INHIBITOR COMPOUNDS | GILEAD SCIENCES INC |
EP3517625 | METHODS FOR DETERMINING LYMPHOCYTE RECEPTOR CHAIN PAIRS | THE UNIV OF BRITISH COLUMBIA UNIV INDUSTRY LIAISON OFFICE |
EP3518303 | N-(4-(8-(PHENYL)NAPHTHALEN-2-YL)PHENYL)-N,N'-DI(PHENYL)-AMINE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN ORGANIC ELECTROLUMINESCENCE DEVICES | SAMSUNG DISPLAY CO LTD |
EP3518304 | N-(((PHENYL)NAPHTHALEN-2-YL)PHENYL)-N-(PHENYL)-DIBENZOTHIOPHENAMINE, -DIBENZOFURANAMINE AND -9H-FLUORENYLAMINE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN ORGANIC ELECTROLUMINESCENCE DEVICES | SAMSUNG DISPLAY CO LTD |
EP3518334 | NON-AQUEOUS ELECTROLYTE SOLUTION ADDITIVE, NON-AQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY, COMPRISING NON-AQUEOUS ELECTROLYTE SOLUTION ADDITIVE | LG CHEMICAL LTD |
EP3518911 | METHODS FOR TREATING OVARIAN CANCER | RADIUS HEALTH INC |
EP3519051 | TREATMENT CANCERS USING COMBINATION COMPRISING PARP INHIBITORS | BEIGENE LTD |
EP3519069 | EQUIPMENT AND PROCESS FOR PROCESSING OF A PRODUCT STREAM RESULTING FROM A CAPROLACTONE PRODUCTION | PERSTORP AB |
EP3519382 | AN IMPROVED PROCESS FOR THE PREPARATION OF LACOSAMIDE | UNICHEM LAB LTD |
EP3519387 | TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | DONG A ST CO LTD |
EP3519396 | NEW STRIGOLACTONE ANALOGS AND THEIR USAGE IN PLANT CONTROL | UNIV KING ABDULLAH SCI & TECH |
EP3519398 | PYRIDINE COMPOUND | DAIICHI SANKYO CO LTD |
EP3519401 | MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR | VERTEX PHARMA |
EP3519407 | DIMETHYLAMINOETHANOL SALT OF A GLP-1 RECEPTOR MODULATOR | CELGENE INT II SARL |
EP3519416 | CHROMANE, ISOCHROMANE AND DIHYDROISOBENZOFURAN DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE | MERCK SHARP & DOHME |
EP3519417 | COMPOUNDS WITH DIAZADIBENZOFURANE OR DIAZADIBENZOTHIOPHENE STRUCTURES | MERCK PATENT GMBH |
EP3519418 | BRIDGED PIPERIDINE DERIVATIVES | HOFFMANN LA ROCHE |
EP3519423 | ENDOSOMOLYTIC AGENTS FOR GENE THERAPY | UCB BIOPHARMA SPRL |
EP3519429 | BACTERIAL INHIBITORS | MEHARRY MEDICAL COLLEGE |
EP3519437 | BISPECIFIC ANTIBODIES AGAINST CD3 | HOFFMANN LA ROCHE |
EP3519822 | CELL MARKERS | CENTRE NAT RECH SCIENT |
EP3519823 | MEMBRANE MARKERS | CENTRE NAT RECH SCIENT |
EP3521266 | SUBSTITUTED BIS(TRIFLUOROVINYL)BENZENE COMPOUND | TOSOH FINECHEM CORP |
EP3521279 | METHODS FOR PROTECTING AND DEPROTECTING A DIOL GROUP | FUJIFILM CORP |
EP3521281 | 1-[(PYRIDIN-3-YL-SULFONYL)-1H-PYRROL-3-YL]METHANAMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | JIANGSU JIBEIER PHARMACEUTICAL CO LTD |
EP3521282 | QUINAZOLINE DERIVATIVES USED TO TREAT HIV | GILEAD SCIENCES INC |
EP3521286 | FUSED 1,4-DIHYDRODIOXIN DERIVATIVES AS INHIBITORS OF HEAT SHOCK TRANSCRIPTION FACTOR 1 | CANCER RESEARCH TECH LTD |
EP3521293 | PROCESS FOR THE PREPARATION OF AN INHIBITOR OF PHOSPHODIESTERASE 4 | DIPHARMA FRANCIS SRL |
EP3521312 | A COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMENT OF PERIPHERAL T CELL LYMPHOMA | INNATE PHARMA SA |
EP3521314 | NEW ANTIBODY-DRUG CONJUGATES AND USE THEREOF IN TREATMENT | UNIV RABELAIS FRANCOIS |
EP3521422 | SUBSTANTIALLY ANIMAL PROTEIN-FREE RECOMBINAT FURIN AND METHODS FOR PRODUCING SAME | BAXALTA GMBH |
EP3522246 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MAT CO LTD |
EP3522715 | MICROBIOCIDAL OXADIAZOLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG |
EP3522919 | VACCINE | GLAXOSMITHKLINE BIOLOGICALS SA |
EP3523269 | ALKYLAROMATIC CONVERSION CATALYST | SHELL INT RESEARCH |
EP3523273 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH |
EP3523286 | NOVEL HYDROCARBON POLYMERS HAVING EXO-VINYLENE CYCLIC CARBONATE TERMINAL GROUPS | BOSTIK SA |
EP3523291 | CYANO-SUBSTITUTED HETEROCYCLES WITH ACTIVITY AS INHIBITORS OF USP30 | MISSION THERAPEUTICS LTD |
EP3523293 | SUBSTITUTED PYRROLIDINES AND THEIR USE IN THE TREATMENT OF CYSTIC FIIBROSIS | ABBVIE SARL |
EP3523295 | DEUTERATED N-(5-(2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDO)-2-FLUOROPHENYL)-2-((4-ETHYLPIPERAZIN-1 -YL)METHYL)QUINOLINE-6-CARBOXAMIDE | CANCER RESEARCH TECH LTD |
EP3523297 | NOVEL FURAZAN-3-CARBOXYLIC ACID DERIVATIVES AND USE THEREOF IN TREATMENT OF CANCER | UNIV BERLIN FREIE |
EP3523299 | 2-(HET)ARYL-SUBSTITUTED CONDENSED BICYCLIC HETEROCYCLE DERIVATIVES AS PEST CONTROL AGENTS | BAYER CROPSCIENCE AG |
EP3523307 | PROCESS FOR THE PREPARATION OF DORAOLZMIDE HYDROCHLORIDE | INDOCO REMEDIES LTD |
EP3523313 | DIBENZO[D,B]SILOLE-BASED REACTIVE MESOGENS | LOMOX LTD |
EP3523315 | INHIBITORS OF GLUCOCORTICOID RECEPTOR | ORIC PHARMACEUTICALS INC |
EP3523316 | MELANOCORTIN-1-RECEPTOR AGONISTS | DSM IP ASSETS BV |
EP3523320 | PEPTIDES FOR BINDING EPIDERMAL GROWTH FACTOR | 3M INNOVATIVE PROPERTIES CO |
EP3523322 | FGF21 RESPONSIVE REPORTER GENE CELL LINE | SVAR LIFE SCIENCE AB |
EP3523324 | METHOD OF PREPARING PEPTIDES COMPRISING A LIPOPHILICALLY MODIFIED LYSINE SIDE CHAIN | SANOFI SA |
EP3524590 | METHOD FOR PRODUCING 1, 4-DICYANOCYCLOHEXANE, 1, 4-BIS(AMINOMETHYL)CYCLOHEXANE AND 1, 4-CYCLOHEXANEDICARBOXYLIC ACID | MITSUBISHI GAS CHEMICAL CO |
EP3524598 | A SOLID FORM OF (S)-3-(4-((4-MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE HYDROCHLORIDE | CELGENE CORP |
EP3524601 | N-{3-[3-CYCLOPROPYL-5-(2-FLUORO-4-IODOPHENYLAMINO)-6,8-DIMETHYL-2,4,7-TRIOXO-3,4,6,7-TETRAHYDRO-2H-PYRIDO[4,3-D]PYRIMIDIN-1-YL]-PHENYL}-CYCLOPROPANECARBOXAMIDE DIMETHYL SULPHOXIDE SOLVATE AS AN MEK1/2 INHIBITOR | R PHARM JOINT STOCK COMPANY R PHARM JSC |
EP3524609 | 3-PHENYL-2,3,4,8,9,10-HEXAHYDROPYRANO[2,3-F]CHROMENE DERIVATIVE AND METHOD FOR SYNTHESIZING OPTICAL ISOMER THEREOF | GLACEUM INC |
EP3524615 | GENE FOR INCREASING PLANT WEIGHT AND METHOD FOR USING THE SAME | TOYOTA MOTOR CO LTD |
EP3524685 | INTERLEUKIN -13 BINDING PROTEINS | ABBVIE BAHAMAS LTD |
EP3525830 | PYRROLOBENZODIAZEPINE CONJUGATES | MEDIMMUNE LTD |
EP3526185 | PROCESS FOR THE PRODUCTION OF 2-ALKYLALKANOL | JOHNSON MATTHEY DAVY TECHNOLOGIES LTD |
EP3526190 | METHOD OF PREPARING HYDROXYALKYLCARBOXYLIC ACID ESTERS | BASF SE |
EP3526192 | MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO | DOW AGROSCIENCES LLC |
EP3526203 | N-ARYL AND N-HETEROARYL PIPERIDINE DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS, COMPOSITIONS, AND THEIR USE | MERCK SHARP & DOHME |
EP3526204 | NEAR-IR ABSORPTIVE COMPOUNDS AND DEVICES INCORPORATING THE SAME | GENTEX CORP |
EP3526208 | NEW COMPOUNDS AND USES THEREOF FOR DETECTION OF TARGET MOLECULES IN A SAMPLE | UNIV GENEVE |
EP3526213 | URINARY POLYAMINES AS PROSTATE CANCER DETECTION BIOMARKERS | NEW LIFE MEDICINE TECH COMPANY LIMITED |
EP3526223 | METHOD FOR ISOLATION AND PURIFICATION OF NALTREXONE | SANECA PHARMACEUTICALS A S |
EP3526229 | PROCESS FOR PREPARING GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZENE DERIVATIVES | BOEHRINGER INGELHEIM INT |
EP3526239 | HIF 1-ALPHA ANTISENSE OLIGONUCLEOTIDES | OLIPASS CORP |
EP3527192 | AMINO ACID DERIVATIVES AND THEIR USES | JOHNSON & JOHNSON CONSUMER INC |
EP3527280 | SELECTIVE MODIFICATION OF POLYMER SUBUNITS TO IMPROVE NANOPORE-BASED ANALYSIS | UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION |
EP3527550 | PROCESS FOR ETHERIFICATION OF MIXED OLEFINIC LIGHT NAPHTHA AND SIMULTANEOUS REDUCTION OF METHANOL IN THE PRODUCT | INDIAN OIL CORP LTD |
EP3527553 | EPSILON-CAPROLACTAM PRODUCTION METHOD | SUMITOMO CHEMICAL CO |
EP3527555 | NOVEL COMPOUND, AND MODIFIED CONJUGATED DIENE-BASED POLYMER CONTAINING FUNCTIONAL GROUP DERIVED FROM COMPOUND | LG CHEMICAL LTD |
EP3527559 | GAMMA-BUTYROLACTONE COMPOSITION AND METHOD FOR PRODUCING SAME | MITSUBISHI CHEM CORP |
EP3527563 | DNA-PK INHIBITORS | VERTEX PHARMA |
EP3527569 | DIHYDROPYRROLOPYRIDINE INHIBITORS OF ROR-GAMMA FOR USE IN TREATING DRYE EYE | VITAE PHARMACEUTICALS LLC |
EP3527575 | BIS(OXYMETHYL)PHOSPHINIC ACID AND BIOGENIC METAL SALTS THEREOF AS REGULATORS OF PLANT GROWTH AND DEVELOPMENT | SINYASHIN KIRILL OLEGOVICH |
EP3527580 | CONTINUOUS, SOLVENT-FREE AND NON-ENZYMATIC PEPTIDE SYNTHESIS BY REACTIVE EXTRUSION | CENTRE NAT RECH SCIENT |
EP3528332 | ELECTROLYTE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG CHEMICAL LTD |
EP3528811 | METHODS OF TREATING DEPRESSION | RUNDLE RES LLC |
EP3528942 | SYNTHESIS AND CHARACTERIZATION OF RU ALKYLIDENE COMPLEXES | UMICORE AG & CO KG |
EP3529231 | CRYSTALLINE DIETHYLAMINE TETRATHIOMOLYBDATE AND ITS PHARMACEUTICAL USES | UCL BUSINESS PLC |
EP3529238 | BIS-DIOX(OL)ANE COMPOUNDS | KONINKLIJKE COOEPERATIE COSUN U A |
EP3529253 | PROCESS | JOHNSON MATTHEY PLC |
EP3529262 | METHODS FOR PROMOTING T CELLS RESPONSE | INST NAT SANTE RECH MED |
EP3529275 | PROTEINS AND USES | UCB BIOPHARMA SPRL |
EP3529361 | SECRETABLE VARIANT IMMUNOMODULATORY PROTEINS AND ENGINEERED CELL THERAPY | ALPINE IMMUNE SCIENCES INC |
EP3530638 | IMPROVED METHOD FOR EXTRACTING HUMIC SUBSTANCES FROM CARBON | FERTINAGRO BIOTECH SL |
EP3530658 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD |
EP3530662 | METHOD FOR PREPARING HEPTAZINES | CENTRE NAT RECH SCIENT |
EP3530663 | PROCESS FOR PREPARING GEM-DIFLUORINATED C-GLYCOSIDE COMPOUNDS | ADVANOMICS CORP |
EP3530667 | PEPTIDE HAVING ANTI-OBESITY AND ANTI-DIABETES EFFICACY AND USE THEREOF | CAREGEN CO LTD |
EP3531129 | IMMUNOASSAY METHOD USING ANTI-HUMAN BNP FRAGMENT (4-32) ANTIBODY | SEKISUI MEDICAL CO LTD |
EP3532024 | COSMETIC USE AND METHOD FOR IMPROVING PHYSIOLOGICAL FUNCTIONS OF THE SKIN BY INCREASING THE EXPRESSION OF UBIAD1 | ISP INVESTMENTS LLC |
EP3532455 | IMPROVED SYNTHESIS OF MONO-CHLORINATED ACETOPHENONE | SIEGFRIED AG |
EP3532458 | BENZYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | BOEHRINGER INGELHEIM INT |
EP3532471 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULPHUR AND HYDROXYLAMINE SUBSTITUENTS | SYNGENTA PARTICIPATIONS AG |
EP3532473 | HETEROBICYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES | SQUIBB BRISTOL MYERS CO |
EP3532478 | CRYSTALLINE FORMS OF DARUNAVIR FREE BASE, HYDRATE, SOLVATES AND SALTS | GILEAD SCIENCES INC |
EP3532486 | ANTIBODY-COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS | JANSSEN PHARMACEUTICA NV |
EP3532490 | ADAPTER CHIMERIC ANTIGEN RECEPTOR EXPRESSING CELLS FOR TARGETING OF MULTIPLE ANTIGENS | MILTENYI BIOTEC GMBH |
EP3532499 | ANTI-IL-33 ANTIBODIES AND USES THEREOF | LILLY CO ELI |
EP3532578 | LUBRICANT ADDITIVE COMPOSITIONS COMPRISING PHOSPHOROUS CONTAINING COMPOUNDS AND USES THEREOF | AFTON CHEMICAL CORP |
EP3532642 | DIGITAL ANALYSIS OF BLOOD SAMPLES TO DETERMINE EFFICACY OF CANCER THERAPIES FOR SPECIFIC CANCERS | MASSACHUSETTS GEN HOSPITAL |
EP3533345 | CHLOROGENIC ACID-CONTAINING COMPOSITION MANUFACTURING METHOD | KAO CORP |
EP3533784 | SPIRO BENZOANTHRACENE-FLUORENE DERIVATIVES AND THEIR USE IN ORGANIC ELECTRONIC DEVICES, DISPLAYS AND LIGHTING DEVICES | NOVALED GMBH |
EP3533796 | AMINO PYRAZOLOPYRIMIDINE COMPOUND USED AS NEUROTROPHIC FACTOR TYROSINE KINASE RECEPTOR INHIBITOR | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD |
EP3533798 | DIBENZOPYRROMETHENE BORON CHELATE COMPOUND, NEAR INFRARED LIGHT ABSORBING MATERIAL, THIN FILM, AND ORGANIC ELECTRONIC DEVICE | NIPPON KAYAKU KK |
EP3533802 | ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE | US HEALTH |
EP3533803 | AMYLOID-BETA BINDING ANTIBODIES | ABBVIE INC |
EP3535238 | AMINOOXYLIPIDS FOR THE CONSTRUCTION OF SELF-ASSEMBLING LIPOSOMAL SYSTEMS ENABLING THEIR SUBSEQUENT MODIFICATION BY BIOLOGICALLY FUNCTIONAL MOLECULES | VS CHEMICKO TECHNOLOGICKA V PRAZE |
EP3535284 | DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS | US HEALTH |
EP3535298 | ANTIBODIES TO PD-1 AND USES THEREOF | JOUNCE THERAPEUTICS INC |
EP3535352 | METHODS OF REDUCING PHOSPHORUS CONTENT IN LIQUID HYDROCARBONS | LYONDELL CHEMICAL TECH LP |
EP3536315 | INHIBITOR OF ATP-DEPENDENT REVERSE TRANSPORTERS OF CELLS AND METHOD FOR PRODUCING SAME | AKTSIONERNOE OBSHCHESTVO TATKHIMFARMPREPARATY |
EP3536683 | POLYISOCYANATE COMPOSITION AND ISOCYANATE POLYMER COMPOSITION | ASAHI CHEMICAL IND |
EP3536686 | METHOD FOR PRODUCING A RADIOPHARMACEUTICAL COMPOSITION | NIHON MEDIPHYSICS CO LTD |
EP3536692 | PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME | MILLENNIUM PHARM INC |
EP3536703 | CONSENSUS PROSTATE ANTIGENS, NUCLEIC ACID MOLECULES ENCODING THE SAME AND USES THEREOF | UNIV PENNSYLVANIA |
EP3536704 | GENE THERAPY FOR RENAL FAILURE | BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC |
EP3536748 | A MODIFIED COLLAGEN | INNOCOLL PHARM LTD |
EP3538503 | A PROCESS FOR THE PRODUCTION OF FLUORINATED CYCLOBUTANE | HONEYWELL INT INC |
EP3538508 | RUTHENIUM COMPLEXES USEFUL FOR CATALYZING METATHESIS REACTIONS | XIMO AG |
EP3538510 | PROCESS FOR THE PREPARATION OF MONO-PROTECTED alpha,omega-DIAMINO ALKANES | SYNTHON BIOPHARMACEUTICALS BV |
EP3538512 | NEW ANTHELMINTIC QUINOLINE-3-CARBOXAMIDE DERIVATIVES | BAYER ANIMAL HEALTH GMBH |
EP3538519 | INDAZOLE DERIVATIVES AS ALPHA V INTEGRIN ANTAGONISTS | SQUIBB BRISTOL MYERS CO |
EP3538527 | AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS | SQUIBB BRISTOL MYERS CO |
EP3539545 | CRYSTALLINE FORM OF GNRH RECEPTOR ANTAGONIST AND PREPARATION METHOD THEREFOR | JIANGSU HENGRUI MEDICINE CO |
EP3539941 | METHOD FOR PREPARING TRIMETHYLOLPROPANE | LG CHEMICAL LTD |
EP3539953 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | LG CHEMICAL LTD |
EP3539955 | METHOD FOR PREPARING TETRAZINES | CENTRE NAT RECH SCIENT |
EP3539961 | POLYCYCLIC AMIDE DERIVATIVES AS CDK9 INHIBITORS | ASTRAZENECA AB |
EP3539964 | BASE ACETAMIDE GLYCERIN ETHER MOLECULE, CHEMICAL SYNTHESIS METHOD THEREFOR, AND APPLICATIONS THEREOF IN FIELD OF GENE THERAPY | UNIV BEIJING |
EP3539965 | AN IMPROVED PROCESS FOR THE PREPARATION OF (3R,4R)-(1-BENZYL-4-METHYLPIPERIDIN-3-YL)-METHYLAMINE | UNICHEM LAB LTD |
EP3539968 | NOVEL TRITYL PROTECTING AGENT | SEKISUI MEDICAL CO LTD |
EP3539970 | POLYMERIZABLE COMPOUND, COMPOUND, AND METHOD FOR PRODUCING BORANOPHOSPHATE OLIGOMER | UNIV TOKYO SCIENCE FOUND |
EP3539972 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD |
EP3539990 | HER3 INHIBITION IN LOW-GRADE SEROUS CANCERS | DANA FARBER CANCER INST INC |
EP3540053 | AMYLASES AND GLUCOAMYLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM | BASF ENZYMES LLC |
EP3540062 | IMMUNOGLOBULIN VARIABLE REGION CASSETTE EXCHANGE | HUMANIGEN INC |
EP3541770 | PROCESSES AND SYSTEMS FOR ACHIEVING HIGH CARBON CONVERSION TO DESIRED PRODUCTS IN A HYBRID CATALYST SYSTEM | DOW GLOBAL TECHNOLOGIES LLC |
EP3541771 | PROCESS FOR PRODUCING 1,2-PROPANEDIOL FROM GLYCEROL | ARCHER DANIELS MIDLAND CO |
EP3541778 | ELECTROCHEMICAL METHOD FOR PRODUCING ARYL ALKYL CARBONATES AND DIARYL CARBONATES | COVESTRO DEUTSCHLAND AG |
EP3541793 | METHOD FOR PRODUCING TRIARYLORGANOBORATES | COVESTRO DEUTSCHLAND AG |
EP3541794 | 4-((6-(2-(2,4-DUFLUOROPHENYL)-1,1-DIFLUORO-2-HYDROXY-3-(5-MERCAPTO-1H-1,2,4-TRIAZOL-1-YL)PROPYL)PYRIDIN-3-YL)OXY)BENZONITRILE AND PROCESSES OF PREPARATION | DOW AGROSCIENCES LLC |
EP3541807 | CRYSTALLINE FORMS OF A MAGL INHIBITOR | ABIDE THERAPEUTICS INC |
EP3541814 | 2-SUBSTITUTED AMINO-NAPHTH[1,2-D]IMIDAZOL-5-ONE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF CROSS REFERENCE TO RELATED APPLICATIONS | BIOELECTRON TECH CORP |
EP3541893 | PROCESS AND SYSTEM FOR CONVERSION OF CRUDE OIL TO PETROCHEMICALS AND FUEL PRODUCTS INTEGRATING VACUUM GAS OIL HYDROTREATING AND STEAM CRACKING | SAUDI ARABIAN OIL CO |
EP3543229 | METHOD FOR PREPARING OPTICALLY PURE (R)-4-N-PROPYL-DIHYDROFURAN-2(3H)-ONE | BEIJING ABLEPHARMTECH CO LTD |
EP3543230 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO LTD |
EP3543248 | PHOSPHORESCENT PtAg2 COMPLEX, PREPARATION METHOD THEREFOR AND USE THEREOF | FUJIAN INST RES STR MATTER CAS |
EP3543252 | METHOD FOR INCREASING THE SECRETION LEVELS OF INTERLEUKIN 2 AND PROTEINS DERIVED FROM IT | CT INMUNOLOGIA MOLECULAR |
EP3543697 | METHOD FOR THE SELECTION OF BIOLOGICAL BINDING MOLECULES | AVA LIFESCIENCE GMBH |
EP3544613 | GSK-3 INHIBITORS | SQUIBB BRISTOL MYERS CO |
EP3544727 | OLIGOMERIZATION PROCESS INVOLVING CRYSTALLINE MOLECULAR SIEVE | HINDUSTAN PETROLEUM CORP LTD |
EP3544928 | METHOD FOR STORING ENERGY IN THE FORM OF HYDRAZINE CARBONATE | SCHAEFFLER TECHNOLOGIES AG |
EP3544945 | PROCESS FOR PREPARING (POLY)ALKYLATED PHENOLS | DSM IP ASSETS BV |
EP3544946 | DIPHENOL PRILLS AND METHOD FOR OBTAINING THE SAME | RHODIA OPERATIONS |
EP3544955 | IMPROVED PROCESS FOR PREPARING ASTACENE | BASF SE |
EP3544961 | POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 | UNIV VANDERBILT |
EP3544962 | DIAMINOTRIAZINE COMPOUNDS | BASF SE |
EP3544973 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PEST CONTROL AGENTS | SUMITOMO CHEMICAL CO |
EP3544976 | N-[5-(AMINOSULFONYL)-4-METHYL-1,3-THIAZOL-2-YL]-N-METHYL-2-[4-(2-PYRIDINYL)-PHENYL]-ACETAMIDE FREE BASE HEMIHYDRATE, METHODS OF MANUFACTURE AND USES THEREOF | AICURIS ANTI INFECTIVE CURES GMBH |
EP3544977 | A MALEATE SALT OF THE FREE BASE OF N-[5-(AMINOSULFONYL)-4-METHYL-1,3-THIAZOL-2-YL]-N-METHYL-2-[4-(2-PYRIDINYL)-PHENYL]-ACETAMIDE, PHARMACEUTICAL FORMULATIONS, METHODS OF MANUFACTURE AND USES THEREOF FOR THE TREATMENT OF HERPES VIRUSES | AICURIS ANTI INFECTIVE CURES GMBH |
EP3544980 | GSK-3 INHIBITORS | SQUIBB BRISTOL MYERS CO |
EP3544981 | BENZODIAZOLIUM COMPOUNDS AS ENAC INHIBITORS | ENTERPRISE THERAPEUTICS LTD |
EP3544982 | CHEMICAL PROCESS FOR PREPARING IMIDAZOPYRROLIDINONE DERIVATIVES AND INTERMEDIATES THEREOF | NOVARTIS AG |
EP3544985 | BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) | MERCK PATENT GMBH |
EP3545009 | PHOTOINITATORS | COLOPLAST AS |
EP3545121 | PROCESS | AVANTIUM KNOWLEDGE CENTRE BV |
EP3545965 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS | IMMATICS BIOTECHNOLOGIES GMBH |
EP3545978 | TRIAZINE BASED RADIOPHARMACEUTICALS AND RADIOIMAGING AGENTS | MOLECULAR INSIGHT PHARM INC |
EP3546439 | METHOD FOR PRODUCING (Z)-1-CHLORO-2,3,3-TRIFLUORO-1-PROPENE | AGC INC |
EP3546440 | REMOVAL UNIT FOR METHANOL AND ACETONE AND SYSTEM COMPRISING SAME FOR PREPARING PHENOL AND BISPHENOL A | LG CHEMICAL LTD |
EP3546441 | METHOD FOR PREPARING ACRYLIC ACID AND METHYL ACRYLATE | DALIAN INST CHEM & PHYSICS CAS |
EP3546443 | METHOD FOR PRODUCING FLUORINE-CONTAINING DIALKYL CARBONATE COMPOUNDS | SAMHWA PAINTS IND CO LTD |
EP3546453 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME | LG CHEMICAL LTD |
EP3546472 | METHOD FOR PURIFYING P1,P4-DI(URIDINE 5'-)TETRAPHOSPHATE | YAMASA CORP |
EP3546474 | CRP CAPTURE/DETECTION OF GRAM POSITIVE BACTERIA | HARVARD COLLEGE |
EP3546484 | IN VITRO PRODUCTION OF RED BLOOD CELLS WITH SORTAGGABLE PROTEINS | WHITEHEAD INST BIOMEDICAL RES |
EP3546494 | CURING AGENT FOR WATER-BASED EPOXY RESIN, WATER-BASED EPOXY RESIN COMPOSITION, AND CURED PRODUCT THEREOF | MITSUBISHI GAS CHEMICAL CO |
EP3546942 | BIOCHIP | NIPPON LIGHT METAL CO |
EP3548457 | AN IMPROVED PROCESS FOR THE PREPARATION OF 2,3,3,3-TETRAFLUOROPROPENE | SRF LTD |
EP3548461 | MECHANOCHEMICAL SYNTHESIS OF RADIOGRAPHIC AGENTS INTERMEDIATES | BRACCO IMAGING SPA |
EP3548477 | NITROGEN-CONTAINING HETEROCYCLES FOR USE IN OLEDS | MERCK PATENT GMBH |
EP3548485 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH |
EP3548486 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH |
EP3548495 | PYRAZOLOPYRIMIDINE DERIVATIVES AS CAM KINASE INHIBITORS | GILEAD SCIENCES INC |
EP3548498 | SILVER ION ALPHA-OXY CARBOXYLATE-OXIME COMPLEXES FOR PHOTOLITHOGRAPHIC PROCESSES TO GENERATE ELECTRICALLY CONDUCTING METALLIC STRUCTURES | EASTMAN KODAK CO |
EP3548501 | NOVEL RUTHENIUM COMPLEX, METHOD OF ITS PRODUCTION AND ITS USE IN REACTION OF OLEFINE METATHESIS | UNIV WARSZAWSKI |
EP3548504 | PEPTIDE-BASED PROTEASOME INHIBITORS FOR TREATING CONDITIONS MEDIATED BY SENESCENT CELLS AND FOR TREATING CANCER | UNITY BIOTECHNOLOGY INC |
EP3548505 | CYTOPLASMIC MALE STERILITY GENE ORF147 OF PIGEONPEA, AND USES THEREOF | INTERNATIONAL CROPS RES INSTITUTE FOR THE SEMI ARID TROPICS ICRISAT |
EP3548508 | NEW COMPOUNDS AS PEPTIDIC TRIGONAL GLP1/GLUCAGON/GIP RECEPTOR AGONISTS | SANOFI SA |
EP3548511 | METHODS AND MATERIALS FOR CLONING FUNCTIONAL T CELL RECEPTORS FROM SINGLE T CELLS | UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION |
EP3548613 | BACTERIAL GLUTAMINYL CYCLASES AND INHIBITORS THEREOF FOR USE IN THE TREATMENT OF PERIODONTITIS | FRAUNHOFER GES FORSCHUNG |
EP3549601 | NON-LIPIDATED VARIANTS OF NEISSERIA MENINGITIDIS ORF2086 ANTIGENS | WYETH LLC |
EP3549936 | 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUND AND ITS USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASE | PTC THERAPEUTICS INC |
EP3549941 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO LTD |
EP3549943 | SALT COMPRISING SILICON-CONTAINING PHOSPHATE ANION, AND LUBRICANT | NISSHINBO HOLDINGS INC |
EP3549944 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | SAMSUNG ELECTRONICS CO LTD |
EP3550362 | COMPOUND, COMPOSITION FOR FORMING ORGANIC FILM, SUBSTRATE FOR MANUFACTURING SEMICONDUCTOR APPARATUS, METHOD FOR FORMING ORGANIC FILM, AND PATTERNING PROCESS | SHINETSU CHEMICAL CO |
EP3551209 | INSULIN-FC FUSIONS AND METHODS OF USE | AKSTON BIOSCIENCES CORP |
EP3551221 | NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME | IMMATICS BIOTECHNOLOGIES GMBH |
EP3551598 | PROCESS FOR SELECTIVE ETHYLENE OLIGOMERIZATION WITH ANTIFOULING COMPONENTS | SAUDI ARABIAN OIL CO |
EP3551605 | PROCESS FOR PRODUCING (METH)ACRYLIC ESTERS | ARKEMA FRANCE |
EP3551610 | BICYCLO[1.1.1]PENTANE INHIBITORS OF DUAL LEUCINE ZIPPER (DLK) KINASE FOR THE TREATMENT OF DISEASE | UNIV TEXAS |
EP3551614 | DIMERIC CONTRAST AGENTS | BRACCO IMAGING SPA |
EP3551617 | COMPOSITIONS AND METHODS RELATED TO PYRIDINOYLPIPERIDINE 5-HT1F AGONISTS | COLUCID PHARMACEUTICALS INC |
EP3551623 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM & HAAS ELECT MATERIALS KOREA LTD |
EP3551633 | SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | LEO PHARMA AS |
EP3551634 | SUBSTITUTED PYRAZOLOAZEPIN-8-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | LEO PHARMA AS |
EP3551635 | THIENO-INDENO-MONOMERS AND POLYMERS | BASF SE |
EP3551652 | GLP-1/GLP-2 DUAL AGONISTS | ZEALAND PHARMA AS |
EP3551664 | ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127 | OSE IMMUNOTHERAPEUTICS |
EP3553046 | PRODUCTION METHOD FOR N ( HYDROXYETHYL) FORMAMIDE, PRODUCTION METHOD FOR N ( ALKOXYETHYL) FORMAMIDE, PRODUCTION DEVICE FOR N ( HYDROXYETHYL) FORMAMIDE, AND PRODUCTION DEVICE FOR N ( ALKOXYETHYL) FORMAMIDE | MITSUBISHI CHEM CORP |
EP3553047 | METHOD FOR PURIFYING N-( -ALKOXYETHYL)FORMAMIDE, METHOD FOR PRODUCING HIGH-PURITY N-( -ALKOXYETHYL)FORMAMIDE, AND DEVICE FOR PURIFYING N-( -ALKOXYETHYL)FORMAMIDE | MITSUBISHI CHEM CORP |
EP3553066 | GLYCOLURIL RING-CONTAINING ORGANOSILICON COMPOUND AND MAKING METHOD | SHINETSU CHEMICAL CO |
EP3553068 | HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS, POLYURETHANE FOAM AND ARTICLES MADE THEREFROM | ICL IP AMERICA INC |
EP3553205 | METHOD AND DEVICE FOR PRODUCING OXIDATION PRODUCTS | FORSCHUNGSZENTRUM JUELICH GMBH |
EP3555035 | INITIATOR SYSTEM FOR CATIONIC POLYMERIZATION OF OLEFINS | ARLANXEO CANADA INC |
EP3555042 | PROCESS FOR PREPARATION OF ISOPROTERENOL HYDROCHLORIDE | EMCURE PHARMACEUTICALS LTD |
EP3555043 | PROCESS FOR MANUFACTURING HYDROXYETHYL ETHYLENE AMINES | NOURYON CHEMICALS INT BV |
EP3555048 | NEW PICOLINIC ACID DERIVATIVES AND THEIR USE AS INTERMEDIATES | NOVARTIS AG |
EP3555053 | HERBICIDAL PHENYLTRIAZOLINONES | BASF SE |
EP3555083 | PESTICIDALLY ACTIVE AZETIDINE SULFONES AMIDE ISOXAZOLINE DERIVATIVES | SYNGENTA PARTICIPATIONS AG |
EP3555086 | 1,4-THIAZINE DIOXIDE AND 1,2,4-THIADIAZINE DIOXIDE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND METHODS OF USE | AMGEN INC |
EP3555099 | PROCESS FOR PREPARING BTK INHIBITORS | HOFFMANN LA ROCHE |
EP3555102 | HERBICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG |
EP3555107 | PROCESS FOR THE PREPARATION OF (S)-2-((2-((S)-4-(DIFLUOROMETHYL)-2-OXOOXAZOLIDIN-3-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)AMINO) PROPANAMIDE | HOFFMANN LA ROCHE |
EP3555110 | DENTAL COMPOSITION | DENTSPLY DETREY GMBH |
EP3555118 | INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE | PIONEER HI BRED INT |
EP3555139 | IMMUNE CELLS EXPRESSING AN ANTIGEN BINDING RECEPTOR AND A CHIMERIC COSTIMULATORY RECEPTOR | MILTENYI BIOTEC GMBH |
EP3555284 | COMPOSITIONS AND METHODS USING CAS9 WITH ENHANCED SPACER ACQUISITION FUNCTION | UNIV ROCKEFELLER |
EP3555325 | SEPARATION OF RARE EARTH METALS | UNIV BELFAST |
EP3556205 | HUMANIZED MOUSE MODEL | AUSTRIA DEBRA |
EP3556206 | GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF | REGENERON PHARMA |
EP3556742 | 1-HALOALKADIENE AND PROCESS FOR PREPARING THE SAME AND A PROCESS FOR PREPARING (9E,11Z)-9,11-HEXADECADIENYL ACETATE | SHINETSU CHEMICAL CO |
EP3556750 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT INCLUDING SAME | LG CHEMICAL LTD |
EP3556761 | PYRROLO-AROMATIC HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF | THE NATIONAL INSTITUTES OF PHARMACEUTICAL RES |
EP3556777 | MULTISPECIFIC ANTIBODY CONSTRUCTS | UCB BIOPHARMA SPRL |
EP3556790 | LOW VISCOSITY CROSSLINKERS CONTAINING ALKOXYSILANE GROUPS | EVONIK DEGUSSA GMBH |
EP3556857 | CDC45L PEPTIDES AND VACCINES INCLUDING THE SAME | ONCOTHERAPY SCIENCE INC |
EP3557254 | PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF | VIB VZW |
EP3557255 | PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF | VIB VZW |
EP3558213 | LILY OF THE VALLEY ODORANT | FIRMENICH & CIE |
EP3558300 | SOLID PHARMACEUTICAL FORMULATIONS OF ASIMADOLINE | TIOGA PHARMACEUTICALS INC |
EP3558396 | DIFFERENTIAL DIAGNOSIS OF PARKINSON'S DISEASE | GE HEALTHCARE LTD |
EP3558907 | PROCESS TO PREPARE PROPYLENE | GASOLFIN B V |
EP3558909 | PARALLEL REACTOR SYSTEM FOR ETHYLBENZENE DEHYDROGENATION | FINA TECHNOLOGY |
EP3558911 | PROCESS AND PLANT FOR PRODUCING OLEFINS | LINDE AG |
EP3558916 | METHOD FOR MANUFACTURING OF BISPHENOL A | SABIC GLOBAL TECHNOLOGIES BV |
EP3558918 | METHOD FOR DECREASING THE CONCENTRATION OF A METAL IN A MONOMER COMPOSITION COMPRISING BIS(BENZOYL)BENZENE | SOLVAY SPECIALTY POLYMERS USA |
EP3558926 | METHOD OF PRODUCING DIAMINES AND POLYAMINES OF THE DIPHENYLMETHANE SERIES | COVESTRO DEUTSCHLAND AG |
EP3558927 | METHOD OF PRODUCING DIAMINES AND POLYAMINES OF THE DIPHENYLMETHANE SERIES | COVESTRO DEUTSCHLAND AG |
EP3558928 | METHOD OF PRODUCING DIAMINES AND POLYAMINES OF THE DIPHENYLMETHANE SERIES AT DIFFERENT PRODUCTION CAPACITIES | COVESTRO DEUTSCHLAND AG |
EP3558929 | METHOD OF PRODUCING DIAMINES AND POLYAMINES OF THE DIPHENYLMETHANE SERIES AT DIFFERENT PRODUCTION CAPACITIES | COVESTRO DEUTSCHLAND AG |
EP3558930 | NEW PROCESS FOR EARLY SACUBITRIL INTERMEDIATES | NOVARTIS AG |
EP3558940 | PROCESS FOR PREPARING AN ISOCYANATE | COVESTRO DEUTSCHLAND AG |
EP3558945 | PROCESS FOR THE PREPARATION OF A 2-PYRIDYLETHYLCARBOXAMIDE DERIVATIVE | BAYER CROPSCIENCE AG |
EP3558951 | METHOD FOR THE MANUFACTURING OF DELMOPINOL | LUNDBECK PHARMACEUTICALS ITALY S P A |
EP3558953 | METHOD FOR THE MANUFACTURING OF 2-(3-(ALKYL AND ALKENYL)MORPHOLINO)-ETHAN-1-OLS | LUNDBECK PHARMACEUTICALS ITALY S P A |
EP3558954 | IMPROVED PROCESS FOR THE MANUFACTURE OF R-6-HYDROXY-8-[1-HYDROXY-2-[2-(4-METHOXYPHENYL)-1,1-DIMETHYLETHYLAMINOETHYL]-2H-1,4-BENZOXAZIN-3(4H)-ONE HYDROCHLORIDE | INKE SA |
EP3558961 | POLYMORPHS | SYNGENTA PARTICIPATIONS AG |
EP3558968 | IMIDAZOPYRAZINE INHIBITORS OF BRUTON'S TYROSINE KINASE | ACERTA PHARMA BV |
EP3558979 | NOVEL BENZYLAMINO SUBSTITUTED QUINAZOLINES AND DERIVATIVES AS SOS1 INHIBITORS | BOEHRINGER INGELHEIM INT |
EP3558989 | TRIAZOLO[1,5-A]PYRIDINE DERIVATIVES AS IMMUNOMODULATORS | INCYTE CORP |
EP3558997 | AMINO-TRIAZOLOPYRIDINE COMPOUNDS AND THEIR USE IN TREATING CANCER | ASTRAZENECA AB |
EP3559009 | COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY | CALITHERA BIOSCIENCES INC |
EP3559022 | VIRULENCE ATTENUATED BACTERIA BASED PROTEIN DELIVERY | UNIV BASEL |
EP3559023 | A MULTI-EPITOPE DNA VACCINE FOR HEARTWATER | AGRICULTURAL RESEARCH COUNCIL |
EP3559155 | PROCESS FOR STEAM CRACKING HYDROCARBONS | EXXONMOBIL CHEMICAL PATENTS INC |
EP3559170 | INTEGRATED PROCESS FOR THE PRODUCTION OF BENZENE AND XYLENES FROM HEAVY AROMATICS | SAUDI ARABIAN OIL CO |
EP3559248 | IN VITRO GLYCOENGINEERING OF ANTIBODIES | HOFFMANN LA ROCHE |
EP3560493 | OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS | CORCEPT THERAPEUTICS INC |
EP3560909 | PRODUCTION METHOD FOR HIGH-QUALITY ADIPIC ACID | HENAN SHENMA NYLON CHEMICAL CO LTD |
EP3560911 | PROCESS FOR CONVERTING S-ENANTIOMER TO ITS RACEMIC FORM | FMC CORP |
EP3560915 | POLYPEPTIDES HAVING OXIDOREDUCTASE ACTIVITY AND THEIR USES | PURAC BIOCHEM BV |
EP3560924 | IMIDAZOLONYL QUINOLINES AND THEIR USE AS ATM KINASE INHIBITORS | MERCK PATENT GMBH |
EP3560928 | FUSED IMIDAZOLE COMPOUND HAVING INDOLEAMINE 2,3-DIOXYGENASE INHIBITORY ACTIVITY | SHENZHEN CHIPSCREEN BIOSCIENCES CO LTD |
EP3560939 | METHOD FOR PRODUCING CYCLOMETALATED IRIDIUM COMPLEX | AIST |
EP3560941 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOUND INCLUDING THE ORGANOMETALLIC COMPOUND | SAMSUNG ELECTRONICS CO LTD |
EP3560954 | MODIFIED J-CHAIN | IGM BIOSCIENCES INC |
EP3561061 | NOVEL L-TRYPTOPHAN EXPORT PROTEIN AND METHOD FOR PRODUCING L-TRYPTOPHAN USING SAME | CJ CHEILJEDANG CORP |
EP3562573 | PURIFIED TEREPHTHALIC ACID (PTA) VENT DRYER VAPOR EFFLUENT TREATMENT | BP CORP NORTH AMERICA INC |
EP3562797 | NEW GENERATION PRIMARY EXPLOSIVE | ATILIM UNIV |
EP3562802 | RESIN WITH PROMOTER AND ANTIOXIDANT | DOW GLOBAL TECHNOLOGIES LLC |
EP3562804 | PURIFIED TEREPHTHALIC ACID (PTA) VENT STEAM UTILIZATION | BP CORP NORTH AMERICA INC |
EP3562809 | PYRAZOLOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF | HOFFMANN LA ROCHE |
EP3562815 | A CATALYST COMPOSITION FOR A PRODUCTION PROCESS OF - LACTONE FROM CARBON DIOXIDE AND 1,3-BUTADIENE | PTT GLOBAL CHEMICAL PUBLIC CO LTD |
EP3562816 | NRF2 ACTIVATOR | BIOGEN MA INC |
EP3562822 | POLY-ADP RIBOSE POLYMERASE (PARP) INHIBITORS | MITOBRIDGE INC |
EP3562829 | CATALYSIS OF DEHYDROCOUPLING REACTIONS BETWEEN AMINES AND SILANES | DOW SILICONES CORP |
EP3562831 | CATALYSTS | BOREALIS AG |
EP3562832 | REVERSIBLY PROTECTED NUCLEOTIDE REAGENTS WITH HIGH THERMAL STABILITY | ROCHE DIAGNOSTICS GMBH |
EP3563111 | GREEN PRIMARY EXPLOSIVE | ATILIM UNIV |
EP3563916 | METHOD AND DEVICE FOR INVERSE SEPARATION OF AROMATICS | AXENS |
EP3564207 | METHOD FOR PRODUCING ALCOHOL COMPOUND | KANEKA CORP |
EP3564208 | METHOD FOR PREPARING 2-(CYCLOHEXENYLENE) MALONIC ACID DERIVATIVE AND USE THEREOF | ORIENTAL LUZHOU AGROCHEMICALS CO LTD |
EP3564212 | METHOD FOR PRODUCING ALIPHATIC ISOCYANATE | HANWHA CHEMICAL CORP |
EP3564218 | METHOD FOR PREPARING 1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID | VIWIT PHARMACEUTICAL CO LTD |
EP3564219 | PROCESS FOR PREPARING OXADIAZACYCLO COMPOUND AND USE THEREOF | ORIENTAL LUZHOU AGROCHEMICALS CO LTD |
EP3564224 | CRYSTALLINE FORM OF VORTIOXETINE HYDROBROMIDE AS ANTIDEPRESSANT DRUG | DIPHARMA FRANCIS SRL |
EP3564226 | METHOD FOR PRODUCING GLYCERIC ACID ESTER | KAO CORP |
EP3564246 | A GOLD(III) COMPLEX, A CONJUGATE OF THE GOLD(III) COMPLEX, A PHARMACEUTICAL COMPOSITION COMPRISING THE GOLD(III) COMPLEX AND USES AND A PROCESS FOR PREPARING THE GOLD(III) COMPLEX | UNIV ALMERIA |
EP3564249 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | LG CHEMICAL LTD |
EP3564252 | MODIFIED NUCLEOTIDE LINKERS | ILLUMINA CAMBRIDGE LTD |
EP3564258 | FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN | SQUIBB BRISTOL MYERS CO |
EP3564264 | VACCINE COMPOSITION COMPRISING A MUTATION OF HUMAN INTERLEUKIN-15 | CT INGENIERIA GENETICA BIOTECNOLOGIA |
EP3564267 | PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC ACTIVITY | CSL BEHRING GMBH |
EP3564674 | HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE | VENTANA MED SYST INC |
EP3565801 | CONVERSION OF WASTE PLASTIC TO PROPYLENE AND CUMENE | SABIC GLOBAL TECHNOLOGIES BV |
EP3565805 | SYNTHESIS OF BENZYLANILINYL PHENYL PHENOL LIGANDS | UNIVATION TECH LLC |
EP3565807 | OXADIAZOLE INHIBITORS OF HIPK2 FOR TREATING KIDNEY FIBROSIS | ICAHN SCHOOL MED MOUNT SINAI |
EP3565821 | SYNTHESIS OF BENZYLOXYPHENOXY PHENOL LIGANDS | UNIVATION TECH LLC |
EP3565826 | USE OF THE CPCR REGULATOR GENE FOR OBTAINING NEW RECOMBINANT STRAINS OF BACILLUS THURINGIENSIS WITH REDUCED SPORULATION CAPACITY | AGRONOMIQUE INST NAT RECH |
EP3565828 | A SIRP1 ALPHA-41BBL FUSION PROTEIN AND METHODS OF USE THEREOF | KAHR MEDICAL LTD |
EP3565830 | COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-MESOTHELIN IMMUNOTHERAPY | LENTIGEN TECH INC |
EP3566703 | PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL)METHANOL | ALLERGAN INC |
EP3566706 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | AGIOS PHARMACEUTICALS INC |
EP3567026 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | LG CHEMICAL LTD |
EP3567042 | CDK INHIBITORS | G1 THERAPEUTICS INC |
EP3568387 | PROCESS FOR THE CONVERSION OF ETHYLENE GLYCOL TO ETHYLENEDIAMINE EMPLOYING A ZEOLITE CATALYST | BASF SE |
EP3568389 | PROCESS FOR THE PURIFICATION OF CAPROLACTAM FROM A SOLUTION OF CRUDE CAPROLACTAM WITHOUT ORGANIC SOLVENT EXTRACTION | AQUAFILSLO D O O |
EP3568392 | HETEROCYCLENE DERIVATIVES AS PEST CONTROL AGENTS | BAYER AG |
EP3568403 | CHEMICAL COMPOUNDS FOR COATING OF NANOSTRUCTURES | SPAGO NANOMEDICAL AB |
EP3569616 | MONOCLONAL ANTIBODY RESISTING AGAINST PD-1 AND APPLICATIONS THEREOF | TAIZHOU HANZHONG BIOPHARMACEUTICS INC |
EP3569619 | CD123 SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY | CELLECTIS |
EP3570882 | NOVEL STABLE FORMULATION FOR FXIA ANTIBODIES | BAYER PHARMA AG |
EP3571178 | MULTIPLE-STAGE CATALYST SYSTEM FOR SELF-METATHESIS WITH CONTROLLED ISOMERIZATION AND CRACKING | SAUDI ARABIAN OIL CO |
EP3571193 | POTASSIUM CHANNEL MODULATORS | CADENT THERAPEUTICS INC |
EP3571208 | IMMUNOPROTEASOME INHIBITORS | PRINCIPIA BIOPHARMA INC |
EP3571238 | POLYOL BLENDS USEFUL FOR PRODUCING VISCOELASTIC FOAM | DOW GLOBAL TECHNOLOGIES LLC |
EP3572397 | METHOD FOR PRODUCING N-( -HYDROXYETHYL)FORMAMIDE AND METHOD FOR PRODUCING N-VINYLFORMAMIDE | MITSUBISHI CHEM CORP |
EP3572401 | ASK1 INHIBITOR AND PREPARATION METHOD AND USE THEREOF | FUJIAN COSUNTER PHARMACEUTICAL CO LTD |
EP3572408 | METHOD FOR PURIFYING AN AMINO ACID-N-CARBOXY ANHYDRIDE | SHINETSU CHEMICAL CO |
EP3572412 | PYRIDINE DERIVATIVE AS ASK1 INHIBITOR AND PREPARATION METHOD AND USE THEREOF | FUJIAN COSUNTER PHARMACEUTICAL CO LTD |
EP3572413 | 1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONE DERIVATIVE AS WEE1 INHIBITOR | SHIJIAZHUANG SAGACITY NEW DRUG DEV CO LTD |
EP3572421 | PEPTIDE, COMPLEX OF PEPTIDE AND SIRNA AND USE THEREOF | POSITEC POWER TOOLS SUZHOU CO LTD |
EP3572515 | GLYCOPROTEIN HORMONE LONG-ACTING SUPERAGONISTS | TROPHOGEN INC |
EP3572517 | HUMANIZED UNIVERSAL LIGHT CHAIN MICE | REGENERON PHARMA |
EP3572876 | MONOMER, POLYMER, NEGATIVE RESIST COMPOSITION, PHOTOMASK BLANK, AND RESIST PATTERN FORMING PROCESS | SHINETSU CHEMICAL CO |
EP3573942 | TRANSALKYLATION PROCESS AND CATALYST COMPOSITION USED THEREIN | EXXONMOBIL CHEMICAL PATENTS INC |
EP3573943 | METHOD FOR OBTAINING PURE 1,3-BUTADIENE | BASF SE |
EP3573949 | PROCESS FOR THE CONVERSION OF MONOETHANOLAMINE TO ETHYLENEDIAMINE EMPLOYING A NANOCRYSTALLINE ZEOLITE OF THE MOR FRAMEWORK STRUCTURE | BASF SE |
EP3573950 | PROCESS FOR THE PREPARATION OF STABLE TOLUENE DIAMINE RESIDUE/WATER BLENDS, RELATED COMPOSITIONS, AND METHODS OF USING SUCH BLENDS AS A FUEL | COVESTRO LLC |
EP3573963 | NRF2 ACTIVATOR | BIOGEN MA INC |
EP3573986 | BICYCLIC BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION | UCB BIOPHARMA SPRL |
EP3574005 | CD28 COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTOR THERAPY | NOVARTIS AG |
EP3575296 | TRIAZINE COMPOUND, COMPOSITION AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO LTD |
EP3575307 | CARBONATE-CONTAINING SILANE COMPOUND AND MAKING METHOD | SHINETSU CHEMICAL CO |
EP3575377 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | CYNORA GMBH |
EP3575798 | PROTEOLYTIC DIGESTION OF CARDIAC TROPONIN I | SIEMENS HEALTHCARE DIAGNOSTICS INC |
EP3576120 | NITRILE-SUBSTITUTED SILANES AND ELECTROLYTE COMPOSITIONS AND ELECTROCHEMICAL DEVICES CONTAINING THEM | SILATRONIX INC |
EP3577097 | WASTE STREAM UPGRADING IN A PROPYLENE OXIDE/STYRENE COPRODUCTION PROCESS | LYONDELL CHEMICAL TECH LP |
EP3577098 | MIXTURE FOR USE AS A LIQUID SORPTION AGENT IN METHANOL SYNTHESIS AND METHANOL SYNTHESIS PROCESS USING SAID MIXTURE | SIEMENS AG |
EP3577101 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH |
EP3577105 | PRODUCTION OF N-SUBSTITUTED AROMATIC HYDROXYLAMINE | SOLVIAS AG |
EP3577114 | PROCESS FOR PREPARING HALOGENATED IMIDAZOPYRIDINE DERIVATIVES | BAYER AG |
EP3578256 | ANTIFOULING OLIGOMERIZATION CATALYST SYSTEMS | SAUDI ARABIAN OIL CO |
EP3578537 | METHOD FOR PRODUCING GAMMA,DELTA-UNSATURATED ALCOHOL | KURARAY CO |
EP3578547 | SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME | UNIV QUEENSLAND |
EP3578558 | HIGHLY EFFECTIVE PHOTOPROTECTIVE AGENTS | 3V SIGMA SPA |
EP3578559 | DYE FOR FLUORESCENT STAINING OF STRATUM CORNEUM, MANNER OF ITS SYNTHESIS AND APPLICATION IN MICROSCOPY, INCLUDING IDENTIFICATION OF ROUTES OF SUBSTANCES PENETRATION TO THE SKIN AND ASSESSMENT OF STRUCTURAL DISORDERS OF THIS LAYER | GDANSKI UNIV MEDYCZNY |
EP3578560 | QUINAZOLINE COMPOUND | ASTELLAS PHARMA INC |
EP3578564 | NOVEL HETEROLEPTIC IRIDIUM COMPLEXES | UNIVERSAL DISPLAY CORP |
EP3578587 | NOVEL COMPOUND HEXADECAPHLORETHOL ISOLATED FROM ISHIGE OKAMURAE AND USE THEREOF | JEJU NATIONAL UNIV INDUSTRY ACADEMIC COOPERATION FOUNDATION |
EP3580190 | IN VIVO STABLE HG-197(M) COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF IN NUCLEAR MEDICAL DIAGNOSTICS AND ENDORADIONUCLIDE THERAPY (THERANOSTICS) | HELMHOLTZ ZENTRUM DRESDEN |
EP3580205 | PROCESS FOR THE PREPARATION OF CYCLOPROPYLDIKETOPIPERAZINES AND OF A KEY INTERMEDIATE OF DS-5272 | FIS FABBRICA ITALIANA SINTETICI SPA |
EP3580206 | PROCESS FOR PREPARING D-GLUCARO-6,3-LACTONE | BASF SE |
EP3580208 | NOVEL HETEROCYCLIC COMPOUND, ITS PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | DAE WOONG PHARMA |
EP3580214 | GERMINATION PROMOTERS | SYNGENTA PARTICIPATIONS AG |
EP3580222 | INDANYLAMINOAZADIHYDROBENZOFURANYLACETIC ACIDS, PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DIABETES | BOEHRINGER INGELHEIM INT |
EP3580228 | MODIFIED NANOPORES, COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF | OXFORD NANOPORE TECH LTD |
EP3581555 | NOVEL SODIUM DIACETATE CRYSTAL AND SOLID DIALYSIS PREPARATION COMPRISING SAID CRYSTAL | FUSO PHARMACEUTICAL IND |
EP3581570 | CARBAZOLE-PYRIDINE-TRIFLUOROMETHYLPHENYL DERIVATIVES AND RELATED COMPOUNDS FOR USE AS TADF LUMINESCENT EMITTERS IN OLEDS | CYNORA GMBH |
EP3581582 | PHARMACEUTICAL COMPOUND | VALLAURIX PTE LTD |
EP3581594 | COMPOUND, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL CO |
EP3582780 | AMINO PYRIMIDINE COMPOUNDS USEFUL AS SSAO INHIBITORS | LILLY CO ELI |
EP3583087 | PROCESS FOR RECOVERY OF LIGHT ALKYL MONO-AROMATIC COMPOUNDS FROM HEAVY ALKYL AROMATIC AND ALKYL-BRIDGED NON-CONDENSED ALKYL AROMATIC COMPOUNDS | SAUDI ARABIAN OIL CO |
EP3583089 | METHOD AND DEVICE FOR CONVERTING CARBON DIOXIDE INTO METHANOL | SIEMENS AG |
EP3583092 | COMPOUNDS FOR OPTICALLY ACTIVE DEVICES | MERCK PATENT GMBH |
EP3583093 | PROCESS FOR PREPARING SUBSTITUTED BIPHENYLS | BASF SE |
EP3583094 | PROCESS FOR THE PREPARATION OF 2-CYANOIMIDAZOLE COMPOUNDS | ADAMA MAKHTESHIM LTD |
EP3583100 | COMPOUNDS CONTAINING SI ATOMS FOR OPTICALLY ACTIVE DEVICES | MERCK PATENT GMBH |
EP3583104 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH |
EP3583129 | CD70 BINDING MOLECULES AND METHODS OF USE THEREOF | KITE PHARMA INC |
EP3584248 | CYCLIC AMINOORGANOXYSILANE COMPOUND AND PROCESS FOR PRODUCING THE SAME | SHINETSU CHEMICAL CO |
EP3584250 | BIS(DIAZADIENE)COBALT COMPOUNDS, METHOD OF MAKING AND METHOD OF USE THEREOF | VERSUM MAT US LLC |
EP3584252 | HUMAN IMMUNODEFICIENCY VIRUS ANTIGENS, VECTORS, COMPOSITIONS, AND METHODS OF USE THEREOF | JANSSEN VACCINES & PREVENTION BV |
EP3585763 | PROCESS FOR METHANOL PRODUCTION | CASALE SA |
EP3585764 | PROCESS FOR THE PREPARATION OF UNSATURATED CARBOXYLIC ACIDS BY CARBONYLATION OF ALLYL ALCOHOLS AND THEIR ACYLATION PRODUCTS | BASF SE |
EP3585767 | A PROCESS AND SYSTEM TO CAPTURE AMMONIA FROM A PURGE GAS OF A UREA PLANT | CASALE SA |
EP3585773 | SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE |
EP3585774 | NOVEL SUBSTITUTED SULFOXIMINE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS | MERCK SHARP & DOHME |
EP3585785 | PROCESS FOR THE PREPARATION OF METHYL-4-[(4,5-DIHYDRO-3-METHOXY-4-METHYL-5-OXO-1H-1,2,4-TRIAZOLE-1-YL)CARBONYL)SULPHAMOYL]-5-METHYLTHIOPHENE-3-CARBOXYLATE | BAYER CROPSCIENCE AG |
EP3585808 | MODIFIED SERPINS FOR THE TREATMENT OF BRADYKININ-MEDIATED DISEASE | UMC UTRECHT HOLDING BV |
EP3585873 | PROCESS FOR MAKING SOLID METHYLGLYCINE DIACETATE (MGDA) ALKALI METAL SALT, AND SOLID PARTICLES | BASF SE |
EP3585902 | METHOD FOR THE PREPARATION OF (3E,7E)-HOMOFARNESIC ACID OR (3E,7E)-HOMOFARNESIC ACID ESTER | BASF SE |
EP3587348 | PARTIALLY HYDROGENATED CHLOROSILANES AND METHODS FOR PREPARING SAME BY SELECTIVE HYDROGENATION | EVONIK OPERATIONS GMBH |
EP3587387 | ACETIC ACID PRODUCTION METHOD | DAICEL CORP |
EP3587406 | 2-HYDROXY-1-{4-[(4-PHENYLPHENYL)CARBONYL]PIPERAZIN-1-YL}ETHAN-1-ONE DERIVATIVES AND RELATED COMPOUNDS AS FATTY ACID SYNTHASE (FASN) INHIBITORS FOR THE TREATMENT OF CANCER | FORMA THERAPEUTICS INC |
EP3587411 | PIPERIDINE OR THIOMORPHOLINE LINKED IMIDAZOLE AND TRIAZOLE DERIVATIVES AND USES THEREOF FOR IMPROVING THE PHARMACOKINETICS OF A DRUG | MERCK SHARP & DOHME |
EP3587418 | INHIBITORS OF CREB BINDING PROTEIN (CBP) | FORMA THERAPEUTICS INC |
EP3587425 | ULTRAVIOLET ABSORBING COMPOUND AND APPLICATIONS THEREOF | |
EP3587448 | HETERODIMERIC PROTEINS | XENCOR INC |
EP3587534 | THERMOCHROMIC COLOR MEMORIZING COMPOSITION AND THERMOCHROMIC COLOR MEMORIZING MICROCAPSULE PIGMENT ENCLOSING SAME | PILOT INK CO LTD |
EP3589607 | A PROCESS FOR PRODUCING FLUTEMETAMOL | GE HEALTHCARE LTD |
EP3589608 | PROCESS FOR PREPARING AN UNSATURATED ALCOHOL | BASF SE |
EP3589609 | PROCESS FOR THE PRODUCTION OF ALLYL COMPOUNDS BY DEOXYDEHYDRATION OF GLYCEROL | UNIV LIEGE |
EP3589611 | EFFICIENT SCALABLE SYNTHESES OF ABSCISIC ACID, 8'-ACETYLENE ABSCISIC ACID AND 8'-CYCLOPROPYL ABSCISIC ACID | NAT RES COUNCIL CANADA |
EP3589612 | METHOD FOR THE PRODUCTION OF FLUOROALKYL NITRILES AND OF THE CORRESPONDING FLUOROALKYL TETRAZOLES | BAYER CROPSCIENCE AG |
EP3589615 | PYRIDYL DERIVATIVES AS BROMODOMAIN INHIBITORS | GLAXOSMITHKLINE IP NO 2 LTD |
EP3589622 | METHOD FOR PREPARING 3,7-BIS(DIMETHYLAMINO)PHENOTHIAZIN-5-YLIUM IODIDE | PROVEPHARM LIFE SOLUTIONS |
EP3589625 | ISOQUINOLIN AND NAPHTHYDRIN COMPOUNDS | LILLY CO ELI |
EP3589630 | CYCLIC SULFAMIDE COMPOUNDS AND METHODS OF USING SAME | ASSEMBLY BIOSCIENCES INC |
EP3589631 | IMIDAZO[4,5-c]RING COMPOUNDS CONTAINING GUANIDINE SUBSTITUTED BENZAMIDE GROUPS | 3M INNOVATIVE PROPERTIES CO |
EP3590517 | HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS | CORCEPT THERAPEUTICS INC |
EP3590530 | ANTIGEN-SPECIFIC T CELL RECEPTORS AND T CELL EPITOPES | BIONTECH CELL & GENE THERAPIES GMBH |
EP3590917 | METHOD FOR THE PREPARATION OF DIALKYLDICARBONATES BY AMINE OXIDES | LANXESS DEUTSCHLAND GMBH |
EP3590934 | PYRAZOLYL QUINOXALINE KINASE INHIBITORS | ASTEX THERAPEUTICS LTD |
EP3590936 | METHOD FOR PRODUCING HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICALS CO |
EP3590942 | HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR | FUJIAN COSUNTER PHARMACEUTICAL CO LTD |
EP3590946 | METHOD FOR THE PREPARATION OF ALKYLALKOXYSILANES | EVONIK OPERATIONS GMBH |
EP3590947 | METHOD FOR PRODUCING TRANSITION METAL-ISOCYANIDE COMPLEX | UNIV KYUSHU NAT UNIV CORP |
EP3590962 | SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST INTRACELLULAR ANTIGENS | SINGH BIOTECHNOLOGY LLC |
EP3591072 | DETECTION OF IMMUNOGLOBULIN LIGHT CHAIN RESTRICTION BY RNA IN SITU HYBRIDIZATION | ADVANCED CELL DIAGNOSTICS INC |
EP3592452 | PROCESS FOR PREPARING ISOCYANATES | DOW GLOBAL TECHNOLOGIES LLC |
EP3592725 | METHOD OF MAKING ACRYLIC ACID FROM LACTIC ACID OR LACTIDE USING MOLTEN SALT CATALYSTS | PROCTER & GAMBLE |
EP3592729 | CATALYTIC C-X-BOND METATHESIS THROUGH ARYLATION | STUDIENGESELLSCHAFT KOHLE MBH |
EP3592730 | PRODRUGS OF SULFASALAZINE, PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR USE IN THE TREATMENT OF AUTOIMMUNE DISEASE | TRULY TRANSLATIONAL SWEDEN AB |
EP3592733 | 2- OR 3-IMIDAZOLINES AS CARBAPENEMASES INHIBITORS | CENTRE NAT RECH SCIENT |
EP3592734 | AMINE SALT OF (1R,3S)-3-(5-CYANO-4-PHENYL-1,3-THIAZOL-2-YLCARBAMOYL)CYCLOPENTANE CARBOXYLIC ACID | PALOBIOFARMA SL |
EP3592745 | PYRIMIDOPYRIMIDINONES USEFUL AS WEE-1 KINASE INHIBITORS | ALMAC DISCOVERY LTD |
EP3592756 | LINCOSAMIDE DERIVATIVES, PREPARATION AND USE THEREOF AS ANTIMICROBIAL AGENT | MIKROBIOLOGICKY USTAV AV CR V V I |
EP3592760 | METHOD FOR PURIFYING PROTEINS USING SILICATE | LIHME PROTEIN SOLUTIONS APS |
EP3594197 | ACETIC ACID PRODUCTION METHOD | DAICEL CORP |
EP3594203 | SUBSTITUTED PYRROLIDINE COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICALS CO |
EP3594207 | ELECTROCHEMICAL ENERGY STORAGE DEVICES | GENTEX CORP |
EP3594223 | TREATMENT OF BIOFILMS | AMICOAT AS |
EP3594225 | A NOVEL PAENIBACILLUS STRAIN, ANTIFUNGAL COMPOUNDS, AND METHODS FOR THEIR USE | BAYER CROPSCIENCE LP |
EP3594238 | ANTIBODY COMPOSITIONS FOR TUMOR TREATMENT | REGENERON PHARMA |
EP3594262 | BIO-ELECTRODE COMPOSITION, BIO-ELECTRODE, AND METHOD FOR MANUFACTURING A BIO-ELECTRODE | SHINETSU CHEMICAL CO |
EP3594360 | COLORIMETRIC DETECTION OF NUCLEIC ACID AMPLIFICATION | LUCIRA HEALTH INC |
EP3595668 | BENZAZEPINE COMPOUNDS, CONJUGATES, AND USES THEREOF | SILVERBACK THERAPEUTICS INC |
EP3596033 | SIMPLIFIED METHOD FOR OBTAINING PURE 1,3-BUTADIENE | BASF SE |
EP3596039 | PROCESS FOR MANUFACTURING CHAIN-EXTENDED HYDROXYETHYLETHYLENEAMINES, ETHYLENEAMINES, OR MIXTURES THEREOF | NOURYON CHEMICALS INT BV |
EP3596045 | METHOD FOR MANUFACTURING 2-HYDROXY-4-(METHYLTHIO)BUTYRIC ACID | ADISSEO FRANCE SAS |
EP3596054 | 5-CARBOXAMIDE-2-THIOBARBITURIC ACIDS AND USE THEREOF AS MEDICAMENTS | FONDAZIONE ST ITALIANO TECNOLOGIA |
EP3596064 | TOSYLACETATE BASED COMPOUNDS AND DERIVATIVES THEREOF AS PHGDH INHIBITORS | BOEHRINGER INGELHEIM INT |
EP3596091 | CHROMATOGRAPHIC COMPOSITIONS | WATERS TECHNOLOGIES CORP |
EP3596106 | PEPTIDE LIBRARY CONSTRUCTING METHOD | HUNAN ZONSEN PEPLIB BIOTECH CO LTD |
EP3596113 | ANTIGEN RECEPTORS AND USES THEREOF | BIONTECH CELL&GENE THERAPIES GMBH |
EP3596180 | ADHESIVE ARTICLES AND METHODS OF MAKING THE SAME | 3M INNOVATIVE PROPERTIES CO |
EP3596464 | TARGET DETECTION USING A MONOVALENT ANTIBODY | NANOTAG BIOTECHNOLOGIES GMBH |
EP3597037 | HUMANIZED NON-HUMAN ANIMALS WITH RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN LOCI | REGENERON PHARMA |
EP3597038 | HUMANIZED RODENTS THAT EXPRESS HEAVY CHAINS CONTAINING VL DOMAINS | REGENERON PHARMA |
EP3597186 | MYC G-QUADRUPLEX STABILIZING SMALL MOLECULES AND THEIR USE | US HEALTH |
EP3597210 | USE OF AMINO ACID SEQUENCES FROM MYCOBACTERIUM TUBERCULOSIS OR CORRESPONDING NUCLEIC ACIDS THEREOF FOR DIAGNOSIS AND PREVENTION OF TUBERCULAR INFECTION, DIAGNOSTIC KIT AND VACCINE THEREFROM | CELLESTIS LTD |
EP3597630 | DISSIMILAR-METAL SALT ASSEMBLY WHICH IS DENDRIMER HAVING FOUR OR MORE TYPES OF DISSIMILAR-METAL SALT COMPOUNDS PRECISELY INTEGRATED THEREIN, AND PRODUCTION METHOD FOR SUBNANO METAL PARTICLES | TOKYO INST TECH |
EP3597641 | LOW-ENERGY CONSUMPTION PROCESS WITH REDUCED AMMONIA CONSUMPTION, FOR THE PRODUCTION OF HIGH-PURITY MELAMINE THROUGH THE PYROLYSIS OF UREA, AND RELATIVE PLANT | EUROTECNICA MELAMINE LUXEMBOURG ZWEIGNIEDERLASSUNG IN ITTIGEN |
EP3597644 | AMINE CATIONIC LIPIDS AND USES THEREOF | DICERNA PHARMACEUTICALS INC |
EP3597649 | SUBSTITUTED [1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL COMPOUNDS AS PDE2 INHIBITORS | DART NEUROSCIENCE CAYMAN LTD |
EP3597657 | UNIVERSAL TAGS WITH NON-NATURAL NUCLEOBASES | SIEMENS HEALTHCARE DIAGNOSTICS INC |
EP3598868 | NEW POLYIMINO KETOALDEHYDES | NOVUM SPERO LTD |
EP3599231 | ACETIC ACID PRODUCTION METHOD | DAICEL CORP |
EP3599234 | STEREOSELECTIVE PROCESS | BOEHRINGER INGELHEIM INT |
EP3599237 | PHARMACEUTICAL COMPOSITION OF THE GLUCOSYLCERAMIDE SYNTHASE INHIBITOR ELIGLUSTAT FOR THE TREATMENT GAUCHER'S DISEASE COMPRISING ADJUSTING THE INDIVIDUAL THERAPEUTICAL DOSE TO THE P450 METABOLISM OF THE PATIENT | GENZYME CORP |
EP3599244 | COMPOSITION FOR PROTEIN DETECTION | ACQUASCIENCE LTD |
EP3601203 | PROCESS FOR SYNTHESIZING FLUORINATED CYCLIC ALIPHATIC COMPOUNDS | UNIV MUENSTER WESTFAELISCHE WILHELMS |
EP3601206 | PROCESS FOR PREPARING AN ANTICORROSION COMPONENT FOR AN ANTIFREEZE | BASF SE |
EP3601211 | CATALYTIC PROCESS FOR SYNTHESIZING N,N-DIMETHYL GLUCAMINE FROM N-METHYL GLUCAMINE | CLARIANT INT LTD |
EP3601218 | NEW METHOD FOR PRODUCING 2-ACRYLAMIDO-2-METHYLPROPANE SULPHONIC ACID | SPCM SA |
EP3601219 | CRYSTALLINE FORM HYDRATED WITH 2-ACRYLAMIDO-2-METHYLPROPANE SULPHONIC ACID | SPCM SA |
EP3601220 | ENHANCED OIL RECOVERY METHOD USING A (CO)POLYMER OF A HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANE SULFONIC ACID | SPCM SA |
EP3601221 | METHOD FOR TREATING A SUSPENSION OF SOLID PARTICLES IN WATER USING A (CO)POLYMER OF A HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANESULFONIC ACID | SPCM SA |
EP3601222 | FRACTURING FLUID COMPRISING A (CO)POLYMER OF A HYDRATED CRYSTALLINE FORM OF 2-ACRYLAMIDO-2-METHYLPROPANE SULPHONIC ACID AND HYDRAULIC FRACTURING METHOD | SPCM SA |
EP3601225 | SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS | JANSSEN PHARMACEUTICALS INC |
EP3601240 | PROCESS FOR MAKING ARYLOMYIN RING ANALOGS | HOFFMANN LA ROCHE |
EP3601243 | NEW CATALYTIC SYSTEM FOR SCALABLE PREPARATION OF INDOXACARB | ADAMA MAKHTESHIM LTD |
EP3601244 | NOVEL IONIC LIQUIDS RESULTING FROM THE ASSOCIATION OF A SPECIFIC CATION AND A SPECIFIC ANION | COMMISSARIAT ENERGIE ATOMIQUE |
EP3601247 | INTEGRATED PROCESS FOR THE PRODUCTION OF FUEL COMPONENTS FROM GLYCERIN | ENI SPA |
EP3601252 | TETRAHYDRATE OF H3 LIGAND, ITS PROCESS OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | BIOPROJET SOC CIV |
EP3601257 | AROMATIC COMPOUNDS | MERCK PATENT GMBH |
EP3601263 | NOVEL PYRIDAZINONE HERBICIDES | FMC CORP |
EP3601266 | SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS | JANSSEN PHARMACEUTICALS INC |
EP3601268 | PROCESS FOR THE PREPARATION OF 6-(CYCLOPROPANEAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE | SQUIBB BRISTOL MYERS CO |
EP3601273 | 4-PIPERIDIN-N-(PYRIMIDIN-4-YL)CHROMAN-7-SULFONAMIDE DERIVATIVES AS SODIUM CHANNEL INHIBITORS | GENENTECH INC |
EP3601281 | CRYSTALLINE FORMS OF 4-(1-(1,1-DI(PYRIDIN-2-YL)ETHYL)-6-(3,5-DIMETHYLISOXAZOL-4-YL)-1H- PYRROLO[3,2-B]PYRIDIN-3-YL)BENZOIC ACID THAT INHIBITS BROMODOMAIN | PLEXXIKON INC |
EP3601282 | NOVEL PYRIDO[2,3-B]INDOLE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | HOFFMANN LA ROCHE |
EP3601287 | 2,6-DISUBSTITUTED-9-CYCLOPENTYL-9H-PURINES, USE THEREOF AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS | UNIV PALACKEHO |
EP3601288 | ISOMERICALLY PURE 18F-LABELLED TETRAHYDROFOLATES | MERCK PATENT GMBH |
EP3601290 | 11,13-MODIFIED SAXITOXINS FOR THE TREATMENT OF PAIN | SITEONE THERAPEUTICS INC |
EP3601295 | PROCESS FOR PREPARING 2-EXO-(2-METHYLBENZYLOXY)-1-METHYL-4-ISOPROPYL-7-OXABICYCLO[2.2.1]HEPTANE | BASF AGRO BV |
EP3601298 | PROCESS FOR PREPARING CHIRAL 2,3-DIHYDROTHIAZOLO[3,2-A]PYRIMIDIN-4-IUM COMPOUNDS | BASF SE |
EP3601304 | METAL COMPLEXES | MERCK PATENT GMBH |
EP3601305 | PROCESS FOR PRODUCING ISOPROPYLIDENE BIS(CYCLOPENTADIENYL)ZIRCONIUM DICHLORIDE | LANXESS ORGANOMETALLICS GMBH |
EP3601310 | UNYLINKER RAPID CLEAVAGE | ROCHE INNOVATION CT COPENHAGEN AS |
EP3601347 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING PROSTATE CANCER USING PROGASTRIN BINDING MOLECULE | PROGASTRINE ET CANCERS S A R L |
EP3604263 | METHOD FOR THE SYNTHESIS OF 9,10-BIS(CHLOROMETHYL)ANTHRACENE | UNIV CASTILLA LA MANCHA |
EP3604265 | METHOD FOR PRODUCING cis,cis-1,2,4-CYCLOHEXANE TRICARBOXYLIC ACID CRYSTAL | MITSUBISHI GAS CHEMICAL CO |
EP3604266 | ACETIC ACID PRODUCTION METHOD | DAICEL CORP |
EP3604272 | PROCESS FOR THE PREPARATION OF GABAPENTIN | DIVIS LABORATORIES LTD |
EP3604278 | PROCESS FOR THE PURIFICATION OF ACROLEIN | EVONIK OPERATIONS GMBH |
EP3604280 | NMP DISTILLING APPARATUS | MITSUBISHI CHEM ENG CORP |
EP3604296 | ORGANIC LIGHT EMITTING ELEMENT AND COMPOSITION FOR ORGANIC MATERIAL LAYER IN ORGANIC LIGHT EMITTING ELEMENT | HEESUNG MAT LTD |
EP3604317 | POLYFLUOROALKYL PHOSPHORIC ACID ESTER OR SALT THEREOF, AND RELEASE AGENT HAVING SAME AS ACTIVE INGREDIENT | UNIMATEC CO LTD |
EP3604333 | PROTEINS COMPRISING AMINO-TERMINAL PROXIMAL SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS AND CELL-TARGETING IMMUNOGLOBULIN-TYPE BINDING REGIONS CAPABLE OF SPECIFICALLY BINDING CD38 | MOLECULAR TEMPLATES INC |
EP3604339 | THERAPEUTIC ANTIBODIES AGAINST ROR-1 PROTEIN AND METHODS FOR USE OF SAME | UNIV CALIFORNIA |
EP3605631 | ORGANIC SEMICONDUCTOR ELEMENT, ORGANIC SEMICONDUCTOR COMPOSITION, ORGANIC SEMICONDUCTOR FILM PRODUCTION METHOD, ORGANIC SEMICONDUCTOR FILM, AND COMPOUND AND POLYMER USED THEREFOR | FUJIFILM CORP |
EP3606524 | DEUTERATED (S)-2-(4-(PIPERIDIN-3-YL)PHENYL)-2H-INDAZOLE-7-CARBOXAMIDE | COMBIPHOS CATALYSTS INC |
EP3606665 | A METHOD OF SYNTHESISING A PT(II) COMPLEX; A PT(II) COMPLEX; USE OF SUCH A COMPLEX AS A PHOTOACTIVATABLE CATALYST IN A HYDROSILYLATION REACTION | JOHNSON MATTHEY PLC |
EP3606871 | PROCESS FOR THE PRODUCTION OF FORMALDEHYDE-STABILIZED UREA | JOHNSON MATTHEY PLC |
EP3606901 | VETIVER ODORANT | FIRMENICH & CIE |
EP3606902 | VETIVER ODORANT | FIRMENICH & CIE |
EP3606907 | RACEMIC BETA-AMINOSULFONE COMPOUNDS | QUIM SINTETICA S A |
EP3606923 | (+)-ALPHA DIHYDROTETRABENAZINE SUCCINATE SALT | ADEPTIO PHARMACEUTICALS LTD |
EP3606926 | HETEROAROMATIC COMPOUNDS USEFUL IN THERAPY | CUROVIR AB |
EP3606929 | BETA-NICOTINATE ESTER NUCLEOTIDES AND PROCESSES FOR PREPARING SAME | UNIV CORNELL |
EP3606930 | DIHYDROCARBYL-SILYL-BRIDGED-1.3 DISUBSTITUTED-2-INDENYL METALLOCENE COMPLEXES FOR OLEFIN POLYMERIZATION | SABIC GLOBAL TECHNOLOGIES BV |
EP3606932 | INDUSTRIAL-SCALE D-MANNOSE EXTRACTION FROM D-MANNOSE BISULFITE ADDUCTS | BORREGAARD AS |
EP3606936 | RECOVERY PROCESS | NOVOZYMES AS |
EP3606953 | FGFR3 BINDING MOLECULES | COVAGEN AG |
EP3606980 | A PROCESS TO PREPARE A CYCLIC OLIGOMER AND A CYCLIC OLIGOMER OBTAINABLE THEREBY AND A PROCESS TO POLYMERIZE IT | SULZER MANAGEMENT AG |
EP3608302 | PROCESS FOR PREPARING A 5-ALKEN-1-YNE COMPOUND, (6Z)-1,1-DIALKOXY-6-NONEN-2-YNE COMPOUND, (2E,6Z)-2,6-NONADIENAL AND (2E)-CIS-6,7-EPOXY-2-NONENAL, AND 1,1-DIALKOXY-6-NONEN-2-YNE COMPOUND | SHINETSU CHEMICAL CO |
EP3608307 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE COMPOUND | LG DISPLAY CO LTD |
EP3608310 | METHOD FOR SEPARATING AND PURIFYING 2-CHLORO-3-TRIFLUOROMETHYLPYRIDINE | ISHIHARA SANGYO KAISHA |
EP3608323 | PYRAN FUSED RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | BEIJING TIENYI LUFU PHARMATECH CO LTD |
EP3608324 | METHOD FOR PREPARING 2-ARYLMALONAMIDE AND APPLICATIONS OF METHOD | ORIENTAL LUZHOU AGROCHEMICALS CO LTD |
EP3608334 | TATK-CDKL5 FUSION PROTEINS, COMPOSITIONS, FORMULATIONS, AND USE THEREOF | UNIV BOLOGNA ALMA MATER STUDIORUM |
EP3609874 | IONIC COMPOUNDS COMPRISING 1,3-DIALKYL-4,5,6,7-TETRAHYDRO-1H-BENZO[D]IMIDAZOL-3-IUM CATIONS FOR USE IN COATINGS AND ADHESIVES | NITTO DENKO CORP |
EP3609875 | AN IMPROVED PROCESS FOR THE PREPARATION OF N-(3-ETHYNYLPHENYL)-7-METHOXY-6-(3-MORPHOLINOPROPOXY) QUINAZOLIN -4-AMINE DIHYDROCHLORIDE | NATCO PHARMA LTD |
EP3609900 | METHOD FOR PREPARING ARYLALKOXYSILANES BY DEHYDROGENATIVE SILYLATION | DOW SILICONES CORP |
EP3609928 | DIENE ELASTOMER MODIFIED BY A GROUP COMPRISING A SILICON ATOM, PROCESS FOR THE SYNTHESIS THEREOF AND RUBBER COMPOSITION CONTAINING SAME | MICHELIN & CIE |
EP3609978 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH |
EP3610005 | PEPTIDE LIGASE AND USE THEREOF | UNIV OXFORD INNOVATION LTD |
EP3610884 | PEPTIDE CONTAINING CONJUGATES FOR DUAL MOLECULAR DELIVERY OF OLIGONUCLEOTIDES | MERCK SHARP & DOHME |
EP3610924 | ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF | SQUIBB BRISTOL MYERS CO |
EP3611153 | METHOD FOR PRODUCING ACETIC ACID | DAICEL CORP |
EP3611154 | METHOD FOR PRODUCING ACETIC ACID | DAICEL CORP |
EP3611169 | NEW GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING | BAYER PHARMA AG |
EP3611173 | ORGANIC LIGHT EMITTING ELEMENT AND COMPOSITION FOR ORGANIC MATERIAL LAYER IN ORGANIC LIGHT EMITTING ELEMENT | HEESUNG MAT LTD |
EP3611176 | NITROGEN-CONTAINING CYCLIC COMPOUND AND COLOR-CHANGING FILM COMPRISING SAME | LG CHEMICAL LTD |
EP3611177 | NOVEL TRANSITION METAL COMPOUND AND METHOD FOR PREPARING SAME | LG CHEMICAL LTD |
EP3611240 | ORGANIC ELECTROLUMINESCENCE DEVICE | LG DISPLAY CO LTD |
EP3611270 | KITS FOR IN VITRO ANTIGEN PRESENTATION, ASSESSING VACCINE EFFICACY, AND ASSESSING IMMUNOTOXICITY OF BIOLOGICS AND DRUGS | UNIV MIAMI |
EP3612237 | GENE THERAPY | OSPEDALE SAN RAFFAELE SRL |
EP3612519 | PHENYL-2-HYDROXY-ACETYLAMINO-2-METHYL-PHENYL COMPOUNDS | LILLY CO ELI |
EP3612520 | AN ISOXAZOLE DERIVATIVES AS NUCLEAR RECEPTOR AGONISTS AND USED THEREOF | IL DONG PHARMA |
EP3612521 | CURABLE RESIN SYSTEM | HUNTSMAN ADVANCED MAT AMERICAS LLC |
EP3612525 | PD-1/PD-L1 INHIBITORS | GILEAD SCIENCES INC |
EP3612534 | PROCESS FOR THE PREPARATION OF PIPERAZINE RING FOR THE SYNTHESIS OF PYRAZINOCARBAZOLE DERIVATIVES | TECNIMEDE SOC TECNICO MEDICINAL SA |
EP3612535 | PROCESS FOR THE PREPARATION OF PIRLINDOLE ENANTIOMERS AND ITS SALTS | TECNIMEDE SOC TECNICO MEDICINAL SA |
EP3612538 | QUINONE-METHIDE PRECURSORS WITH BODIPY CHROMOPHORE, METHOD OF PREPARATION, BIOLOGICAL ACTIVITY AND APPLICATION IN FLUORESCENT LABELLING | RUDJER BOSKOVIC INST |
EP3612568 | CELL | AUTOLUS LTD |
EP3612620 | 4-ETHYL-OCTENE-2/3-NITRILE AS A FRAGRANCE | SYMRISE AG |
EP3613734 | PROCESS FOR PRODUCING PYRROLE COMPOUND | TAKEDA PHARMACEUTICALS CO |
EP3613737 | NOVEL INHIBITOR OF CYCLIN-DEPENDENT KINASE CDK9 | GENFLEET THERAPEUTICS SHANGHAI INC |
EP3613745 | SOLID FORMS AND FORMULATIONS OF (S)-4-(8-AMINO-3-(1-(BUT-2-YNOYL)PYRROLIDIN-2-YL)IMIDAZO[1,5-A]PYRAZIN-1-YL)-N-(PYRIDIN-2-YL)BENZAMIDE | ACERTA PHARMA BV |
EP3613748 | METHOD FOR THE PREPARATION OF TRIALKYL GALLIUM COMPOUNDS AND THEIR USE | UMICORE AG & CO KG |
EP3613752 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | SAMSUNG ELECTRONICS CO LTD |
EP3615037 | TRIAZOLE BISPHOSPHONATE GERANYLGERANYL DIPHOSPHATE SYNTHASE INHIBITORS | UNIV NEBRASKA |
EP3615314 | METHOD OF MAKING A THREE-DIMENSIONAL OBJECT USING PPSU | SOLVAY SPECIALTY POLYMERS USA |
EP3615499 | METHOD FOR PURIFYING 1,1,1,2,2-PENTAFLUOROPROPANE | ARKEMA FRANCE |
EP3615500 | METHOD FOR THE PRODUCTION AND PURIFICATION OF 2,3,3,3-TETRAFLUOROPROPENE | ARKEMA FRANCE |
EP3615506 | NOVEL COMPOUNDS OF FORMULA (I) AND USE THEREOF IN THERMOCHROMIC PIGMENT COMPOSITIONS | SOC BIC |
EP3615516 | IMIDAZOPYRAZINE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, AND THEIR USES AS LUCIFERINS | PASTEUR INSTITUT |
EP3615518 | PROCESS FOR THE MANUFACTURE OF VORTIOXETINE HBR ALPHA-FORM | H LUNDBECK AS |
EP3615519 | PROPENE RECOVERY BY SCRUBBING WITH A SOLVENT/WATER MIXTURE | BASF SE |
EP3615522 | C5-ANILINOQUINAZOLINE COMPOUNDS AND THEIR USE IN TREATING CANCER | ASTRAZENECA AB |
EP3615526 | PHENOXYQUINAZOLINE COMPOUNDS AND THEIR USE IN TREATING CANCER | ASTRAZENECA AB |
EP3615530 | SUBSTITUTED SUCCINIMIDE DERIVATIVES AS PESTICIDES | BASF SE |
EP3615533 | FUSED INDAZOLE PYRIDONE COMPOUNDS AS ANTIVIRALS | NOVARTIS AG |
EP3615543 | PROCESS FOR PREPARING OPTICALLY ACTIVE 2,3-DIHYDROTHIAZOLO[3,2-A]PYRIMIDIN-4-IUM COMPOUNDS | BASF SE |
EP3615545 | PYRROLOPYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF INFLUENZA VIRUS REPLICATION | COCRYSTAL PHARMA INC |
EP3615556 | PROTEINS AND PEPTIDE TAGS WITH ENHANCED RATE OF SPONTANEOUS ISOPEPTIDE BOND FORMATION AND USES THEREOF | UNIV OXFORD INNOVATION LTD |
EP3616706 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS | IMMATICS BIOTECHNOLOGIES GMBH |
EP3616720 | PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT | SHIONOGI & CO |
EP3616727 | INSULIN ANALOG CONJUGATES AND USE THEREOF | HANMI PHARM IND CO LTD |
EP3617201 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | CYNORA GMBH |
EP3617216 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | SAMSUNG ELECTRONICS CO LTD |
EP3617218 | DIHYDROARTEMISININ-STEROID CONJUGATE AND PREPARATION METHOD AND USE THEREOF | YUNBAIYAO ZHENGWU SCIENCE AND TECH SHANGHAI CO LTD |
EP3617220 | HIGH PH PROTEIN REFOLDING METHODS | SQUIBB BRISTOL MYERS CO |
EP3619183 | BY-PRODUCT STREAM UPGRADING IN A PROPYLENE OXIDE/STYRENE COPRODUCTION PROCESS | LYONDELL CHEMICAL TECH LP |
EP3619186 | PROCESS FOR THE PRODUCTION OF SEMIFLUORINATED ALKANES | NOVALIQ GMBH |
EP3619194 | PROCESS AND PLANT FOR THE SYNTHESIS OF UREA | CASALE SA |
EP3619199 | PREPARATION OF 2-([1,2,3]TRIAZOL-2-YL)-BENZOIC ACID DERIVATIVES | IDORSIA PHARMACEUTICALS LTD |
EP3619202 | TRISUBSTITUTED PYRIMIDINE COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CANCER, RETINAL DISORDERS, AND CARDIOMYOPATHIES | FONDAZIONE ST ITALIANO TECNOLOGIA |
EP3619207 | SUBSTITUTED 5-(HALOALKYL)-5-HYDROXY-ISOXAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE |
EP3619212 | 2-(HET)ARYL-SUBSTITUTED CONDENSED BICYCLIC HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS | BAYER AG |
EP3619215 | PROCESS TO CONVERT CRUDE ASCOMYCIN INTO PURIFIED PIMECROLIMUS | MEDA PHARMA GMBH & CO KG |
EP3619217 | PROCESS FOR PREPARING CHIRAL 2,3-DIHYDROTHIAZOLO[3,2-A]PYRIMIDIN-4-IUM COMPOUNDS | BASF SE |
EP3620447 | IONIZABLE CATIONIC LIPIDS | TRANSLATE BIO MA INC |
EP3620452 | PROCESS FOR THE PREPARATION OF LENVATINIB | INDENA SPA |
EP3620454 | CARBOXYLIC ACID DERIVATIVE AS AT2R RECEPTOR ANTAGONIST | SHANDONG DANHONG PHARMACEUTICAL CO LTD |
EP3621941 | USE OF PRECURSORS FOR THE PRODUCTION OF CARBON-11-LABELLED AMINO ACIDS AND DERIVATIVES THEREOF | ABX ADVANCED BIOCHEMICAL COMPOUNDS GMBH |
EP3621948 | AMINO (METH)ACRYLATES | ALLNEX BELGIUM SA |
EP3621949 | PROCESS FOR THE SYNTHESIS OF N-ACYL AMINO ACIDS WITHOUT THE USE OF SOLVENTS OR ACID CHLORIDE | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC |
EP3621959 | METHOD FOR THE SYNTHESIS OF AN N-ACYL COMPOUND WITHOUT THE USE OF ORGANIC SOLVENT OR ACID CHLORIDE | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC |
EP3621960 | THIENOPYRIDINES AND BENZOTHIOPHENES USEFUL AS IRAK4 INHIBITORS | SQUIBB BRISTOL MYERS CO |
EP3621970 | ORGANOBORON COMPLEXES FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH |
EP3621971 | CARBAZOLE-BASED BODIPYS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH |
EP3621972 | BENZOTHIAZOLE-CONTAINING SILANES, METHOD FOR THE PREPARATION AND USE THEREOF | EVONIK OPERATIONS GMBH |
EP3622081 | PROCESS FOR PRODUCING AN AZAPHILONE IN TALAROMYCES ATROROSEUS | UNIV DANMARKS TEKNISKE |
EP3622292 | GENETICALLY ENCODED POTASSIUM ION INDICATORS | UNIV GRAZ MEDIZINISCHE |
EP3622813 | ANIMAL MODELS AND THERAPEUTIC MOLECULES | KYMAB LTD |
EP3622953 | COMBINATION TREATMENT OF CANCER | SCANDION ONCOLOGY AS |
EP3623360 | PRODUCTION METHOD FOR 1 AMINO CYCLOPROPANE CARBOXYLIC ACID NONHYDRATE | SUMITOMO CHEMICAL CO |
EP3623361 | LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS | NOVARTIS AG |
EP3623374 | STEM CELL CULTURES | SCRIPPS RESEARCH INST |
EP3623376 | SECONDARY AMINE, RADICAL, AND ALKOXY AMINE COMPOUND | |
EP3623444 | ORGANIC ELECTROLUMINESCENT DEVICES AND METAL COMPLEX COMPOUNDS | UDC IRELAND LTD |
EP3623463 | TALE TRANSCRIPTIONAL ACTIVATORS | MASSACHUSETTS GEN HOSPITAL |
EP3624922 | ABSORBENT AND PROCESS FOR SELECTIVELY REMOVING HYDROGEN SULFIDE | BASF SE |
EP3625196 | METHOD FOR RECOVERING A STREAM OF C2+ HYDROCARBONS IN A RESIDUAL REFINERY GAS AND ASSOCIATED FACILITY | TECHNIP FRANCE |
EP3625199 | HYDROFORMYLATION METHOD FOR THE LARGE-SCALE PRODUCTION OF ALDEHYDES AND/OR ALCOHOLS | BASF SE |
EP3625201 | METHODS OF MAKING A POLYFLUORINATED ALLYL ETHER AND COMPOUNDS RELATING TO THE METHODS | 3M INNOVATIVE PROPERTIES CO |
EP3625210 | SILICA-BASED ZINC CATALYSTS. THEIR PREPARATION AND USE IN THE ALKOXYCARBONYLATION OF AMINES | COVESTRO DEUTSCHLAND AG |
EP3625211 | PROCESS FOR PREPARING METHIONINE | EVONIK OPERATIONS GMBH |
EP3625220 | CGRP RECEPTOR ANTAGONISTS | LILLY CO ELI |
EP3625221 | 3-METHYL-PYRROLIDINE-2,5-DIONE DERIVATIVES USEFUL AS CGRP RECEPTOR ANTAGONISTS | LILLY CO ELI |
EP3625222 | PHENYL DERIVATIVES AS PGE2 RECEPTOR MODULATORS | IDORSIA PHARMACEUTICALS LTD |
EP3625223 | PYRIMIDINE DERIVATIVES | IDORSIA PHARMACEUTICALS LTD |
EP3625224 | N-SUBSTITUTED INDOLE DERIVATIVES | IDORSIA PHARMACEUTICALS LTD |
EP3625228 | PYRIMIDINE DERIVATIVES AS PGE2 RECEPTOR MODULATORS | IDORSIA PHARMACEUTICALS LTD |
EP3625236 | A PROCESS FOR PREPARING AN OPTICALLY ACTIVE CINEOLE DERIVATIVE | BASF AGRO BV |
EP3625237 | A METHOD FOR SEPARATING OPTICALLY ACTIVE HYDROXY CINEOLE DERIVATIVES | BASF AGRO BV |
EP3625239 | A HAFNIUM COMPLEX; A SUPPORTED HAFNIUM COMPLEX; METHODS OF FORMING A POLYMER USING SUCH COMPLEXES | UNIVATION TECH LLC |
EP3625250 | SINGLE CHAIN VH-L1-CKAPPA-L2-CH1- ANTIBODIES | TRIANNI INC |
EP3625280 | POLYISOCYANATE (P) AND METHOD FOR THE PRODUCTION THEREOF | BASF SE |
EP3625347 | INDUCIBLE PROMOTER FOR GENE EXPRESSION AND SYNTHETIC BIOLOGY | AGRONOMIQUE INST NAT RECH |
EP3626704 | ISOCYANATE PRODUCTION METHOD | ASAHI CHEMICAL IND |
EP3626705 | ISOCYANATE PRODUCTION METHOD | ASAHI CHEMICAL IND |
EP3626706 | METHOD FOR INCREASING THE GUANIDINE CARBONATE YIELD IN A COMBINED MELAMINE PROCESS AND GUANIDINE CARBONATE TREATMENT PROCESS | BOREALIS AGROLINZ MELAMINE |
EP3626723 | INTERMEDIATE OF ERIBULIN AND PREPARATION METHOD THEREFOR | SELECTION BIOSCIENCE LLC |
EP3626729 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS | IMMATICS BIOTECHNOLOGIES GMBH |
EP3626731 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS | IMMATICS BIOTECHNOLOGIES GMBH |
EP3626819 | TRANSGENIC MOUSE WHICH PRODUCES HYBRID ANTIBODIES CONTAINING HUMAN VARIABLE REGIONS AND MOUSE CONSTANT REGIONS | REGENERON PHARMA |
EP3628041 | OXIDATIVE COUPLING OF METHANE | SHELL INT RESEARCH |
EP3628677 | METHOD FOR PREPARING A CYCLOPEPTIDE | |
EP3628680 | MODULATION OF COMPLEMENT ACTIVITY | RA PHARMACEUTICALS INC |
EP3628686 | HUMANIZATION OF RABBIT ANTIBODIES USING A UNIVERSAL ANTIBODY FRAMEWORK | ESBATECH ALCON BIOMED RES UNIT |
EP3628687 | BCMA CHIMERIC ANTIGEN RECEPTORS | BLUEBIRD BIO INC |
EP3628731 | NOVEL ANTI-PRESEPSIN ANTIBODY | MOCHIDA PHARM CO LTD |
EP3630111 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS | ENTASIS THERAPEUTICS INC |
EP3630710 | PROCESS FOR PREPARING METHACROLEIN | ROHM & HAAS |
EP3630711 | PROCESS FOR PREPARING METHACROLEIN | ROHM & HAAS |
EP3630712 | PROCESS FOR PREPARING METHACROLEIN | ROHM & HAAS |
EP3630713 | PROCESS FOR PREPARING METHACROLEIN | ROHM & HAAS |
EP3630714 | METHOD AND DEVICE FOR PURIFYING ACETONE/WATER MIXTURES BY MEANS OF DOUBLE-EFFECT DISTILLATION | RHODIA ACETOW GMBH |
EP3630715 | CALCIUM L-LACTATE FRAMEWORKS AS NATURALLY DEGRADABLE CARRIERS | UNIV CALIFORNIA |
EP3630718 | PROCESS FOR THE MANUFACTURING OF METHANE SULFONIC ACID | BASF SE |
EP3630720 | PROCESS FOR PREPARING METHIONINE | EVONIK OPERATIONS GMBH |
EP3630726 | CRYSTALLINE SOLID FORMS OF SALTS OF N-{4-[(6,7-DIMETHOXYQUINOLIN-4-YL) OXY]PHENYL}-N'-(4-FLUORPHENYL) CYCLOPROPANE-1,1-DICARBOXAMIDE, PROCESSES FOR MAKING, AND METHODS OF USE | EXELIXIS INC |
EP3630727 | PROCESS FOR MANUFACTURING A CYCLIC UREA ADDUCT OF AN ETHYLENEAMINE COMPOUND | NOURYON CHEMICALS INT BV |
EP3630729 | PYRIMIDINE COMPOUND | OTSUKA PHARMA CO LTD |
EP3630730 | POLYSUBSTITUTED PYRIMIDINES INHIBITING THE FORMATION OF PROSTAGLANDIN E2, A METHOD OF PRODUCTION THEREOF AND USE THEREOF | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I |
EP3630737 | BORATED BENZOXAZINE FOR USE IN THE SYNTHESIS OF POLYBENZOXAZINE | MICHELIN & CIE |
EP3630756 | PROCESS FOR THE PREPARATION OF A NOVEL UMECLIDINIUM SYNTHESIS INTERMEDIATE | OLON SPA |
EP3630761 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | AMGEN INC |
EP3630764 | HEXACYCLIC HETEROAROMATIC COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH |
EP3630780 | 1,3-DIAZO-4-OXA-[3.3.1]-BICYCLIC DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND THEIR USE AS A MEDICAMENT, IN PARTICULAR FOR TREATING DIABETES | UNIV PISA |
EP3630781 | PRODUCTION OF TRIALKYLINDIUM COMPOUNDS IN THE PRESENCE OF CARBOXYLATES | UMICORE AG & CO KG |
EP3630784 | PREPARATION OF ISOCYANATOSILANES | MOMENTIVE PERFORMANCE MAT INC |
EP3630786 | SYNTHESIS AND USE OF AMINOPNICTOGENS | UNIV DRESDEN TECH |
EP3630927 | COMPOUND COMPRISING POLYAMINE, ACIDIC AND BORON FONCTIONALITIES AND ITS USE AS A LUBRICANT ADDITIVE | TOTAL MARKETING SERVICES |
EP3632902 | 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUND AND ITS USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASE | PTC THERAPEUTICS INC |
EP3632905 | METHOD FOR PREPARING N-ACYL ORTHO-AMINOBENZAMIDE | MAX RUDONG CHEMICALS CO LTD |
EP3632912 | PYRIDOQUINAZOLINE DERIVATIVES USEFUL AS PROTEIN KINASE INHIBITORS | ONCOSTELLAE S L |
EP3632917 | METHOD FOR PREPARING HETEROCYCLIC DERIVATIVE COMPOUND, COMPOSITION CONTAINING SAME COMPOUND, AND HYDRATE OF SAME COMPOUND | JW PHARMACEUTICAL CORP |
EP3632921 | ANCILLARY LIGANDS FOR ORGANOMETALLIC COMPLEXES | UNIVERSAL DISPLAY CORP |
EP3633383 | FAST PROTEIN SEQUENCING | REGENERON PHARMA |
EP3634928 | METHOD OF INCREASING ALPHA-OLEFIN CONTENT | LIQUIDPOWER SPECIALTY PRODUCTS INC |
EP3634939 | METHODS OF MAKING COMPOUNDS HAVING ANTIDEGRADANT AND ANTIFATIGUE EFFICACY | EASTMAN CHEM CO |
EP3634940 | COMPOUNDS AND MIXTURES WITH ANTIDEGRADANT AND ANTIFATIGUE EFFICACY AND COMPOSITIONS INCLUDING SUCH COMPOUNDS | EASTMAN CHEM CO |
EP3634957 | NMDA RECEPTOR MODULATORS, COMPOSITIONS COMPRISING SAME AND USE OF THESE COMPOUNDS IN THE TREATMENT OF DISEASES INVOLVING THE CENTRAL NERVOUS SYSTEM | ADPUERIVITAM |
EP3634958 | CYCLOPROPYL UREA FORMYL PEPTIDE 2 RECEPTOR AND FORMYL PEPTIDE 1 RECEPTOR AGONISTS | SQUIBB BRISTOL MYERS CO |
EP3634961 | (4-(([1,2,4]TRIAZOLO[4,3-A]PYRIDINE-6-YL)OXY)-1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL) UREIDO DERIVATIVES AS ANTI-INFLAMMATORY P38 MAPK INHIBITORS FOR TREATING DISEASES OF THE RESPIRATORY TRACT | CHIESI FARM SPA |
EP3634971 | BODIPY COMPOUNDS FOR USE IN DISPLAY DEVICES | NITTO DENKO CORP |
EP3634977 | METHOD OF ISOLATION OF POLYPEPTIDE-APTAMER-POLYMER CONJUGATES | GEN ELECTRIC |
EP3636627 | NOVEL CYCLOPROPYLMETHOXY DERIVATIVES | INT FLAVORS & FRAGRANCES INC |
EP3636630 | PRODUCTION METHOD FOR 1 AMINO CYCLOPROPANE CARBOXYLIC ACID NONHYDRATE | SUMITOMO CHEMICAL CO |
EP3636641 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH |
EP3636652 | MODIFIED POLYMERIZATION INITIATOR AND PREPARATION METHOD THEREFOR | LG CHEMICAL LTD |
EP3636725 | ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE COMPOUND | LG DISPLAY CO LTD |
EP3637488 | ORGANIC ELECTROLUMINESCENCE DEVICE | LG DISPLAY CO LTD |
EP3638645 | CONTINUOUS PROCESS FOR THE CONVERSION OF OLEFINS AND CARBON DIOXIDE TO ACRYLATES VIA SOLUTION PHASE REACTOR | CHEVRON PHILLIPS CHEMICAL CO LP |
EP3638650 | PROCESS FOR THE PREPARATION OF SUBSTITUTED PHENOXYPHENYL ALCOHOLS | BASF AGRO BV |
EP3638653 | PROCESS FOR PREPARING 3,4-DICHLORO-N-(2-CYANOPHENYL)-5-ISOTHIAZOLECARBOXAMIDE | BAYER AG |
EP3638654 | MELT ADDITIVE COMPOUNDS, METHODS OF USING THE SAME, AND ARTICLES AND COMPOSITIONS INCLUDING THE SAME | 3M INNOVATIVE PROPERTIES CO |
EP3638659 | NEW WATER SOLUBLE MONO-BRANCHED AND DI-BRANCHED COMPLEXING AGENTS, AND CORRESPONDING LANTHANIDE COMPLEXES | CISBIO BIOASSAYS |
EP3638663 | PRODUCTION OF TRI-METHYL BENZENE DERIVATIVES | RHODIA OPERATIONS |
EP3638665 | HERBICIDALLY ACTIVE 3-PHENYLISOXAZOLINE-5-CARBOXAMIDES OF TETRAHYDRO AND DIHYDROFURAN CARBOXYLIC ACIDS AND ESTERS | BAYER AG |
EP3638666 | HERBICIDALLY ACTIVE 3-PHENYLISOXAZOLINE-5-CARBOXAMIDES OF TETRAHYDRO AND DIHYDROFURAN CARBOXAMIDES | BAYER AG |
EP3638670 | SUBSTITUTED PYRROLOPYRIDINE-DERIVATIVES AS MAP4K1 MODULATORS FOR THE TREATMENT OF CANCER DISEASES | BAYER PHARMA AG |
EP3638698 | ANTI-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS | REGENERON PHARMA |
EP3638749 | ORGANIC MOLECULE, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH |
EP3640231 | METHOD AND ASSEMBLY FOR RECOVERING ETHYLENE | LINDE AG |
EP3640238 | METHOD FOR THE PREPARATION OF DI- AND POLYAMINES OF THE DIPHENYL METHANE SERIES | COVESTRO DEUTSCHLAND AG |
EP3640255 | METHOD FOR PRODUCING SILICON COMPOUND, AND SILICON COMPOUND | SHINETSU CHEMICAL CO |
EP3642181 | METHOD FOR PREPARING INTERMEDIATE OF 4-METHOXYPYRROLE DERIVATIVE | DAE WOONG PHARMA |
EP3642213 | TRIDENTATE IMINOPYRROLYL NICKEL COMPLEXES AND THEIR USE AS CATALYSTS FOR THE REACTION OF POLYMERISATION OF ETHYLENE TO HYPERBRANCHED POLYETHYLENE | INST SUPERIOR TECNICO |
EP3642303 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX INC |
EP3642311 | PRODUCTION OF RENEWABLE BASE OIL AND DIESEL BY PRE-FRACTIONATION OF FATTY ACIDS | NESTE OYJ |
EP3642343 | IMPROVED PROTEIN EXPRESSION STRAINS | ALBUMEDIX LTD |
EP3643308 | COUMARIN-LIKE CYCLIC COMPOUND AS MEK INHIBITOR AND USE THEREOF | CSTONE PHARMACEUTICALS |
EP3643699 | METHOD FOR THE PURIFICATION OF ANILINE | COVESTRO DEUTSCHLAND AG |
EP3643709 | ISOINDOLINE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF | KANGPU BIOPHARMACEUTICALS LTD |
EP3643720 | ORGANIC COMPOUNDS, ORGANIC SEMICONDUCTOR LAYER AND ORGANIC ELECTRONIC DEVICE | NOVALED GMBH |
EP3645307 | SILANE, RUBBER MIXTURE CONTAINING THE SILANE AND VEHICLE TYRE HAVING THE RUBBER MIXTURE IN AT LEAST ONE COMPONENT | CONTINENTAL REIFEN DEUTSCHLAND GMBH |
EP3645484 | METHOD FOR PREPARATION OF ALKYLATED OR FLUORO, CHLORO AND FLUOROCHLORO ALKYLATED COMPOUNDS BY HETEROGENEOUS COBALT CATALYSIS | LONZA AG |
EP3645491 | POLYORGANOSILOXANE COMPOSITIONS CONTAINING A 2-SUBSTITUTED-1-ALKYNYL-1-CYCLOHEXANOL USEFUL AS A HYDROSILYLATION REACTION INHIBITOR | DOW SILICONES CORP |
EP3645498 | PROCESS FOR RECOVERING ACETIC ACID FROM AN AQUEOUS STREAM COMPRISING THE SAME | NOURYON CHEMICALS INT BV |
EP3645506 | PROCESS FOR THE PREPARATION OF A MIXTURE OF CHELATING AGENTS, MIXTURE OF CHELATING AGENTS AND METHODS OF USING THEM | KEMIRA OYJ |
EP3645507 | PROCESS FOR MANUFACTURING A COMPLEXING AGENT | BASF SE |
EP3645509 | METHOD FOR PREPARING SUBSTITUTED 4-AMINOINDANE DERIVATIVES | BAYER AG |
EP3645515 | 4-(3,4-DIHYDRONAPHTH-1-YL OR 2H-CHROMEN-4-YL)-5-HYDROXY-2H-PYRADIZIN-3-ONES AS HERBICIDES | FMC CORP |
EP3645518 | SYNTHESIS OF OMECAMTIV MECARBIL | AMGEN INC |
EP3645522 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH |
EP3645524 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH |
EP3645535 | NEW SALT OF N-(2,6-DIETHYLPHENYL)-8-({4-[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]-2-METHOXYPHENYL}AM INO)-1-METHYL-4,5-DIHYDRO-1H-PYRAZOLO[4,3-H]QUINAZOLINE-3-CARBOXAMIDE, ITS PREPARATION AND FORMULATIONS CONTAINING IT | SERVIER LAB |
EP3645539 | PYRIDO-IMIDAZO RIFAMYCIN DERIVATIVES AS ANTIBACTERIAL AGENT | BIOFER SPA |
EP3645540 | SILOLE AND GERMOLE FUSED RING PHOTOCHROMIC COMPOUNDS | TRANSITIONS OPTICAL LTD |
EP3645543 | SYNERGISTIC COMBINATIONS OF PLATINUM AND RHODIUM COMPOUNDS AS CATALYSTS IN HYDROSILYLATION | HERAEUS DEUTSCHLAND GMBH & CO KG |
EP3645550 | COMPSTATIN ANALOGS WITH INCREASED SOLUBILITY AND IMPROVED PHARMACOKINETIC PROPERTIES | UNIV PENNSYLVANIA |
EP3645555 | POLYPEPTIDES HAVING TREHALASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME | NOVOZYMES AS |
EP3645565 | BISPECIFIC ANTIBODIES TO ROR1 AND CD3 | UCL BUSINESS LTD |
EP3645570 | VISTA ANTIGEN-BINDING MOLECULES | HUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD |
EP3645571 | HER3 ANTIGEN-BINDING MOLECULES | HUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD |
EP3645609 | ISOCYANATE-FUNCTIONAL SILICONE-POLYETHER COPOLYMER, SILICONE-POLYETHER-URETHANE COPOLYMER FORMED THEREWITH, SEALANTS COMPRISING SAME, AND RELATED METHODS | DOW SILICONES CORP |
EP3645615 | METHOD FOR PRODUCING A SILANE, METHOD FOR MODIFYING A SILICA WITH THE SILANE, AND MODIFIED SILICA | CONTINENTAL REIFEN DEUTSCHLAND GMBH |
EP3645677 | CETANE-BOOSTING FUEL ADDITIVES, METHOD OF MANUFACTURE, AND USES THEREOF | SABIC GLOBAL TECHNOLOGIES BV |
EP3645786 | PROCESS FOR SEPARATING LIGNIN FROM LIGNOCELLULOSIC MATERIALS | FUNDACION TECNALIA RES & INNOVATION |
EP3647304 | METHOD FOR PREPARING 2-FLUOROACRYLATE | LINHAI TIANYU PHARMACEUTICAL CO LTD |
EP3647318 | LINKAGE MODIFIED OLIGOMERIC COMPOUNDS | IONIS PHARMACEUTICALS INC |
EP3647322 | STABILIZED FIBRONECTIN BASED SCAFFOLD MOLECULES | SQUIBB BRISTOL MYERS CO |
EP3647392 | LIGHT-EMITTING MATERIAL, COMPOUND, LONG-PERSISTENT PHOSPHOR AND LIGHT-EMITTING ELEMENT | KYULUX INC |
EP3648866 | METHOD AND SYSTEM FOR SEPARATING A STARTING MIXTURE | LINDE AG |
EP3648882 | CATALYSTS FOR POLYESTEROL SYNTHESIS | BASF SE |
EP3648890 | PROCESS TO TREAT CARBONATITIC NON-SULFIDIC ORES AND COLLECTOR COMPOSITION THEREFOR | NOURYON CHEMICALS INT BV |
EP3649101 | METHOD FOR THE PREPARATION OF 4-(HEPTAFLUORO-2-PROPYL) ANILINES | LONZA AG |
EP3649104 | PROCESS FOR PRODUCING LONG CHAIN AMINO ACIDS AND DIBASIC ACIDS | VITAWORKS IP LLC |
EP3649105 | SODIUM METHYL GLYCINE-N,N-DIACETIC ACID COMPOUND, PROCESS TO PREPARE IT AND USE THEREOF | NOURYON CHEMICALS INT BV |
EP3649109 | ETHYNYL COMPOUNDS, THEIR PREPARATION AND THEIR THERAPEUTIC USE FOR THE TREATMENT OF MALARIA | SANOFI SA |
EP3649111 | POLYAROMATIC MOLECULE HAVING A NITRILE OXIDE FUNCTION | ARKEMA FRANCE |
EP3649119 | NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS | GALAPAGOS NV |
EP3649124 | FLUOROPIPERIDINE COMPOUNDS AS PURE 5-HT6 RECEPTOR ANTAGONISTS | SUVEN LIFE SCIENCES LTD |
EP3649134 | PROCESS FOR PREPARING BICYCLIC ENOLETHER | FIRMENICH & CIE |
EP3649145 | IMPROVED REP PROTEIN FOR USE IN A DIAGNOSTIC ASSAY | DEUTSCHES KREBSFORSCH |
EP3649160 | IRON COMPOUND USED AS A CATALYST FOR HYDROSILYLATION, DEHYDROGENATIVE SILYLATION AND CROSSLINKING OF SILICONE COMPOSITIONS | ELKEM SILICONES FRANCE S A S |
EP3649179 | PRODUCTION PLANT FOR PRODUCING A CHEMICAL PRODUCT BY REACTING H-FUNCTIONAL REACTANTS WITH PHOSGENE, AND METHOD FOR OPERATING SAME | COVESTRO DEUTSCHLAND AG |
EP3649214 | TERBIUM AND DYSPROSIUM COMPLEXES WITH OPTIMISED ANTENNA, USED AS LUMINESCENT MARKERS | ECOLE NORMALE SUPERIEURE LYON |
EP3650435 | DISSOCIATION OF 1,4-BIS (4-PHENOXYBENZOYL)BENZENE - LEWIS ACID COMPLEX IN A PROTIC SOLVENT | ARKEMA FRANCE |
EP3650439 | SALTS OR CO-CRYSTALS OF 3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL | GRUENENTHAL GMBH |
EP3650442 | METHOD FOR THE PREPARATION OF DIFLUOROMETHYL PYRAZOLE CARBOXYLIC ALKYL ESTER AND ITS ACID | LONZA AG |
EP3650450 | CRYSTAL FORM II OF THIENOPYRIDINE DERIVATIVE BISULFATE AND PREPARATION METHOD THEREFOR AND USE THEREOF | ZHONGRONG KAITE BEIJING BIOTECHNOLOGY CO LTD |
EP3650452 | METHOD FOR PRODUCING IODINE-CONTAINING SILICON COMPOUND | SHINETSU CHEMICAL CO |
EP3650456 | PURIFICATION AGENT FOR SUGAR CHAIN OR GLYCOPEPTIDE, AND USE THEREOF | SUMITOMO BAKELITE CO |
EP3650457 | METHOD FOR PRODUCING A RECOMBINANT PEPTIDE AND RESULTANT PEPTIDE | IVIX COMPANY LTD |
EP3650557 | METHOD FOR DETERMINATION OF RESTRICTION EFFICIENCY OF ENDONUCLEASES MEDIATING DOUBLE-STRAND BREAKS IN DNA TARGET SEQUENCES | UNIV JUSTUS LIEBIG GIESSEN |
EP3652137 | PROCESS AND FACILITY FOR PRODUCING PROPYLENE BY COMBINING PROPANE DEHYDROGENATION AND A STEAM CRACKING METHOD WITH PROPANE RECIRCULATION INTO THE STEAM CRACKING METHOD | LINDE AG |
EP3652138 | PROCESS AND FACILITY FOR PRODUCING PROPYLENE BY COMBINING PROPANE HYDROGENATION AND A STEAM CRACKING METHOD WITH PRE-SEPARATION STEPS IN THE TWO METHODS FOR PARTIALLY REMOVING HYDROGEN AND METHANE | LINDE AG |
EP3652141 | PREPARATION OF DIESTERS OF (METH)ACRYLIC ACID FROM EPOXIDES | EVONIK DEGUSSA GMBH |
EP3652142 | PROCESS FOR THE PREPARATION AND PURIFICATION OF MISOPROSTOL | CHINOIN PHARMACEUTICAL AND CHEMICAL WORKS PRIVATE CO LTD |
EP3652148 | AMORPHOUS FORM OF VILANTEROL TRIFENATATE AND PROCESSES FOR THE PREPARATION THEREOF | HOVIONE SCIENTIA LTD |
EP3652152 | UREA FINISHING AND OFF-GAS TREATMENT PLANT AND PROCESS | STAMICARBON |
EP3652154 | PROCESS TO PREPARE ETHYLENE AMINES AND ETHYLENE AMINE DERIVATIVES | NOURYON CHEMICALS INT BV |
EP3652155 | PROCESS TO PREPARE HIGHER ETHYLENE AMINES OR UREA DERIVATIVES THEREOF | AKZO NOBEL CHEMICALS INT BV |
EP3652157 | 1,3-DIAZA-SPIRO-[3.4]-OCTANE DERIVATIVES | GRUENENTHAL GMBH |
EP3652168 | 5-MEMBERED AND BICYCLIC HETEROCYCLIC AMIDES AS INHIBITORS OF ROCK | SQUIBB BRISTOL MYERS CO |
EP3652171 | COOLING COMPOSITION | FIRMENICH & CIE |
EP3652176 | NOVEL SUBSTITUTED XANTHINE DERIVATIVES | BOEHRINGER INGELHEIM INT |
EP3652182 | 2-OXO-1-IMIDAZOLIDINYL IMIDAZOTHIADIAZOLE DERIVATIVES | UCB BIOPHARMA SRL |
EP3652183 | 2-OXO-1,3-OXAZOLIDINYL IMIDAZOTHIADIAZOLE DERIVATIVES | UCB BIOPHARMA SRL |
EP3652187 | IMPROVED PROCESS FOR PREPARING IMETELSTAT | GERON CORP |
EP3652198 | CELL FACTORY HAVING IMPROVED IRON-SULFUR CLUSTER DELIVERY | BIOSYNTIA APS |
EP3652215 | IMPROVED DUAL SPECIFICITY POLYPEPTIDE MOLECULE | IMMATICS BIOTECHNOLOGIES GMBH |
EP3652232 | INORGANIC TIN COMPOUNDS AND USE THEREOF | COVESTRO DEUTSCHLAND AG |
EP3653604 | METHOD FOR THE PREPARATION OF ISOCYANATE BY PARTIALLY ADIABATIC PHOSGENATION OF THE CORRESPONDING AMINE | COVESTRO DEUTSCHLAND AG |
EP3653605 | METHOD FOR THE PREPARATION OF ISOCYANATE BY PARTIALLY ADIABATIC PHOSGENATION OF THE CORRESPONDING AMINE | COVESTRO DEUTSCHLAND AG |
EP3653616 | FULLERENE DERIVATIVES, AND ORGANIC PHOTOELECTRIC DEVICE, IMAGE SENSOR, AND ELECTRONIC DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD |
EP3653726 | PROBES FOR IMPROVED MELT DISCRIMINATION AND MULTIPLEXING IN NUCLEIC ACID ASSAYS | LUMINEX CORP |
EP3653735 | REPTILE SKIN PRODUCT AND PRODUCTION METHOD FOR REPTILE SKIN PRODUCT | CITIZEN WATCH CO LTD |
EP3655006 | ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE | AKSTON BIOSCIENCES CORP |
EP3655380 | PHOTOCHEMICAL SEPARATIONS AND COMPOSITIONS | UNIV FLORIDA STATE RES FOUND INC |
EP3655381 | PROCESS FOR THE PRODUCTION OF 2,3,3,3-TETRAFLUOROPROPENE | ARKEMA FRANCE |
EP3655385 | PROCESS OF PRODUCTION OF 3,7-DIMETHYL-9-(2,6,6-TRIMETHYL-1-CYCLOHEXEN-1-YL)-NONA-2E,7E-DIEN-4-YNE-1,6-DIOL | DSM IP ASSETS BV |
EP3655395 | PROCESS FOR THE PREPARATION OF N-((1R,2S,5R)-5-(TERT | SQUIBB BRISTOL MYERS CO |
EP3655399 | PROCESS FOR PREPARING ALKANEDIOL AND DIALKYL CARBONATE | SHELL INT RESEARCH |
EP3655407 | PYROPHEOPHORBIDE CONJUGATE AND USE THEREOF IN THE TREATMENT OF CANCER AND AS A FLUORESCENT MARKER | INST NAT SANTE RECH MED |
EP3655408 | CONFORMATIONAL RESTRICTION OF CYANINE FLUOROPHORES IN FAR-RED AND NEAR-IR RANGE | US HEALTH |
EP3655413 | PRODUCTION OF GLUFOSINATE BY REACTION OF 3-[N-BUTOXY(METHYL)PHOSPHORYL]-1-CYANOPROPYL ACETATE TO AFFORD A MIXTURE OF N-BUTYL (3-AMINO-3-CYANOPROPYL)METHYLPHOSPHINATE AND (3-AMINO-3-CYANOPROPYL)METHYLPHOSPHINIC ACID AMMONIUM SALT | BASF SE |
EP3655414 | DEFEROXAMINE DERIVATIVES AS MEDICAMENTS | BIOTECHNOLOGICKY USTAV AV CR V V I |
EP3655415 | PROCESS FOR PREPARING PLATINUM ORGANOSILOXANE COMPLEXES USING AN ENONE ADDITIVE | DOW SILICONES CORP |
EP3655416 | PROCESS FOR PREPARING PLATINUM ORGANOSILOXANE COMPLEXES | DOW SILICONES CORP |
EP3655419 | PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF OBETICHOLIC ACID AND DERIVATIVES THEREOF | BIONICE S L U |
EP3655424 | PEPTIDES MODULATING SPERM MOTILITY BY MODULATING THE PHOSPHOPROTEIN PHOSPHATASE 1 COMPLEX. | UNIV OF WOLVERHAMPTON |
EP3655425 | PEPTIDES WITH ANTIBIOTIC POTENTIAL AGAINST MYCOBACTERIUM TUBERCULOSIS | ADENIUM BIOTECH APS |
EP3655532 | A TWO-COMPONENT VECTOR LIBRARY SYSTEM FOR RAPID ASSEMBLY AND DIVERSIFICATION OF FULL-LENGTH T-CELL RECEPTOR OPEN READING FRAMES | GENOVIE AB |
EP3656765 | SALTS OR CO-CRYSTALS OF 3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL | GRUENENTHAL GMBH |
EP3656766 | 2,5-BIS(AMINOMETHYL)FURAN PRODUCTION METHOD | MITSUBISHI GAS CHEMICAL CO |
EP3656776 | INDOLOCARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | SFC CO LTD |
EP3656777 | COMPOUND AND COLOR CONVERSION FILM COMPRISING SAME, BACKLIGHT UNIT, AND DISPLAY DEVICE | LG CHEMICAL LTD |
EP3656779 | BORYLIMIDE CATALYSTS | SCG CHEMICALS CO LTD |
EP3656782 | PEPTIDE AMIDE COMPOUND AND PREPARATION METHOD AND MEDICAL USE THEREOF | SICHUAN HAISCO PHARMACEUTICAL CO LTD |
EP3656856 | LIVE, ATTENUATED CORONAVIRUS COMPRISING A VARIANT REPLICASE GENE ENCODING POLYPROTEINS COMPRISING A MUTATION IN NSP-10. | THE PIRBRIGHT INST |
EP3658192 | GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF | ABBVIE INC |
EP3658249 | METHOD FOR PURIFYING (METH)ACRYLIC ESTERS | ARKEMA FRANCE |
EP3658522 | IMMUNOMODULATOR COMPOUNDS | CHEMOCENTRYX INC |
EP3658524 | METHOD FOR THE PRODUCTION OF CANNABINOIDS FROM TYPES OF INDUSTRIAL HEMP | INALCO S R L |
EP3658528 | A METHOD FOR PRODUCTION OF METHYL METHACRYLATE BY OXIDATIVE ESTERIFICATION USING A HETEROGENEOUS CATALYST | ROHM & HAAS |
EP3658540 | PROCESS FOR THE PREPARATION OF ARIPIPRAZOLE LAUROXIL | INTERQUIM SA |
EP3658545 | METHOD FOR PREPARING 3-[(3S)-7-BROMO-2-OXO-5-(PYRIDIN-2-YL)-2,3-DIHYDRO-1H-[1,4]-BENZODIAZEPIN-3-YL]PROPIONIC ACID METHYL ESTER, AND COMPOUNDS USEFUL IN THAT METHOD | MOEHS IBERICA SL |
EP3658549 | PROCESS FOR PREPARING AND PURIFYING THE LFA-1 ANTAGONIST LIFITEGRAST | INTERQUIM SA |
EP3658564 | METAL COMPLEXES | MERCK PATENT GMBH |
EP3658570 | TYROSINASE ANTISENSE OLIGONUCLEOTIDES | OLIPASS CORP |
EP3659995 | METHOD FOR PRODUCING BIS-ACYLOXYLATED EXOMETHYLENE COMPOUND | KURARAY CO |
EP3659998 | AROMATIC AMINE COMPOUND, CURING AGENT FOR EPOXY COMPOUND, CURABLE COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING CURED PRODUCT, AND METHOD FOR PRODUCING AROMATIC AMINE COMPOUND | TOKYO OHKA KOGYO CO LTD |
EP3660002 | METHOD FOR ISOLATING CAPROLACTAM FROM THE UPPER LACTAM PHASE COMPRISING THE STEPS OF 1) DISTILLATION, 2) REFINING WITH HYDROGEN IN THE PRESENCE OF A NOBEL METAL CATALYST AND 3) RECTIFICATION | VS CHEMICKO TECHNOLOGICKA V PRAZE |
EP3660012 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO LTD |
EP3660024 | POLYCYCLIC AROMATIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | SFC CO LTD |
EP3660033 | LONG-ACTING COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS | APELLIS PHARMACEUTICALS INC |
EP3660047 | HUMAN ANTIBODIES TO FEL D1 AND METHODS OF USE THEREOF | REGENERON PHARMA |
EP3661873 | 1,1,1-TRIS(ORGANOAMINO)DISILANE COMPOUNDS AND METHOD OF PREPARING SAME | DOW SILICONES CORP |
EP3661913 | A UREA PRODUCTION PROCESS AND PRODUCTION PLANT USING CO2 PRODUCED BY OXY-COMBUSTION | SAIPEM SPA |
EP3661920 | 3-ACYL-BENZAMIDES AND THEIR USE AS HERBICIDES | BAYER AG |
EP3661925 | NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS | INFLAZOME LTD |
EP3661929 | ISOCHROMAN COMPOUNDS AND USES THEREOF | SUNOVION PHARMACEUTICALS INC |
EP3661932 | COMPOSITIONS AND METHODS FOR STABILIZING BENZOTHIAZOLE LUCIFERIN ANALOGS | PROMEGA CORP |
EP3661936 | [1,2,4]TRIAZOLO[4,3-A]PYRAZIN-6(5H)-ONE DERIVATIVES | LILLY CO ELI |
EP3661939 | INTERMEDIATE COMPOUNDS AND METHDODS | BOEHRINGER INGELHEIM INT |
EP3663283 | CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THIN FILM FORMED FROM THE COMPOSITION | SAMSUNG DISPLAY CO LTD |
EP3663284 | IMPROVED METHOD FOR THE PREPARATION OF TRIACETONAMINE | EVONIK OPERATIONS GMBH |
EP3663290 | POLYMETHINE COMPOUNDS AND THEIR USE AS FLUORESCENT LABELS | ILLUMINA CAMBRIDGE LTD |
EP3663292 | DIPHENYLMETHANE DERIVATIVE IN CRYSTALLINE FORM | DAE WOONG PHARMA |
EP3663298 | ORGANIC THIN FILM AND ORGANIC THIN FILM TRANSISTOR AND ELECTRONIC DEVICE | SAMSUNG ELECTRONICS CO LTD |
EP3663300 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO LTD |
EP3663304 | SURFACE TREATMENT AGENT AND SURFACE TREATMENT METHOD USING THE SAME | SHINETSU CHEMICAL CO |
EP3663306 | LIGAND COMPOUND, TRANSITION METAL COMPOUND, AND CATALYST COMPOSITION CONTAINING SAME | LG CHEMICAL LTD |
EP3663308 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | SAMSUNG ELECTRONICS CO LTD |
EP3663382 | SULPHUR-CONTAINING POLYESTER | OLEON N V |
EP3665151 | TWO-STEP PROCESS FOR CONVERTING CYCLIC ALKYLENE UREAS INTO THEIR CORRESPONDING ALKYLENE AMINES | NOURYON CHEMICALS INT BV |
EP3665154 | REACTIVE SEPARATION PROCESS TO CONVERT CYCLIC ALKYLENE UREAS INTO THEIR CORRESPONDING ALKYLENE AMINES | NOURYON CHEMICALS INT BV |
EP3665170 | PESTICIDALLY ACTIVE THIOPHENE DERIVATIVES | SYNGENTA PARTICIPATIONS AG |
EP3665174 | [1,2,4]TRIAZOLO DERIVATIVES AS PDE1 INHIBITORS FOR THE TREATMENT OF DIABETES | LILLY CO ELI |
EP3665269 | USE OF MAGNETIC CELLS TO MANIPULATE NON-MAGNETIC CELLS | GREINER BIO ONE NORTH AMERICA INC |
EP3665291 | INTEGRATION SITES IN CHO CELLS | BOEHRINGER INGELHEIM INT |
EP3666778 | A CRYSTALLINE CYCLIC BORONIC ACID ESTER DERIVATIVE, METHOD FOR THE PREPARATION AND THERAPEUTIC USES THEREOF | REMPEX PHARMACEUTICALS INC |
EP3666779 | ORGANIC ELECTROLUMINESCENT DEVICES COMPRISING HOST COMPOUNDS | CYNORA GMBH |
EP3667804 | ELECTROLYTE SOLUTION CONTAINING UNSATURATED CYCLIC CARBONATES, ELECTROCHEMICAL DEVICE AND LITHIUM-ION SECONDARY BATTERY COMPRISING THE SAME | DAIKIN IND LTD |
EP3668519 | USE OF GINSENOSIDE M1 FOR MANUFACTURING MEDICAMENT FOR TREATING ORAL CANCER | |
EP3668826 | ETHANE OXIDATIVE DEHYDROGENATION | SHELL INT RESEARCH |
EP3668827 | ETHANE OXIDATIVE DEHYDROGENATION | SHELL INT RESEARCH |
EP3668830 | ELECTROCHEMICAL METHOD FOR PRODUCING VALERIC ACID | STICHTING WAGENINGEN RES |
EP3668831 | METHOD FOR CONTINUOUSLY PRODUCING ACRYLIC ACID N-BUTYL ESTER OR ACRYLIC ACID ISOBUTYL ESTER | BASF SE |
EP3668848 | PROCESS FOR PRODUCING (METH)ACRYLATES FROM GLYCEROL CARBONATE | BASF SE |
EP3668849 | PROCESS FOR PREPARING CYCLIC CARBONATES | BASF SE |
EP3668850 | AMBER ODORANT | FIRMENICH & CIE |
EP3668855 | HERBICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG |
EP3668864 | NOVEL N-(2,2-DIFLUOROETHYL)-N-[(PYRIMIDINYLAMINO)PROPANYL]ARYLCARBOXAMIDES | BOEHRINGER INGELHEIM INT |
EP3668870 | 6-AMINO-7,9-DIHYDRO-8H-PURIN-8-ONE DERIVATIVES AS IMMUNOSTIMULANT TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS | SQUIBB BRISTOL MYERS CO |
EP3668871 | 6-AMINO-7,9-DIHYDRO-8H-PURIN-8-ONE DERIVATIVES AS IMMUNOSTIMULANT TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS | SQUIBB BRISTOL MYERS CO |
EP3668873 | IMIDAZO[1,2-A]IMIDAZOL-2-ONE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS PARKINSON'S DISEASE | HOFFMANN LA ROCHE |
EP3668874 | PYRROLOBENZODIAZEPINE CONJUGATES | MEDIMMUNE LTD |
EP3668879 | NOVEL COMPOUNDS | GLAXOSMITHKLINE IP DEV LTD |
EP3668880 | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE | IDORSIA PHARMACEUTICALS LTD |
EP3668985 | METHOD OF PURIFYING GLYCOSYLATED PROTEIN FROM HOST CELL GALECTINS AND OTHER CONTAMINANTS | JUST EVOTEC BIOLOGICS INC |
EP3670499 | PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS | ASTRAZENECA AB |
EP3670523 | 5-METHOXY. 3'-OH UNBLOCKED, FAST PHOTOCLEAVABLE TERMINATING NUCLEOTIDES AND METHODS FOR NUCLEIC ACID SEQUENCING | AGILENT TECHNOLOGIES INC |
EP3670526 | METHOD FOR THE FERMENTATIVE PRODUCTION OF L-LYSINE USING C. GLUTAMICUM STRAINS WITH A MUTATED KUP TRANSPORTER | EVONIK OPERATIONS GMBH |
EP3670528 | SCLEROSTIN BINDING AGENTS | UCB PHARMA SA |
EP3672943 | MICROBIOCIDAL QUINOLINE (THIO)CARBOXAMIDE DERIVATIVES | SYNGENTA PARTICIPATIONS AG |
EP3672953 | BENZIMIDAZOLE DERIVATIVES USEFUL AS POTASSIUM CHANNEL INHIBITORS | ACESION PHARMA APS |
EP3672956 | ORGANIC TRIAZINE CONTAINING MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH |
EP3672967 | AZAINDOLYLPYRIDONE AND DIAZAINDOLYLPYRIDONE COMPOUNDS | SPRINT BIOSCIENCE AB |
EP3672971 | TRIAZOLO PYRIDINES AS MODULATORS OF GAMMA-SECRETASE | BOEHRINGER INGELHEIM INT |
EP3672978 | PROCESS FOR MAKING IXAZOMIB OR INTERMEDIATES THEREFOR | SYNTHON BV |
EP3672979 | CHEMICALLY STABLE LIGNIN DERIVATIVE AND METHOD FOR PREPARING SAME | INSTITUT NATIONAL DE RECH POUR LAGRICULTURE LALIMENTATION ET LENVIRONNEMENT |
EP3674282 | DIHYDROXYBIPHENYL COMPOUND, BISPHOSPHITE COMPOUND, CATALYST, METHOD FOR PRODUCING ALDEHYDES, AND METHOD FOR PRODUCING ALCOHOL | MITSUBISHI CHEM CORP |
EP3674299 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | CYNORA GMBH |
EP3674308 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD |
EP3676279 | CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS | SQUIBB BRISTOL MYERS CO |
EP3677329 | PROCESS FOR PREPARING GUANIDINO ACETIC ACID | EVONIK OPERATIONS GMBH |
EP3677580 | CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEMICAL LTD |
EP3679014 | METHOD FOR CLEANING PHOSGENE CONDUCTING APPARATUS | COVESTRO DEUTSCHLAND AG |
EP3679017 | CO-CRYSTAL OF AN ORALLY AVAILABLE HIF PROLYL HYDROXYLASE INHIBITOR | SANDOZ AG |
EP3679039 | TYROSINE ANALOGUES DERIVATIVES AS RHO- KINASE INHIBITORS | CHIESI FARM SPA |
EP3679059 | NEW IMPROVED GLUCOSE ISOMERASES | METGEN OY |
EP3679107 | MOISTURE CURING POLYURETHANE HOT-MELT ADHESIVE HAVING GOOD ADHESION TO POLAR SUBSTRATES | SIKA TECH AG |
EP3680228 | METHOD FOR REMOVING PRIMARY ALCOHOL IN ESTERIFICATION, AND METHOD FOR PRODUCING ESTER COMPOSITION, INCLUDING SAME | LG CHEMICAL LTD |
EP3680243 | PENTACYCLIC COMPOUND | EISAI R&D MAN CO LTD |
EP3680665 | TIME-RESOLVED FLUORESCENT IMMUNOCHROMATOGRAPHIC TEST STRIP FOR DETECTING VANCOMYCIN AS WELL AS PREPARATION METHOD AND APPLICATION THEREOF | BEIJING DIAGREAT BIOTECHNOLOGIES CO LTD |
EP3681285 | MICROBIOCIDAL QUINOLINE (THIO)CARBOXAMIDE DERIVATIVES | SYNGENTA PARTICIPATIONS AG |
EP3681286 | MICROBIOCIDAL QUINOLINE (THIO)CARBOXAMIDE DERIVATIVES | SYNGENTA PARTICIPATIONS AG |
EP3681855 | METHOD FOR RECOVERY OF METHACROLEIN AND METHANOL FROM METHACROLEIN DIMETHYLACETAL | DOW GLOBAL TECHNOLOGIES LLC |
EP3681867 | MICROBIOCIDAL QUINOLINE (THIO)CARBOXAMIDE DERIVATIVES | SYNGENTA PARTICIPATIONS AG |
EP3681868 | MICROBIOCIDAL QUINOLINE (THIO)CARBOXAMIDE DERIVATIVES | SYNGENTA PARTICIPATIONS AG |
EP3681869 | MICROBIOCIDAL QUINOLINE (THIO)CARBOXAMIDE DERIVATIVES | SYNGENTA PARTICIPATIONS AG |
EP3681870 | MICROBIOCIDAL QUINOLINE (THIO)CARBOXAMIDE DERIVATIVES | SYNGENTA PARTICIPATIONS AG |
EP3681890 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH |
EP3681972 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH |
EP3681973 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH |
EP3681987 | LILY OF THE VALLEY ODORANT | FIRMENICH & CIE |
EP3682905 | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF | MODERNATX INC |
EP3683207 | N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOSTERIC MODULATORS OF NR2B | CADENT THERAPEUTICS INC |
EP3683223 | COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | NOVALED GMBH |
EP3684183 | HERBICIDALLY ACTIVE PYRIDYL-/PYRIMIDYL-PYRIMIDINE DERIVATIVES | SYNGENTA PARTICIPATIONS AG |
EP3684487 | PROCESS FOR SEPARATING FURANIC COMPOUNDS, IN PARTICULAR 5- HYDROXYMETHYLFURFURAL, FROM DIMETHOXYSULFOXIDE BY LIQUID-LIQUID EXTRACTIONS | IFP ENERGIES NOW |
EP3684751 | CATALYST FOR THE OXIDATIVE ESTERIFICATION OF ALDEHYDES TO CARBOXYLIC ACID ESTERS | ROEHM GMBH |
EP3684759 | CRYSTAL FORM OF A DITHIOLENE NICKEL COMPLEX | BASF SE |
EP3684763 | PYRIMIDIN-4-CARBAMATE OR UREA DERIVATIVES AS HERBICIDES | SYNGENTA PARTICIPATIONS AG |
EP3684764 | PYRAZINE-4CARBAMATE OR -UREA DERIVATIVES AS HERBICIDES | SYNGENTA PARTICIPATIONS AG |
EP3684777 | PROCESS FOR THE PRODUCTION OF ORGANOHYDRIDOCHLOROSILANES | MOMENTIVE PERFORMANCE MAT INC |
EP3684783 | GENE EXPRESSION INHIBITORS | PIVARIS BIOSCIENCE GMBH |
EP3684835 | COLOUR-STABLE CURING COMPOSITIONS CONTAINING POLYISOCYANATE (CYCLO)ALIPHATIC DIISOCYANATES | BASF SE |
EP3686179 | METHOD FOR OPERATING A PLANT FOR THE SYNTHESIS OF METHANOL | THYSSENKRUPP IND SOLUTIONS AG |
EP3686189 | PRODUCTION METHOD FOR 5-HYDROXY-1H-IMIDAZOLE-4-CARBOXAMIDE路3/4HYDRATE | FUJIFILM CORP |
EP3686206 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | CYNORA GMBH |
EP3686208 | INTERMEDIATES FOR PREPARING HALICHONDRIN COMPOUNDS AND PREPARATION METHOD THEREFOR | BEIJING TIENYI LUFU PHARMATECH CO LTD |
EP3686251 | RADIATION CURABLE INKJET INKS FOR INTERIOR DECORATION | AGFA NV |
EP3687979 | RESORCINOL DERIVATIVES FOR THEIR COSMETIC USE | OREAL |
EP3687984 | PROCESS FOR PREPARING MIXTURES OF EPOXIDIZED FATTY ACID ESTERS | PROVIRON HOLDING N V |
EP3687996 | SALTS OF PYRROLOTRIAZINE DERIVATIVES USEFUL AS TAM INHIBITORS | INCYTE CORP |
EP3688002 | SYNTHESIS OF CYCLIC ORGANIC COMPOUNDS AND METALLOCENES | UNIVATION TECH LLC |
EP3688052 | ACTIVATOR FOR ACCELERATED ADHESION DEVELOPMENT | SIKA TECH AG |
EP3689846 | POLYMERIZABLE MONOMER, POLYMER COMPOUND FOR CONDUCTIVE POLYMER, AND METHOD FOR PRODUCING THE POLYMER COMPOUND | SHINETSU CHEMICAL CO |
EP3689850 | ELECTROLYTES FOR ELECTROCHEMICAL GENERATOR | COMMISSARIAT ENERGIE ATOMIQUE |
EP3689856 | SYMMETRICAL IMINES AND A METHOD OF SYNTHESIZING SYMMETRICAL IMINES | WOJSKOWY INST TECHNIKI INZYNIERYJNEJ IM PROFESORA JOZEFA KOSACKIEGO |
EP3689867 | COMPOSITION, ORGANIC SEMICONDUCTOR LAYER AND ELECTRONIC DEVICE | NOVALED GMBH |
EP3689888 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD |
EP3691784 | PROCESS FOR THE TRANSITION METAL CATALYZED CYANATION OF ARYL/VINYL HALIDES | STUDIENGESELLSCHAFT KOHLE MBH |
EP3692031 | PESTICIDALLY ACTIVE PYRROLE DERIVATIVES | SYNGENTA PARTICIPATIONS AG |
EP3692126 | PRO-FRAGRANCES AND METHOD OF PREPARATION THEREOF | HENKEL AG & CO KGAA |
EP3692127 | PRO-FRAGRANCES AND METHOD OF PREPARATION THEREOF | HENKEL AG & CO KGAA |
EP3693355 | FLEXIBLE MANUFACTURE OF MTBE OR ETBE AND ISONONANOL | EVONIK OPERATIONS GMBH |
EP3693437 | COMPOUNDS AND ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH |
EP3694840 | PIPERAZINE DERIVATIVES AS MAGL INHIBITORS | HOFFMANN LA ROCHE |
EP3694868 | METHOD FOR PRODUCING AN ANTITUMORAL ARENAVIRUS AS WELL AS ARENAVIRUS MUTANTS | ABALOS THERAPEUTICS GMBH |
EP3696173 | METHOD FOR PRODUCING 2,5-BIS(AMINOMETHYL) TETRAHYDROFURAN | MITSUBISHI GAS CHEMICAL CO |
EP3696246 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | CYNORA GMBH |
EP3697749 | ETHERIFICATION PROCESS | BP PLC |
EP3697755 | NOVEL SYNTHESIS METHOD FOR THE PREPARATION OF DIBENZOATE COMPOUNDS, SUCH AS 4-[BENZOYL(METHYL)AMINO]PENTANE-2-YL DIBENZOATE | SABIC GLOBAL TECHNOLOGIES BV |
EP3697782 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH |
EP3697788 | BIS(PENTAHYDROXYHEXYL)AMINO SUBSTITUTED 2-{[(3-AMINO-PYRAZIN-2-YL)FORMAMIDO]METHYL}-1H-1,3-BENZODIAZOL-3-IUM DERIVATIVES AS ENAC INHIBITORS FOR TREATING RESPIRATORY DISEASES | ENTERPRISE THERAPEUTICS LTD |
EP3700884 | METHOD FOR PRODUCING ETHYLENEAMINES | BASF SE |
EP3700885 | SEPARATION OF N-METHYLETHYLENEDIAMINE FROM EDA-CONTAINING MIXTURES | BASF SE |
EP3700886 | METHOD FOR THE PRODUCTION OF ETHYLENEAMINES | BASF SE |
EP3700887 | IMPROVEMENTS IN OR RELATING TO ORGANIC MATERIAL | UNIV LIEGE |
EP3700888 | HIGH PRESSURE CARBAMATE CONDENSER | STAMICARBON |
EP3700893 | VECTOR CONTROL COMPOSITIONS, METHODS AND PRODUCTS UTILIZING SAME | SYNGENTA PARTICIPATIONS AG |
EP3700895 | POLYCYCLIC AMIDES AS MUSCARINIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | SUVEN LIFE SCIENCES LTD |
EP3700913 | PRODRUGS OF SUBSTITUTED TRIAZOLE DERIVATIVES AND USES THEREOF | BAYER AG |
EP3700922 | VESICLE INCORPORATING TRANSMEMBRANE PROTEIN | AQUAPORIN AS |
EP3700925 | NOVEL T-CELL RECEPTOR | UNIV COLLEGE CARDIFF CONSULTANTS LTD |
EP3704082 | MULTINUCLEAR COMPLEXES AND THEIR PREPARATION | UNIV FREE STATE |
EP3704085 | PROCESS OF MAKING ORGANIC COMPOUNDS | GIVAUDAN SA |
EP3704116 | PROCESS FOR THE SYNTHESIS OF 2-BENZHYDRYL-3 QUINUCLIDINONE | PROCOS SPA |
EP3704134 | ANTIMICROBIAL TETRAPEPTIDES | DSM IP ASSETS BV |
EP3704146 | TRIFAB-CONTORSBODY | HOFFMANN LA ROCHE |
EP3705483 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO LTD |
EP3707121 | UREA PRODUCTION PROCESS AND PLANT | STAMICARBON |
EP3707140 | PURINE BASED COMPOUNDS AS TOLL-LIKE RECEPTOR 9 ANTAGONIST | COUNCIL SCIENT IND RES |
EP3707141 | SUBSTITUTED 2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONES AND USE OF SAME | BAYER AG |
EP3707142 | PYRROLOPYRAZINE DERIVATIVES AS ALPHA V INTEGRIN INHIBITORS | BRISTOL MYERS SQUIBB CO |
EP3707229 | CYCLOHEXENE PROPANAL DERIVATIVES AS PERFUMING INGREDIENTS | FIRMENICH & CIE |
EP3708572 | SENSOR FOR DETECTING GAS ANALYTE | CARRIER CORP |
EP3709011 | SENSOR FOR DETECTING GAS ANALYTE | CARRIER CORP |
EP3710438 | TRIAZOLE N-LINKED CARBAMOYL CYCLOHEXYL ACIDS AS LPA ANTAGONISTS | BRISTOL MYERS SQUIBB CO |
EP3710469 | POLYPEPTIDES WITH IMPROVED ARABINOSE TRANSPORT SPECIFICITY | DSM IP ASSETS BV |
EP3710485 | ANTI-SEZ6 ANTIBODY DRUG CONJUGATES AND METHODS OF USE | ABBVIE STEMCENTRX LLC |
EP3712148 | CRYSTAL FORM OF URAT1 INHIBITOR, AND PREPARATION METHOD THEREFOR | MEDSHINE DISCOVERY INC |
EP3712152 | 4,5,6,7-TETRAHYDRO-1H-IMIDAZO[4,5-C]PYRIDINE AND 1,4,5,6,7,8-HEXAHYDROIMIDAZO[4,5-D]AZEPINE DERIVATIVES AS JANUS KINASE INHIBITORS | TOPIVERT PHARMA LTD |
EP3713418 | BENZOXABOROLE COMPOUNDS | BASF SE |
EP3713909 | METHOD FOR PRODUCING VINYL ACETATE | WACKER CHEMIE AG |
EP3713923 | 2-PHENYLPYRIMIDINE-4-CARBOXAMIDES AS AHR INHIBITORS | BAYER AG |
EP3713927 | PYRIDINONE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS | NOVARTIS AG |
EP3713936 | SUBSTITUTED TRIFLUOROMETHYLOXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE |
EP3713939 | IMPROVED PROCESS FOR THE SYNTHESIS OF LINKER-DRUG VC-SECO | BYONDIS BV |
EP3713946 | SULFONIUM SALTS OF DNTT AND RELATED COMPOUNDS AS SOLUBLE PHOTOCLEAVABLE PRECURSORS FOR ORGANIC SEMICONDUCTORS FOR USE IN ORGANIC FIELD-EFFECT TRANSISTORS | CLAP CO LTD |
EP3714060 | PROCESS FOR THE PURIFICATION OF A SIALIC ACID FROM A FERMENTATION BROTH | JENNEWEIN BIOTECHNOLOGIE GMBH |
EP3714070 | A NOVEL CIP2A VARIANT AND USES THEREOF | TURUN YLIOPISTO |
EP3715339 | PREPARATION METHOD OF BETA-HYDROXYCARBOXYLIC ACID ESTER | SHENYANG GOLD JYOUKI TECH CO LTD |
EP3715469 | LABELING METHOD FOR NUCLEIC ACID | KURUME RES PARK CO LTD |
EP3717025 | IMAGING AGENTS | UCB BIOPHARMA SRL |
EP3717448 | PROCESS FOR THE CONTINUOUS PREPARATION OF 1,2-PROPYLENE DIAMINE (1,2-PDA) AND DIMETHYLDIETHYLENE TRIAMINE (DMDETA) | BASF SE |
EP3717464 | NITRATION | ETH ZUERICH |
EP3717488 | SUBSTITUTED FURANOPYRIMIDINE COMPOUNDS AS PDE1 INHIBITORS | DART NEUROSCIENCE LLC |
EP3717495 | PHOSPHORESCENT PLATINUM (II) ANHC COMPLEXES | UNIV DRESDEN TECH |
EP3720854 | SOLID PHASE SYNTHESIS OF NIR FLUORESCENT PROBE | BRACCO IMAGING SPA |
EP3720861 | CHEMICAL PROCESS FOR THE SYNTHESIS OF HERBICIDAL PYRAZOLIDINEDIONE COMPOUNDS | SYNGENTA PARTICIPATIONS AG |
EP3720862 | SYNTHESIS OF NOROXYMORPHONE | SIEGFRIED AG |
EP3720863 | 2-(2'-DIARYLAMINOPHENYL)BORABENZENE DERIVATIVE AND ORGANIC ELECTRONIC DEVICE INCLUDING THE DERIVATIVE | LG CHEMICAL LTD |
EP3723858 | FIXAXFX BISPECIFIC ANTIBODY WITH COMMON LIGHT CHAIN | KYMAB LTD |
EP3724157 | METHOD FOR SIMULTANEOUSLY ELIMINATING ISOBUTANAL AND ACETONE FROM OLEFINIC FEEDSTOCKS BY ADSORPTION ON A ZEOLITE MATERIAL | IFP ENERGIES NOW |
EP3724199 | PROCESS FOR PREPARING SHAPED METAL-ORGANIC FRAMEWORK MATERIALS | MOF TECH LIMITED |
EP3724203 | PREPARATION OF METAL-PYRIDINE DERIVATIVE COMPLEXES FOR USE IN MEDICAL IMAGING | UNIV OF NORTHUMBRIA AT NEWCASTLE |
EP3724209 | ELASTOMERIC PEPTIDE | MILANO POLITECNICO |
EP3728167 | A PROCESS FOR THE PREPARATION OF CRISABOROLE | OLON SPA |
EP3728184 | METHOD FOR PRODUCING CARBODIIMIDES | LANXESS DEUTSCHLAND GMBH |
EP3728186 | PROCESS FOR THE PREPARATION OF METHYL MERCAPTAN | ARKEMA FRANCE |
EP3728213 | PROCESS TO CONTINUOUSLY PREPARE A CYCLIC CARBONATE | NEW GREEN WORLD B V |
EP3728215 | PREPARATION OF RACEMIC NICOTINE BY REACTION OF ETHYL NICOTINATE WITH N-VINYLPYRROLIDONE IN THE PRESENCE OF AN ALCOHOLATE BASE AND SUBSEQUENT PROCESS STEPS | SIEGFRIED AG |
EP3728218 | AMINO INDOLE COMPOUNDS USEFUL AS TLR INHIBITORS | SQUIBB BRISTOL MYERS CO |
EP3728261 | CO-CRYSTAL OF AN ORALLY AVAILABLE JANUS KINASE INHIBITOR | SANDOZ AG |
EP3728264 | DIAZAINDOLE COMPOUNDS | SQUIBB BRISTOL MYERS CO |
EP3728532 | ODOROUS ACETALS OF ETHYL VANILLIN AND ETHYL VANILLIN DERIVATIVES | S H KELKAR AND COMPANY LTD |
EP3730505 | A MOLECULAR MAGNETIC MATERIAL AND A METHOD FOR PREPARATION THEREOF | UNIV JAGIELLONSKI |
EP3730506 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP |
EP3731872 | PROCESS FOR PROVIDING PEGYLATED PROTEIN COMPOSITION | HOFFMANN LA ROCHE |
EP3732183 | METAL COMPLEX COMPRISING AMIDINE AND THIOPHENE FUSED CYCLOPENTADIENYL LIGANDS | ARLANXEO NETHERLANDS BV |
EP3735405 | METHOD FOR PRODUCING METHYLENE-DIPHENYLENE-DIISOCYANATES AND POLYMETHYLENE-POLYPHENYLENE-POLYISOCYANATES | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG |
EP3736267 | MODULATORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN AND METHODS OF USE | ABBVIE OVERSEAS SARL |
EP3736270 | MODULATORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN AND METHODS OF USE | ABBVIE OVERSEAS SARL |
EP3737671 | PROCESS FOR THE PREPARATION OF 4-(4-AMINOPHENYL)MORPHOLIN-3-ONE | RICHTER GEDEON NYRT |
EP3737756 | METHODS AND SYSTEMS FOR SUPERCOILING DNA | STICHTING VU |
EP3737765 | ENHANCED IMMUNE CELLS USING DUAL SHRNA AND COMPOSITION INCLUDING THE SAME | CUROCELL INC |
EP3740493 | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE | IDORSIA PHARMACEUTICALS LTD |
EP3741763 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD |
EP3744416 | METHOD AND SYSTEM FOR SYNTHESISING METHANOL | THYSSENKRUPP IND SOLUTIONS AG |
EP3746453 | PROCESS FOR THE CONVERSION OF A SOLID MATERIAL CONTAINING HEMICELLULOSE, CELLULOSE AND LIGNIN | AVANTIUM KNOWLEDGE CENTRE BV |
EP3749637 | DIFUNCTIONAL BIPHENYL COMPOUNDS, PREPARATION, AND USES | ARIANEGROUP SAS |
EP3749670 | 5-ALKYLTHIO-7-[(4-ARYLBENZYL)AMINO]-1(2)H-PYRAZOLO[4,3-D]PYRIMIDINES FOR TREATMENT OF LYMPHOMA | UNIV PALACKEHO |
EP3752484 | INDUSTRIAL PROCESS FOR CONTINUOUSLY SYNTHESIZING ALKANE-SULPHONIC ACID | ARKEMA FRANCE |
EP3752490 | HERBICIDAL 3-AZASPIRO[5.5]UNDECANE-8,10-DIONE COMPOUNDS | SYNGENTA PARTICIPATIONS AG |
EP3755445 | METHOD FOR SELECTIVELY SEPARATING IMPURITIES PRESENT IN A HYDRO-ALCOHOLIC CUT BY RECYCLING THROUGH A LIQUID-LIQUID EXTRACTION COLUMN | IFP ENERGIES NOW |
EP3755700 | CONDENSED BICYCLIC HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS | BAYER AG |
EP3757085 | PERFLUORINATED POLYOLS AND THEIR USE FOR THE ENANTIOMERIC SEPARATION OF CHIRAL ANIONS | CENTRE NAT RECH SCIENT |
EP3765475 | SUBSTITUTED PYRIDOPYRROLOPYRIMIDINE RIBONUCLEOSIDES FOR THERAPEUTIC USES | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I |
EP3766886 | COMPOUND, COLOR CONVERSION FILM COMPRISING SAME, BACK-LIGHT UNIT, AND DISPLAY DEVICE | LG CHEMICAL LTD |
EP3770166 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD |
EP3774726 | PROCESS FOR PRODUCING 4,4`-DICHLORODIPHENYL SULFOXIDE | BASF SE |
EP3774807 | PROCESS FOR PREPARING BICYCLIC GUANIDINES | WACKER CHEMIE AG |
EP3774823 | POLYMORPH OF SODIUM NERIDRONATE AND PREPARATION PROCESS THEREOF | ABIOGEN PHARMA SPA |
EP3775925 | METHOD | UNILEVER PLC |
EP3778546 | METHOD FOR PREPARING (METH)ACRYLIC ACID ESTER-BASED COMPOUND | LG CHEMICAL LTD |
EP3778595 | PANCREATITIS TREATMENT | CALCIMEDICA INC |
EP3778700 | FLUORINATED ETHER COMPOUND, FLUORINATED ETHER COMPOSITION, COATING LIQUID AND ARTICLE | AGC INC |
EP3781578 | METHOD FOR THE DEHYDROGENATION OF DICHLOROSILANE | WACKER CHEMIE AG |
EP3784652 | ENHANCED CONVERSION OF TAURINE TO ALKYL TAURATE AMIDE USING PHOSPHORIC ACID CATALYSTS | UNILEVER PLC |
EP3793971 | OPTIMIZATION OF 2-EH PRODUCT RECOVERY SYSTEM USING PROCESS INTENSIFICATION | SABIC GLOBAL TECHNOLOGIES BV |
EP3807258 | PHOTOCHROMIC ANNELATED NAPHTHOPYRANE SYSTEMS WITH SPECIAL SUBSTITUENTS, FOR ATTAINING RAPID LIGHTENING SPEEDS | RODENSTOCK GMBH |
EP3810579 | METHOD FOR PREPARATION OF N-CARBOXYANHYDRIDES | LONZA AG |
EP3816169 | METHOD FOR PRODUCING ACYL-GERMANIUM DERIVATIVES | EVONIK OPERATIONS GMBH |
EP3816171 | NOVEL PHOSPHACYCLIC PHOSPHITES | EVONIK OPERATIONS GMBH |
EP3816172 | PHOSPHACYCLIC PHOSPHITES FROM THE ENOL 1-HYDROXY-2-ACETONAPHTHONE | EVONIK OPERATIONS GMBH |
EP3816173 | PHOSPHACYCLIC PHOSPHITES FROM PYRIDOINE AND FUROIN | EVONIK OPERATIONS GMBH |
EP3826997 | PROCESS AND INTERMEDIATES FOR THE PREPARATION OF BILASTINE | FAES FARMA SA |
EP3847042 | AMINOSILYL-FUNCTIONALIZED CONJUGATED DIENES, THEIR PREPARATION AND THEIR USE IN THE PRODUCTION OF RUBBERS | SYNTHOS SA |
EP3856733 | METHOD FOR MANUFACTURING (2,2-DIMETHYL-1,3-DIOXOLAN-4-YL)METHANOL | DEASYL SA |
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-12-25 22:26
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社